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Brooke Elizabeth Swash – The unmet psychosocial needs of 
haematological cancer patients and their impact upon psychological 
wellbeing. 
Unmet psychosocial needs indicate a desire for additional support in cancer patients, 
having a direct clinical utility in directing the provision of supportive care.  There is 
evidence in wider cancer groups that unmet needs relate to psychological wellbeing but 
this relationship has yet to be fully explored and factors that may explain or moderate this 
relationship yet to be examined.  There has been little investigation of type or prevalence 
of unmet need in haematological cancer patients, however, haematological cancers are 
noteworthy for their high levels of associated distress.  Understanding causality of distress 
is key to the effective implementation of supportive care services. 
 
This thesis aimed to highlight the unmet needs most relevant to haematological cancer 
patients and to explore their impact upon psychological wellbeing.  This thesis comprises 
four interconnected research studies: a systematic review exploring existing knowledge of 
unmet needs; a qualitative exploration of patient experiences of unmet needs and their 
impact; a quantitative questionnaire study of unmet need and psychological wellbeing in 
newly diagnosed haematological cancer patients, placing a special emphasis on the 
difference between active treatment and watch and wait regimes; and, a second 
quantitative questionnaire study that explores unmet need, psychological wellbeing, and 
psychological flexibility as a potential moderator in their relationship in a sample of 
haematological cancer survivors. 
 
This thesis demonstrates a relationship between unmet need and psychological wellbeing 
in haematological cancer patients.  Fear of recurrence, concerns about loved ones, being 
able to do the things you used to, and a need for information were all found to be of 
relevance.  The qualitative study highlighted that patients feel that, as haematology 
patients, they are distinct from other cancer patients which impacts upon the perceived 
acceptability of support services and specific barriers to the accessing of support services 
are presented.  Significant correlations between unmet need and key psychological 
outcomes such as anxiety, depression and quality of life were observed in both quantitative 
studies.  In addition, the concept of psychological flexibility was found to moderate the 
relationship between unmet need and psychological wellbeing in haematological cancer 
survivors.   
 
This work has clear implications for both future research and clinical practice.  Unmet 
needs assessment has the potential to be used as a screening tool for overall psychological 
wellbeing, a way to stratify and understand the specific causes of distress and poor quality 
of life for this patient group.  In the UK, on-going support for cancer patients diminishes at 
the end of treatment, these findings suggest that further support is needed in order to 
meet the psychological needs of cancer survivors.  Further research is needed to further 
explore the role of psychological flexibility in cancer-related distress: interventions that 
target psychological flexibility have the potential to improve both unmet need and distress.   
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Introduction to the thesis 
This PhD thesis examines the unmet psychosocial needs of haematological cancer patients, 
and the psychological impact of living with such a disease. It comprises a series of research 
studies undertaken in the pursuit of answering this overarching research question: what 
are the unmet psychosocial needs of haematological cancer patients and how does unmet 
need relate to psychological wellbeing? 
The thesis is presented in such a way as to not only describe the research, but to explain 
the research process undertaken.  As such, the chapters are laid out chronologically in the 
order the studies were undertaken.  Each chapter builds on the last in terms of knowledge 
gleaned and each informs the development of later studies described in this thesis. Each 
new study is funnelled down from the last, building and deepening knowledge of unmet 
psychosocial need as the PhD progresses.   
The first phase of this PhD is a systematic review of existing literature examining the unmet 
psychosocial needs of haematological cancer patients.  This review had a dual purpose.  It 
served both as a research study in its own right, collating and evaluating all the existing 
research relating to unmet need in this patient group and it served the wider purpose of 
providing the researcher with a thorough appreciation of the strengths and weaknesses of 
existing research, enabling the researcher to make informed research decisions that were 
grounded in previous studies. 
The major finding of the systematic review was that there was very little published 
knowledge already in existence. From this baseline, the next stage of this PhD was to 
undertake a qualitative research study that sought to understand unmet need from the 
patient perspective.  This study aimed to understand the impact and relevance of unmet 
needs from the lived experiences of patients.  In the light of a surprising paucity of existing 
research, it was felt that an exploration of both type and importance of need was required, 
along with a deepening of understanding relating to the impact of unmet need on the 
patient.  It was at this point that an exploration of potential differences between 
haematological and solid tumour patients began to emerge. 
Once the qualitative research had established an understanding of importance and 
relevance of unmet need, the next step was to begin to quantify presence of unmet need 
and the relationship with psychological wellbeing.  This took the form of a questionnaire 
xiv 
 
study that assessed both unmet need and psychological wellbeing in newly diagnosed 
haematological cancer patients.  A special focus was placed on the differences between 
patients who were actively treated and those who were monitored via ‘watch and wait’ 
post-diagnosis.  This tied into the researcher’s personal research interests; how do people 
adjust and cope when diagnosed with a terminal or incurable disease. 
At the beginning of the PhD process, it was anticipated that the PhD would consist of just 
three studies: a systematic review; qualitative exploration of unmet need; and a 
quantitative assessment of unmet need and wellbeing in newly diagnosed haematological 
cancer patients.  As research progressed, it became apparent that there was another level 
to which the examination of the relationship between unmet need and psychological 
wellbeing could be taken and the fourth study presented in this thesis (Chapter 5) was 
conceived. This fourth study sought to both extend understanding of unmet need in 
haematological cancer patients by assessing this concept in a survivor cohort and to try and 
understand the active mechanisms that function within the relationship between unmet 
need and wellbeing.  By adding this study it was possible to expand knowledge beyond 
what had already been gained through the study of wider cancer groups. It also had the 
potential to make a novel contribution to how we understand the presence of distress in 
cancer patients and therefore how we seek to combat distress in this patient group.   
The development of this thesis was a journey for a researcher, not just in the deepening 
understanding of unmet need and how we understand and conceptualise distress in cancer 
patients, but also in the development of the self as a researcher.  At the start of this PhD 
journey, the researcher was working as a clinician for the NHS, with comparatively little 
research experience.   
The process of undertaking this PhD has: 
 Acted as an apprenticeship in applied health research, providing insights into the 
research process and how it informs clinical practice. 
 Shown how research can help clinicians focus time and resources in the right 
direction. 
 Enabled a deeper understanding of the facts and what they mean for patients and 
for future practice. 
 Provided collaborative networks with wider organisations, with the potential in 
future of making a difference to patients 
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 Hasn’t answered all of the questions asked, but has highlighted areas of future 
research need. 
The chronological structure of this thesis also demonstrates the progression of knowledge 
and skill development over the three years, detailing the journey of the academic 
apprenticeship.  There is a strong clinical perspective to this thesis, stemming both from 
the researcher’s background which created a desire to improve understanding of clinical 
need from a practical perspective and a desire for research to have tangible outcomes for 
patients, but also from the organic way in which the project was conceived.  The input of 
both the nurses and consultants who supported this research must also be acknowledged, 
as it was their desire to understand that helped to initiate the project and to develop an 
idea into a project with tangible applications for patient care. 
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Chapter 1 - An Introduction to 
Haematological Cancers and the 
Psychological Wellbeing of Cancer 
Patients. 
Overview 
Being diagnosed with a life threatening illness such as cancer can induce significant levels 
of emotional and psychological distress for both patients and their loved ones (Holland & 
Alici, 2010; Pitceathly & Maguire, 2003; Carlson et al., 2004).  Haematological cancers are a 
unique and highly diverse groups of diseases that are known to impact upon a person’s 
wellbeing (Molassiotis et al., 2011; Manitta et al., 2011) with key differences between 
these diseases and solid cancerous tumours, yet there is a lack of published research 
relating to the specific unmet supportive care needs that are most pertinent to this patient 
group.  Clinical distress is known to be high in haematological cancer patients, at up to 48% 
(Carlson et al., 2004), a figure that anecdotally is seen as a low estimate.  The often 
intensive nature of treatment for haematological malignancies creates a burden of 
treatment that can be substantial, impacting upon patients’ functional, vocational and 
social roles (Sherman et al., 2005); and affecting functionality, fertility, sexuality and 
emotional wellbeing (Paul, 2011).  Despite this, psychosocial research into haematological 
cancers is sparse when compared to that conducted in more common cancer diagnoses.  
Unmet psychosocial needs, otherwise known as unmet supportive care needs or simply 
unmet needs, refer to the presence of a desire for help or support in an area that relates to 
a person’s emotional or psychological wellbeing (Boyes et al., 2009; Watson et al., 2012).  A 
poor understanding of the psychosocial issues that are important to a patient group make 
it difficult to design and implement supportive care interventions that are efficient and 
effective for patients while also making the best use of limited healthcare resources. 
This PhD thesis will identify the unmet psychosocial needs of patients with a diagnosis of 
haematological cancer.  Unmet psychosocial needs are a vital area of research within the 
field of psycho-oncology as they are able to highlight areas of supportive care that could aid 
patient coping and reduce distress.  Understanding where unmet needs lie can influence 
both the immediate support given to that patient but also, cumulatively, by observing 
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trends and population patterns, can influence overall provision of support services within 
the clinical setting.  This thesis will go on to explore the relationship between level of 
unmet need and overall psychological morbidity in haematological cancer patients, and will 
attempt to identify any specific factors that may influence the relationship between unmet 
need and distress.   The identification of potential moderators of distress is important when 
considering the potential implications for both how needs assessment is used within the 
clinical setting and how interventions that target distress are developed.   Understanding 
mental processes of change enables the promotion of efficient, effective interventions that 
specifically target the active component for change.  In turn this enables interventions to 
be honed and streamlined while maximising effect, crucial in the current climate of limited 
resources within healthcare services (Stanton, Leucken, MacKinnon & Thompson, 2012).   
This first thesis chapter provides an introduction to the haematological malignancies as a 
group of diseases and will provide the reader with a background knowledge of unmet need 
and distress within cancer patients from which subsequent chapters will build.  The aims of 
the thesis will be identified and the methodological approach to the work laid out.     
What are haematological cancers and how do they differ from 
solid tumours? 
Haematological cancers are cancers of the blood, bone marrow and lymphatic system 
(NICE, 2004).  There are three overarching diagnoses—leukaemia; lymphoma; and 
myeloma –within which lie a diverse group of diseases, each with their own specific 
challenges.  Historically, the haematological cancers have been grouped according to the 
organs that display the most involvement: leukaemias are cancers of the blood; lymphoma 
of the lymph nodes; and myeloma of the bones.  These classifications are still in use; 
however more modern classifications also make use of the cell populations from which the 
cancer originates: myeloid cell lines ultimately become cells of the blood system with 
lymphoid cells ending up as cells within the lymphatic system.  Some haematological 
cancers are extremely acute and require immediate, aggressive treatment while others are 
so slow growing that they are commonly detected only by chance.  Typical symptoms can 
vary from the lumps which are most typical of lymphoma, to the bone fractures and kidney 
problems that are characteristic of myeloma, and the fatigue and susceptibility to infection 
commonly observed in leukaemia.  Haematological malignancies are rare in children when 
compared to the prevalence in adults, although acute leukaemia is the diagnosis given to 
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one in three children with cancer (CRUK, 2013).  As an overall group of diseases, they 
become more common with increasing age, with people over the age of 65 being the most 
commonly diagnosed age group.  Diagnosis is also more common in males than females 
(HMRN, 2011).  While the haematological cancers may not be the most common cancers 
found in the UK, in total they are still expected to affect approximately 37 590 people per 
year (HMRN, 2011).    
Leukaemia 
Leukaemia is a cancer of the white blood cells that originates from dysfunction in the bone 
marrow.   There are four main types of leukaemia with differences between diagnoses 
relating to the type of white blood cell affected and whether the disease is chronic or acute 
in nature.  These include: acute lymphoblastic leukaemia (ALL); chronic lymphocytic 
leukaemia (CLL); acute myeloid leukaemia (AML); and chronic myeloid leukaemia (CML).  
Leukaemia as an umbrella term, including all sub-types, is the 12th most commonly 
diagnosed cancer in the UK (CRUK, 2014) and the 9th most common cancer in males.  
Overall, leukaemia accounts for 2.5% of cancer cases in the UK, yet makes up 2.9% of the 
total number of deaths by cancer.  Survival rates are poorer than for other haematological 
malignancies, with only 44.3% of patients surviving five or more years.    
ALL is a rare cancer, affecting only in the region of 400 people per year in the UK 
(Macmillan, 2011).  It is caused by an overproduction of immature lymphocytes, or blast 
cells.  The overproduction of lymphocytes means that the bone marrow becomes full of 
these immature cells and is then unable to make new blood cells properly.  The 
lymphocytes are immature and therefore do not fulfil their normal function (to fight 
infection) to full effect; and due to overcrowding, the bone marrow is unable to make 
healthy red blood cells and platelets.  There are two peaks in the most common age groups 
diagnosed with ALL; those that are aged 15-25 and those aged over 75.  The main 
treatment type is chemotherapy and approximately 40% of patients diagnosed will be alive 
at five years post-diagnosis (CRUK, 2014).   
AML is also a cancer that originates in the bone marrow, in this case blood cells are made 
at too high a rate and the immature cells do not develop into fully functioning cells.  Most 
often, too many immature white blood cells are produced which crowd the bone marrow 
and circulate throughout the body while not functioning as they should.  AML is most 
commonly diagnosed in people over the age of 65 and is usually treated via chemotherapy 
4 
 
although both radiotherapy and transplant may be considered.  Survival rates for AML are 
poor with only 12% surviving beyond five years (CRUK, 2014).   
CML is a form of chronic leukaemia that originates from the overproduction of 
granulocytes, a type of white blood cell, that do not fully mature.   Over time, the 
granulocytes collect in the spleen, causing enlargement, and the bone marrow preventing 
the production of healthy blood cells.  CML is most common in adults over the age of 50 
and has varied survival rates; if caught early and a bone marrow transplant is undertaken, 
survival may be 15 years or more.  If the patient is in the blast phase (the acute phase 
where blast cells make up more than 20% of the blood or bone marrow) at diagnosis, 
survival may be only months.  Imatinib is the most common treatment for CML although, 
dependent upon stage of disease, transplantation and chemotherapy may also be 
considered. 
Finally, CLL is a chronic form of leukaemia.  CLL develops slowly and, when also taking the 
incurable nature of the illness into account, many people do not receive immediate 
treatment for their CLL but rather may be monitored via ‘watch and wait’ for months or 
even years.  In CLL, the body makes too many lymphocytes that do not fully mature and 
build up over time in the lymphatic system.  This causes enlargement of the lymph nodes 
and also affects production of healthy blood cells as the bone marrow becomes 
overcrowded.  Once the patient becomes symptomatic and treatment is required, options 
include chemotherapy and stem cell transplantation.  CLL is predominantly a disease that 
affects older adults, being most common in people over the age of 65.   
Lymphoma 
Lymphoma is a cancer of the lymphatic system that can be broken down into two broad 
categories: Hodgkin lymphoma (HL) and Non-Hodgkin lymphoma (NHL).  NHL is the most 
commonly diagnosed haematological cancer and is the sixth most commonly diagnosed 
cancer in the UK (CRUK, 2013) and the 12th most common cause of death from cancer 
(CRUK, 2013).  Survival rates of NHL have improved, with 63.4% of patients surviving five or 
more years after diagnosis.  There are many subtypes of NHL; broadly grouped into B-Cell 
type or T-Cell type, dependent upon the type of cell in which the cancer originates; B-Cell 
lymphoma is far more common than T-Cell lymphoma.  As with haematological cancers 
more generally, NHL can either be highly aggressive or more indolent and slow growing in 
nature.  The type of cancer and how fast it is likely to grow influences treatment decisions, 
indolent NHL can be monitored via watch and wait until symptoms present but 
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symptomatic or aggressive NHL can be treated by chemotherapy, radiotherapy or biological 
agents.  NHL is more common in the over 50s age group (CRUK, 2013).  
HL is less common, accounting for 0.6% of cancer cases in the UK (CRUK, 2013) and 0.2% of 
cancer deaths.  The survival rates for HL are higher than NHL with 83.2% of patients 
surviving five or more years post diagnosis (CRUK, 2013).  HL accounts for around 20% of all 
lymphoma diagnoses (Macmillan, 2011).  HL can be differentiated from NHL as, when 
examined under the microscope, the Reed-Sternberg cell is present in the lymph nodes.  
The Reed-Sternberg cell is a type of white blood cell that has become cancerous, and 
prevents other white blood cells from fulfilling their normal role (i.e. to make antibodies to 
fight infection in the body).  HL has two diagnosis peaks: in young adults and the over 50s.  
Generally, treatment for HL is by chemotherapy and survival rates are good with over 80% 
living for over five years post-diagnosis. 
Myeloma 
Myeloma is the least common type of haematological malignancy, accounting for 1.4% of 
cancer cases in the UK (CRUK, 2013).   It is an incurable diagnosis and accounts for 1.7% of 
cancer deaths with only 37% of patients surviving beyond five years after diagnosis.     In 
myeloma, large numbers of abnormal plasma cells are produced.  These myeloma cells 
produce large amounts of an abnormal antibody (paraprotein) which cannot effectively 
fight infection and interferes with normal antibody production.  The myeloma cells can also 
spread throughout the bone marrow and can affect healthy bones causing bone-thinning 
and associated pain and fractures.   As with CLL and certain types of NHL, myeloma can be 
monitored via watch and wait rather than requiring immediate treatment if the patient is 
asymptomatic.  Where active treatment is required, chemotherapy is most commonly 
used.  Myeloma incidence increases with age and less than 30% of patients will survive 
longer than five years.   
Key differences in comparison with other cancer groups 
Haematological cancers display several key differences to solid tumours such as breast, 
lung or colorectal cancer.   There are pathological differences (Lakhani et al., 2004) that can 
affect treatment type, but, perhaps more importantly for patients, these differences 
translate into differences in the organisation of services and there is a clear degree of 
separation from those services aimed at solid tumours (NICE, 2003).   
Patients diagnosed with a haematological malignancy are more likely to be cared for by a 
smaller team of healthcare professionals (HCPs).  For some, diagnosis and subsequent 
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treatment decisions are made by a single clinician rather than the multidisciplinary decision 
making seen elsewhere: whether or not this is a negative aspect of haematology treatment 
is not clear, but it does allow for continuity for the patient and for an on-going relationship 
to be forged with their Consultant.  Patients with a haematological cancer have also been 
identified as being less likely to access palliative care services than patients with a solid 
tumour (Howell et al., 2010).  This may well relate to the fact that haematology patients are 
cared for by a smaller, more consistent team of HCPs who may feel that they then know 
the patient and their needs and are best placed to continue care at end of life.  
Alternatively, it is possible that this is an access issue due to the small numbers of 
individuals affected.  Whether or not this results in any differences in the support services 
available to haematology patients, in terms of resulting referrals, is not clear.    
The number of haematology referrals into a clinic is typically low when compared to the 
numbers seen within oncology clinics, perhaps a factor in the tendency to have consistent 
relationships between patient and clinician.  While this may enable a more supportive 
environment for a patient, dependent upon the patient-HCP relationship, the lack of 
external input into patient care may result in a reduced number of services becoming 
available to haematology patients.  The comparatively low number of palliative care 
referrals has been highlighted, but national statistics regarding the number of haematology 
patients who access psychological support services, occupational therapy services or make 
use of charity-led support programmes has not been forthcoming.    
Cumulatively, the differences between haematological malignancies and the solid tumours 
in which the majority of psychosocial oncology research is conducted makes it difficult to 
predict the extent to which parallels can be drawn between the two groups.  It is logical 
that where considerable differences exist between two patient groups, that there will also 
be differences in the type and prevalence of unmet need and in their psychological 
wellbeing.  A key aim of this thesis is to explore the unmet needs of haematological cancer 
patients and to expand the currently limited evidence base related to the psychological 
wellbeing of this group. 
Distress and cancer 
That distress is common in those with a diagnosis of cancer is a phenomenon that has been 
relatively well explored and is certainly not a new concept within the cancer literature.  
Previous research indicates that the overall prevalence rate for distress in cancer patients is 
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between 35.1% (Zabora et al., 2001) and figures as high as 75% (Jacobsen et al., 2007), a 
significant proportion of patients.  Distress in this context generally relates to the presence 
of psychological morbidity as measured by an assessment tool.  Anxiety and depression are 
commonly highlighted within the psycho-oncology literature (Ibbotson et al., 1994; Carroll 
et al., 1993) but post-traumatic stress disorder, adjustment disorders and changes to a 
person’s personality and their perceptions of their world can also be affected (Smith et al., 
1999; Mitchell et al., 2011).    Each disorder has its own specific challenges for patients but 
all ultimately impact upon a person’s experiences and their overall wellbeing.  
Understanding distress in all forms in people with cancer would facilitate better care for 
patients and would allow for the relationship between distress and both the precipitating 
and resulting factors to be better examined.   A brief overview of some of the most 
common forms of distress in cancer is presented below. 
Anxiety 
Anxiety in and of itself is not unusual and will affect most people to some degree at some 
point in their lives.  Upon being diagnosed with cancer, however, the normal presence of 
anxiety in reaction to a threatening situation can become prolonged, thereby negatively 
impacting upon quality of life (Brown et al., 2010).  Research has indicated that 13% of 
patients will experience clinically significant levels of anxiety (Aass et al., 1997) as assessed 
by the Hospital Anxiety and Depression Scale (Zigmond & Snaith, 1983).  Anxiety was more 
prevalent in hospitalised patients and in women when compared to men within this study.  
In women with breast cancer, the prevalence of anxiety has been found to be slightly 
higher at 16% (Luboonthavatchai, 2007).  One study that included lymphoma patients 
found that 48% of patients reported sufficient levels of anxiety for an anxiety disorder to be 
considered and a diagnostic clinical interview to be carried out (Stark et al., 2002). 
The presence of anxiety in cancer patients can create distinct challenges for the medical 
professionals involved in caring for patients and who are: (a) not trained in managing 
mental health; and, (b) not confident in their ability to distinguish between normal levels of 
anxiety that may come with being diagnosed and treated for cancer and clinically 
significant anxiety (Stark & House, 2000).  There is also the innate difficulty in deciding 
what clinically significant anxiety actually is given that the diagnosis relies on the presence 
of the anxiety of being disproportionate to the level of threat.  As cancer represents the 
ultimate threat to many people, the potential threat to life, what qualifies as 
disproportionate is not necessarily clear.   
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Depression 
Along with anxiety, depression is one of the more commonly cited psychological disorders 
seen in people living with cancer.  Depression is a mental disorder that impacts upon a 
person’s mood and can affect the ability to gain pleasure from usual activities, sleep, 
appetite and cognitive abilities (American Psychiatric Association, 2013).  As with anxiety, 
some impact on mood can be expected when receiving a life threatening diagnosis, 
however, it is essential that patients and healthcare professionals are able to recognise 
what is normal and when extra support to help manage low mood is required. 
Depression has received attention as a potential predictor of cancer incidence (Spiegel et 
al., 2003) yet findings have been inconclusive.  More established is the relationship 
between depression, and also anxiety, in predicting disease progression and mortality.  
Meta-analysis has indicated that there are reasonable grounds to believe that the presence 
of depression directly influences mortality, but studies of this type are unable to make a 
statistical association with disease progression (Satin et al., 2009).  Depression has also 
been linked to pain levels and quality of life in cancer patients (Spiegel et al., 2006; Hulbert-
Williams et al., 2012).  Those with high pain levels were found to be more likely to also 
have depression.  Whether the increased level of pain is instrumental in the development 
of depression or whether those with depression are more likely to report pain is unclear.   
In addition, associations have been made between depression and quality of life in cancer 
patients (Hulbert-Williams et al., 2012) with levels of depression being significantly 
associated with later levels of quality of life. 
PTSD 
Post-traumatic stress disorder (PTSD) is a psychiatric illness that is associated with a change 
in psychological wellbeing after a traumatic event (APA, 2013).  Precipitating traumatic 
events can include life-threatening illness, such as cancer, and results in a range of 
symptoms that include changes in mood, a heightened state of arousal, intrusive thoughts 
relating to the traumatic event and changes in behaviour (APA, 2013).  PTSD is less 
common in cancer patients than anxiety or depression with estimates of prevalence at 3-
4% in early stage patients and up to 35% in patients who were assessed post-treatment 
(Gurevich et al., 2002).  These statistics relate to a clinical diagnosis of PTSD as required by 
the DSM-IV-TR, however, incidence of relevant symptoms that do not meet the full 
diagnostic criteria are much higher, at up to 80% in patients post-treatment (Gurevich et 
al., 2002).   
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Research on PTSD in cancer has been conducted across a variety of cancer diagnoses, but 
there has been a specific focus on the haematological cancer, notably in the case of 
patients who require bone-marrow transplantation.   Studies of PTSD in patients with 
haematological malignancies have estimated prevalence to be from 8% in NHL to 17% in 
post bone marrow transplantation patients (Smith et al., 2008; Black et al., 2005).  A 
potential correlation between physical functioning and PTSD symptomology has been 
found in this group (DuHamel et al., 2001).  In patients with poorer levels of physical 
functioning, any type of change was associated with greater incidence of PTSD 
symptomology.   
The Everyday Impact of Cancer 
While anxiety, depression and PTSD are commonly cited in the psycho-oncology literature 
and have formed the basis of psychological intervention (Sheard & Maguire, 1999; 
Jacobsen et al., 2008), the absence of clinically significant levels of distress does not 
necessarily mean that the person does not need support to help them come to terms with 
their diagnosis and subsequent life changes.  Being diagnosed with cancer affects multiple 
aspects of a person’s life and their sense of self, all of which have the potential to impact 
upon a person’s psychological wellbeing.  Appearance can often be affected as a result of 
the intensive treatment required to manage cancer, leading to body image concerns 
(Hopwood, 2003).  While there are ways of assessing the impact cancer has on body image 
(Hopwood, 2003), this is not something that is typically explored with patients in the clinic 
setting.  Higher levels of body image concerns have been associated with: treatment type; 
weight change; pain; fatigue; and anxiety (Rosenberg et al., 2013).  Change in body image is 
important as it has been found to correlate with overall quality of life.  In men diagnosed 
with prostate cancer (Taylor-Ford et al., 2013) and in women with breast cancer there is a 
link to overall psychological distress (Helms et al., 2008).  In patients diagnosed with 
haematological cancer, research has implied that patient’s body image and the way in 
which they perceive their body becomes altered (Weber et al., 2001).  Perceptions of 
control related to their bodies were also decreased yet emotional constructs were 
comparatively high indicating that a diagnosis of haematological cancer results in feelings 
of loss of control of one’s own body and has a high emotional impact.   Changes to the body 
as a result of treatment are likely to be seen as outside of the patient’s own locus of control 
and may exacerbate any feelings of loss of control which may further impact upon the 
perceptions that a person has of themselves and can ultimately feed back into the overall 
presence of distress.   
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Cancer can not only affect the relationship that a person has with themselves, but also how 
they relate to those close to them.  A diagnosis of cancer is not only potentially distressing 
for the person diagnosed, but their family and friends also have to confront the possibility 
of losing a loved one.  Clinically significant distress is not only more prevalent in those 
diagnosed with cancer, but increased levels of anxiety and depression have also been 
highlighted in partners (e.g. Grov et al., 2005).  In addition, the very fabric of relationships 
and how a couple relates to each other can be altered.  Changes in body image, along with 
the potential for pain and discomfort as a result of the diagnosis, can impact upon sexual 
relationships (e.g. Takahashi et al., 2008; Badr et al., 2009).   The notably intensive nature 
of the treatments often required by patients with haematological cancer can also bring 
with it specific challenges for family and friends; with many taking on caregiver roles 
(Beattie & Lebel, 2011), bringing an entirely new dynamic to a relationship. Interestingly, in 
the caregivers of patients due to undergo stem cell transplantation, caregiver distress was 
found to be at its highest pre-transplant (Beattie & Lebel, 2011) which may be indicative of 
concerns about the impact of the treatment on their loved one and how their relationship 
may change as a result, however, the reality is easier to manage.   Carer wellbeing can be 
important within the context of the wellbeing of the patient as it has been shown that 
interpersonal relationships can impact upon how well a person copes with significant life 
events, serious illness included (Bloom et al., 2001: Holland & Hollahan, 2003).   
Ultimately, being diagnosed with cancer and the changes that such a diagnosis can bring, 
can impact on a person’s perception of who they are, their identity.  Living through cancer 
may force a person to create a new sense of self which can impact upon their overall 
wellbeing and the way in which they relate to the world.  Little is known about how 
patients ultimately end up viewing themselves (Park et al., 2009) but words such as 
‘survivor’, ‘patient’ and ‘victim’ were all endorsed in the paper by Park.  Each would bring 
with it a different view of the world and associated feelings about their experiences.  
Throughout the experience of being diagnosed and treated, it may be that identity is a 
constantly evolving concept, and it is also possible that those who are more adaptable may 
be better suited to incorporate these changes into their perceptions and expectations.   A 
degree of caution must be taken however, when attaching fighting language to cancer 
patients.  There is an emerging literature that suggesting that the military metaphors so 
often used in connection with cancer (fighting, battling, war) are not well received by 
patients.  The British Medical Journal (BMJ) has now published two papers (Wiggins, 2012; 
Berger, 2014) exploring the use of such terminology in connection to cancer.  While the 
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goal of such language is to motivate, to unite both patient and clinician against a common 
enemy, there is a danger that creating the illusion of a battle being fought places the locus 
of control solely with the patient.  ‘Thinking positively’, does have associated benefits in 
terms of increased motivation and adherence, yet cannot fundamentally cure the patient 
from cancer.  If a patient does not achieve remission or experiences a relapse, then it is not 
because they have lost some psychological test of will against the cancer (Coyne et al., 
2007) yet there is a danger that creating this perception will result in patients feeling like 
they could have tried harder somehow.   
Screening for distress in cancer  
In 2009, the International Psycho-Oncology Society (IPOS) unanimously endorsed the 
concept of distress as a sixth vital sign in cancer settings and subsequently proposed 
screening for distress to be a recognised IPOS strategy in 2010 (Watson & Bultz, 2010), 
publishing their Standard of Quality Cancer Care (Holland, Watson & Dunn, 2011).  In 
essence, this proposes that distress should be considered alongside temperature, 
respiration, heart rate, blood pressure and pain to be a fundamental aspect of patient 
wellbeing and should be assessed as such (Bultz & Carlson, 2005).  Since this time, distress 
as the sixth vital sign has been endorsed by several UK based charities such as Breast 
Cancer Care, the British Psychosocial Oncology Society and Macmillan Cancer Support.  
Recognising that the presence of distress can be as important to patients as aspects of their 
physical wellbeing is crucial and the endorsement by both national and international 
organisations promotes awareness within the medical setting and provides an indication of 
the perceived importance of distress.   
Given the proven presence of distress in a subset of those living with a diagnosis of cancer, 
it is important to have a method of accurately detecting distress in its various forms.   
Generally speaking, there are assessment tools to measure levels of clinically significant 
distress for each different disorder.  Commonly used examples are the Hospital Anxiety and 
Depression Scale (HADS) for anxiety and depression (Zigmond & Snaith, 1983); the Mental 
Adjustment to Cancer (MAC) scale (Watson et al., 1988), for adjustment in people with 
cancer; and the EORTC QLQ C30 (Aaronson et al., 1993) to assess quality of life in people 
with cancer.  While by no means exhaustive, this list represents some of the most 
commonly used tools within both research and clinical settings.   
Despite the growing recognition within the research literature that distress can significantly 
impact upon a patient’s wellbeing and their recovery, screening for the presence of distress 
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within the clinical setting has witnessed slower uptake.   The debate around whether or not 
to routinely screen patients has been one that has been fiercely contested by those 
working within the field of psycho-oncology (Coyne, 2013).   Those who advocate the use of 
screening maintain that screening improves patient-professional communication and 
increases the likelihood of a referral to psychosocial support services being made (Mitchell, 
2013) while its opponents emphasise the lack of a conclusive link between screening and 
patient benefit and the potential for services to become ‘rationed’ (Coyne, 2013).  
Regardless of the differences in opinion regarding screening, for maximised effectiveness, 
screening must be delivered by those adequately trained to do so, be conducted in a 
manner that is acceptable to patients and there must be adequate resources available to 
support those shown to be in need (Mitchell, 2013).   If a healthcare professional is going to 
screen for the presence of distress in patients with cancer, then they must also have the 
ability to make appropriate referrals to resources already in place to support that patient.   
This will only be successful if the hospital or clinic has someone in post who is able to 
undertake a full assessment if the need arises, usually a mental health professional, and 
have access to further support services.  Without this system in place, screening may serve 
to aid communication between patient and professional but would not fulfil its purpose of 
improving access to psychological support thus potentially leaving a patient dissatisfied.   
If the very purpose of assessing for the presence of distress is to then be able to refer 
patients on to support services, the question of acceptability must be raised.  Even where 
the presence of distress is indicated by an assessment tool, the support being proposed 
must be both wanted by and acceptable to the patient.  Previous research has suggested 
that only 36% of distressed cancer patients express a desire for help with their distress 
(Baker-Glenn et al., 2011).  This highlights the need to understand exactly where patient’s 
support needs lie in order to be better able to target acceptable support services to those 
most in need.   
Human Need 
The concept of need is well established within the field of psychology and the wider health-
related literature.  In 1943, Abraham Maslow set out his now famous Hierarchy of Need 
which theorised that people are motivated by need, ranging from basic needs such as 
physiological need, the need for safety and the need to be loved, moving on to needs that 
are required for growth, or as Maslow defined it, self-actualisation.  A deficiency in need 
was thought to provide people with the motivation to act, for example, if hungry, to go and 
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find food.  In order for higher needs to be met, the lower, basic needs must be met first.  
Doyal and Gough proposed the Theory of Human Need (1991), stating, like Maslow, that 
basic health needs are of prime importance and that, when these health needs are 
threatened, they must take precedence over what were termed autonomous needs (Doyal 
& Gough, 1991).  At their core, health needs are centred around avoiding harm to our 
person and therefore as humans, we behave accordingly.   
Both theories place need as a deviation from a desired state of being and a person’s actual 
state of being.  They place human need as highly individual, with the ultimate aim to be 
able to become a fully-functioning and contributing member of society, providing a sense 
of belonging.  The presence of need is indicative of potential harm and therefore people 
strive to ensure that needs are met, and goals can therefore be achieved. 
The diagnosis of a major illness such as cancer poses the ultimate threat to the most basic 
health needs, life versus death.  While people have ongoing unmet needs relating to their 
illness, these theories postulate that patients will be unable to fully achieve psychological 
wellbeing.  This approach is limited in that there is no clear standard of health desired by 
all.  Need and desires are ultimately subjective, therefore, it is difficult to apply any 
constants or standards to need theory that would allow for a universal understanding of 
what a basic level of need is. 
Psychosocial needs within cancer 
People diagnosed with cancer, including those with a haematological cancer, can have a 
range of unmet needs.  Unmet psychosocial needs refer to the presence of a desire for help 
or support that relates to a person’s emotional or psychological wellbeing (Boyes et al., 
2009; Watson et al., 2012).  It is this desire for support that differentiates an unmet need 
from the presence of distress or patient concern where there may be no wish for external 
assistance to combat the issue in question.  Unmet needs can relate to psychological 
concerns such as the presence of anxiety or depression, or the wish to see a healthcare 
professional as a result of these concerns.  They can also relate to the social aspects of 
illness such as the impact upon relationships, or the practical for example the impact that 
cancer has on a person’s employment.  Unmet needs assessment directly measures the 
patient’s own desire for help with psychosocial concerns rather than assessing for the 
presence of distress or other issues without determining whether the patient wishes for 
the concern to be addressed.  This is an important distinction when considering the distinct 
concepts of need and unmet need.  Need alone does not imply a desire for help.  Accurate 
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and routine assessment of unmet patient needs is central to ensuring that appropriate 
supportive care is provided (Zucca er al., 2014) and in order to identify deficits in current 
care provision.   In a healthcare system with limited resources this enables the provision of 
supportive care services to be tailored towards those who have identified themselves as 
needing help. 
Assessment of patient need and assessment of patient distress are often similar in format 
and in how they are carried out within the clinical setting.  Indeed, the Holistic Needs 
Assessment (NCSI, 2013) is an increasingly common way of assessing overall patient 
wellbeing within the clinic setting in UK hospitals.   The two concepts are likely to be 
connected in more ways than simply similar methods of detection; the presence of high 
levels of unmet psychosocial need is indicative of patient need for support in areas of their 
life relating to the psychological and emotional wellbeing and is, therefore, likely to have a 
direct link to the presence of distress (Armes et al., 2009; Morrison et al., 2012).  Indeed, 
previous research has indicated that anxiety is more common in those with higher levels of 
unmet need (Cull et al., 1995).  Conversely, it may be that the presence of distress is the 
underlying cause of the presence of need, and that those who are more significantly 
affected by their diagnosis are more likely to seek support.   While the precise relationship 
is not currently understood within the relevant literature, it seems likely that one does exist 
and that assessing patient wellbeing in this way may be more acceptable in format for 
patients.  As such, researching unmet needs within patients groups has the potential to 
impact upon patient wellbeing in three distinct ways.  Firstly, an unmet needs assessment 
provides immediate information to the care team with regards to where a patient feels 
that they would benefit from the provision of extra support.  Secondly, the relationship 
between unmet need and psychological outcomes, if proven, means that unmet needs 
assessment has the potential to act as a screening measure for overall wellbeing and 
distress.  Finally, if we are able to identify that there is a predictive relationship between 
unmet needs and psychological wellbeing, then there is the potential to develop 
preventative interventions that will meet patient need and reduce the subsequent negative 
impact on wellbeing.  In addition, this type of assessment may be more acceptable to both 
patients and their clinicians who can feel a lack of confidence in addressing formal 
psychological concerns in their patients (Moorey, 2013).  The research presented in this 
thesis is linked to implementation and clinical relevance, as opposed to being removed 
from the practicalities of providing supportive care for cancer patients.   
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Previous research into unmet need in general cancer groups has categorised type of need 
into overarching subgroups of need, for example: psychologic; health system and 
information; physical and daily living; patient care and support; and sexuality (Sanson-
Fisher et al., 2000).  Further exploration of unmet need within cancer is undertaken in 
Chapter Two.   
Specific needs of different patient groups 
As a group of cancers, haematological malignancies have received comparatively little 
empirical attention within the literature when compared with more common diagnoses 
(Paul et al., 2011).  Within psycho-oncology research, there has been a tendency for the 
majority of the literature to be conducted with patients diagnosed with breast cancer and, 
therefore, women.  The existing research relating to unmet psychosocial needs has often 
been conducted on either mixed diagnostic samples or samples of breast, lung or prostate 
cancer patients (Harrison et al., 2009).  Research relating to rarer patient groups is needed 
as these patients are typically less well recognised by charities and, therefore, available 
research funding is often smaller in scale (National Cancer Institute, 2014).  In addition, the 
psychological wellbeing of men living with cancer is also less well understood at present 
and warrants further exploration.    
Instinctively, it would seem probable that differences in the unmet needs of men and 
women exist yet this is still to be fully explored within the literature.  Previous research 
relating to women with a diagnosis of breast cancer found that level of unmet needs 
remained relatively stable over time and that the most commonly identified unmet needs 
were patient education, counselling and alternative treatment options (Von Heyman-Horan 
et al., 2013).  Education, the lack of a partner, and the presence of anxiety all contributed 
to the presence of unmet needs within this sample.   Other research carried out with this 
patient group indicated that while the presence of needs remains over time, the nature of 
the needs identified changes (Park & Hwang, 2012).  Initially, needs in all domains (with the 
exception of sexuality) were noted but as patients moved into the first three years of 
survival, needs relating to psychological and information came to the fore.  Again, the 
presence of needs was related to psychological wellbeing with unmet needs being 
significantly associated with depression and quality of life.  Similar research on men with 
prostate cancer has found that needs relating to care were deemed most important and 
that support needs, while rated as being most unmet, were deemed less important (Boberg 
et al., 2003).  This indicates a potential contrast with the unmet needs identified by female 
16 
 
samples who identified counselling and psychological needs as relevant.   In cancer carers, 
women report higher levels of distress than their male counterparts, possibly due to an 
increased perceived burden of care (Perz et al., 2011), again suggesting that women are 
more likely to report psychological distress relating to a cancer diagnosis.   There are also 
recognised age related differences in the level of distress associated with a diagnosis of 
cancer with those who are younger at the time of diagnosis typically displaying higher 
levels of anxiety and depression (Linden et al., 2012).  This large scale study fed into the 
already developing understanding that younger patients and women are both at higher risk 
of psychological distress as a result of cancer.   
In addition to variations in unmet needs according to age and gender, there are differences 
in the reported unmet needs of different ethnic groups.  In a US based study, women of 
Latina origin reported higher levels of unmet information and care needs than women of 
other ethnic groups (Janz et al., 2008).  Research comparing the unmet needs of female 
German and Chinese cancer patients found that Chinese women were more likely to report 
the presence of unmet need than German women (Lam et al., 2011), yet more German 
women reported the presence of anxiety and depression than Chinese women.   In a similar 
study comparing the needs of American and Egyptian cancer patients, again, there were 
differences found in the type of needs most commonly identified (Ali et al., 1993).   The 
most commonly reported unmet need in the American sample was the need for 
information while the Egyptian sample reported relief from dependency as being the most 
important. 
There are clear differences in the type of unmet needs reported by different demographic 
groups, whether they be gender, age or culture dependent.   Specific areas of need emerge 
within each subgroup that seem to be of notable importance to that particular group.   
Given that there are innate differences between cancer diagnoses as well as the clinical 
demographics of patients, it seems likely that the type of needs identified would also be 
variable between cancer diagnoses.  Haematological cancers differ from all other solid 
tumours in their presentation, treatment type and the environment in which care is 
provided.  The specific challenges that accompany a diagnosis of haematological cancer will 
be discussed as an on-going theme within this thesis: the systematic review in Chapter 2 
syntheses what is already known in the literature and Chapters 3, 4 and 5 employ empirical 
mixed methods research to better understand the link with distress outcomes. 
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Psychological Flexibility 
People who are more adaptable, who therefore may be better suited to incorporate 
change into their perceptions of the world and their expectations of their own lives, may 
also be less likely to experience cancer as a highly negative event or to have high levels of 
unmet need.  Within contextual behavioural science, adaptability is paralleled with being 
more psychologically flexible, a concept that has been defined as being made up of two 
separate processes: acceptance of experience and a commitment to values-based 
behaviour (Hayes, Luoma, Bond, Masuda & Lillis, 2006).  In essence, psychological flexibility 
is the ability to connect with the overall context of a situation and to be able to continue to 
behave in such a way as to be in line with one’s own life aims and values.  It is proposed 
that psychological flexibility should be viewed as fundamental to psychological health 
(Fledderus et al., 2013) and that the ability to adapt, to shift mind-set when a situation 
compromises functional or emotional wellbeing, to maintain balance and to remain 
committed to deeply held life values holds more importance to overall wellbeing than the 
more traditional concepts of the satisfaction of basic psychological needs or positive 
thinking (Kashdan, 2010).  If this holds true and people who are more psychologically 
flexible also enjoy higher levels of psychological wellbeing, then this concept may be 
influential in the maintenance of wellbeing during cancer. 
Not all patients who receive a cancer diagnosis experience a negative psychological impact 
and it has been postulated that those who are able to maintain positive wellbeing and are 
those people who are more likely to adopt values-based behaviours and live according to 
their own identified values (Ciarrochi & Bailey, 2008).   Those who are more easily able to 
accept negative life events and maintain their ability to live according to their life values are 
also more likely to adapt successfully to a diagnosis of an illness such as cancer and to 
experience less emotional consequences of unmet psychosocial needs than patients for 
whom a diagnosis carries a profound negative impact.   Having an unmet psychosocial need 
implies a desire for help or support in order to maintain one’s psychological wellbeing: 
those who are more psychologically flexible may be better able to generate their own 
internal support and therefore able to view their diagnosis within the greater context of 
their lives to accept the life changes that a diagnosis such as cancer can bring, regardless of 
whether they identify as having unmet psychosocial needs or not.  If psychological 
flexibility is more important to psychological health than whether or not a person’s 
psychological needs are met, then this concept may have real importance for how the 
impact of unmet psychosocial needs are interpreted in the context of their impact on 
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psychological wellbeing.   Chapter 5 of this thesis explores how psychological flexibility 
relates to both unmet need and psychological wellbeing in haematological cancer 
survivorship. 
Thesis Aims 
The evidence base relating to unmet psychosocial needs is currently typically focussed on 
the identification of type of need within specific patient groups.  While this holds real value 
in being able to accurately identify where patients feel that they require additional support 
and can be easily translated through into clinical practice, as research it is somewhat 
descriptive and does not provide any real insight into the psychological processes or 
mechanisms of change that might be involved in the maintenance of psychological 
wellbeing during the cancer experience.   More information is needed regarding the 
evolution of unmet needs over time, and whether or not this is common within differing 
cancer diagnoses.  There are indications within the existing literature that a relationship 
between unmet needs and psychological morbidity in cancer patients exists, however, this 
relationship has not been well defined in any great depth nor has it been explored within 
patients with a haematological diagnosis.  In addition to being able to accurately define the 
relationship between unmet need and wellbeing, we need to be able to understand the 
mechanisms that are active within the relationship and to define them within an 
overarching psychological framework.   
Understanding process allows for the development of interventions that are targeted 
towards the mechanisms that are active in maintaining psychological wellbeing, as such 
making them more efficient and effective.  If an intervention can be tailored so that it acts 
on concepts that are influential in maintaining wellbeing and does not target concepts that 
do not ultimately improve distress, then interventions can be honed and streamlined, 
essential in an environment of limited healthcare resources.  This PhD aims to undertake a 
psychological exploration of need within haematological cancer to provide the necessary 
information and knowledge for such application. 
This thesis aims to address the following questions: 
1. What is the current evidence base regarding the unmet psychosocial needs of 
haematological cancer patients and where do the gaps in our knowledge lie? 
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2. What do haematological cancer patients perceive to be their key areas of 
psychosocial needs and why were those specific needs important during the 
patient experience of cancer? 
 
3. What are the unmet psychosocial needs and psychological outcomes of newly 
diagnosed patients and are these two concepts related? 
 
4. What are the long term psychosocial needs of haematological cancer survivors 
and does the concept of psychological flexibility moderate the relationship 
between need and psychological wellbeing? 
 
These aims will be met by employing a mixed methods approach over a series of four 
separate but related studies.   Question 1 will be addressed by a systematic review of the 
existing literature relating to unmet needs in this patient group.  Following this a qualitative 
study of patient experiences of need will address Question 2 and build upon the knowledge 
gained from the systematic review.  Subsequently, Questions 3 and 4 will be met by 
conducting quantitative assessments of need and psychological morbidity in patients with a 
diagnosis of haematological cancer making use of the knowledge gained in the preceding 
studies.   
Mixed methods research approaches have particular value and utility when conducting 
research and as such have gained in popularity in recent years (Johnson & Onwuegbuzie, 
2004).  Mixed methods research can traditionally be viewed as belonging within the 
pragmatic paradigm, that is when the research question becomes central and the ‘what’ 
and ‘how’ of that specific problem take the fore (Mackenzie & Knipe, 2006), however, the 
use of multiple methods can also fit within the transformative paradigm where it can be 
viewed as enabling the researcher to view the world through multiple lenses or viewpoints.   
It is now common for researchers to view qualitative and quantitative research as 
complementary, allowing them to adopt the most appropriate method of data collection 
and analysis for their particular research question (Creswell, 2003).   
Proponents of mixed methods research argue that it enables a more comprehensive 
approach to addressing a research question than either qualitative or quantitative research 
alone (Newman, Ridenour, Newman, & DeMarco, 2003).  It has been asserted that there 
are five reasons to conduct mixed methods research and that all studies within this 
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paradigm can be categorised as fitting within one or more of the following five aims 
(Greene, Caracelli & Graham, 1989): triangulation; complementarity; development; 
initiation; and expansion.  This thesis can be viewed as adopting a mixed methods approach 
for reasons of triangulation, development and expansion as the unmet needs of 
haematology patients will be examined in all four studies.  This will enable the 
identification of clear patterns of unmet need across different samples with shared 
diagnoses to add weight to the assertion that specific areas of need are particularly 
relevant to haematology patients (triangulation).   The studies included within this thesis 
were developed and undertaken sequentially to allow knowledge from each study to 
inform subsequent work (development).  Finally, in each subsequent study, the breadth 
and depth of the research question will be expanded with the different methods each 
being employed to answer specific aims within the overall research question (expansion).   
Employing multiple methodological perspectives will allow for a deeper explanation of the 
phenomena under investigation.  In addition, this thesis takes a critical perspective, 
exploring the challenges of conducting research both within psycho-oncology in general 
and in haematological oncology more specifically. 
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Chapter 2 - Unmet Psychosocial 
Needs in Haematological Cancer: A 
Systematic Review 
Overview 
The literature review included within Chapter 1 highlighted that a diagnosis of cancer can 
have a significant impact upon both psychological and emotional wellbeing.  This review of 
the literature concluded in a number of research aims being identified that would facilitate 
the expansion of existing knowledge and develop our understanding of the unmet 
psychosocial needs and psychological wellbeing of haematological cancer patients.  This 
chapter will seek to address the first thesis question of what is currently understood about 
type of unmet psychosocial need that affects people with a diagnosis of haematological 
cancer via a systematic review.  Identification of both type and prevalence of the 
psychosocial needs most relevant to those diagnosed and treated for this group of cancers 
in order to be able effectively to target and implement appropriate support services.  A 
systematic review was conducted to examine, in depth, the existing evidence base.  Prior to 
this systematic review, the literature relating to unmet psychosocial needs within this 
patient group had not been collated or appraised, despite this being an important step in 
developing a clear understanding of psychosocial need in haematological malignancy.  This 
review was designed to act both as a standalone research project, and to create a 
knowledge baseline from which later stages of this PhD project could build.   
What does the literature tell us about unmet psychosocial needs in 
cancer? 
Patient-centred care has become the gold standard in the provision of healthcare across 
the UK and beyond.  Provision of care should no longer focus solely on the delivery of 
medical treatment, but should also look to encompass the person’s psychological and social 
needs in order to fully support that person’s emotional and psychological wellbeing 
throughout their illness (NICE, 2004).   
For the purposes of this study, the term psychosocial needs relates to the needs that 
underlie a person’s emotional and psychological wellbeing.  A need can be thought of a 
something that is required (Carlson, Waller, & Mitchell, 2012; Watson et al., 2012), 
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something that is important to the person.  Psychosocial needs are a relatively broad 
category of need that can encompass issues such as identity, body image, spirituality, 
relationships and social support mechanisms or the more practical issues related to a 
person’s illness (Sanson-Fisher et al., 2000).   The types of needs within this category are 
diverse and far reaching, having the potential to impact upon all areas of a person’s life.   It 
is understood that needs of this nature are often underreported to treating clinicians (Wen 
& Gustafson, 2004), and, therefore, have the potential to be left unacknowledged and the 
patient without assistance in their area of need.   
If psychosocial needs are defined as the needs that underlie a person’s psychological and 
emotional wellbeing, then their importance becomes clear when we look at the impact that 
a negative psychological response to illness can have upon prognosis.   The presence of 
anxiety, depression and a poor quality of life have all been found to negatively impact upon 
a variety of treatment outcomes: from adherence to treatment, motivation, ability to cope 
with the diagnosis and on prognosis (Hemingway & Marmot, 1999).   
The existing literature on psychosocial need within cancer populations has highlighted that 
needs are prevalent and that currently, there are still areas of need that are not being 
adequately catered for.   Levels of unmet psychosocial need have consistently been found 
to be affected by age, gender, psychiatric history, marital status, treatment type and 
socioeconomic status (Puts, Papoutsis, Springall, & Tourangeau, 2012).  Previous research 
has indicated that both type and prevalence of need differs between individuals and across 
time.  Increased levels of need have been previously identified in those who are younger, 
female, unmarried, indicate a past psychiatric history or current problems in this area, have 
a poor QoL, physical difficulties, whose disease is already at an advanced stage at the time 
of diagnosis, those with a low income, financial difficulties or who live in rural areas 
(Hodgkinson, Butow, Hunt, & Wain, 2006).   
Harrison and colleagues (2009) systematically reviewed literature that looked at unmet 
needs across a general cancer sample found that the type and prevalence of need differ 
across time points within the cancer journey.   The largest proportion of studies identified 
focused on needs within the treatment phase indicating that this is where the majority of 
the research is currently centred.  Specific needs relating to the diagnosis phase, post-
treatment phase and advanced and palliative care phase were also noted.   It is worth 
noting that, in the context of this systematic review, none of the papers included within the 
Harrison review were specific to haematology and therefore it was not possible to use this 
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work as a guide for how the level of unmet needs may evolve during this specific type of 
illness. 
The majority of studies on unmet needs have reported results based on mixed samples 
with fewer looking specifically at a single diagnosis.  While this does make the findings 
applicable to larger groups of people, needs that are specific to a particular diagnosis are 
difficult to distinguish and the variation between methods makes comparison between 
studies challenging (Harrison, Young, Price, Butow, & Solomon, 2009).   Where the existing 
literature serves the function of highlighting a range of needs that are commonly found 
across different diagnoses, in order for research to become fully applicable to a 
haematology setting r, an understanding of whether or not the same type of unmet 
psychosocial needs are present and relevant is required. 
Categorisation of Need 
Types of need and the way in which they are categorised can differ between both needs 
assessment tools and the research articles in which they are reported (Armes et al., 2009; 
Bonevski et al., 2000; Tamburini et al., 2000).  Needs may span multiple categories or be 
categorised differently by different researchers or clinicians.  This has implications both 
when considering the types of need relevant to a patient group and for this review.   
Psychosocial needs are diverse and far reaching.  There is now a recognition that high 
quality care must take into account all aspects of wellbeing, not just the physical.  However, 
the ways in which needs are recognised and understood can differ dramatically both across 
members of the same profession and between the various professions that are involved in 
patient care.  The emphasis and nature of a person’s background may impact upon how 
they understand psychosocial need and the importance that is afforded to them.  A 
medically trained oncology consultant for example, may well have a very different 
perspective to the counsellor or the occupational therapist, all of whom may be treating 
the same patient. 
The International Psycho-Oncology Society (IPOS) has published its Standard of Quality 
Cancer Care (Holland, Watson, & Dunn, 2011), this is an international quality standard to 
support the development and implementation of new clinical practice guidelines.   There 
are two aspects to the Standard of Quality Cancer Care: 
1. Quality cancer care today must integrate the psychosocial domain into routine 
care; 
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2. Distress should be measured as the 6th Vital Sign after temperature, blood 
pressure, pulse, respiration and pain.   
IPOS has requested that cancer organisations around the world act to endorse their 
standards to address supportive care issues for cancer patients and their families.  In the 
UK, the British Psycho-Oncology Society (BPOS), Cancer Focus Northern Ireland and 
Macmillan Cancer Support have all signed up to endorse these standards of care.   
Disparity between definitions of psychosocial need is also seen within the academic world 
and in the literature that has been published on the subject.  For the purposes of this 
thesis, the term psychosocial needs is being used to describe any needs that could be 
described as impacting upon a person’s psychological or emotional wellbeing.  In other 
publications however, alternative terms such as supportive care needs (Armes et al., 2009; 
Harrison, et al., 2009), perceived needs (Boyes et al, 2006), unmet needs (Lobb et al., 2009) 
or simply needs (Clavarino, Lowe, Carmont, & Balanda, 2002) are used, all of which refer to 
the same concepts and ideas in relation to the unfulfilled requirements of people with a 
cancer diagnosis.  In addition, some studies have focussed on investigating a specific area 
within the type of needs currently being discussed.  Information needs have often been 
highlighted as a particular area of interest (Hammond et al., 2008; Hawkins et al., 2008; 
Jenkins, Fallowfield, & Saul, 2001).    
This impacted upon the way in which the search string was derived for this systematic 
review: for broadest applicability, all aspects relating to the concept of psychosocial need 
were taken into account and included within the search strategy.  The danger of conducting 
a systematic review where the central concept is defined so variably is that the search 
strategy will not be sensitive enough to highlight all relevant papers whilst remaining 
specific enough to ensure that the number of irrelevant papers screened is kept to a 
minimum (Montori, Wilczynski, Morgan, Haynes, & Hedges, 2005).  In order to minimise 
this risk, the search string was designed based upon terms used in previous relevant 
publications.  Past papers were examined to see how need was defined in both the abstract 
and the key words.  In addition, the reference lists of included papers were also searched 
for any further relevant papers that had not been selected by the original search.   
Measurement of Need 
Psychosocial needs are measured via the use of self-report needs assessment tools; 
clinically relevant measures that are used in clinical populations to measure and assess type 
and level of needs and their importance to the patient in the context of that individuals’ 
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lifestyle and circumstance.   Their aim is to assist in the collection of information about the 
patient; these tools can be viewed as being key to developing clinicians’ understanding of 
what is important to their patient and, therefore, their ability to deliver high quality, 
person-centred care.   Over the past 30 years, there has been an increase in the number of 
needs assessment tools being developed for use in cancer populations (Boyes, Girgis, & 
Lecathelinais, 2009; Hodgkinson, Butow, Hobbs, et al., 2007; Hodgkinson, Butow, Hunt, et 
al., 2007) and at present, in part due to the commitment of the Department of Health to 
support this area, there is an interest in taking this further.  Research has indicated that 
patients would welcome questions regarding the psychosocial aspects of their illness (Hack, 
Degner, Parker, & Team, 2005) but that, at present, the way in which this task is 
approached by healthcare professionals is often unsystematic at best, and in some cases 
absent entirely.   Both healthcare professionals and patients vary considerably in both their 
ability and desire to talk about psychosocial issues.  Patients can feel unsure about 
approaching their clinical team about issues that are perceived as not directly relevant to 
their illness (Detmar, Aaronson, Wever, Muller, & Schornagel, 2000) or that their problems 
are an unavoidable consequence of their diagnosis and therefore it would be pointless to 
address them.   
Recent NICE guidelines have indicated that assessment of a person’s needs should be the 
first step in the provision of supportive care and appropriate services (NICE, 2004) and has 
proved influential in the development of needs assessment here in the UK.   Assessment of 
need should not be a one-time event but rather should be part of a flexible, evolving 
approach to a person’s care that reflects a person’s current needs and requirements 
(Watson, et al., 2012).   Incorporating routine psychosocial needs assessment into patient 
care allows for a more tailored approach to treating patients and allows patients the 
opportunity to discuss their needs with their clinical team.   Specific assessment tools and 
issues relating to their implementation will be discussed further in Chapter Three of this 
thesis. 
How will this review help to further knowledge and understanding? 
Haematological cancers stand slightly apart from other cancer diagnoses in a variety of 
ways.  Previous findings have indicated that the manner and the setting in which 
haematological malignancies are treated can differ from that in solid tumours.  Those 
diagnosed with a haematological cancer are less likely to be treated in a palliative care 
setting (NCIN, 2011; McGrath & Joske, 2002) than patients with other diagnoses and more 
generally, treatment in the UK is commonly carried out in district general hospitals, or 
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satellite units, rather than in larger specialist cancer centres.  As such they may not have all 
of the same resources available to them.  Those treated with a blood cancer are still more 
likely to die in a hospital and the proportion of patients for whom this is a reality is falling 
more slowly than for other cancer diagnoses (NCIN, 2011).  The reasons behind the 
underdeveloped link between haematology and palliative care is not clear, however it 
could be due to a range of factors.  It may be that care tends to remain within the team 
that have treated the patient throughout the course of their illness, that teams ‘take care 
of their own’, or it may be that haematological malignancies are viewed as being slightly 
apart from other diagnoses and that some preconception is playing a role, or that the 
nature of the illness means that transitions are too sudden meaning that there is little time 
for palliative input (Ansell et al., 2007; Howell et al., 2011; Manitta, Philip, & Cole-Sinclair, 
2010).   It is clear that the difference between treatment of curative and palliative intent is 
either not well understood or poorly implemented.   
Regardless of the causes of the differences between haematological and solid 
malignancies, the fact that these differences exist brings with it the possibility that these 
two patient groups will have distinct and separate types of unmet psychosocial needs.  
Until the literature has been examined in greater depth than has occurred to date, it is 
unclear firstly, if differences in need exist, and secondly, if there is a difference in need, 
what the needs most relevant to haematological cancer patients are.   
What were the aims of the review? 
This systematic review was designed to collate the literature relating to unmet psychosocial 
needs in patients with a diagnosis of haematological cancer, answering Thesis Question 1:   
1. What is the current evidence base regarding the unmet psychosocial needs of 
haematological cancer patients and where do the gaps in our knowledge lie? 
Secondary study objectives aimed to fulfil the following: 
 To produce information regarding the type and prevalence of unmet psychosocial 
needs in haematological cancer; 
 To gain an understanding of the information regarding need that is available to 
clinicians working in oncology; 
 To highlight any gaps within the current literature; 
 To create a baseline for further projects within the PhD. 
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This systematic review is the first to explore unmet psychosocial needs in haematological 
cancer.  The previous work conducted within this area has focused on either solid tumours 
or mixed cancer samples.  Prior to this systematic review, the literature relating to levels of 
unmet psychosocial need in haematological cancer had not been systematically collated 
and analysed as a whole.  The result being that there has to date existed a gap in our 
knowledge of psychosocial need in haematology and bringing this understanding in line 
with that which exists for other, more common cancer diagnoses. 
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Methodology 
The Literature Search 
Key psychological and medical databases were selected based upon them being the 
sources most likely to contain articles of the type being searched for and permitting a 
multiprofessional focus to the review.   This review focussed only on published literature, it 
was felt that searching both medical and psychological databases and journals would bring 
up studies that were most relevant to the research question.  The following databases were 
included: CINAHL, MEDLINE, PsychINFO, Web of Knowledge, COCHRANE and DARE.  
EMBASE was excluded from this review as it has a biomedical basis and is especially strong 
in it its coverage of drug and pharmaceutical research which was not felt to be consistent 
with the aims of the review.  All databases were searched using the search string presented 
below.   
Alongside the database searches, the archives of key journals were hand searched for 
relevant papers.  The journals chosen were Psycho-Oncology, British Journal of Cancer and 
Journal of Psychosocial Oncology.   These three journals are well respected within their 
fields, with both good impact factors and high relevance to the area of research.  As with 
the chosen databases, the journals covered aspects of both psychological and cancer 
literatures and preliminary scoping searches conducted prior to the commencement of the 
systematic review indicated that these journals were all relevant to this review.  Due to the 
time constraints associated with conducting this review as part of a PhD project, it was felt 
that these three journals would offer the greatest likelihood of containing relevant papers 
whilst remaining practicable within the time limits available.  All databases and journal 
archives were searched during a ten day period between the 2nd and 12th January 2012.  
In addition to the searches defined above, the reference lists of all articles meeting 
inclusion criteria were searched for any additional relevant articles that had not been 
selected by the search strategy within the original search.  As the literature in print relating 
to psychosocial needs in haematology is small, it was felt that any other relevant papers 
were highly likely to be included within reference lists of the papers collated from the 
databases and journal searches.   
Search Strategy 
The search strategy was designed to strike a balance between targeting only the most 
relevant papers while simultaneously not being so specific as to risk potentially excluding 
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pertinent articles (Montori, et al., 2005; Wilczynski, Haynes, & Hedges, 2007).  The terms 
used in the search strategy were determined by consideration of the research question and 
by the corresponding aims of the review combined with looking to past papers that had 
been published in relevant areas to identify both the key words and definitions of terms 
most commonly used.   
Three areas were identified as being key to the research question: ‘haematological cancer’, 
‘psychosocial’ and ‘unmet needs’.  Each of these three terms were considered to be central 
to the research question and were therefore expanded into a list of synonymous search 
terms with the aid of previous literature.  These terms were then used to make up the 
search strategy in order to ensure that all relevant articles would be selected by the search 
strategy as the terms used within the search string may be used as either a key word or be 
present within the abstract of relevant articles. 
The following search string was developed and inputted into the selected databases as 
follows: 
Haematological Cancer 
1. (cancer OR neoplasm$ OR malig$) 
2. H*em$ 
3. 1 AND 2 
4. blood cancer 
5. leukaemia 
6. lymphoma 
7. myeloma 
8. 3 or 4 or 5 or 6 or 7 
 
Psychosocial 
1. psychosocial  
2. psychologic$ 
3. social 
4. emotional 
5. adjustment 
6. adaptation 
7. supportive 
8. information 
9. communication 
10. practical 
11. spiritual 
12. health 
13. identity 
14. coping 
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15. body image 
16. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 
 
Unmet Need / Outcomes 
1. unmet AND need 
2. distress 
3. anxiety 
4. depression 
5. quality of life 
6. psychosocial AND need  
7. supportive AND care 
8. help-seeking 
9. need$ AND assessment 
10. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9  
 
Study Selection 
In order for a paper to be included within the review, it had to fulfil the following inclusion 
criteria, taking into account the PICOS system (Sayers, 2008) for defining inclusion criteria 
(population, intervention, comparators, outcomes and study design):   
 Studies must include an assessment of unmet psychosocial need. 
 Studies must be conducted with an adult sample with participants over the age of 
18. 
 The sample must be, at least in part, comprised of patients with a diagnosis of 
haematological cancer.   
 All studies must have been conducted within an appropriate healthcare or 
community setting, studies conducted within inpatient psychiatric or forensic 
institution were not eligible for inclusion due to the potential bias relating to the 
cause of need.    
 Reporting of need must be via direct patient report and not via a family member or 
healthcare professional. 
There were no restrictions placed upon the proportion of the sample which had to be made 
up of patients with a haematological malignancy.  Additionally, there were no restrictions 
placed on the point of the cancer journey at which needs were to be assessed or the time 
point at which needs were reported.   Given that a key aim of the review was to quantify 
type and prevalence of unmet need, qualitative studies were not included in the analysis. 
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The following flow chart presents the number of studies at each stage of the systematic 
review and reasons for exclusion.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1: Flow diagram of results  
Number of potentially relevant publications 
resulting from the literature searches = 
14549 
 Titles screened after de-duplication = 7947 
Abstracts screened = 1675 
 
Full text articles reviewed by two reviewers = 
175 
 
Number of publications excluded as titles 
revealed not relevant = 6272 
 
Abstracts rejected = 1500 
Reasons for exclusion:   
Sample does not contain haematological cancer = 6 
Non-adult sample = 0 
Qualitative study = 7 
Does not assess psychosocial need = 141 
Inappropriate setting = 0 
Indirect report = 2 
Not in English = 7 
Not a research study = 1 
 
Journals found from reference lists of 
included papers = 6 
 
Total number of papers included in review = 
19 
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Once all searches had been completed, all references were exported into EndNote and 
then de-duplicated.  The inclusion assessment was comprised of three stages.  Initially, the 
complete collection of references was visually screened to exclude any papers that 
obviously did not fit the criteria.  Secondly, the abstracts of the remaining papers were read 
and compared to the pre-defined inclusion criteria, any papers that did not meet the 
inclusion criteria were excluded.  Finally, all remaining papers were read in full and 
assessed against the inclusion criteria.  The final stage of the inclusion assessment was 
double screened by an independent second reviewer in order to ensure that no relevant 
papers were discarded and to exclude any possibility of the presence of bias within the 
study.  In the case of any disagreements regarding the inclusion or exclusion of a study, the 
academic supervisor acted as moderator.  
Data Extraction 
Once the inclusion assessment was complete, data was extracted from all studies selected 
for inclusion with the aid of a standardised form (see appendix 1).  For each study, the 
following information was gathered: 
 A brief summary of the study: author, date, publishing journal, identification 
number. 
 A description of the sample: recruitment, size, inclusion and exclusion criteria. 
 Information about the design of the study: setting, timings, interventions. 
 Outcome measures. 
 Method of analysis. 
 An evaluation of the work: limitations, implications for future work or clinical 
practice. 
 Any comments: author, reviewer.  
At the same time as data extraction was undertaken, each paper was assessed against a 
quality assessment checklist (Kmet et al, 2004).  The quality assessment checklist was taken 
from the paper published by Kmet and colleagues in an attempt to create standardised, 
empirically grounded quality assessment criteria for use when evaluating research papers.  
There are a range of quality assessment checklists that have been created for use within 
systematic reviews (Oxman, 1994; Shea et al., 2007), however, the criteria developed by 
Kmet were designed to be applicable to a diverse range of studies, not just randomised 
control trials.  As this was expected to be the case with the studies included in this 
systematic review, this quality assessment checklist was deemed the most suitable. 
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Both qualitative and quantitative criteria were generated by the Kmet et al tool paper.  To 
suit the purposes of this review, only the criteria for use with quantitative research papers 
were used.  For each item in the checklist, a response and relating score was determined: 
yes (2), partial (1) or no (0) as recommended in the Kmet paper.  An examination of the 
quality of included studies is an important component of a systematic review as it allows 
the reader to consider how trustworthy or reliable to findings being presented can be 
considered to be (The Cochrane Collaboration, 2002).  Provided that a study has met all of 
the inclusion criteria, then a poor quality score would not mean that the study is 
discounted, rather this provided contextual information to be discussed within the 
narrative synthesis of the results.   
Synthesis of Results 
While a meta-analysis can be viewed as the ‘gold-standard’ of data synthesis within 
systematic reviewing, the data extracted in this review precluded the use of meta-analysis.   
Narrative synthesis (Popay et al., 2006) was selected as the method of handling the data 
gathered and of combining the results of the studies.  Of the papers included in the review, 
there were five papers reporting the results of four separate studies that shared a common 
needs assessment measure and the time-point at which needs were assessed.  Some 
consideration was given to conducting a small-scale meta-analysis as a sub-section of the 
results; however, it was felt that this sample size was too small for the production of 
reliable results (Rosenthal, 1995; Papworth & Milne, 2001; Field, 2001).  There is some 
debate within the literature concerning meta-analysis as to how many studies are required 
for the generation of reliable results, however, five studies were not likely to provide 
results that were stable enough to provide a reliable estimate of population variances and 
that the probability of a Type I error was too great (Field, 2003).   
Prior to synthesising the results, the first step of a narrative synthesis is to tabulate the 
included studies (Popay et al., 2006).  Two tables were drawn up: the first compiled 
information of each of the studies including study date, sample, design, needs assessment 
and key findings; the second summarised the results of the quality assessment process and 
highlighted particular strengths and weaknesses of each study.  Presenting the information 
in a clear yet detailed manner is beneficial in that it allows for transparency in the methods 
(Petticrew & Roberts, 2006; Smith, Devane, Begley, & Clarke, 2011) and makes it clear how 
the reviewer went about appraising the study data.  Having the data presented in this way 
paves the way for the reviewer to begin the synthesis of the results. 
34 
 
Organisation of studies is the second stage of the narrative synthesis process.  Having the 
data tabulated prior to attempting to organise the studies helps to clarify both the context 
and contribution of each study which is invaluable when deciding how to organise studies 
into meaningful categories.  For this review, in order to be better able to investigate the 
presence of psychosocial needs in a meaningful way, studies were organised according to 
whether the sample was a mixed cancer sample or focussed on haematological cancer only.  
This was to allow for differentiation between needs expressed solely with those with the 
diagnosis of the research question, or needs that may reflect a wider population.  Within 
the mixed or haematological only categories, papers were organised according to the time-
point at which unmet psychosocial needs were assessed.  The time-points were identified 
based on those used successfully in previous literature (Harrison et al, 2009; McIllmurray et 
al, 2001; Soothill et al, 2004) and were: at diagnosis; during treatment; at the end of 
treatment; into survivorship; with the additional category for study that assessed needs 
across a sample of participants at differing time-points.   
After the studies are organised into appropriate categories, the next stage of conducting a 
narrative synthesis is to complete a ‘within study analysis’ or a preliminary synthesis.  This 
stage of the synthesis process seeks to provide a narrative description of each of the 
studies included in the systematic review to include an account of the quality assessment 
and its outcomes.  As the results of the within study synthesis can be viewed as being the 
preliminary stage of the overall synthesis, a further stage of narrative synthesis is required 
to develop the findings and to further examine emerging trends.   
The final stage of the narrative synthesis, the between study analysis, seeks to generate an 
overall account of the evidence, to encompass an exploration of the differences between 
the included studies and their findings and of any factors that may have impacted upon 
how widely applicable the results are deemed to be (Popay et al., 2006).  The key aim of 
the between study synthesis is to explore the relationships within the data.  Variations in 
outcomes, methods, samples, settings and so on should be examined.   Within the 
narrative synthesis, the quality of all included studies must be reflected upon when 
considering the overall quality and robustness of the results.  
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Results 
This review includes the results of 18 studies written up as 19 separate publications.  For 
each of the studies included in the review, data was extracted from each paper according 
to the process detailed in the methodology section.   
A summary of the key data extracted is presented in Table 2.1 and quality assessment data 
in Table 2.2.  An example of the study data extraction form can be found within the 
appendices (Appendix 1). 
Study Characteristics and Study Quality 
The quality of the included studies was generally good, the mean quality score was 82.9 
and the median quality score was 88.3.  This is likely to be due, at least in part, to the fact 
that the scope of this review was limited to published studies.  This means that all of the 
studies included in this systematic review have been peer assessed and found to be of an 
acceptable standard for publication within academic journals.   
There were several issues to arise from the data extracted from the studies included within 
the review.  One such problem concerning the way in which the data could be analysed was 
the lack of a consistent needs assessment tool.  Of the 18 different studies included in this 
review, 11 different needs assessment tools were used.  Four studies used the Supportive 
Care Needs Survey (SCNS) to assess unmet need in participants, two studies used the 
Cancer Survivors Unmet Needs assessment (CaSUN) and five papers reporting four studies 
used the Patient Needs Inventory (PNI) as their measure.  Of the remaining eight studies, 
each used a different measure with three studies using a measure that they had designed 
specifically for use within their study.  This leads to problems with generalisability between 
the results of different studies as in each different measure, the way in which psychosocial 
needs are categorised and the method of assessment of the presence of unmet need will 
differ.   
Sampling was another key issue identified within the review.  Four of the studies were 
deemed to have a small sample size (Boyes et al., 2006; Clavarino et al., 2002; Lobb et al., 
2009; Molassiotis et al., 2011), with other studies identifying recruitment bias (Soothill et 
al., 2001; Soothill et al., 2004) or a sample of convenience (Armes et al., 2009).  Across the 
reviewed papers, there are differences in the specific haematological cancer diagnoses 
included and variations in the time-point at which needs was assessed.  When combined 
with samples with the identified weaknesses, it may be that in places the results lack 
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weight due to methodological limitations and small sample sizes.  Two of the studies that 
were deemed to have a small sample size were two of the three studies that used 
haematology specific samples thus meaning that the total number of participants with 
haematological cancer diagnoses is comparatively small, limiting the generalisability of the 
findings presented within this review.
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Table 2.1: Summary of data extracted from each included study. 
Author Year Country Source Sample Sample 
size 
Measure Key Findings 
 
Armes et al 2009 UK Journal of 
Clinical 
Oncology 
Mixed cancer 
diagnoses currently 
receiving treatment 
1152 SCNS 66% expressed few or no 
needs at baseline, 69% 
expressed few or no needs at 
follow up.  Most frequently 
reported needs at both time 
points were psychological 
needs and fear of recurrence.   
 
Ashbury et 
al 
1998 Canada Journal of Pain 
and Symptom 
Management 
Mixed cancer 
diagnoses who have 
received treatment 
within last two years 
 
913 Designed for 
study 
Fatigue and anxiety most 
commonly reported 
symptoms. 
Boyes et al 2006 Australia European 
Journal of 
Cancer Care 
Mixed cancer 
diagnoses attending 
clinic for first 
consultation 
80 SCNS Psychological needs most 
commonly reported. 
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Clavarino et 
al 
2002 Australia Australian 
Journal of 
Rural Health 
Mixed cancer 
diagnoses currently 
receiving treatment 
28 SCNS Psychological needs most 
commonly reported.  Fear of 
recurrence (42.9%) and 
concerns about the worries 
of those close to you (50%) 
most common unmet needs 
in patient group 
 
Hammond 
et al 
2008 USA Fertility and 
Sterility 
NHL patients in 
survivorship phase. 
250 Information 
needs 
questionnaire 
61% of young people 
expressed the need for 
information about fertility. 
 
Hawkins et 
al 
2008 USA Journal of 
Psychosocial 
Oncology 
Mixed cancer 
diagnoses with a 
recent diagnosis 
731 Designed for 
study 
Information needs in areas 
of social, lifestyle and 
financial concerns identified.  
Also required more 
information regarding long-
term implications.  
 
Jenkins et al 2001 UK British Journal 
of Cancer 
Mixed cancer 
diagnoses having 
regular consultations. 
2331 Adaptation of 
Cassileth's 
Information 
Needs 
87% preferred to have as 
much information as 
possible. 
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questionnaire 
 
Liang et al 1990 Australia British Journal 
of Cancer 
Mixed cancer 
diagnoses currently 
receiving treatment 
188 Designed for 
study 
Family was reported as the 
highest need, followed by 
dealing with emotional 
stress. 
 
Lobb et al 2009 Australia Patient 
Education and 
Counselling 
Haematological cancer 
diagnosis who had 
completed treatment 
113 CaSUN Most frequently endorsed 
need was the need to feel as 
though I am managing my 
health together with the 
medical team, the most 
frequent unmet need was 
fear of recurrence. 
 
McDowell et 
al 
2010 Australia Psycho-
Oncology 
Mixed cancer 
diagnoses 
438 SCNS-SF34 Unmet needs decrease over 
time since diagnosis. Unmet 
needs at diagnosis predict 
later presence of unmet 
needs. 
 
McIllmurray 
et al 
2001/2003 UK European 
Journal of 
Mixed cancer 
diagnoses 
402 PNI Needs relating to health 
professionals most 
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Cancer Care / 
Palliative 
Medicine 
commonly expressed.  
Information and support 
networks also common 
areas. 
Found that religion was 
related to fewer unmet 
needs.  Highest percentages 
of unmet needs related to 
health professionals and 
identity.  
 
Mesters et 
al 
2001 Netherlands Patient 
Education and 
Counselling 
Mixed cancer 
diagnoses 
498 PINQ A need for information about 
disease and treatment was 
the strongest theme. 
 
Molassiotis 
et al 
2011 UK Psycho-
Oncology 
Multiple Myeloma 
patients  
132 CaSUN Highest reported need was 
for more accessible hospital 
parking, followed by 
insurance and then fear of 
recurrence. 
 
Preyde et al 2010 Canada Journal of 
Psychosocial 
Mixed cancer 
diagnoses currently 
156 ESAS, CES-D 
and Perceived 
Fear of recurrence main 
need identified. 
41 
 
Oncology receiving treatment Social Support 
Scale 
 
Sollner et al 2001 Austria British Journal 
of Cancer 
Mixed cancer 
diagnoses currently 
receiving treatment 
298 Hornheide 
Questionnaire, 
Questionnaire 
to Assess the 
Need for 
Psychosocial 
Support 
20% of participants 
expressed an urgent need 
for psychotherapeutic 
support, 14.7% expressed an 
urgent need for counselling 
by a social worker. 
 
Soothill et al 2001 UK Supportive 
Care in Cancer 
Mixed cancer 
diagnoses 
295 PNI 4.4% of sample had 10+ 
significant unmet needs. 
Confidence in healthcare 
professionals most 
commonly rated as 
important or very important.  
Most common unmet needs 
were help with financial 
matters, help filling out 
forms, help with anger and 
opportunities to meet people 
in the same situation. 
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Soothill et al 2003 UK European 
Journal of 
Oncology 
Nursing 
Mixed cancer 
diagnoses 
233 PNI Most common patient 
reported unmet needs: help 
with financial matters; help 
filling out forms; help with 
dealing with anger.  Majority 
of patient-carer pairs 
expressed importance of 
good relationships with 
healthcare professionals and 
good quality information. 
 
Soothill et al 2004 UK Journal of 
Psychosocial 
Oncology 
Mixed cancer 
diagnoses 
380 PNI Found that patterns of 
psychosocial need differ 
between distinct patient 
groups.   
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Table 2.2: Study quality 
Study Year Strengths Weaknesses Quality Score 
Armes et al 2009 Large sample size. 
Included a follow up assessment.  
Used recognised needs assessment tool. 
 
Convenience sample used.   
Does not report results according to diagnosis. 
20/22 
90.1% 
Ashbury et al 1998 Large sample size. Measure developed for use in study. 
Variation in clinical demographics – stage etc. 
Aspects of the study not well defined. 
Needs not well defined. 
 
14/22 
63.6% 
Boyes et al 2006 Recognised needs assessment tool used. 
 
Small sample size. 
High attrition rate. 
 
24/26 
92.3% 
Clavarino et al 2002 Recognised needs assessment tool used. Small sample size. 
Not all sample paired. 
Poorly defined methods. 
 
12/22 
54.5% 
Hammond et al 2008 Specific to haematological cancer.  Poorly defined report. 
Poorly defined measure used. 
 
15/22 
68.2% 
Hawkins et al 2008 Large sample size. Some clinical information missing. 18/22 
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Study part of a larger study – unclear what larger 
study was investigating. 
Measure developed for use within study. 
 
81.8% 
Jenkins et al 2001 Used recognised assessment tool. 
Large sample size. 
Well defined. 
 
Specific to information needs. 21/22 
95.4% 
Liang et al 1990 Looks at concerns specific to diagnosis. 
Clearly defined looking at psychosocial need. 
Unclear how measure used was validated. 
General areas of need investigated, lacks specifics. 
 
18/22 
81.8% 
Lobb et al 2009 Solid analysis. 
Specific to haematological cancer. 
Recognised needs assessment tool used.   
Relatively small sample size. 
Not all clinical information known. 
Variations in stage and time. 
 
21/22 
95.4% 
McDowell et al 2010 Recognised needs assessment used. 
Longitudinal design.  
Limited information provided regarding sample. 20/22 
90.1% 
 
McIllmurray et al 2001 Clearly defined. 
Recognised measure used. 
Broken down according to diagnosis and stage. 
  
Low response rate. 22/22 
100% 
McIllmurray et al 2003 Clearly defined. Low response rate. 22/22 
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Recognised measure used 
 
100% 
Mesters et al 2001 Solid analysis.  Focus of the study on validating the measure not on 
needs assessment.   
Only part of the study included patients with a 
haematological malignancy. 
 
20/22 
90.1% 
Molassiotis et al 2011 Recognised needs assessment tool used. 
Specific to haematological cancer. 
Clearly defined. 
Looks at one diagnosis only. 
 
Relatively small sample. 22/22 
100% 
Preyde et al 2010 23% of sample haematological cancer. Clinical details missing. 
Small sample size. 
Questionnaires used. 
 
14/22 
63.6% 
Sollner et al 2001 Solid analysis. 
 
 
Some clinical information not known. 
Not assessed over time. 
20/22 
90.1% 
Soothill et al 2001 Recognised needs assessment measure used.  Recruitment bias identified. 
Low response rate. 
Weaknesses in report detail. 
 
16/22 
72.3% 
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Soothill et al 2003 Recognised needs assessment measure used.  Level of demographic information reported.  
Analysis methodology could be more explicit. 
 
17/22 
77.2% 
 
Soothill et al 2004 Recognised needs assessment measure used. Recruitment bias identified. 
Low response rate. 
19/22 
86.4% 
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An area where several studies scored poorly in the quality assessment was in the quality 
and level of detail of their reporting.  Where studies designed their own needs assessment 
tool, it was often not clear enough how the resulting tool was assessed for psychometric 
robustness and suitability for its intended use.  In some instances, the particular focus of a 
paper meant that other aspects of the work were neglected, for example, in the study 
conducted by Mesters and colleagues (2001), the focus of the paper was on the validation 
of their measure and as a result the level of detail surrounding the assessment of need was 
reduced.  In other work, the level of detail provided regarding the clinical data of 
participants was less than it might have been (Lobb et al, 2009; Preyde et al, 2010; Sollner 
et al, 2001).  While it is appreciated that each of the papers included within a review was 
written for publication within an academic journal and therefore is likely to have adhered 
to a pre-determined word limit, the quality of reporting, overall, could have been 
improved.   
Due to the type of studies included in this review, that is where a specific outcome is 
assessed within pre-defined patient groups, random allocation and interventional blinding 
was generally not applicable.  This reflects the methodologies used and was not deemed to 
negatively impact upon the quality of the included works.   
Results of Individual Studies 
Included studies were categorised according to both sample and time point at which needs 
were assessed.  Initially, studies were organised into mixed cancer samples and 
haematology only samples.  Within these categories, studies were organised according to 
whether needs were assessed at diagnosis, during treatment, at the end of treatment, into 
survivorship or at mixed time points.  The studies are categorised and shown below. 
Mixed Diagnoses 
Two studies were identified where participants were recruited at diagnosis: 
 Boyes et al., 2006 - This study was a questionnaire study that assessed needs using 
a truncated version of the SCNS.  For each item, participants rated their perceived 
level of need between none and high.  The most commonly reported needs in both 
the control and intervention groups were psychological needs and in both of these 
groups psychological needs were found to decrease over time.  Indeed, needs 
across all areas were found to decrease as time passed since diagnosis.  This study 
scored well on the quality assessment, scoring 92.35, lending credence to the 
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results.  The use of a recognised needs assessment tool was deemed to be a 
positive, however, the sample size was small and the attrition rate was high.   
 
 Hawkins et al., 2008 - This paper described a questionnaire study where 
participants rated their needs on a Likert scale from 1 to 5.  The study highlighted 
that participants identify needs for more information about whether treatment will 
work (63.1%), being able to have children (62.5%) and paying for care (59.2%) as 
their most pressing cause for concern.  The study was not clear on the precise 
measure used to assess needs in participants.  This study scored 81.8% on the 
quality assessment, indicating a good level of study quality. Drawbacks highlighted 
included the use of a novel assessment measure and lack of clarity regarding the 
aims and objectives of the larger project of which this study was a part.   
Studies where participants were recruited during treatment in a mixed sample: 
 Armes et al., 2009 - This paper reports a questionnaire survey where psychosocial 
needs were assessed using the SCNS.  Need for help was rated on a 5 point scale 
from none (0) to high (5).  The highest rated needs at both time points within the 
study were psychological: fear of the cancer spreading (30% at baseline, 26% at 
follow up), concerns about the worries of those close to you (26% at baseline) and 
uncertainty about the future (26% at baseline, 20% at follow up).  The results 
indicated a general trend of needs decreasing in the time between baseline and 
follow up.   A high score was obtained by this study on the quality assessment at 
90.1%.  
 
 Clavarino et al., 2002 - This paper outlines a questionnaire study using the SCNS to 
assess level of need.  Levels of need are rated between 1 and 5.  The highest 
reported needs by patients were psychological: concerns about the worries of 
those close to you (50%), fears about the cancer returning (42.9%).  7 items of high 
need came from the psychological domain.  This study achieved the lowest score 
on the quality assessment, scoring on 54.5%, therefore indicating these results to 
be the least reliable of the studies included within the review. 
 
 Liang et al., 1990 - This paper reports on a questionnaire survey that assessed 
unmet need using a measure designed for use within this study.  Items on the 
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assessment tool measure broad areas of need rather than specific concerns.  
Participants were asked to rate area of need between 1 (low) and 8 (high) 
according to how much worry resulted from the need.  Overall, it was found that 
family was the area associated with highest levels of need.  Family was also the 
highest need reported by participants with a diagnosis of lymphoma.  Participants 
with lymphoma reported higher levels of need in the areas of sex and work in 
comparison to other diagnoses and reported the lowest levels of needs in relation 
to stress.  This study received a good score on the quality assessment, 81.8%, 
however, was marked down on the use of a non-validated needs assessment 
measure.   
 
 Jenkins et al., 2001 - This study focussed specifically on the assessment of 
information needs.  It was designed as a questionnaire survey using an adaption of 
Cassileth’s Information Needs Questionnaire.   Most commonly reported absolute 
need was whether or not it is cancer (60%) and what are the possible side effects of 
treatment (60%).  This study received an excellent score in the quality assessment, 
95.4%, indicating a high quality level.  
 
 Preyde et al., 2010 - A questionnaire study using the ESAS, CES-D and Perceived 
Social Support Scale. Fear of recurrence was the main need identified.  This study 
scored comparatively poorly in the quality assessment, receiving 63.6%. 
 
 Sollner et al., 2001 - A questionnaire study using the Hornheide Questionnaire and 
the Questionnaire to Assess the Need for Psychosocial Support as measures to 
assess unmet needs.  As the name of the measure suggests, this study focussed 
specifically on need for formal psychosocial support rather than a general 
assessment of need.  The study found that 20% of patients expressed an urgent 
need for psychotherapeutic support and 14.7% expressed an urgent need for 
counselling by a social worker.  In addition, oncologists were found to significantly 
under-estimate the level of need experienced by patients.  A solid quality 
assessment score of 90.1% was obtained by this study. 
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Studies where participants were recruited at the end of treatment: 
 Ashbury et al., 1998 - A questionnaire study using a measure specifically developed 
for use within the study.  Participants were asked to rate questions on Likert scales.  
Fatigue (78%) and anxiety (77%) were the most common issues identified.  
Weaknesses in the measure used and the way in which aspects of the study were 
defined meant that this study received a relatively low quality assessment score of 
63.6%. 
There were no studies identified that assessed need at the survivorship time-point in a 
mixed sample.  
 
 
Several studies were found that recruited participants from varying time-points: 
 
 McDowell et al., 2010 - This study was designed as a longitudinal survey design that 
utilised the SCNS-SF34, a shortened version of the SCNS, to assess psychosocial 
need.  Needs were measured across a five point scale as with other studies 
previously described that used the SCNS to assess need.  The three most commonly 
reported needs were lack of energy/tiredness, not being able to do the things you 
used to and fears about the cancer spreading, needs which spanned the physical 
and psychological domains.  The general trend across the sample was that needs 
decreased over time.  This study achieved a solid quality assessment score of 
90.1%.  
 
 McIllmurray et al., 2001 and McIllmurray et al., 2003 - Two papers reported a 
questionnaire study that used the PNI to assess need.  Needs were rated on a scale 
of 1 to 5 of how important they were felt to be.  Needs relating to health 
professionals and support network most commonly rated highly.  (Note – the PNI 
does not have a psychological needs section.)  These publications scored the 
maximum scores in their quality assessments, 100%, indicating that this research is 
of an excellent quality.    
 
 Mesters et al., 2001 - A study involving interviews that were quantitatively 
analysed and needs assessed using the PINQ.  It was found that participants 
identified needs relating to information about disease and treatment.  This study 
was restricted for the purposes of this analysis by the fact that only part of the 
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study included haematology patients but a solid design meant that a quality 
assessment score of 90.1% was achieved.   
 
 Soothill et al., 2001 - A cross-sectional survey study that used the PNI to assess 
unmet needs in participants. Needs are rated on a scale from 1 (low) to 5 (high) 
according to how important they are.  The most common needs reported as being 
important are confidence in health professionals (94%) and health professionals 
who have time to discuss issues with me (92%).  The needs most commonly 
reported as being unmet however, were help with financial matters (35%) and help 
with filling out forms (24%).  Recruitment bias, low response rate and some 
weaknesses in the report detail impacted upon the quality assessment score 
received at 72.3%.   
 
 Soothill et al., 2003 - A cross-sectional questionnaire survey of both cancer patients 
and their carers. Needs were assessed using the PNI.  The need most often rated as 
important for both patient and carer was confidence in the health professionals 
that I meet (88.8%) followed by honest information (88.4%).  The most important 
need for patients but not carers were help with any distressing symptoms (29.2%), 
help with transport (28.8.5) and help with any fears (27%).   The most commonly 
reported unmet needs for patients were help with financial matters (40%), help 
with filling out forms (28%) and help with my anger (20%) however, these were all 
rated comparatively low in terms of their importance to patients.  Weaknesses in 
the amount of detail reported lowered the quality assessment score, however a 
good score of 72.3% was still achieved.  
 
 Soothill et al., 2004 - A cross-sectional questionnaire study using the PNI to assess 
needs.  Unmet needs were broken down according to sub-groups of patients 
organised according to response patterns for their unmet needs.  Unmet needs 
relating to information of health professionals had the highest probability of being 
present in the largest number of sub-groups.  A good quality assessment score of 
86.4% was achieved, let down by recruitment bias and low response rates.   
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Haematological Cancer Only 
No studies were identified where participants were recruited at the diagnosis time point in 
a haematology-only sample. 
One study was identified at the treatment time-point: 
 Molassiotis et al., 2011 - A cross-sectional questionnaire study using the CaSUN to 
assess needs.  Patients with multiple myeloma made up participants within sample.  
The most commonly reported needs were more accessible hospital parking 
(10.6%), help with life or travel insurance (10.4%) and help to manage concerns 
about the myeloma coming back (7.9%).  This study achieved a perfect quality 
assessment score of 100% indicating a high level of quality of this research. 
 One study was identified that recruited participants at the end of treatment: 
 
 Lobb et al., 2009 - A questionnaire study using the CaSUN to assess unmet needs.  
The sample included patients who had been diagnosed and treated for any 
haematological malignancy.  The most frequently reported unmet needs were help 
to manage my concerns about the cancer coming back (42%), the need for an on-
going case manager to whom I can go and find out about services whenever they 
are needed (33%) and the need to know that doctors talk to each other to 
coordinate my care (31%).  This study achieved an excellent quality assessment 
score of 95.4%.   
One study was identified that recruited participants in the survivorship phase: 
 
 Hammond et al., 2008 - A questionnaire study using an Information Needs 
Questionnaire (INQ).  The sample for this study included patients with NHL only.  
This study looked specifically at the information needs of patients with NHL and 
found that 61% of young people expressed the need for information about fertility.  
This paper achieved a comparatively poor quality assessment score at 68.2% which 
was due to poor definition of both the measure used and the results more 
generally.   
 
53 
 
Synthesis of Results 
Results of mixed sample studies 
The results from the mixed samples indicate a range of key areas of need.  Psychological 
needs, where measured, were typically scored highly.  Within the area of psychological 
need, fear of recurrence was identified as the single most commonly identified unmet 
need.   Needs relating to health professionals were scored highly within the studies that 
used the Patient Needs Inventory (PNI) to assess need.  It is worth noting, however, that 
the PNI does not have a category dedicated to the assessment of psychological need, 
therefore we cannot determine how important this set of participants would have rated 
needs of this type to be in relation to their own needs.  Information needs were another 
area that was highlighted within the studies conducted with mixed cancer samples.  Fatigue 
was identified as a key concern in two studies.   
Results of haematology only studies 
Within the haematology only samples, two key areas of need were identified.  Fear of 
recurrence was identified in two out of the three studies and the third paper identified a 
need for information about fertility in younger patients as a key finding.  
Commonalities between mixed and haematology only samples 
Overall, when considering the needs raised in both samples, fear of recurrence and 
information needs were the most consistently identified.   Explaining similarities between 
groups according to time-point: at diagnosis, there were no studies identified in the 
haematology only sample with which to form a comparison with the mixed diagnoses 
sample.  In studies conducted when participants were receiving treatment for their 
diagnosis, fear of recurrence was raised in both sample groups.  While fear of recurrence 
was highlighted in both groups, it is worth noting that in the haematology only study, this 
was only the third most commonly expressed need and that other needs were rated more 
highly.  However, this is the result of a single study and the dataset therefore is too small to 
make firm conclusions.  Only one study was identified in either group where patients had 
been recruited during survivorship, meaning that it was not possible to draw comparisons 
between groups here. 
There is some suggestion that fertility issues are important to this patient group.  While 
there is not a wealth of data relating to fertility, as a theme it emerged within both the 
mixed and haematology only samples.  In the mixed sample, not being able to have a child 
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was highlighted and in the haematology only sample, an unmet need for more information 
relating to fertility was identified.   
Differences between mixed and haematology only samples 
While there have been several similarities highlighted between the mixed cancer sample 
and the haematology only sample, there are also a number of differences that merit 
exploration.   The first difference to note is that none of the studies identified with a 
haematology specific sample were longitudinal in design.  It is not possible therefore to 
form any comparisons with the apparent trend in the mixed sample group where the level 
of unmet needs decreases over time.   
At diagnosis, again it is not possible to form comparisons between groups as no studies 
were identified at this time-point in the haematology only sample.  Within the mixed 
sample, psychological needs emerged as being the most prevalent yet we have no 
information as to whether this trend is also seen in haematological cancer patients at the 
time of diagnosis. 
At the treatment time-point, unmet practical needs were highlighted within the 
haematology only sample but were not found to be present in the mixed cancer samples.  
Additionally, at the same time-point, in the mixed sample, concerns about those close to 
you was repeatedly expressed yet this was not raised within the haematology only sample.   
There were fewer studies published at the end of treatment time-point, with only one in 
each sample.  While there is, therefore, little evidence to compare between samples, the 
key unmet needs reported in each study did differ from the other.  In the haematology only 
sample, fear of recurrence was the primary unmet need while in the mixed sample, fear 
and anxiety were raised.  While the needs are different in precisely how they were 
assessed and reported, we can identify some similarities in that fear is common to both 
patient groups indicating the presence of psychological need across both. 
The final time-point investigated was survivorship.  As with the diagnosis time-point, we 
are unable to form comparisons between patient groups as no studies were identified with 
a mixed cancer sample at this time-point.  In the haematology only sample, a need for 
information regarding fertility in younger patients was highlighted yet it is not known 
whether this trend would be reflected in the mixed sample.   
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How reliable are the stated findings? 
Overall, the evidence included within this review was generally of a good methodological 
standard as determined by the quality assessment which lends credence to the findings.  
When considering unmet needs that might be most relevant at different time-points, it 
must be noted that some time-points have less supporting evidence than others.  At the 
survivorship time-point for example, there were no studies identified with a mixed cancer 
sample and only one conducted with a haematology only sample within which the 
haematology only group received a comparatively low quality assessment score of 68.2%.  
This is indicative of a need for further research in this area.  Similarly, there were no studies 
found that assessed need at the time of diagnosis with a haematology only sample and only 
two that assessed need at diagnosis with mixed cancer samples, again indicative of a lack of 
research in this area.  
When considering the unmet psychosocial needs identified in the three studies that were 
carried out with participants with haematological cancer only, two of the three studies 
identified concerns about the cancer coming back, or fear of recurrence, as a key unmet 
psychosocial need.  The third study which did not share the same finding scored a much 
lower score on the quality assessment, 68.2%, as a result of poor definition of both the 
needs assessment measure used within the study and of the results more generally.  This 
perhaps suggests that we can have more confidence in the findings predicted by the two 
studies that highlighted fear of recurrence which obtained quality assessment scores of 
100% and 95.4%.   
Overall, the highest study quality is found in the studies that assess unmet needs at mixed 
time-points.  The overall lowest quality assessment score was given to a study that falls 
within the treatment time-point, however, as this study is one of six that assess unmet 
need at this time-point, the overall quality of the results for that section is buoyed by the 
higher quality ratings of the other studies.  
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Discussion 
The systematic review into unmet psychosocial needs of haematological cancer patients 
outlines the scarcity of research in this area.  Only 18 papers were identified which had 
aimed to investigate the unmet needs of cancer patients including those with a diagnosis of 
haematological cancer, although only three of these placed a specific emphasis on 
haematological cancer.    
Summary of Evidence 
The findings indicate the presence of unmet psychosocial needs in haematological cancer 
patients.  Fear of recurrence was the single most commonly identified need, being 
highlighted in five separate studies, suggesting a real relevance to the patient group.  Fear 
of recurrence, which can be categorised within the domain of psychological need, was 
highlighted by studies in both the mixed and haematology only samples indicating a more 
widespread significance across cancers.  Indeed, it may be that even fear of recurrence is 
even more prevalent than suggested (Llewellyn et al., 2008).  The study conducted by Liang 
and colleagues (1990) simply tested for the presence of psychological need in general 
rather than looking at any more specific needs within this domain and Boyes et al. (2006) 
reported their results as needs within the psychological domain, psychological being the 
domain under which fear of recurrence is categorised.  
When considering the prevalence and the importance of psychological needs as an overall 
domain, it is worth noting that the PNI does not include psychological needs as a separate 
area of need within its subscale structure in the way that alternative needs assessment 
tools do.  There is a category for unmet emotional and spiritual needs which is the closest 
alternative to psychological needs, but the way in which this type of need is assessed does 
differ when the PNI is used.  The PNI is the method of assessing need in five of the included 
papers and therefore may have impacted upon the prevalence of psychological needs 
identified within this review by underestimating the presence of psychological need.   
Regardless, the results of this review highlight the importance of both fear of recurrence as 
an unmet need, and psychological needs more generally as an area of importance to those 
with a haematological malignancy.   
The importance of psychological needs has been reflected in the wider cancer literature.  A 
systematic review on unmet needs within a general cancer population found psychological 
needs to be the second most commonly reported unmet need (12-85%) (Harrison, et al., 
2009).  This review highlighted the variability of level of need within a general cancer 
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sample, yet it was difficult to tease apart differences in level of need according to diagnosis.  
The significant difference in levels of need reported from different studies does raise the 
suggestion that people with different diagnoses and therefore who experience cancer 
within different context may experience different needs, explaining this variability.   Fear of 
recurrence as a concern for those with a diagnosis of cancer has been raised repeatedly 
within the general cancer literature.  Two seminal papers within needs research (Bonevski 
et al., 2000; Sanson-Fisher et al., 2000) found fear of recurrence within the domain of 
psychological needs to be highly relevant within their samples.  Neither of the samples 
used in these papers however, included patients with a haematological diagnosis which 
suggests that, in this, haematology and other cancer diagnoses share a common fear.   A 
study published after this systematic review was conducted found that help with worries 
about spread of cancer or recurrence was amongst the least well met needs (Morrison et 
al., 2012), although interestingly this wasn’t the case within the haematology participants.  
Whether this was because this need was not felt to be relevant to participants or because 
this need was felt to be met amongst the haematology patients is unclear, although fear of 
recurrence was not rated within the top five least salient needs by the haematology 
patients indicating some recognition of importance.   
Information needs were identified within five separate studies, as was fear of recurrence, 
however the way in which unmet information needs were identified differed between 
these studies and the precise need identified by participants was not the same throughout.  
For example, the haematology only study carried out by Hammond and colleagues (2008) 
highlighted an unmet need for information relating to fertility for younger patients whilst in 
the work by Mesters et al. (2001) unmet needs for information about disease and 
treatment were identified.  As an overall area of need therefore, information needs 
emerged strongly but there is less continuity between studies.  The reason for this may lie 
in the way in which needs were assessed by different studies, for example the previously 
mentioned study by Hammond (2008) focussed specifically on the assessment of unmet 
needs relating to fertility in patients with NHL and therefore it is not surprising that this is 
what their findings highlighted.  We do not know from the data available whether, had this 
study assessed for information needs more generally, a more homogenous pattern of 
unmet needs would have emerged.   The wider literature relating to information needs 
suggests that needs of this nature are often rated highly by patients as being important to 
them (Bonevski, et al., 2000; Meredith et al., 1996; Mistry, Wilson, Priestman, Damery, & 
Haque, 2010; Sanson-Fisher, et al., 2000).  For cancer patients, the source of their 
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information most often comes from the healthcare professionals involved in their care and 
a previous systematic review focussed on information needs within a general cancer 
population found that information needs related to treatment are the most frequent 
(Rutten, Arora, Bakos, Aziz, & Rowland, 2005).   
Concerns about the worries of those close to you emerged as being important at the 
treatment time-point in studies conducted with mixed cancer samples.  While this was not 
highlighted as one of the most prevalent unmet needs within a haematology only sample at 
diagnosis (Molassiotis et al., 2011), four unmet needs relating to a patient’s significant 
others appear in the 15 most commonly identified unmet needs.  This suggests the 
potential for needs relating to patient’s loved ones to be key to both samples, however, 
with limited research published in haematology samples, it is not possible to form any firm 
conclusions.  This need is not one that has been highlighted by previous systematic reviews 
on general cancer samples, and, even within this review it does not appear as a 
homogenous need.  As previously discussed, the variations in needs assessment tools may 
in part explain the absence of this need in previous works, however, it is also possible that 
concerns about those close to you is a psychosocial need with a specific relevance to 
haematological cancer patients.  
Needs relating to fertility were raised in studies conducted by both Hawkins et al. (2008) 
and Hammond et al. (2008) meaning that it was raised across both haematology and mixed 
samples.  There were differences in exact unmet need identified, although the general 
theme of fertility was shared.  As with other areas of unmet needs, the presence or 
absence of unmet needs relating to fertility could be attributed to the way in which the 
assessment tool used within the studies categorised need.  The focus of some papers may 
have excluded fertility issues from being identified because of choice of measurement tool 
used, and so this would need further investigation before any firm conclusions could be 
made.  As with concerns about those close to you, needs relating to fertility have not been 
raised as important in previous reviews of need.  Again, this could be related to the way in 
which types of unmet needs are assessed for, however, it could also indicate a need that is 
specific to this patient group.   
Overall quality and robustness of results 
The majority of the included studies scored well in the quality assessment.  The lowest 
quality score achieved was 54.5% while 13 of the studies scored over 80%.   The decision to 
only review published literature had a positive impact on the quality of the research 
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included within the review as all papers have been through a peer assessment process and 
were found to be of an acceptable standard prior to publication.  Common reasons for 
studies scoring lower on the quality assessment were small sample sizes, poor response 
rates and a lack of detailed reporting of the work.   Within the wider psycho-oncology 
literature, response rates are a key issue.  The innately small sample size of some of some 
cancer populations can also be problematic, an issue that is discussed at greater length in 
Chapter 6 of this thesis. 
There were differences in the way in which studies were designed and carried out that limit 
how easily trends within the data can be determined.  Within the data collated from the 
longitudinal studies of mixed cancer patients, the level of unmet psychosocial needs was 
found to decrease over time.  Due to the lack of longitudinal data within the haematology 
only sample, it is not possible to develop comparisons and it is therefore uncertain to what 
extent this trend is relevant in haematology.   
A methodological weakness of the included papers as a group was that only three studies 
were found that looked solely at haematological cancer patients.  There were no studies 
identified in either sample group that looked at needs in haematological patients at the 
survivorship phase, meaning that there is no research evidence looking at long term unmet 
needs in these patients.  There are some similarities when studies are grouped according to 
diagnosis and time-point, however, no single group contains more than six studies.  These 
relatively small sample sizes mean that generalisability of the results drawn from these 
groups is limited and that exploration of sub-sample differences was not possible.   
Consequences of Unmet Psychosocial Needs 
The impact of the presence of high levels of unmet needs lies at the heart of needs 
research.  It is thought that high levels of unmet needs are associated with the presence of 
psychological distress (McIllmurray et al., 2001), however, this association has been poorly 
tested.  Of the three studies included in this systematic review that focussed solely on 
haematological diagnoses, only one required participants to also complete outcome 
measures along with the measure of unmet needs.   The study conducted by Molassiotis 
and colleagues (2011) included the Hospital Anxiety and Depression Scale (HADS) and the 
EORTC QLQ-C30 and the myeloma specific MY20 and found that both anxiety and 
depression were prevalent within their sample.  This study found a relationship between 
the ‘side effects of treatment’ subscale on the EORTC MY20 and level of unmet needs.  
However, this study was looking at predictors of unmet needs, not at the impact that 
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unmet needs have upon psychological wellbeing.  The fact that a relationship was found 
between a quality of life subscale and unmet needs indicates that there is the potential for 
a predictive relationship between needs and outcomes.  At present however, there is too 
little research conducted within this specific patient group to cast any firm judgement as to 
the reliability of any such relationship.    
More work is needed that evaluates the levels of unmet psychosocial needs in 
haematological cancer patients over longer periods of time.  Ideally future work would also 
include common psychological outcome measures such as anxiety, depression, quality of 
life, adjustment and coping to investigate the possibility of a causal relationship.  This work 
would allow us to feel confident in our knowledge and understanding of unmet need and 
would feed into the current culture within healthcare services towards risk stratification 
(Watson et al., 2012).  At the present time, and on the basis of the evidence identified, we 
are not in this position and more research is required.  If the factors involved in causing 
psychological distress were better understood then more support could be provided to 
those at risk at an earlier stage to minimise the presence of distress in patients.  
For the purposes of this review, outcomes can be defined as the presence of unmet needs.  
The results of the review highlighted variations in the type of unmet needs identified, 
which can potentially be attributed to differences between the ways in which unmet needs 
were assessed.  Of the 19 papers included within the review, there were 11 different needs 
assessment tools used.  Different assessment tools mean differences in the ways in which 
needs are classified which will impact upon the types of needs identified.  Even where 
needs appear to fall within the same category differences in categorisation limit 
generalisability, for example psychological needs were identified as was fear of recurrence.  
Within research, fear of recurrence is often classed as a psychological need, however, when 
a paper uses an assessment tool that simply asks participants whether they have any 
psychological needs, it is unclear what exactly this means to participants when they chose 
to acknowledge this need.  Additionally, some papers chose to focus their investigations 
upon a specific aspect of psychosocial need, for example information needs, meaning that 
this was the only category of need identified within that paper.  This has led to some needs 
being commonly identified within this review but it is unclear whether they would have the 
same prominence had all studies assessed needs in a common manner.   
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Conclusion 
In conclusion, this systematic review identified 18 relevant papers via systematic searches 
of relevant databases and journals in addition to examining the reference lists of included 
papers.  Each paper in some way assessed unmet psychosocial needs in a quantitative 
manner in an adult sample that included participants with a diagnosis of haematological 
cancer.  Prevalence of unmet psychosocial needs, type of psychosocial needs identified and 
the trends within the data were found to be highly variable with very limited data available 
in some of the areas investigated.  The key unmet psychosocial needs most relevant to this 
patient group appear to be fear of recurrence, psychological needs and information needs.  
However, these conclusions are likely to be, at least in part, due to the way in which the 
current evidence base has attempted to identify unmet psychosocial needs in this patient 
group.  In addition, few studies attempted to look at the trajectory of the levels of unmet 
psychosocial needs over time meaning that there is currently a lack of information 
regarding how haematological cancer patients’ needs may change over time.    
While this review may have succeeded in providing an indication of where potential key 
needs may lie, it is not yet possible to draw any firm conclusions with regards to the type 
and prevalence of the unmet psychosocial needs that play the biggest role in the 
psychological wellbeing of this patient group.  This review highlights the need for further 
research that assesses unmet psychosocial needs in haematological cancer patients, in 
particular via longitudinal cohort studies that assess type and level of unmet psychosocial 
need over time.  The current evidence base is on longitudinal trends in needs is also 
lacking, no such studies were identified with a haematology sample.  Moving forwards, 
there are two key concerns: 1) standardisation of assessment for greater consistency; and, 
2) the systematic identification of need in clinical practice.  This systematic review sought 
to understand type and prevalence of unmet need; as such, qualitative studies were not 
included within the review.  The lack of evidence found during the review process however, 
highlights the potential utility of qualitative research to act as preparatory work for future 
quantitative studies and that will expand our understanding of need to include why areas 
of need are felt to be relevant or important to patients.  As such, the work explored in the 
next chapter (Chapter 3), will seek to build on this and to introduce the patient voice into 
this body of work before moving on to quantitative identification of need in Chapters 4 and 
5.   
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Chapter 3 - The Lived Experiences 
of Patients with Non-Hodgkin’s 
Lymphoma: An Interpretative 
Phenomenological Analysis  
Overview 
The systematic literature review of the unmet psychosocial needs of haematological cancer 
patients (Chapter 2) outlines a scarcity of research.  Without having an appreciation of the 
type of needs that are important to patients, and truly understanding the causes and 
implications of unmet needs, it becomes difficult to create a standard of evidence-based 
practice within our healthcare service.  The present chapter will outline the development 
and findings of a qualitative study that aimed to: identify the unmet needs of 
haematological cancer patients; to understand how well suited existing needs assessment 
tools are for this patient group; and to understand the patient experience of living with this 
diagnosis and the impact of unmet need.  By understanding both how unmet need is 
currently assessed in cancer patients, and what this specific patient group perceive as being 
important, as researchers and clinicians we will be better placed to understand optimal 
ways of assessing need and to act on those needs.  The lack of existing literature that 
examines type and importance of unmet needs in this patient group means that, at 
present, the patient’s voice is absent from the research literature.   
Background  
The assessment of psychosocial needs in oncology, while generally recognised as having 
merit, is currently unsystematic at best and often neglected altogether.   Over recent years, 
there has been an emphasis on improving patient assessment following the publication by 
the National Institute for Clinical Excellence (NICE), Guidance for Improving Supportive and 
Palliative Care for Adults with Cancer (2004).  This highlighted the importance of 
considering the patient experience of receiving a diagnosis and treatment for cancer.   A 
previous study that examined the extent to which GP practices in the UK have adopted 
recommended practices for supportive and palliative care found adoption to be highly 
variable (Hughes, Bath, Ahmed & Noble, 2010).   
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The need for psychosocial assessment of cancer patients becomes clear when we consider 
the estimated prevalence of distress in haematology patients as being as high as 50% for 
some diagnoses (Zabora et al., 2001).   Allowing distress to develop not only goes against 
the best interests of the patient, but is also likely to prove more costly for health services in 
the longer term (Carlson & Bultz, 2004) as greater levels of psychological input are 
required.  Early intervention for mental health problems is widely recognised as being 
beneficial for the maintenance of psychological wellbeing (Antoni et al., 2001), yet 
screening for the presence of distress is not practiced routinely within cancer care 
(Jacobsen, 2007).   
Carrying out needs assessments in people who are living with a diagnosis of cancer can 
highlight areas in which that person is experiencing difficulties.  Needs relating to 
psychological wellbeing, social support, practical issues or communication with others have 
all been highlighted as being present in cancer patients (Sanson-Fisher et al., 2001; 
Harrison et al., 2009) and, if left unaddressed, have the potential to cause considerable 
psychological distress.  Assessing for unmet needs could highlight potential problems 
before they occur, and at the very least make clear to those providing care to the patient 
where extra support is required.   
Psychosocial need is an area that has also received increased attention from the academic 
psychosocial oncology community over recent years, the focus predominantly falling on 
descriptive studies aiming to document the specific psychosocial needs that are most 
relevant to a particular patient group.  The assessment of psychosocial needs differs from 
the assessment of distress in that the focus of the needs assessment is to determine where 
patients feel that they require assistance with their concerns, rather than simply 
acknowledging that there is a concern but finding that the patient has no desire to address 
this with their clinical team, perhaps wishing to seek support elsewhere (Carlson, Waller & 
Mitchell, 2012).  
As discussed in Chapter 2, while there has been an expansion of work investigating need 
within cancer patients in general, there has been little that has done so specifically in 
patients with haematological malignancies; the specific requirements of this patient group 
thus remain largely unknown and unexplored.  The systematic review identified just three 
papers that assessed need in haematology patients only and, of these papers, only one 
assessed need across the whole spectrum of diagnoses.  The review indicated some 
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similarities in the type of needs found in both haematology and solid tumour cancer 
groups, however, there are also indications that there may be key differences. 
What are the differences in need between haematological and other cancers? 
There are recognised differences between cancer patients with a haematological diagnosis 
and a diagnosis of a solid tumour (NICE, 2004).   Haematological malignancies are different 
in the way that they present, are treated and in their likely prognosis when compared with 
other cancer types (NICE, 2004).   The much publicised scenario where a patient finds a 
lump and seeks medical advice does not apply to those being diagnosed with a 
haematological cancer.  More common are symptoms of tiredness, weight loss, fever, 
breathlessness or night sweats.  These are not the typical symptoms generally expected of 
cancer, as such, a new patient may not present to their GP with the expectation of a cancer 
diagnosis.  Indeed, some report delayed diagnosis due to the fact that their symptoms are 
confused with other, less troublesome, diagnoses (Caplan, 1996).  
Treatment options for those diagnosed with a haematological malignancy are notably 
intensive in nature.  Bone marrow transplants can be used to treat both acute and chronic 
leukaemia, along with myelomas in certain circumstances.  A bone marrow transplant 
involves the harvest of healthy bone marrow stem cells from the donor and transplanting 
them into the bone marrow of the recipient (CRUK, 2013).  The risk of infection is greatly 
increased, and, the recipient is often placed in protective isolation.  This, combined with 
the fact that the patient will feel very unwell for an extended period of time makes this a 
distressing time for patients, with a number of studies highlighting a link between bone 
marrow transplant and post-traumatic stress disorder (Jacobsen et al, 1998; Johnson 
Vickberg et al; 2001).  At the other end of the treatment spectrum, some patients will 
receive no treatment at all in the months, or even years after their diagnosis.  ‘Watch and 
wait’ is a term used for the monitoring of patients who have received a diagnosis of 
haematological cancer but who do not yet require immediate treatment.  Instead they will 
often attend via an outpatient clinic for regular blood tests to monitor any progression of 
their disease (Leukaemia and Lymphoma Research, 2011).  This can present a psychological 
challenge for patients, albeit in a different way to the difficulties associated with of bone 
marrow transplantation.  Not receiving treatment after being given a cancer diagnosis may 
feel counter-intuitive to patients and is often not in line with their preconceptions about 
what it means to have cancer.  While treatment can be physically and psychologically 
difficult, it can also instil a sense of hope and of moving forward towards regaining a sense 
66 
 
of normality.  Conversely, the lack of treatment can mean that patients feel a lack of 
progress and like they are waiting indefinitely for something to happen.   
In addition to the differences in the way haematological cancers can be treated, the 
settings in which they are treated can also differ.   Previous research has highlighted that 
people with a haematological cancer are significantly less likely to be treated in a palliative 
care or hospice setting than those with other cancers (Howell et al, 2011).  Potential 
reasons for this are continued care provision from the haematology team, an uncertainty 
around when it is appropriate to refer someone into palliative care and a quick disease 
trajectory meaning that there is little time in which the patient can receive palliative care.  
The bulk of this research is comprised of qualitative research carried out in Australia 
(McGrath, 2001; McGrath, 2002; McGrath & Holewa, 2006).  It is not clear whether 
patients in the UK experience similar unmet care needs.  NICE (2003) recommend the 
integration of haematology and palliative care services from the point of diagnosis 
however, if the scenario that patients remain under the care of the haematology team is 
accurate, it may be that any needs are met by that team, making the lack of a transition to 
palliative care services one that concerns the correct implementation of policy rather than 
a cause of concern or unmet needs for patients.   
These differences between haematological cancers and solid tumours give rise to the 
possibility that the type of unmet needs associated with the two groups of diseases may 
differ.  Haematological cancers begin with different symptoms, may be diagnosed 
differently, treated differently and have care provided by different services.  Findings from 
the systematic review demonstrate that psychological needs feature highly in those with 
haematological cancers, something that may be tied into these differences and the 
surrounding sense of uncertainty, however, this knowledge comes from a very limited 
evidence base.  We also know from previous research that treatment for haematological 
cancer can affect a person’s ability to fulfil their usual roles in society: social, vocational and 
relationship roles can all suffer (Sherman et al., 2005).  When looked at in combination with 
the high distress rates in haematological patients (Carlson et al., 2004), a strong rationale 
emerges for the further exploration of the type of unmet needs present in haematology 
patients and to qualitatively explore their experiences of cancer and how this feeds into the 
type of need experienced.   
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Assessment of Unmet Psychosocial Need 
Current needs assessment tools 
As the amount of literature describing trends in unmet psychosocial needs in cancer 
populations has grown, so too have the number of needs assessment tools that are 
available for clinicians to use.   Existing needs assessment tools can be broadly 
characterised according to the time-point at which they were designed to assess patients’ 
level of unmet needs, however, the majority of measures have been designed for use in 
patients with any type of cancer diagnosis (Carlson, Waller & Mitchell, 2012).  A small 
number of measures have been developed for use within specific diagnostic populations, 
namely lung cancer (NA-ALCP), prostate cancer (PCNQ) with others developed for specific 
groups such as advanced cancer patients (NA-ACP, NEST, SPARC-45).   There is a tool that 
was developed for both lymphoma and colon cancer patients that assesses concerns 
relating to their treatment (CaTS – Schofield et al., 2012).  However as this measure states 
that it is to be used to measure patient concerns in the lead up to the start of 
chemotherapy, it falls outside of the definition of a needs assessment tool (see Chapter 2).  
More recently, the Supportive Unmet Needs Survey (SUNS), a needs assessment tool 
developed for use with cancer survivors (Campbell et al., 2010) has been assessed for both 
validity and reliability when used with haematological cancer survivors (Hall et al., 2014).  
This study has begun to address the gap in the literature regarding appropriate use of 
measures in haematological cancer samples yet predictive validity, test-retest reliability 
and confirmation of the factor structure still need to be confirmed.   
The distinction between measures that assess need and those that assess concerns is not 
always clear or easily distinguished within the literature.  Often those measures that are 
used to assess patient concerns are grouped together with those that measure needs 
(Carlson et al., 2012).  As needs are being defined as something that is required to underlie 
a person’s emotional and psychological wellbeing, then the fact that a patient has a 
concern within this area does not necessarily equate to them wanting further support from 
the hospital to meet this need (Baker-Glenn et al., 2011).  For example, it has been shown 
that even those who present with clinically significant levels of distress do not necessarily 
want support from their treating hospitals to manage this (Baker-Glenn et al., 2011; 
Mitchell et al., 2011).   A recent systematic review aimed to collate all of the current tools 
that assess unmet need specifically in cancer patient (Carlson et al., 2012).  The majority of 
the assessments found were created to be able to assess need in patients with any type of 
cancer diagnosis with a smaller subset designed to assess the specific needs of those with 
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advanced disease, within a specific clinical setting or of cancer survivors.  In total, 29 
assessment tools were identified that were deemed to assess unmet needs in cancer 
patients.  Further examination of the literature suggests three that are most commonly 
employed within research studies: 
 The Cancer Survivor’s Unmet Needs measure (CaSUN) was designed as a self-report 
measure to assess cancer survivor’s supportive care needs (Hodgkinson et al., 
2007).  It includes questions about the patient’s information and medical care 
issues, quality of life, emotional and relationship issues and the impact that cancer 
has had on life perspective ranging from no need/not applicable to high need.  The 
measure was developed based on an examination of existing literature, needs 
assessment tools and a prior qualitative study of unmet needs with cancer 
survivors and their partners.  
 The Supportive Care Needs Survey (SCNS) was originally developed to assess the 
unmet needs of cancer patients undergoing treatment (Bonevski et al., 2000; 
Sanson-Fisher et al., 2000).  The measure assessed needs across a range of areas: 
psychological, health system and information, physical and daily living, patient care 
and support and sexuality.  The original SCNS has been developed into a smaller 
version, the SCNS SF-34, with the aim to make the assessment less burdensome 
and, therefore, more likely to be used regularly in a clinical setting (Boyes et al., 
2009). 
 The Needs Evaluation Questionnaire (NEQ) was designed to assess the informative, 
psychological, social and practical needs of hospitalised cancer patients (Bonevski 
et al., 2000).  The measure was created based upon interviews with patients 
regarding their psychosocial needs. 
The assessment process 
As part of their Guidance on Improving Supportive and Palliative Care for Adults with 
Cancer (NICE, 2004), NICE spearheaded a new drive for the assessment of patient need in 
cancer.  This guidance recognised the need to assess patient need and the fact that needs 
were not always met.  Patients being unaware of the services available, healthcare 
professionals being unaware of the benefits of referring patients to supportive services, 
professionals not eliciting the needs of patients during consultations and poor 
communication between healthcare professionals were all cited within the report as 
barriers to implementation.   Since 2000, there has been an increase in the amount of 
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research published relating to the unmet needs of cancer patients, indicating an increasing 
awareness of the needs to address this issue in order to improve patient outcomes.   
A report on patient need also published in 2004 (Richardson et al, 2004) found that over 
half of needs assessments conducted in a clinical setting were carried out by nursing staff 
with over three-quarters of assessments taking place face-to-face between patient and 
healthcare professional.  Perhaps most pertinently, the average time taken for an 
assessment was 38 minutes.  In an environment where time is often precious and the 
average consultation time is short (Howie et al., 1999), this raises issues for the feasibility 
of conducting regular needs assessment for all patients in the secondary care setting.   
How often a needs assessment is, and should be, carried out in the clinical setting remains 
a pertinent issue.  The National Cancer Patient Survey in 2011/2012 found that only 24% of 
cancer patients were offered a needs assessment and subsequent care plan (NCIN, 2012) 
while research has indicated that 30% of patients are left with unmet needs after the 
completion of treatment (Armes et al., 2009).  The National Cancer Action Team (NCAT) 
suggests that needs assessment should take place at a range of key time points from 
diagnosis onwards as standard (NCAT, 2013).  The average time taken to complete a needs 
assessment, with further time required to put together, implement and continually monitor 
a comprehensive care plan, may go some way to explain why this process is still absent for 
the majority of cancer patients in the UK.  It is also unclear to what extent this process is 
valued by patient, something to be addressed by qualitative research.  While previous 
research has indicated that unmet needs are common in cancer patients (Harrison et al., 
2009), there has been little research conducted into whether or not patients feel that 
needs assessment is an important part of their overall care and to what extent any 
resulting care plans are valued.   These statistics relate to the degree of needs assessment 
that takes place within a general cancer setting, there is even less research available that 
indicates to what extent haematology patients are routinely offered these resources.  What 
is clear is the need for a holistic assessment of patient need in order to be able to 
understand which needs are most important to patients and which needs should be 
addressed by the care team.  
Who were current needs assessment tools designed for? 
In general, needs assessment tools are developed to assess the needs of a specific patient 
group and are developed and validated accordingly.  Some tools have been developed for 
the assessment of needs at a specific time point with measures developed for patients with 
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active disease (Tamburini et al., 2000), for survivors (Hodgkinson et al., 2007) and patients 
in palliative care or at end of life (Osse et al., 2004).  Most tools however, were developed 
for generic use with cancer patients and for use within an outpatient clinic.   
In theory, a needs assessment using a specific tool should, therefore, only be carried out at 
the time point for which that measure was developed.  The extent to which this happens is 
practice is unclear.  We know that needs assessment is often unsystematic (Carlson et al., 
2004), with levels of implementation varying between clinics and even between clinicians.  
It is likely that each clinic has one specific measure that they adopt to assess their patients 
regardless of timing or other clinical factors.   In addition, while all of the tools identified 
were developed with the aim of assessing unmet need, the precise focus of the assessment 
can vary.   Not all tools will assess unmet needs across all domains and not all tools assess 
the extent to which a patient desires help or assistance with their unmet need (Richardson 
et al., 2007).   The generic needs assessment tools, therefore, have the widest clinical utility 
and are perhaps more likely to be adopted at practice level.  
The practicality of an assessment tool is a key concern when considering how best to make 
assessment an integral part of practice.  Time taken to complete the tool can vary 
considerably, with estimates between five minutes and 45 minutes for different measures 
(Richardson et al., 2007).  The method of implementation also requires consideration: most 
commonly, assessment tools are self-completion measures that patients can complete with 
minimal input from the clinical team (Bonevski et al., 2000; Sanson-Fisher et al., 2000).  
Other measures require an interview with the clinical team (First & Gibbon, 2004).  There 
are benefits to both approaches, with an interview with a healthcare professional allowing 
for a more in-depth exploration of the person’s need and the healthcare professional can 
provide the meeting of their needs.  This approach, however, is more time intensive for 
clinicians and may make this approach unfeasible for large numbers of patients, a particular 
problem within outpatient clinics.  
Why do we need to understand patient’s perceptions of need rather than just be 
able to identify them?  
Previous research on unmet needs in cancer has comprised of quantitative studies that use 
an assessment tool to determine whether or not a person has an unmet need in a specific 
area.  This is valuable information and well-suited for a quick assessment within the clinical 
setting, but is limited in how much it can tell us about why people are rating needs as 
unmet.  In some cases, it may be that a person indicates that they have many unmet needs 
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but that, on further investigation, each of those unmet needs is only impacting upon the 
person’s life in a small way.  Conversely, someone may only rate a small number of needs 
as being unmet but that does not mean that those unmet needs are not causing a 
significant level of distress or impairment.   
A more recent needs assessment tool (Morrison et al., 2012) went some way to address 
this by indicating not only the presence of need but also saliency of that need and the 
degree to which these needs have been met.  Prior to this, few tools had addressed both 
issues.  Many needs assessment tools will include a ‘not applicable’ option for patients who 
don’t believe that the need in question applies to them, but this style of quantitative 
assessment cannot tell us why that patient does not feel that a specific need is not 
applicable. It may be that the patient is genuinely unaffected by the issue or, it might be 
that they do not wish to address that specific concern with their healthcare team.  
Qualitative research allows researchers to explore the patient experience and the 
meanings behind the tick box.  This can indicate not just what needs are present but why 
they are important to patients and the extent to which an unmet needs impacts upon a 
person’s wellbeing.   This study attempts to fill the literature gap with relation to 
understanding the context of unmet need for haematological cancer patients. 
 
What were the aims of the study? 
This study aimed to answer Thesis Question 2: 
What do haematological cancer patients perceive to be their key areas of 
psychosocial need and why were those specific needs important during the 
patient experience of cancer? 
Secondary objectives included: (a) forming a deeper understanding of why specific needs 
are important and relevant to patients; and, (b) to use the data gathered to assess how 
suitable current needs assessment tools are for assessment within this patient group.  
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Methodology 
Design 
This study involved two phases.  A thematic analysis of existing needs assessment tools was 
undertaken to determine type of need identified across published measures.  This was 
followed by a series of focus groups that investigated patient views on the type and level of 
psychosocial need present within those diagnosed with a haematological cancer.  Each 
focus group involved an unprompted discussion of needs and experiences, followed by a 
more structured discussion of areas of need based upon the areas highlighted within the 
thematic analysis.  The original intention was to run a series of focus groups organised 
according to diagnosis: one with patients diagnosed with an acute leukaemia or a high 
grade lymphoma; one for patients diagnosed with chronic leukaemia or a low grade 
lymphoma; one for patients diagnosed with myeloma; and one for healthcare professionals 
working within a haematology oncology setting.  The rationale for organising the groups 
this way was to run focus groups with participants who had all experienced similarities in 
both the type of diagnosis received and the likely treatment undertaken.  Due to lower 
recruitment rates than expected, three focus groups ran, all with patients with a diagnosis 
of Non-Hodgkin’s Lymphoma.  Reasons for this will be explored later in the chapter.    
An Interpretative Phenomenological Analysis approach was adopted for analysis of this 
data which was especially suited given that one of the primary goals of the study was to 
understand lived experiences of need within this patient group (Smith, 2004).  IPA allows 
the researcher to develop a deeper understanding of the phenomenon in question than 
other qualitative methodologies by seeking to not only reduce the phenomenon to a 
discrete set of categories, but by studying the phenomenon within the context in which it is 
experienced by those with first-hand experience (Giorgi & Giorgi, 2008).  This was 
necessary, along with the quantitative studies later in this thesis, in order to fill the current 
gap in the literature and to inform effective interventions to meet the needs of this group. 
Participants 
The initial recruitment strategy for this study was to recruit patients with a variety of 
haematological diagnoses and to run a series of focus groups with participants grouped 
according to their diagnosis.  In the four months that recruitment was open for the study 
however, only participants with a diagnosis of Non-Hodgkin’s lymphoma had been 
identified and consented.  
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In total, six participants were recruited into the study and together made up a homogenous 
sample group.  All had been diagnosed with Non-Hodgkin’s lymphoma, all were white 
British, all had been treated at the same hospital, all were within  a similar age range, lived 
within a similar geographic area in the North West of England, had partners, and were 
working at the time of diagnosis.  There were five males and one female in the sample.   
Sample Size 
Sample size in qualitative research can be a divisive issue, with fewer ‘rules’ in place than 
for quantitative sample size calculations.  When making a decision regarding sample size in 
qualitative research, the epistemological, methodological and practical issues must be 
taken into consideration (Baker & Edwards, 2012).  The epistemological position here takes 
a phenomenological stance, yet the interpretive nature of IPA as a methodology must also 
be considered.  IPA typically utilises small samples, most often between three and 15 
(Brocki & Wearden, 2006), although between three and six has been cited as the optimal 
sample for student theses (Smith, Flowers & Larkin, 2009).  This is much smaller than would 
be deemed appropriate for other qualitative methodologies, where 50 has been proposed 
as an appropriate number of participants for a PhD thesis (Baker & Edwards, 2012).  IPA is 
concerned with detail, with understanding the complexity of human thoughts and 
emotions, as such it is believed that keeping the sample size small creates the optimum 
balance of quality over quantity.  A ‘concentrated focus on a small number of cases’ should 
allow for the development of areas of both similarity and of difference between 
participants, yet prevent the researcher from becoming overwhelmed by the amount of 
data and the level of analysis required by IPA (Smith, Flowers & Larkin, 2009).  
When considering the demands of IPA as a methodology, and taking into account the 
research communities’ prior experience with sample size for this methodology, it was felt 
that 6 was a sufficient number of participants from which a solid IPA could be developed.  
In addition, this was appropriate for the practical constraints that are present when 
conducting research with cancer patients, the recruitment strategy is outlined below.   
Recruitment 
Recruitment of patients took place in collaboration with the clinical staff team at the 
Countess of Chester Hospital Haematology Oncology ward under the guidance of the 
Consultant Haematologist.  The clinical team identified patients meeting eligibility criteria 
for the study and provided a brief introduction regarding the premise of the study and 
what taking part would involve.  In addition to a verbal introduction to the project, 
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potential participants were provided with a flyer (Appendix 8) and a consent form 
(Appendix 9) to indicate whether or not they were interested in receiving more information 
from the research team.  The inclusion criteria for each focus group were as follows: 
 Adult over the age of 18. 
 A diagnosis of haematological cancer. 
 Not currently undergoing active treatment. 
 Able to provide informed consent.  
 Currently a patient at the Countess of Chester Hospital. 
If a patient indicated that they wished to receive more information, a full information pack 
was posted out to them containing an invitation letter (Appendix 10), an information sheet 
(Appendix 11), a demographic questionnaire (Appendix 12) and a consent form to be filled 
in should the patient wish to take part in the study, along with a pre-paid envelope 
addressed to myself at the university in which the consent form could be returned.  
As previously highlighted, though patients with all haematological cancer diagnoses were 
eligible to take part in the study, only patients with NHL were successfully recruited.  There 
are several possible explanations as to why NHL was the only diagnosis recruited within the 
timeframe: 
 Overestimation of the numbers of patients who are no longer receiving active 
treatment but that are still attending regular clinic appointments.  (NHL is the most 
commonly diagnosed haematological cancer and therefore, as a patient group are 
more commonly seen on a regular basis within the clinic setting.) 
 Acute leukaemia were less likely to meet the inclusion criteria as they are more 
likely to be undergoing treatment, do not survive to the survivorship stage 
required, or are “cured” so do not come into clinic on a frequent enough basis to 
be picked up within a few months’ timeframe. 
 Comparatively lower incidence of myeloma in comparison with NHL patients.  
Myeloma is additionally an incurable diagnosis and, as such, there are few who 
have completed treatment/are not receiving active treatment for their diagnosis. 
After a four month recruitment period, the decision was made to cease recruitment and to 
move forward with the study with a sample that was smaller in size and clinical scope than 
initially anticipated.  Considerable challenges encountered when attempting to recruit 
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participants into the study.  While homogeneity within the sample was appropriate given 
the use of IPA, it does reflect a wider problem within psychosocial oncology research in 
attempting to recruit diverse samples that reflect society within the UK today.  However, 
the dominance of males within the sample was deemed positive as men are typically 
harder to engage in psychosocial oncology research than women.  Indeed, difficulty 
recruiting cancer patients into psychosocial studies is a challenge beyond that presented 
within this thesis and is a challenge for psychosocial research in the UK today, the causes 
and implications of this are discussed at length in Chapter 6.   
Of those recruited, saturation appeared to be achieved with some patients approached 
twice (over consecutive clinic visits) by the healthcare team.  As this study was intended as 
a preparatory study to later empirical work, it was felt that allowing the recruitment 
window to continue for an unlimited period of time was neither feasible nor helpful to the 
thesis aims.  Additionally, an IPA approach was already intended: this is idiographic in 
nature and therefore small, homogeneous samples are common and to be expected.  The 
number recruited was sufficient for this analysis to be performed in line with published 
methodological guidance (Smith & Osbourn, 2004; Brocki & Wearden, 2006).   
The Development of a Focus Group Schedule  
Prior to conducting the focus groups, a thematic analysis of existing needs assessment tools 
was carried out in order to create a list of psychosocial needs that were currently 
recognised by existing measurement tools.  There were several reasons for doing this: i) to 
create a prompt for discussion during the focus groups; ii) to facilitate a discussion 
regarding whether the needs identified were deemed important or relevant by 
haematology patients; and, iii) to determine to whether the needs of haematology patients 
were included in these measures developed for general cancer samples and, therefore, 
whether or not current tools were adequate for the assessment of unmet needs in this 
patient group.   
A separate literature search was conducted in addition to the systematic review outlined in 
Chapter 2 in order to identify existing needs assessment tools.  PsychINFO, Medline, Cinahl 
and Web of Knowledge were searched along with Google Scholar.  To be included, tools 
had to assess unmet needs and be specific about this as their purpose.  Tools that assessed 
concerns, problems, or other psychosocial outcomes were not included.   
In total, 12 needs assessment tools were identified and included within the thematic 
analysis: 
76 
 
 Patient Needs Assessment Tool (PNAT) (Coyle et al., 1996) 
 Needs Near the End of LifeScale (NEST) (Emmanual, Alpert & Emmanual, 2001) 
 Problems and Needs in Palliative Care Questionnaire (PNPC) (Osse et al., 2004) 
 Needs Evaluation Questionnaire (NEQ) (Tamburini et al., 2001) 
 Supportive Care Needs Survey (SCNS-LF59) (Bonevski et al., 2000; Sanson-Fisher et 
al., 2000) 
 Cancer Rehabilitation Evaluation System (CARES) (Ganz et al., 1992) 
 Information and Support Needs Questionnaire (ISNQ) (Chalmers et al., 2003) 
 Patient Needs Inventory (PNI) (Thomas et al., 2001) 
 Oncology Clinic Patient Checklist (OCPC) (Romsaas et al., 1983) 
 Sheffield Profile for Referral and Assessment for Care (SPARC) (Ahmedzai et al., 
2004) 
 Cancer Survivors Unmet Needs (CaSUN) (Hodgkinson et al., 2007) 
 Supportive Unmet Needs Survey (SUNS) (Campbell et al., 2010) 
Each needs assessment tool was examined and a collated list of the needs assessed in each 
was created (Appendix 3).  The list of questions was then analysed using a thematic analysis 
approach to group like needs together and to eliminate duplicates.  Once this was 
completed, the resulting list of needs was analysed to identify overarching areas of need 
that could be grouped together (Appendix 4).  The final list of themes was tabulated and 
then used as a prompt within the focus groups (Appendix 5). 
A semi-structured interview schedule was created based upon the findings from the 
thematic analysis of assessment tools.  The schedule retained a large degree of flexibility to 
include some unprompted discussion of experiences and concerns encountered and 
therefore the ability to explore in more depth areas of need that were identified as being of 
importance to participants, although the researcher ensured that each area of the schedule 
was included within each focus group.   To assist in this, after an initial period of 
unprompted discussion, each participant was provided with a table that included the areas 
of need identified by the thematic analysis of existing measures (Appendix 3 and 4).  
Each focus group ran to the same overall schedule as detailed below: 
1. Unprompted discussion of their needs/their understanding of patients’ needs. 
2. Time to look at the item pool drawn up from existing needs assessment tools and 
discussion of the relevance of items. 
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3. The comparative importance of both the needs that they themselves identified 
and the needs identified from the current assessment tools.  
4. Participants were asked to highlight the needs most important to them and to rank 
them where appropriate.  
The interview schedule was intended to be open-ended, utilising the schedule to facilitate 
discussion and to allow participants to tell their story.  All interviews were audio recorded 
on two tape recorders for transcription purposes.  In the case of sound interruption, 
ambiguity or interference the researcher would leave the interfered section as inaudible. 
Procedure 
Prior to participant recruitment, ethical approval was obtained from the University of 
Chester, the NHS Research Ethics Committee, and local research governance approval 
secured at the appropriate site.   
Data was collected using focus group methodology.  Focus groups can be an excellent way 
of encouraging participants to think laterally and to explore ideas that they may not have 
brought up if interviewed alone.  This new thinking about a topic can result in the 
formation of new ideas and create a much more in-depth discussion than might otherwise 
occur.  Additionally, focus groups can seem like a more comfortable environment for 
participants, particularly when discussing sensitive or potentially distressing topics as they 
are with others who have experienced the same phenomena (Halcomb et al., 2007).  A 
group setting can allow for a participant not to take part in a discussion if they feel 
uncomfortable with a specific topic.  Of course, this can also have disadvantages and, when 
conducting group interviews, the researcher must work harder to ensure that all members 
of the group seem comfortable with the discussion.  Having a co-facilitator is a real benefit 
when running a focus group as the second person can be on hand to assist any participant 
who needs any help or support during the session without disrupting the rest of the 
interview.   The role of the facilitator is key to a successful focus group: they must be 
comfortable in leading the group and have the interpersonal skills required to moderate 
the session well (Gibbs, 1997).    
While focus groups can be beneficial in seeing how participants interact within a group 
dynamic, for this research study, it was important to maintain the individual accounts of 
each participant’s experience of their illness to allow for an in-depth IPA analysis of each 
experience to take place.   As such, small focus groups were ideal and a maximum of three 
or four participants was included in each.  Due to the timing of each group however, none 
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of those conducted exceeded two participants.  While two participants constitutes a very 
small focus group, the decision was made to go ahead as it was felt that two participants 
was enough to generate the benefits of a focus group format already mentioned, while in 
addition may also be helpful in the context of an IPA study in that it would allow for the 
individual’s narrative to emerge with greater ease.   
Each focus group was held at the Countess of Chester Hospital where a seminar room away 
from the ward environment was made available.  It was felt that this would be a more 
comfortable environment for participants rather than being on the ward where they had 
been diagnosed and treated for their NHL.   
Data analysis 
IPA is a qualitative research method that seeks to put the meaning placed upon a 
phenomenon by the participant at the centre of the analysis and resulting understanding, 
an approach that has been used widely within health psychology (Brocki & Wearden, 
2006).  Due to the homogenous nature of the sample and the small sample size recruited, 
IPA was both ideally suited to the data and research aims by allowing for an in depth 
exploration of patient experiences, adding a richness to the needs literature and 
illuminating the importance and relevance of specific needs for this particular patient 
group. 
IPA is concerned with understanding the lived experiences of participants and to 
understand, in detail, how they make sense of their world (Smith & Osborn, 2008).  The 
method incorporates both phenomenological and hermeneutic approaches in its origins. 
While other qualitative research methods, thematic analysis included, aim to produce an 
objective statement regarding an event or occurrence that can be generalised across a 
population, IPA seeks to understand individual’s perceptions and experiences and attempts 
to examine participant’s lived experiences, therefore, adopting a phenomenological stance 
than other methodologies (Smith et al., 2004).   This approach allows the researcher to gain 
an insight into the participants’ inner lives, a factor that was central to the decision to 
adopt IPA methodology for this study.  IPA assumes that participants seek to interpret their 
experiences in a way that is understandable to them (Brocki & Wearden, 2006) which was 
appropriate for this study where the primary aim was to provide a depth of understanding 
regarding why specific areas of unmet need are deemed important to patients during their 
cancer experiences.    
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As a philosophy, phenomenology can be traced back to Edmund Husserl in the early 
twentieth century.  IPA is phenomenological in that it seeks to understand how an 
individual views and understands their world, rather than to try and produce an objective 
or removed record of an event.  Phenomenological research aims to detail a particular 
phenomenon, to study in depth the first-person experiences of an event or context (Giorgi 
& Giorgi, 2008).   The aim of data collection is to try and capture the lived experience within 
the context in which the experience took place.  From here, analysis attempts to seek the 
deeper psychological meanings by investigating and seeking to understand these lived 
examples.    
The extent to which the research is able to successfully interpret and make sense of the 
world as viewed by participants is dependent on their interpretation.  IPA involves a two-
stage interpretation process (a double-hermeneutic), in that not only must the researcher 
attempt to understand the participant’s world, but the participant must also try to make 
sense of their own world during the interview process (Smith & Osborn, 2008).  In addition, 
it has been argued that IPA operates a double-hermeneutic in a second way, in how it seeks 
to form an interpretative position (Smith, Flowers, & Larkin, 2009).  IPA can be seen as 
combining a hermeneutics of empathy, that is to say to attempt to reconstruct the 
experience within its own context and terms, with a hermeneutics of questioning, to allow 
the researcher to stand alongside the participant and seek to question and to explore their 
words.  The joint reflections of both participant and researcher come together to form the 
analytic account of the study (Brocki & Wearden, 2006).  It is this combination of empathy 
and questioning, that creates true understanding (Smith, Flowers & Larkin, 2009). 
Traditionally, data collection for IPA has been conducted via semi-structured interviews 
(Smith & Osborn, 2004), however, the approach has always been used with a degree of 
eclecticism (Palmer et al., 2010).  Indeed, the approach demonstrates flexibility both in its 
theory and its application.  Analysing data gathered from focus groups is a newer 
application of the method, however, Jonathon Smith, one of the key figures in the 
development of IPA, endorsed the use of focus group data for IPA as being worthy of 
further investigation, albeit with a degree of caution exercised (Smith, 2004).  Since that 
time, there have been a number of papers published using both focus groups and IPA 
(Aubeeluck et al., 2012; Earle et al., 2005), giving an indication of the successful integration 
of methodology and data collection. 
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When considering the use of IPA for data collected via focus groups, it is imperative to 
maintain the ethos of the approach, that the individual narrative of each participant is 
allowed to be told (Smith, 2004) and the complexity of the interactions within a focus 
group should not detract from this (Palmer et al., 2010).  Each person taking part in the 
focus group must be given the opportunity to tell their own story in sufficient depth to 
allow the researcher to understand that individual’s experiences.  It should be kept in mind 
that the accounts shared by participants will not only be shaped by the questions asked by 
the researcher, but also by the shared experiences of all members of the focus group 
(Palmer et al., 2010).   
Homogeneity within the sample, as was the case in the present study, is something 
commonly associated with IPA (Smith, 2004), and less so with other types of qualitative 
analysis.  Indeed, IPA is concerned with participants’ subjective accounts and is not 
expected to be generalizable to the same degree that a thematic analysis might which 
seemed to fit with the data and the local knowledge detailed by the participants. 
In accordance with IPA recommendations, transcripts were validated independently by a 
second researcher (Nick Hulbert-Willams (NHW)).  Following first analysis by the researcher 
(BS) NHW selected one transcript (of the three) at random.  He read this in full checking 
both the accuracy of notes made by BS, and adding his own additional thoughts and 
themes. In addition NHW checked the audit trail of analysis by matching the noted 
transcripts to the theme tables.  Once a first draft of the results narrative was complete, 
NHW again selected another of the transcripts at random to provide a second level of 
validation to ensure that the analysis framework proposed fitted with the raw data 
accurately.  In this way, the validation of themes became part of the analysis process as it 
added a further layer to the exploration and interpretation of the data.    Designing 
research studies in such a way as to maintain a high level of quality and to reduce the 
potential for bias is essential in the production of high quality studies.  Validation is key to 
this process in qualitative research as it reduces the possibility of misinterpretation of the 
data and assists in the maintenance of objectivity.    Due to the nature of the sample and 
the use of focus groups, respondent validation was not considered appropriate.  As 
participants were recruited because of their cancer diagnosis, it was felt to be 
inappropriate to re-contact people whose ongoing health status after the focus group was 
uncertain.  In addition, the decision to conduct the interviews as dyads meant that there 
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was potential for one participant to comment on another’s prose, which was not felt to 
reflect the true purpose of respondent validation.   
Prior to undertaking this piece of research, the researcher had conducted a systematic 
review of unmet need in cancer patients which provided an a priori assumption that there 
would be needs present within the sample.  This influenced the creation of the interview 
schedule in that the initial part of each focus group was an unstructured discussion of 
participant need and experiences with minimal input from the facilitators before moving on 
the ask participants to comment on pre-existing areas where needs have been recognised 
in people living with cancer.   Having an unprompted discussion at the start of the interview 
schedule was felt to reduce the chance that the themes generated in the data analysis 
would be biased by either prior knowledge on the part of the researcher or by the use of 
the tabulated items resulting from the thematic analysis of existing measurement tools. 
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Results 
Individual’s Experiences of Cancer 
The initial part of each focus group included an icebreaker question designed to relax the 
participants and develop rapport.  This had the added benefit of allowing more practical 
background nature about each participant’s narrative of diagnosis and treatment.   These 
participant biographies are important as they demonstrate the individualistic nature of 
how haematological cancer presents and is treated; these are summarised below, including 
an overview of each participant’s reporting of their psychosocial adjustment and 
experiences. 
David  
David began his participation in the focus group with a description of his diagnosis process 
and subsequent treatment.  David was unusual in the sample in that he had initially 
accessed treatment via private healthcare services and this is where the diagnosis was 
given.  David was unhappy with the waiting times cited before he could see a private 
haematologist and so took it upon himself to find a haematologist who could see him 
sooner.  On the advice of the private haematologist, David moved to be treated in an NHS 
hospital (on haematologist recommendation) this for treatment due to the experience of 
staff there in administering chemotherapy.  Initially David was monitored on “watch and 
wait” and found that challenging due to the uncertainty and the expectancy of what was to 
come.  David described the period immediately after diagnosis as the most challenging 
psychologically and emotionally but then describes feeling able to accept that it was his 
“turn” to be ill.  A strong family support network is described but there are some 
indications that he did not wish to burden his family with his fears.   David was extremely 
keen to know everything about his diagnosis and treatment, and this is possibly linked to 
feeling more in control which may act as a coping mechanism.  He described some 
differences in haematological cancers compared to other cancers, likening his lymphoma to 
a chronic illness.  He is very active in his own care, for example speaking at a NICE 
committee.  David also attends a Lymphoma Association support group regularly. 
William  
William also began his discussion of his experiences with a description of how he was 
diagnosed and the initial treatment that he received.   He described a need to keep positive 
throughout his experience, both from himself and from those around him.  William came 
across as being very stoical in nature and describes himself as accepting of what has 
83 
 
happened to him.   The relationship with the healthcare professionals involved in his care 
was clearly important to him, perhaps particularly so in light of the fact that he described 
little in way of a support network although he stated that he has a partner.   Physical and 
practical needs were both endorsed although there was little that was described as having 
a significant negative impact upon his life.   
James  
James began his discussion of his experiences of living with haematological cancer with 
comments on the information that was given at the time of diagnosis.  It was felt that clear, 
simple information was needed here.  The initial diagnosis was described as being a shock, 
but then James seemed to quickly get used to the idea of being ill and began to focus on 
getting better. James described the presences of unmet support needs within his family, 
with his wife in particular finding his diagnosis difficult.  This concern was on-going, 
however, as his family did not receive any kind of psychological or practical support.  James 
did have physical needs during his illness but seems to accept these as part of having 
cancer and was therefore was psychologically able to cope with them.  Anxiety only 
appears to have been present in context of being in hospital and being unclear about what 
was going to happen to him.  Once that immediate anxiety was resolved, the presence of 
any acute anxiety appears to have diminished.   
Mark  
Mark was vocal about wanting to know about his illness and treatment and was 
comfortable addressing this with HCPs.  Initially Mark had been very unwell and care had 
been accessed from multiple hospitals with some confusion over the initial diagnosis.  He 
was very unwilling to identify himself as a cancer patient and actively tried to avoid this by 
avoiding anything that would tie him to diagnosis.  Due to this, body image was a big 
concern; to him his appearance was a physical manifestation of the illness that he did not 
want to be defined by.  He identified that he had psychological needs and that these were 
unmet but was very reluctant to engage in any kind of support that might ease these 
needs.  Throughout the focus group, Mark seemed to place locus of control within himself 
in that he believes needs are met by asking for help and that it is up to the patient to do 
this.   
Ray  
Ray began with some discussion of his diagnosis process, describing this as 'fraught' as it 
was difficult to obtain a precise diagnosis. Initially he is quite descriptive in how he speaks 
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about his illness, although fairly quickly more emotive language begins to be used.   He 
described significant difficulties coping psychologically once treatment had finished and he 
no longer had a goal to aim for.  Severe anxiety and depression meant that Ray saw a 
psychiatrist privately when it was too difficult to access psychiatric services through the 
NHS.  He did not go back to work after completing treatment due to the impact of his 
illness on his mental state at that time.  Ray described having a very supportive family but 
had significant feelings of guilt associated with surviving, with the positive encouragements 
of others and about living his life after surviving cancer.   
Daphne  
Daphne was the only female to take part in the focus groups.  She described finding it 
difficult to get a diagnosis initially, after being told by her GP that she was depressed.  The 
physical side effects of treatment were significant, affecting her ability to eat and her pain 
levels were high.   Daphne’s husband found it difficult to cope with her diagnosis and would 
not accompany her on hospital visits.  She describes having a strong support network of 
friends and attributes this as being part of her ability to stay positive.  She felt that she 
needed more help throughout her experience and would have liked a designated person to 
call with concerns; instead she felt that she had to wait until she came into clinic and this 
was a source of difficulty.  The impact of changes to body image was significant as this 
affected how Daphne perceived herself and how she felt others saw her.  Daphne was keen 
to give back to others after her own experience and felt that, as someone who had 
experienced haematological cancer, she could be useful to those going through it.  Daphne 
was particularly vocal about the perceived lack of services available to haematology 
patients compared to other cancer patients, in particular breast cancer patients.   
 
Super-Ordinate Themes 
In total, six super-ordinate themes emerged from the analysis.  Theme titles and their 
corresponding sub-ordinate themes are presented in Table 3.1.  Following the table is an 
interpretative summary of each theme, including exemplar quotes. 
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Table 3.1: Overview of themes 
Super-Ordinate Themes Sub-Ordinate Themes 
The Everyday Impact of Cancer Practical; 
Physical 
Psychological Needs Adjustment Throughout the Cancer 
Experience; 
The Importance of Environment; 
Perceptions of Self; 
Specific Areas of Psychological Need 
The Need to Feel Supported Throughout the 
Cancer Experience 
Social Support; 
Feeling Supported by Medical Professionals; 
Availability and Acceptability of 
Psychological Support; 
Being Supported as a Haematology Patient 
Barriers to Accessing Support Feeling Unable to Ask for Help; 
Physical vs. Psychological; 
Psychosocial Concerns Not Discussed 
Making Sense of the Cancer Experience Personal Changes; 
Understanding My Experiences; 
Control 
Need for Information Delivery of Information; 
Having Personalised Information Available 
 
The Everyday Impact of Cancer  
Being diagnosed with haematological cancer has an impact upon how able patients are to 
maintain their everyday routine.  Both physically and practically cancer can have huge 
repercussions and can impact upon daily functioning. 
Practical  
Practical needs were endorsed by all six participants.  The type of need identified varied 
between participants but in general, being diagnosed with cancer meant that tasks that 
were either easily maintained before or had just not been considered a priority now 
became issues that required consideration: 
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"I was thinking only the other day that I need to update my will" David 
 
"you could help at home but just... didn't feel like it.  Just didn't seem to have... the energy" 
James 
 
Sometimes the practical issues discussed became a concern because participants did not 
have prior knowledge of how the relevant systems work, and the lack of clarity both fed 
into a more general sense of uncertainty, but also created additional work and stress. 
“You do need someone who knows the system to help you” William 
 
Generally speaking, most of the minor practicalities associated with living with a diagnosis 
of cancer were described as being managed well by the hospital staff.  Although practical 
concerns did arise throughout the course of their illness, generally these needs were 
deemed as being met which diminished any resulting psychological distress as a result of 
the presence of need. 
“They do go to quite a lot of effort don’t they to find out who you live with, who’s there, 
what your property’s like” Mark 
 
Physical  
Physical needs were repeatedly identified by participants.  However, as with many practical 
issues, they were often deemed to have been met by the nursing staff.   
“I would say, around the physical stuff there, the, um, a lot of that was dealt with by the 
nursing people on the ward” Mark 
 
“Anything around, if you needed, you know, erm, the washing, the dressing, the sleeping 
stuff, yeah that was dealt with” Mark 
 
On-going physical needs were still a concern for some participants and prevented them 
from doing the things that they would have liked to or had done before they were 
diagnosed.   
“the pain, the pain was extraordinary” William 
 
"Yes, the, the exhaustion does continue.  I find that I can't do what I used to." Ray 
 
This change from ‘normality’ seems to be what made physical needs difficult to manage yet 
there was an expectation that there would be physical consequences of having an illness 
such as cancer.  This expectation that there would be both physical and practical effects of 
cancer lessened the impact of unmet need within these domains, and participants 
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generally seemed able to cope and to adjust to these needs, even where suffering was 
present. 
“as you get older the physical needs and issues change regardless of how well you are” 
David 
Psychological Needs  
Adjustment Throughout the Cancer Experience 
Being diagnosed with cancer was the first time that participant’s had to acknowledge their 
own mortality and were forced to accept that their lives were going to change.  The way in 
which patients received the news that they had cancer impacted upon how difficult the 
subsequent adjustment process was, with some describing rather blunt and brutal 
conversations with their HCPs which seemed to feed into a sense of feeling lost and 
uncertain. 
"basically I sat in front of him and he said 'you've got cancer'… what you got is probably 
incurable, and you need to see a specialist.  And then, off you go.  So." David 
 
While participants wanted to know what was wrong with them, the truth was always 
deemed to be important, the way in which this was communicated by the hospital staff 
was key.  The point of diagnosis was traumatic for participants and often stood out as the 
worst point in their entire experience, as such being spoken to honestly, clearly and yet 
kindly was highly valued.  Once diagnosed, the psychological impact of being a 
haematological cancer patient was felt immediately.  For some, the negative connotations 
associated with having cancer and facing up to being ill was the most difficult hurdle to 
overcome. 
 
“when they do tell you it’s cancer… it knocks the wind out of your sails” James 
 
For another participant however, there was a sense of relief to finally know what was 
wrong after having been told that there was nothing wrong by their GP: 
“he (GP) said it was everything except, oh you’ve got depression, you’ve got this, you’ve got 
that…it was a hell of a relief to know there was something wrong, rather than me thinking it 
was…” Daphne 
 
The end of treatment was also a crucial time in psychological adjustment.  During the 
diagnosis and treatment process, patients are regularly visiting the hospital and have the 
security of seeing their clinicians regularly and being able to ask any questions that they 
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may have.  Once treatment ended, this safety net is removed and people are then left to 
cope on their own.   
"I think the emotional bit comes in right at the end to be honest with you… When you’re in 
it and the treatment is there and you think, right, from here we’re going to have chemo 
next, we’re going to have this next, we’ll have reconstructive stuff.  And then when you get 
kind of fired off at the end.  You’re at home aren’t you? Well, you are, and I think that 
maybe that’s the time" Mark 
 
Additionally, participants described putting everything into ‘fighting’ their illness, and then 
having nothing left to give once that process was complete.   The ‘fight’ was over and the 
real impact of having had cancer became apparent.  
“I just, having got the all clear and having got that letter, I just… just descended.  I just 
couldn’t face anything.  And I don’t know… I’d just given everything.” Ray 
 
Once cancer was ‘over’ and treatment completed, the sense of purpose and moving 
forward can become lost.  There was a lack of certainty around what to expect after cancer, 
and the reduced level of contact with the hospital meant that there was less opportunity to 
speak to clinical staff or to seek reassurance. 
"is that what we're supposed to expect after?" Daphne 
 
A sense of uncertainty and isolation can permeate and leave patients feeling vulnerable 
and unsure of what will come next at a time when many patients feel that their lives should 
be returning to ‘normal’. 
The Importance of Environment  
The environment in which care was given had a psychological impact upon participants.  A 
physical environment that was seen as depressing, or one that was seen as a place for ill 
people to be, impacted negatively on participant’s own sense of wellbeing: 
“I did go to [hospital] on one occasion.  And, I, I found it a very sad experience, I found it a 
very sad hospital.  That… There were so many very ill people round there… And, er, I really 
didn’t want to go back there, it depressed me no end that… experience.” William 
 
"once I was out of there, I was back to normal" James 
 
The hospital ward setting is not always seen as being the best place in which to raise 
psychosocial concerns, a theme that is discussed in depth under ‘Barriers to Accessing 
Support’.  Given the reluctance of participants to discuss psychological concerns in the 
hospital clinic setting, it may be that a physically separate environment would be more 
conducive to patients feeling comfortable about broaching concerns of this nature.  
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“we do need to perhaps have a separate clinic, not necessarily in here but somewhere else 
in the hospital or somewhere else where you can come and talk to us about it” David 
  
There was a feeling of separation between the physical illness that the hospital is deemed 
to be there to cure, and the psychological impact of living with such an illness.  A sense of 
continuity and being physically comfortable was important in the enabling the treatment 
environment to become comfortable psychologically and, where present, this impacted 
positively on wellbeing.  
"And the attitude changed... and that made a huge difference to me" Ray 
 
"I always liked to be in the same place for my chemo, treated in the same little corner and 
sit and watch everything that’s going on." Ray 
 
Perceptions of Self 
Other people’s perceptions of their illness were important.  There was a need felt by 
participants to keep positive and this meant that experiencing other people’s negativity 
was difficult.  Patients need to believe that they will get better and any opinions to the 
contrary challenged this belief and make the belief more difficult to maintain. 
“a lot of people think as soon as you’ve mentioned cancer, they think god, we’ll be burying 
him soon” James 
 
The perceptions that others have of cancer, and that it is often equated with death, can 
also create a mis-match with the patient’s own expectations for their future and their 
recovery.  This created a conflict with the need to think positively and to believe that they 
would get better, which is difficult when the patient is trying to think in a certain way about 
their illness.   
"I didn't expect to die when I was give that, told I had cancer" David 
 
There was also a sense that other people who haven’t experienced lymphoma don’t fully 
understand what it is like to live with cancer and, therefore, some of the views expressed 
by others or within the media seemed to antagonise, and to create distance between 
participants and those around them. 
 
“everyone talks about, again, you know, the media, fighting… battling cancer, fighting 
cancer, so and so’s beaten cancer four times.  Well, I… I don’t know what that means 
really.” Mark 
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The way that participants perceived other people’s view of them to change as a result of 
their diagnosis fed through into perceived changes in the way that participants were 
treated by others and the degree to which they felt viewed as an individual rather than a 
patient.   
“I’ve just been thinking about respect for the individual, as you were talking about that, I 
think, sometimes, when people are ill, some people see the illness and not the individual 
still. Um, I think, I’m hoping we’ve gone through this but I’m hoping, when HIV first came 
along and people saw HIV and not the individual.  And I think that’s an absolute travesty.  
You know, it’s not the way it should be. And I think, sometimes, if you’ve had cancer, people 
see you as a cancer sufferer, or a recovering cancer sufferer, rather than as John or Fred or 
Mary or Jane or whoever you are…  Who happens to have this, rather than, that’s your 
defining element.” David 
   
 
This difference was a difficult thing for many participants to manage as it called into 
question further their perception of self and their role in the world.  For participants who 
had viewed themselves as being powerful people, being treated as an ‘ill’ person was 
challenging, they did not identify with being an ill person. 
“You know, I suppose in a way, I, I was always very, I’m amazed, you get some people in the 
newspaper now and they say, cancer survivor so and so, or there’s a young girl in Chester 
who is constantly doing charity work cos she’s a cancer survivor and stuff like this.  Well, 
even at the time I was pretty touchy about it… I didn’t want to be defined… as a cancer 
sufferer.”  Mark 
 
For others, being treated with respect was difficult as it was felt that being diagnosed with 
cancer was something that happens to you, not something that is earned.  
“Erm, I found the respect as an individual rather difficult.  Erm, because, err… through the 
school, you know, I was going to beat that and they passed that information on to 
everybody else and I was getting messages from school and everything… and I did not see 
myself as being an inspiration to anybody.” Ray 
 
For some, being seen as a ‘cancer patient’ was something to be actively avoided.  There 
was a strong desire to maintain appearances to others and any evidence to the contrary 
resulted in anger and frustration.  Changes in appearance and the impact that this had on 
body image was a key concern for two participants, Mark and Daphne, in particular.  
Physical changes represent a physical manifestation of their disease, particularly difficult 
when someone strives not to be seen as cancer patient, as Mark did, and changes how the 
person feels about themself and how they believe that they are perceived by others. 
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“It made me so ill.  It’s taken me… this is my hair now, and I lost it two years last August.  
And this is all I’ve still got so you can imagine.  Somebody who’s been in fashion all their life 
with no hair.  Erm… but the fact that I’ve never been as thin as this in my life, and so you 
feel a mess, a mess in clothes.  And so I found it hard to, to… get going to put one foot in 
front of the other, I was just so exhausted… I just felt a freak” Daphne 
 
There was a perception within this group of patients that, when compared with other 
issues related to cancer, body image should be something that matters less when 
compared to the potentially life threatening nature of the disease yet, physical appearance 
was something that really mattered to some as it is the way in which they present 
themselves to the world, an integral part of their identity. 
"It matters what you... it matters to the person." Daphne 
Specific Areas of Psychological Need 
Psychological need was highly prevalent within the sample and an area where needs often 
went unmet.  All participants identified some area within psychological needs that had 
been important to them during their experience.  The impact of having unmet needs in this 
area was described as being significant, in one instance impacting so severely on a patient’s 
life that he was still unable to live the life that he had had before being diagnosed with 
cancer. 
"And I was in one hell of a state.  Mentally.  And, I still am." Ray 
 
For others, the impact was less severe but having a diagnosis of cancer still impacted 
negatively upon psychological wellbeing and it was felt that the help available for 
psychological concerns was less accessible than for other issues: 
“they’re the ones which I felt most strongly and they’re the ones which I didn’t get any help 
with” Mark 
 
 
Emotional 
Having cancer was, at times, a highly emotional period of the participant’s lives.  Key events 
such as birthdays or Christmas seem to have been triggers for participants to realise the 
impact of their diagnosis and participant’s described how this affected them emotionally.   
“I can remember driving home from work on the motorway, and, I was crying while I was 
driving.  And thinking ‘I wonder how many more birthday’s I’m going to have” David 
 
Bursts of intense emotions were present even in those participants who describe 
themselves as accepting of their illness.  For all, facing your own mortality forces the 
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confrontation of fears that otherwise remain unacknowledged and the desire to live comes 
to the fore.   
Guilt was not something that was widely discussed within all of the focus groups nor was 
something that was explicitly asked about by the researcher.  However, one participant 
described feelings of considerable guilt that had an on-going significant impact upon his 
psychological wellbeing.   
“I still feel very guilty when I think of the time and I haven’t made the most of the 
opportunities I have got” Ray 
 
There was guilt at defying the expectations of being diagnosed with cancer, that is that one 
will become very ill and that death is highly likely.  In turn, there were feelings around 
needing to make the most of life in light of being so lucky to still be alive which perhaps set 
unrealistic expectations of what life after cancer might look like which in turn fed into the 
presence of guilt around not being the hero who had survived cancer. 
Coping 
A range of coping strategies were described, each employed to help that person to come to 
terms with what was happening to them and the potential implications of having cancer.  
Some found talking about their experiences helpful and welcomed this.  Others took part in 
voluntary work with relevant cancer charities, while not directly discussing their illness; this 
enables the person to be with others with similar experiences and to adjust to having 
cancer as a part of their life.   
"the more I talk, the more I can, not come to terms with it but the more it settles into your 
psyche" David 
 
In contrast, one person described trying not to get into emotional feelings about their 
cancer and actively avoided being seen as a cancer patient where possible in order to try to 
maintain as much of a sense of normality as possible.   
"But it wasn’t a Big Deal.  Sorry, can I rephrase.  I was a big deal cos I was away from home 
for too long and I wasn’t at work and, you know, eventually went onto half pay at work and 
all this sort of stuff so it was a big deal in that sense.  But... I couldn't get into that big 
emotional feeling" Mark 
 
By maintaining the façade that things are fine, it may be that these participants found it 
easier to hold onto the belief that things are indeed so.  
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Fear of Recurrence 
Fear of Recurrence (FoR) was an issue that was raised repeatedly within the focus groups 
as being a concern; however, there was a sense that participants felt that worrying about 
the cancer coming back was inevitable given their experiences.   
“worries for the future, I can’t say that’s not a… you don’t want, you never want to face the 
facts do you” Daphne 
 
There was also a sense from two participants that they were sure that their cancer would 
return.  Whether this was based upon information provided by their clinicians or was in fact 
a way of coping with this concern by attempting to accept it is unclear.   Both participants 
who expressed this view stated that they had been told that there was a possibility of 
recurrence but neither explicitly stated that they had been told this definitively.  
"you have to get into a position mentally where you accept the recurrence, rather than fear 
it" David 
 
The description of ‘accepting’ the sense of recurrence is telling as it indicates that taking 
this stance is a means of protecting the self from the possibility of recurrence to reduce the 
negative impact should this arise.  The shock of diagnoses has been discussed as a notably 
difficult time for patients, anticipating a recurrence prevents re-experiencing a subsequent 
diagnosis in the same manner.   
Hope/positivity 
Keeping positive was a key need for participants.  There appear to be several elements that 
were integral to this need: participants felt the need for positivity from those around them.   
"you need people around you that, even if they don't think it, they need to show it that 
they've got a positive attitude" James 
 
This was helpful in maintaining their own sense of positivity but participants also often 
described feeling unable to care for the psychological needs of others when they were 
feeling so overwhelmed and this understanding is undoubtedly related to their need for 
their supporting relatives to be positive and thus non-reliant on the patient.   
Keeping positive and maintaining a positive outlook also appears to act as a way of coping 
for some participants, they need to maintain the hope and belief that they will get better as 
the alternative is to accept that death is a possibility and this would have a considerable 
negative impact on psychological wellbeing.   
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"my attitude right the way through was that I was going to beat it" Ray 
 
The Need to Feel Supported Throughout the Cancer Experience  
In general, support needs were noted as being important to participants and where this 
need was felt to be unmet, the impact was felt to be significant.   
Social Support 
The relationships held with family and close friends provided a great deal of emotional 
support and were highly valued.  Being diagnosed with cancer had the potential to impact 
negatively upon relationships with some participants expressing surprise at how certain 
friends reacted to the news, providing less support than expected by the participant.  This 
was a difficult thing to deal with and to not to have the expected support was challenging, 
particularly in light of how highly valued social relationships were.   
 
“Yeah, it was really important, it really raised my spirits but, you know, as I say I was a little 
bit surprised really about who kind of put what into the pot in a sense.” Mark 
 
For some, the maintenance of social relationships became difficult throughout their 
experiences.  The weight of their own concerns and distress was such that it became 
impossible to take on the distress of others also. 
"I didn't want to make contact cos I just couldn't cope cos I was up to here" Daphne 
 
This results in a reduced support network, the presence of which is known to be beneficial 
for patients. 
 
Employment was felt to be an area where people might need significant support, however, 
most of the participants in this sample felt that their work related needs had been 
managed during their illness.   Where the social support from colleagues was felt to be 
good, this had a positive impact on overall wellbeing: 
“I have to say the office, they’ve been terrific.” David 
 
It was recognised though that, had this not been the case and had employers not been 
willing to accommodate their needs during their illness, then the potential implications 
both practically and psychologically were significant. 
 
“As a group it’s extremely relevant.  Gaining and maintaining” David 
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Feeling Supported by Medical Professionals 
Communication 
Communication between participants and their healthcare professionals was crucial for 
determining how comfortable and supported participants felt with their future care.  
Successful communication was deemed to be when it was clear and tailored to the 
individual patient.  Corresponding with the later theme on information needs, in order for 
patients to feel supported within the clinical environment, the way in which information 
was given had to be right.   
“even though they kept explaining things… they use big words and names of stuff.  If it was 
written down you’d probably be able to take it in easier” James 
 
Having one key member of the medical team who could act as a point of contact was 
deemed to be beneficial as it would allow patients to build a relationship with that HCP and 
to be able to trust that they could approach them with any difficulties that they might 
have.  This was not always felt to have been the case for participants, and the lack of a key 
worker was felt to be a barrier to being able to build a rapport with a member of staff 
which would have made it easier to know who to approach in a crisis. 
“I just feel if only I had somebody like (nurse), like (nurse), somebody who would go through 
things with you… when you’re desperate.  That’s what we’re short of.”  Daphne 
 
Communication between medical professionals was felt to be highly important in allowing 
patients to feel at ease with the decisions being made about their care and, when felt to be 
done well, created a sense of satisfaction for participants. 
“the liaison between the surgeons and the consultants and this hospital and another… all of 
these columns, as I suppose you might expect, that’s where I felt I had the greatest need 
and where I felt they were met most fully.” Mark 
 
When communication between HCPs and patients was not well achieved, however, it 
impacted negatively upon how the relationship was perceived. 
“I said I’m not having any more [treatment], I’ve only come to see Dr (name).  Anyway, next 
thing he comes and says you’ve got another six” Daphne 
 
It was important that patients felt part of their treatment decision making process and that 
they were understood and their opinions valued by their treating clinicians.   
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Contact with hospital 
Having regular contact with the healthcare professionals involved in their care was a key 
need for participants and creating a feeling of being supported by those providing care. 
“I was coming in here every three weeks or every couple of months.  And that was really 
helpful because you’re constantly seeing the same people, who are experts in their field all 
the time” David 
 
When regular contact ended at the end of treatment, the feelings of support that had been 
fostered during the treatment phase were suddenly absent, leaving participants feeling 
alone. 
“And then you get fired off at the end.  You’re at home aren’t you?” Mark 
 
It is the contrast between perceived support during the treatment phase when hospital 
appointments are frequent and the end of treatment phase when this tails off that makes 
this a difficult time for patients.  There is a need to feel that help is available if needed and 
regular contact facilitates this.   
Treatment 
 
As with diagnosis, the experience of being treated for their cancer was something that all 
participants talked about within the focus groups.  This was a common experience for 
participants, even where the exact nature of the treatment given differed, all had had 
similar experiences of being treated at the hospital and the physical side-effects and 
uncertainty that this brought with it.  Treatment was a topic where participants could feel 
sure of shared experiences, yet that did not seem to be a source of any embarrassment or 
discomfort making it an easy topic of conversation.   
Treatment needs were present but the way that they were discussed indicated that they 
were an expected part of cancer treatment.  This seems to lessen the psychological impact 
of having treatment related needs and fed into an increased ability to cope with concerns 
in this area.   
“you expect the treatment to make you feel ill.  That’s what I found, when I started it, I 
expected to feel bad” David 
 
That being said, there was a real need for support from HCPs during treatment.  In 
particular, side-effects were noted as being are area where further support was needed. 
“the side effects of the treatment.  You need more help.” Daphne 
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For some, the physical impact of treatment was high and there was a perception of 
insufficient support available outside of the hospital setting to manage unexpected effects 
that arose.   While undergoing treatment, support was immediately available from staff 
administering, yet when patients went home between appointments, it was not clear when 
or who to contact for concerns as they come up. 
Where treatment deviated from the expected model of treatment for cancer (i.e. 
chemotherapy, radiotherapy, surgery or a combination of all), it was challenging for the 
participant to make sense of the deviation from expected outcome. 
"One of the many aspects of this that I've found... challenging, in a way, is the watch and 
wait" David 
This lack of treatment goes against the perceived conventions for cancer treatment and the 
prolonged waiting to become progressively more ill made this time difficult.  This feeds into 
a sense of uncertainty and anxiety both around what the future will look like but also 
allows fear around the cancer to develop and grow. 
Availability and Acceptability of Psychological Support 
There were differences in the extent to which participants would have been willing to 
engage with formal psychological support.  Some felt that they would have benefitted from 
this kind of support while others were adamant that they did not feel that it was right for 
them. 
“I’d rather have somebody prescribe something than deep, psycho, self analysis” Mark 
 
The presence of unmet psychological needs did not appear to correspond with patient 
desire to seek or receive support for their needs, indeed, those participants who expressed 
unmet psychological needs were also, on occasion, those participants who stated that they 
did not want help with psychological concerns.   There was a sense that participants 
thought that psychological support would be available to them if a patient directly asked 
for it, but the onus was seen to be on the patient to ask. Participants differed in how 
comfortable they would have felt doing so.   
“you don’t get any interaction with a psychologist or someone who understands these 
things, if you are feeling depressed, you would probably tend to keep it to yourself because 
you’re sat in a room with 12 other people” David 
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It was also felt that it is unclear what kind of support would be available or offered, the 
uncertainty of which may feed into the reluctance to ask, giving rise to thoughts of “do I 
want that type of support that might be given?”. 
“they don’t really advertise it to you much” James 
 
The lack of understanding of what a psychology service can provide fed into the shared 
reluctance by some to consider these services as an acceptable support option.  Better 
advertisement of the type of support available would demystify psychological input and 
would increase perceived acceptability for some patients. 
While not all participants were comfortable with the idea of formal psychological support 
for themselves, there was a recognition that their families were in need of support and this 
was felt to be an area where there was a real lack of support.   
"the family suffer worse… my wife still goes into tears over it" James 
 
 Concerns about those close to participants were prevalent and added a layer of complexity 
to the participant’s own feelings and concerns regarding their illness.  The wellbeing of 
patient’s families directly feeds into the patient’s own wellbeing as the family is often the 
primary support system and the patient is likely to be concerned about any distress that 
their family experiences as a result of their illness.  
Being Supported as a Haematology Patient 
Other people’s understanding of haematological cancers 
It was clear from each of the focus groups that haematology is perceived as being 
somehow different from other cancers.  As a diagnosis, it was thought to be less well 
understood by both peers and other healthcare professionals which added to feelings of 
being different and being separated from other ‘cancer patients’.  
“they think cancer’s cancer, and it isn’t is it?” Mark 
 
The psychological impact of feeling separated from others has the potential to be 
significant.  The separation is potentially multi-layered with patients not identifying 
themselves as being ‘cancer patients’ yet nor can they feel a sense of understanding from 
their loved ones from whom they would previously have drawn on for support and 
comfort.  This has the potential to produce feelings of isolation and vulnerability at a time 
when social support is known to be particularly important. 
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The perception of poor understanding of lymphoma extended from social circles to HCPs 
involved in patient care. 
“I think the GPs should be taught a little bit more about lymphoma” Daphne 
 
While the expert support from the haematology teams was generally deemed excellent at 
providing physical care for their illness, the level of understanding of lymphoma from 
primary care clinicians was often felt to be lacking.   The GP is often the first person that a 
patient will come into contact with when becoming ill and feeling as though their clinician 
does not have an adequate level of knowledge of their condition can create feelings of 
anxiety and anger with the people who should be a source of support and reassurance.     
Haematological cancers are different 
Participants identified perceived differences between themselves as haematological cancer 
patients and cancer patients with other diagnoses.    
“I’m in remission and, you know, hope to be so for as long as possible but, there’s no 
outward signs.  Now, if you’ve had aggressive breast cancer and, for instance, you’ve had a 
mastectomy… and your body image changes.  Whereas here there isn’t much to take away, 
it’s all, it’s more medicine as opposed to surgery and it’s more like diabetes that’s 
controlled” David 
 
There are differences in the way that haematological cancers are treated; David likened his 
treatment to that of a chronic diagnosis rather than the ‘surgical’ approach that he felt was 
more commonly associated with cancer treatment.    
"they say, you've got cancer, we're not going to do anything about it" David 
 
This deviation from the expected had a psychological impact that patients may not have 
anticipated when initially given their diagnoses.  Watch and wait requires on-going 
monitoring of a patient’s condition but no active treatment is undertaken until the patient 
becomes symptomatic.  Commencing treatment brings with it a sense of ‘fighting’ the 
disease, something that has become part of the general stance regarding what a patient 
should be doing when they are diagnosed with cancer.  Not only does a lack of active 
treatment take this sense of purpose and moving forward away from patients, it also 
requires them to wait in the knowledge that, at some unknown time, their illness will 
progress and they will become ill.  Information about what to expect is provided but the 
individualistic nature of cancer means waiting for something that is not fully 
comprehended yet perceived to be negative. 
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Even where active treatment was undertaken, the nature of haematological cancer 
treatment meant that a sense of ambiguity remained. 
 “but once, with breast cancer, once they take it away it makes a big difference” Daphne 
 
With the haematological cancers, surgery is much less common than for solid tumours with 
many patients being treated with chemotherapy alone.   One participant described feeling 
as though surgery would have been preferable as this would have enabled her to feel as 
though her cancer had been removed, a perception that was not forthcoming with 
chemotherapy alone.  When a cancer of the blood and bone marrow is diagnosed, patients 
can feel as though the cancer is everywhere and has taken over their body.  This can mean 
that patients do not get the sense that their cancer has been removed and continue to feel 
as though their bodies have been invaded by this malevolent being. 
This difference in treatment also translated to differences in appearance when compared 
to what might be ‘expected’ of cancer patients.  Feeling ‘different’ in this way may act to 
impact upon how isolated patients feel during their illness, compounding any feelings that 
personal relationships are affected by diagnosis. 
“what I think is interesting about this particular disease is that you don’t actually look ill” 
David 
 
The absence of altered appearance resulted in difficulties for both the patients themselves 
and those around them to perceive them as a ‘cancer patient’. 
"it is easy to sort of internalise them, and it's easy to ignore them and, erm, for others to 
ignore them if you like" David 
 
For some, this would have been a positive as it means that they were more easily able to 
maintain a sense of normality.  For others, being diagnosed with cancer was a highly 
significant event in their lives and while they may not have wanted to continually engage 
with thoughts about cancer, it was important that the significance of what was happening 
to them was recognised. 
Support available 
The reduced awareness of haematological diagnoses and the inherent differences 
combined to create the perception that, as haematological cancer patients, they were less 
well catered for in terms of the level of support available.   
“Now if you’ve got cancer, the Macmillan nurses are superb” Daphne 
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The use of the phrase “if you’ve got cancer” is notable, again indicating a lack of 
identification with the self as a cancer patient.  Rather, patients seem to feel that they have 
their own distinct identity as a haematology patient.   
The perceived lack of support was compounded by comparisons made with the level of 
support available to other diagnoses, with breast cancer being given as an example.   
“If you’ve got breast cancer, you get a lot more… erm… cushioning.” Daphne 
 
The sense that they are different and that this means less support was challenging for 
participants.  Daphne in particular felt a sense of unfairness that there was so much 
support available for some patients but not for her as a haematology patient.  This acts to 
feed to sense of isolation and difference from other, potentially resulting in heightened 
emotions for a group that do not feel willing or able to access psychological support. 
Giving something back 
As patients now in remission, participants described feeling the desire to give something 
back and to help others now in the situation that they themselves had previously 
experienced.   
"I did this whole school assembly once, I just said to all the kids, look... I woke up one 
morning and had a lump the size of an orange on my shoulder" Mark 
 
This desire to help others with their illness may stem from their own sense of being 
different and the resulting feelings of isolation experienced, participants did not want 
others to have to go through the same experience as they had. 
"I go along to show people that it's not just people in their 70s that suffer from this" David 
 
Being able to provide support for others is also likely to be a source of comfort and support 
for patients themselves.  Although their disease may be in remission, feelings of being 
somehow different are more persistent and spending time with others in the same 
situation can lessen feelings of isolation and provide comfort in its own right.   
Barriers to Accessing Support  
Feeling Unable to Ask for Help 
Participants described feeling unable to raise psychological concerns with healthcare 
professionals, it was not a comfortable topic for participants.   
102 
 
“When you’re not used to doing that, and perhaps not comfortable with doing that” 
William 
 
This problem may be exacerbated by the fact that this sample was predominately 
composed of older men, an age group that are perhaps unused to discussing their feelings 
and emotions with other people.  The business of the ward environment was not conducive 
in enabling people to ask for help.  If someone is not comfortable talking about their 
emotions, then trying to do so in an environment where there are a lot of people present 
and where the staff are obviously busy, there is a fear that they would be either disturbing 
the staff member or that their concerns are simply not important enough, and this acted as 
a real barrier to psychosocial concerns being raised. 
“I think the support is there if you, you want it.  You just ask.  But I think sometimes, do you 
not think people are afraid to ask? In case, because everyone’s busy, I think some people 
get it in their head, oh I can’t, I’d better not ask in case they’re busy” Mark 
 
There was a perception held by participants that asking for help with a concern that was 
not physical in nature was somehow less valid that a directly medical concern, again 
reducing the likelihood of patients seeking help.  Hospitals were viewed as places where 
illness is treated medically, and anything that fell outside of this remit became an area of 
uncertainty.   
"But I was reluctant because... pride.  Erm, but yes I think you cover a lot up." Daphne 
 
There was a sense that not to be coping well with illness was somehow shameful.  Feeling 
too proud to admit to struggling, or feeling as though you should be able to cope, were 
obstructions to open and frank discussions around psychosocial issues. 
Physical vs. Psychological Concerns 
The clinic environment was noted to be busy and full of other people with HCPs being 
incredibly busy trying to provide assistance to large numbers of patients.   When patients 
are already uncomfortable with raising a concern, doing so in front of many others felt 
almost impossible. 
“I don’t know if you’ve been to clinic here recently, there’s a hundred people out there” 
David 
 
The medical staff at the hospital were held in high esteem by all participants, however, this 
may actually have compounded the feelings of discomfort around asking for psychological 
help as patients feel concerned about ‘troubling’ staff when they are perceived to be too 
busy. 
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"I kept saying that I, I'm sorry, I don't like troubling you" William 
 
Again, there is a sense that psychological concerns are just not important enough to 
‘bother’ HCPs who are busy doing things that are of perceived greater importance.  There 
seems to be a perception that hospitals are for treating physical illness and there was an 
uncertainty about whether it was OK to discuss other issues with hospital staff.  In addition, 
where other patients were seen to be struggling physically, it was deemed unfair to ask the 
staff to deal with psychological issues rather than the physical ones. 
“I was so grateful and so lucky that in my first session of chemo all I got…  And to see other 
people there… how can I be dragging nurses away from them to deal with the way I was 
thinking about things, not feeling, but thinking about things?  It just didn’t come into the 
equation.” Ray 
 
Psychosocial Concerns Not Discussed 
As a consequence of patients feeling uncomfortable asking for help and having the 
perception that the staff are either too busy or that psychological issues are less valid than 
physical concerns, psychosocial fears were simply not discussed.   
“I was just sitting there listening, reading my paper, being as jolly as possible when 
someone came round so, maybe they thought, well this is a guy who doesn’t seem to be 
presenting as anything” Mark 
 
Patients don’t feel able to raise their concerns and described putting on a ‘brave face’ but 
then this meant that the healthcare professionals were unaware that a problem existed 
and did not raise psychosocial issues either.   
“unless they’ve got time to spend speaking to you, they cannot hear what’s happening 
inside you.  And it’s the bits you can’t see.” Ray 
 
The result of this was that psychosocial concerns were simply not discussed within the 
clinic setting.  This meant that the impact of psychological or emotional needs was able to 
develop and become more problematic as the needs grew in the absence of support from 
the hospital. 
Making Sense of the Cancer Experience 
Personal Changes  
While cancer was generally deemed to have been a negative experience, there were 
instances where participants chose to look for the positive in what they had been through.  
Personal growth as a result of living through their illness was one such benefit. 
104 
 
"it kind of makes you a different person at the end of it" David 
 
Participants felt that having faced their own mortality, they now had a clarity in their lives 
that had not been there before and, as a result, chose to live a life that was closer to how 
they had always hoped it would be.  Priorities became clearer and it was easier to put what 
mattered to each person first without feeling apologetic about doing so as the awareness 
that life is not infinite had been harshly realised. 
Understanding My Experiences  
Throughout the focus groups, participants formed comparisons with others in such a way 
that seemed to play a role in helping them understand their own experiences.   Creating 
positive comparisons with others who have survived the illness was a way of providing 
hope and reassurance that their situation was not as bad as it could be.  
"I went along to my first support group at the Lymphoma Association and there's a lady 
there who was diagnosed with NHL 18 years ago" David 
 
But, conversely, to see other people pass away as a result of their illness was difficult for 
participants to cope with and contradicted the need to remain positive and to believe that 
they would get better.   
"So she said… oh, anyway, unfortunately (name) was dying.  Now can you imagine going 
through all this and thinking she's just told me two years." Daphne 
 
While seeing others survive and thrive after cancer was a powerful source of hope, seeing 
others struggle throughout their illness was not only difficult in that it caused participants 
to acknowledge the possibility of death but also it meant that participants had to rate 
themselves on a sort of scale of how well they were coping with their illness in comparison 
with others. 
"looking at others, and the way that some people would only get halfway through their first 
lot of the day and be really struggling..." Ray 
 
"my problem was a tiny one" Daphne 
 
Comparisons caused participants to feel as though their concerns were minor in 
comparison but this also had the adverse effect of creating feelings of guilt that they felt 
how they did when others were perceived to be coping with worse.  This also fed back into 
a reluctance to speak to staff about psychological concerns, these problems were deemed 
to be insignificant in comparison to the physical suffering that others were experiencing.    
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Control  
Taking control 
Taking control of one’s own care emerged strongly as being important to some 
participants.  In such a potentially uncertain time where outcomes were so unsure, it was 
important for some to be able to find a sense of control wherever possible and for some 
that was by taking control of their own medical care. 
"that's when I referred myself to (Dr), because they couldn't find me a haematologist within 
about, two months, which I didn't think was good enough" David 
 
For David, the care that he received at the very start of his illness experience was deemed 
unsatisfactory and, as such, he made the decision to seek out his own healthcare privately.  
This is a rather dramatic example of a patient taking direct control over their experiences 
but smaller instances of needing to feel in control of your own body and illness became 
evident. 
“I went for a number two (hair cut), because I thought I’m not going to go around looking 
like tufty” William 
 
There was variation in where participants appear to place the locus of control for their 
treatment and recovery.  Some participants took an active role in their own care while 
others deferred to the perceived expertise of their clinicians.   
"There's nothing you can do about it, you're in the hands of other people who will hopefully 
do the right thing for you" David 
 
This quote also came from David, the patient who took such significant control over his 
treatment at the start of his illness, suggesting that the ability of the patient to let their 
HCPs take charge is something that is built on trust.  Where the patient feels able to trust in 
their treating clinician and the competence of those involved in their care, the need to be 
in such overwhelming control of treatment decisions diminishes.  This is likely to have a 
positive impact on patient psychological wellbeing, to have faith in HCPs, and to trust that 
they will make the best decisions for them thereby taking the onus off the patient to be in 
charge during such a vulnerable time. 
"the doctors will go in and sort it out, that was my attitude" Mark 
 
This same sentiment was echoed by other participants who also reported a strong need to 
be in control of their own situation and to maintain their prior roles.   The need to feel in 
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control appears to diminish over time, perhaps in direct correlation with the development 
of a relationship with the patient’s HCPs. 
Feeling in control as coping mechanisms 
Control, both taking control directly and seeking out knowledge in order to enhance 
understanding as a way of feeling more in control, can be framed as coping mechanisms. 
The need to feel in  control of one’s own treatment has already been highlighted above but 
this can be framed not only as a need which is important to many patients, but as a coping 
strategy that allows patients to feel as though they are coping with and managing their 
illness.   
"I did feel as if we knew exactly where we were and what the next step was, and broadly 
what the significance of every part of the intervention was really" Mark 
 
Cancer patients regularly describe wanting to know as much as possible about their illness 
and treatment, and information needs will be discussed separately as a theme in their own 
right, but again this need feeds into a sense of gathering knowledge as a way to feel in 
control and to try to understand what is happening, that again functions as a coping 
mechanism for many patients.   
"If it's... cancer... so what? I know where I am." Ray 
 
There was a feeling within the sample that knowledge and understanding reduced levels of 
anxiety and that as long as patients knew what their current prognosis and treatment plans 
were, then they could start to process and to come to terms with their illness.   It was 
uncertainty that was the root of many anxieties and even worst case scenarios can 
compare favourably than being left in a state of not knowing. 
Need for Information  
Delivery of Information 
Participants raised the issue of how information was presented to them.  Generally it was 
felt that the way that information was given was appropriate  
"that's fine with me, you know that's the way I want the information" Ray 
 
And the provision of information had a positive impact of reassurance for many, allowing 
them to feel as though they knew what to expect and what was coming next. 
 
“he went through it all and explained it all to me and what was going to happen” William 
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However, some participants felt that info could have been delivered in a more helpful way.  
It wasn’t always clear and the use of medicalised terminology meant that it was too 
complex to understand 
"words of one syllable… and plain, simple English" James 
So, in this case it is likely that whilst information was sought as a way to reduce need, the 
impact would have been minimal – the information was not presented in a helpful way and 
so the need would not be reduced. 
Having Personalised Information Available 
Having information about diagnosis and treatment was highly valued but it was felt that 
there was a need to receive information that was tailored to their individual circumstances 
rather than generic information given to everybody.   In addition, it was felt that there 
needed to be some clinical judgement displayed by the clinician that determines when 
information is provided.   
"they also give you the five to ten year prognosis, which is, not very helpful when you're 
forty-something" David 
 
Information needed to be relevant to each person and focussed on the patient’s most 
immediate concerns. 
"when you first start you get all these generic leaflets on you know, how do you get a wig, I 
don't need a wig, what's going to happen if, what's the likely side effect." Mark 
 
While it was acknowledged that HCPs often had to present patients with the worst case 
scenario, it was also felt that simply being told the general statistics for your illness without 
taking into account the specific age and stage of the patient was unhelpful as it did not 
necessarily reflect the most likely prognosis.   
“for me it was understanding as well as I could, exactly what was happening to me” David 
 
As already outlined, having sufficient information to be able to feel that you understand 
your own illness and treatment plan was found to be highly beneficial for patients and fed 
into the presence of a sense of being in control. 
“I think you get as much information as you, as you ask for.  As you can handle.” Mark 
 
It was felt that there needs to be a balance of being given sufficient information to be able 
to feel that you understand what is going to happen without being given too much negative 
information that could potentially make the patient lose their sense of hope. 
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"there has got to be a happy medium" William 
 
Participants advocated the provision of information as being staged.  In the beginning, 
there is an immediate requirement for information about the diagnosis and likely 
treatment, but not necessarily much beyond that as patients found it difficult to take in 
large quantities of information after receiving such devastating news. 
"so if you then see any of those signs and symptoms, you can then ask for the information 
to deal with that as a result" Ray 
 
It was deemed important, however, that access to relevant information was available as 
and when it was needed, and that patients should be clear about what resources they have 
available to them.  
 
The Most Commonly Reported Unmet Needs 
At the end of each focus group, participants were asked to highlight the needs that were 
most important to them during their illness on the prompt sheets used to stimulate 
discussion during the focus group (see Table 3.2).  For the complete table of unmet needs 
highlighted as being most important for each participant, see Appendix 6. 
Table 3.2: Number of times an unmet need within each domain was ranked as important. 
Area of need 
Number of times individual needs 
within a category were highlighted 
Physical 17 
Psychological 13 
Identity 2 
Social 4 
Practical 5 
Medical 12 
Information 7 
Communication 4 
Cognitive 2 
Employment 1 
Financial 3 
Spiritual 1 
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Table 3.3: The most commonly cited unmet needs and number of participants who endorsed the need as 
important. 
 
Unmet Need Times Highlighted 
Having a key worker 4 
Understandable info 4 
Keeping positive  5 
Fatigue 4 
Eating related 3 
Fear of recurrence 3 
 
Physical needs were the most commonly endorsed (17), followed by psychological needs 
(13).   The three most commonly endorsed individual needs were: keeping positive (5); 
having a key worker (4); and receiving understandable information (4).  These needs fall 
within the psychological, medical and information categories respectively.  The most 
commonly identified need was the need to keep positive, a psychological need.   
Maintaining a positive mind-set throughout was felt to be instrumental in how participants 
experienced their illnesses.  Fear of recurrence, fatigue and eating-related concerns were 
also highlighted as a concern by at least half of the sample.    
The greatest number of unmet needs individually highlighted fell within the physical 
domain, followed by unmet needs in the psychological domain.  Between them, these two 
areas represent where our participants had the greatest concerns during their experience.   
There are differences however, between physical and psychological needs, both in the way 
that participants understand these needs and the impact that they were felt to have.  
Physical needs were felt to have been present but, in general, were more often met as part 
of the routine care provided by the hospital.  Physical needs also seem to have less of a 
negative impact than the presence of unmet psychological needs.  This may be attributable 
to the fact that participants described expecting to experience physical changes and 
discomfort when they were diagnosed with cancer.  Unmet physical needs were therefore 
viewed as a normal part of the cancer experience and were something that participants felt 
comfortable addressing with their healthcare professionals.  Conversely, the presence of 
psychological needs was less well anticipated by participants and so the negative impact 
was more profound.  In addition, these needs tended to be less likely to be met.  This is 
likely to be attributable to psychological distress not being viewed by participants as an 
integral part of the cancer experience in the way that physical needs were, and so these 
needs were less often addressed with healthcare professionals at the hospital.   
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Discussion 
This qualitative study aimed to examine the experiences of unmet needs of adults with a 
diagnosis of haematological cancer using an analysis of existing needs measures as a 
starting point.   The findings from the systematic review detailed in Chapter 2 
demonstrated a paucity of research relating to unmet need within this patient group yet 
the concept of unmet need has been often explored within other groups in the psycho-
oncology literature.  The findings from this study indicate the presence of similarities in the 
experiences and needs of haematology patients to those of other cancer groups, yet key 
differences were also highlighted.  Six super-ordinate themes were identified, representing 
areas that were of particular importance to participants with key issues worthy of 
discussion emerging.  In addition, the findings of this study can be applied to the 
appropriate assessment of unmet need in haematological cancer patients: if we understand 
the type of unmet need likely to arise and the relevance to a patient group, then the 
assessment of need can be equally relevant and tailored to that group of patients.   
The Distinct Challenges of Being a Haematology Patient 
There were recurrent indications that participants felt themselves to be different as 
haematology patients from those who were perceived to be ‘cancer patients’.   These 
perceived differences were a cause of frustration and feelings of isolation, resulting from 
perceptions of being less well understood by others and less well catered for within the 
cancer setting.   Feelings of isolation or loneliness as a result of a cancer diagnosis have 
been highlighted previously (Macmillan, 2013; Helgason et al., 2001; Refsgaard & 
Frederikson, 2013), yet this has commonly been in relation to changing lifestyles or altered 
relationships with significant others.  Across this sample no participant identified 
themselves as a ‘cancer patient’.  For some, the issue was around not wanting to be 
perceived as being ill or different to the person that they had been before and having a 
cancer diagnosis caused feelings of no longer being the person they had once been and 
wished to be still.  For others, they clearly felt that they were a lymphoma patient, not a 
cancer patient.  For these participants, there were innate differences between the two 
groups. What is novel about this finding is the sense of isolation from other cancer patients 
as opposed to the wider community.  Feeling different from people who don’t have cancer 
may be to be expected, but feeling different from other cancer patients has not been 
observed previously.   
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Previous research has advocated attendance at support groups to combat feelings of 
isolation during cancer.  Shared experiences have been shown to reduce feelings of 
loneliness and provide a sense of acceptability and community (Ussher et al., 2006).  The 
application of this finding may be problematic however, for a group of patients who do not 
cite a sense of belonging with the group for whom support groups are intended.   Not 
feeling a sense of belonging with this identified group impacted upon the perceived 
applicability and acceptability of support services that are targeted at ‘cancer patients’, a 
finding that has not previously been explored within the haematological malignancy 
literature.  No participants reported taking part in groups or services that had been set up 
to support cancer patients, where support was accessed from outside of the medical team, 
it was in the form of haematology specific support groups or charities.  Choosing not to 
attend a support group is not in itself unusual for cancer patients, research has shown that 
very few attend groups of this nature (Grande, Myers & Sutton, 2006), however previously 
explored reasons for non-attendance have typically centred on why people choose to 
attend and who is more likely to attend (e.g. Taylor et al., 1986; Krizek et al., 1999) rather 
than who the support groups were perceived to be targeted at.  For this sample in 
particular, there may have been specific barriers in place.  The haematology oncology ward 
is physically separated from the oncology unit, creating a physical and seemingly 
psychological barrier between the two groups.  As a result, even where participants had 
offers of support made to them, because those services were labelled as being for cancer 
patients, there was uncertainty around whether they were actually able to attend or 
whether those services would be adequate in meeting their needs.  It is also worth noting 
that the sample was predominantly male and previously females have been found to be 
more likely to attend support groups (Grande et al., 2006).  Grande also found that patients 
who already had access to formal support were more likely to attend a support group, and 
this access was felt to be lacking by patients in this sample. 
Patients reported feeling uncomfortable about raising psychosocial issues with their 
clinicians but clinicians also did not typically raise these kinds of concerns, implying that 
psychosocial concerns often simply weren’t discussed.  It has been recognised that 
clinicians can find it difficult to raise psychological issues with patients, yet NICE (2004) 
proposed a model of stepped-care to illustrate how clinicians at all levels can contribute to 
the maintenance of psychological wellbeing in cancer patients.  Training packages have 
been developed that aim to improve clinician efficacy at detecting and managing distress 
within a general healthcare setting (Merckaert et al., 2005; Fallowfield et al., 2002).  While 
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these kinds of training programmes do seem to improve clinician confidence in their 
abilities and short-term competence (Fallowfield et al., 2003), there is less convincing 
evidence as to whether there are also improvements in ability to accurately detect distress 
or whether ultimately patient experience is improved (Moorey, 2013).  The idea that cancer 
professionals do not always accurately detect the presence of psychological morbidity is 
not new (e.g. Fallowfield, Ratcliffe, Jenkins & Saul, 2001) and further work is needed to 
extrapolate the current evidence base in order to improve clinician confidence in raising 
psychological concerns with patients and to ultimately improve patient experience.   
The Process of Adjustment 
Experiencing cancer brings distinct challenges and for participants within this study there 
were pivotal moments in the on-going process of adjustment, beginning at the time of 
diagnosis.  Being diagnosed with cancer was distressing for participants, marking the end of 
their current life as they know it and fundamentally altering their understanding of their 
world and how they feel perceived by others.  It is well recognised that diagnosis can be a 
time of shock and distress for both patients and their families (Turner et al., 2005; Edwards 
& Clarke, 2004).  The delivery of appropriate information was of utmost importance to 
allow patients to develop an understanding of their illness, likely futures and to feel 
supported (Parker et al., 2001), the first step in adjusting to their new lives.  The way in 
which information is delivered at the time of a cancer diagnosis is highly individual and 
needs differ between patients (Schofield et al., 2003), and, when perceived to have been 
done well, patient experience and coping have been found to improve (Pollock et al., 
2008).  
After the initial diagnosis, all participants received treatment for their disease, whether 
immediately or after a period of watchful waiting. The physical impact of treatment, or the 
perception of, varied across the sample but generally this was a time when participants felt 
supported due to frequent contact with HCPs.  Once treatment ended, however, the level 
of support available to participants was felt to drop away without allowing participants 
time to acclimatise which was felt by participants to be difficult to manage.  While research 
relating to the unmet needs of haematology patients is scarce, it has been suggested that 
in the 12 months after treatment is completed new needs emerge or existing ones remain 
unresolved (Lobb et al., 2009).  The time taken to regain a new sense of normality was 
unexpected for participants in this sample, and the gulf between perception and reality 
impacted strongly.  The realisation that their previous life was no longer had a lasting 
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impact, one that was not felt to be supported by the healthcare system.  Maintaining a 
sense of normality and the creation of a new ‘normal’ after cancer has been the subject of 
much attention within the related literature (e.g. Denford et al., 2011; Ekman et al., 2004). 
It has been proposed that being able to find a sense of meaning during stressful life events 
is essential for successful adjustment (Park, 2010).  Where patient’s appraisals of a 
situation do not fit well with their overall global belief systems, the ability to find 
constructive meaning in a situation is impaired and adjustment hampered.  While 
ultimately, most participants had come to terms with their new ‘normal’, the process of 
adjustment to get there was more complex than had been anticipated which brings with it 
specific worries and concerns that are not currently well supported.   
The Language of Cancer 
The language used by participants throughout the focus groups provided some interesting 
insights into the way that they were thinking about their cancer.   Language can be a 
divisive subject for both cancer patients and researchers.  Even the term ‘cancer survivor’, 
one that has been taken on board by researchers and cancer charities alike, can have 
different meanings for patients.  Many simply do not associate themselves with the term, 
either because of their perceived level of on-going threat or their thinking styles.  Often 
language used by participants in this study was emotive (brutal; freak; butcher; scared to 
death; tears were streaming), which was indicative of the level of emotion participant’s 
experiences of cancer.  One participant talked about receiving their prognosis as waiting to 
hear the ‘verdict’, a term more associated with a legal environment than a medical one.  At 
other times, the language used took on a fighting quality, or ‘struggle language’ (Seale, 
2001).  Words like ‘fight’, ‘battle’ and ‘mustard gas’ were all used by participants to 
describe their cancer experience.  This symbolises the level of trauma associated with 
having cancer, to liken it to a war-like environment, but also ties into participants’ need to 
hope and the need to place the locus of control with the self rather than believe that their 
cancer and their prognosis was something outside of their control.    
The use of metaphors and fighting language is not unusual in the public discourse around 
cancer, yet is something that can divide opinion and evoke strong feelings in patients 
(Reisfield & Wilson, 2004) and clinicians.  Ever since President Nixon declared ‘war on 
cancer’ in 1971, naming the disease as the ‘enemy’, the use of military metaphors has 
permeated the discourse around cancer.   However, it has been proposed that using words 
such as ‘battle’, ‘fight’ or ‘conquer’ can place the onus on overcoming the disease on the 
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patient, in turn potentially creating feelings of guilt and shame at not having fought hard 
enough (Hulbert-Williams et al., 2014; Taylor, 1983; Sontag, 1978).  In addition, 
contextualising cancer as a fight or a battle, places an assumption upon the patient’s 
perception of their illness that may not be reflective of their actual views of the situation.  
There was a real dislike by some participants of words such as ‘battling’ or ‘fighting’ when 
used in connection with how they were coping with their illness.  It was felt as though this 
implied a feeling that was not present and that actually words such as this misrepresent 
what it meant to those participants to really be a cancer patient.  These participants, Mark 
most notably, argued that they were simply trying to live and to imply anything else was 
inaccurate and to be rebelled against.   
There is also the risk that such terminology highlights the negative aspects of the cancer 
experience (Hayes et al., 2011). The notion that one must fight cancer and that to ‘keep 
positive’ is in itself a sign of positive adjustment to illness has become so entrenched into 
societies understanding of cancer, that there is an associated expectation of those living 
with the disease to act in this way or to be deemed as not adjusting well (Hulbert-Williams 
et al., 2014).  There is a danger that patients will simply use language of this nature because 
this is what is expected, and that those around them will understand this to mean that they 
are coping well when in fact this language is simply compliance behaviour (Hulbert-
Williams et al., 2014).   
Differences Between Participants 
While the sample of the study was relatively homogenous, there were some distinct 
differences between participants.  Psychological needs were one of the areas of unmet 
needs that were ranked highest by participants, yet the desire to actively engage with 
formal psychological support to meet these needs was variable.  One participant, Mark, 
was adamant that speaking to “an employee” from the hospital would not be beneficial to 
them and they were not willing to engage with this kind of support.  Not wishing to engage 
with formal psychological support services is not a new findings (Baker-Glenn et al., 2011), 
indeed it is well recognised that the presence of psychological morbidity does not always 
equate to a desire for help.  Another participant, Ray, had very different perceptions of 
psychological support and actively sought this out but described being unable to access the 
desired support via the hospital.  Other participants, when asked about psychological needs 
expressed an interest although this was not something that was actively sought during 
their treatment.   
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Body image as an unmet need differed in the degree to which participants felt that it was 
important to them.  For some, body image and the changes to their body and appearance 
that occurred as a result of treatment caused distress and impacted upon their self-
confidence and perceptions of how they were viewed by others.  Changes in bodily 
appearance represented being ill and were a physical manifestation of the disease, 
something that was unwelcomed by participants.  Previous research in breast cancer 
patients has highlighted the impact that cancer and its treatment can have upon women’s 
body image (Kraus, 1993), their self-esteem (Anderson & Johnson, 1993), and their long-
term distress levels (Przezdziecki et al., 2013).  Changes in appearance can also represent a 
difference between the person that participants have previously perceived themselves as 
being and the person that they feel that they are seen as now.  One participant, Daphne, 
described having worked in fashion all their life, and how, for someone who has been in 
that environment, changes to the way that they look were difficult.  For another 
participant, Mark, the loss of their hair was the main cause of distress as not only was this 
felt to be a physical sign of their illness, something that they were anxious to avoid, but also 
it was felt to change the way that other perceived them.  Having a skinhead was associated 
with a certain type of behaviour for this person and this was not felt to be in line with that 
person’s own perception of themself.  For the remaining four participants, body image was 
not identified as a key concern and was an expected aspect of cancer treatment. 
The degree to which having had cancer was continuing to impact upon participants 
appeared to differ considerably across the sample.  Two participants expressed on-going 
difficulties that affected their everyday lives, Ray and Daphne, with Ray reporting 
considerable on-going distress as a result.  This is in line with the finding by Lobb (2009), 
that unmet needs persist after treatment has ended and patients enter the survivorship 
phase of their illness.   The remaining participants reported regaining a sense of normality 
in their lives, albeit in a different way to what was deemed ‘normal’ pre-cancer.  Again, this 
is to be expected.  Previous literature that examines unmet needs in cancer survivors has 
demonstrated that while the presence of need is problematic for some, there will also be a 
sub-group of patients for whom on-going unmet needs are not a concern (Harrison et al., 
2009; Armes et al., 2009). 
There were some very different feelings about being seen as a cancer patient across the 
sample and the way in which participants identified with this title.  For Mark, having cancer 
was a temporary concern and not something they wished to be viewed as or associated 
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with.  Strong feelings were expressed by him that having cancer was simply something that 
had happened to them but that was not permanent and was not part of who they were.  
Therefore anything associated with being a cancer patient was avoided.  For other 
participants, having had cancer was something that was assimilated into their lives and 
their perceptions of themselves.  While having had cancer did not define them, it became 
part of who they were and several participants expressed a wish to use their experiences to 
help others in a similar situation.  For some, helping others meant that they would be 
willing to get involved in direct peer support, getting involved with haematological cancer 
charities or even acting as a patient representative for a NICE committee. 
As participants differed in the way in which they perceived their status as a cancer patient, 
they also differed in the way in which they took control over their experience.   Some 
patients actively tried to play an active role in their own care, either by feeling that they 
were engaging in a dialogue with their clinicians and seeking as much information as 
possible about their illness or by getting involved in the policy of cancer treatment by 
attending a NICE committee as a patient representative.   For others, control was placed 
with their healthcare professionals and the belief that the doctors would do what they 
thought best for them was expressed.  While not taking an active role in their own care, 
this could still represent those participants taking control of their experience by placing the 
control and decisions in the hands of those perceived to be the experts. 
How does this work affect our understanding of why specific needs 
are important to patients? 
Qualitative research can add a depth to findings that is difficult to achieve in quantitative 
work (Pope & Mays, 1995).  Looking just at the number of needs highlighted as important 
to participants on their rating charts, physical and psychological needs are both identified 
as key areas of unmet needs for patients.  Qualitative discussion within the focus groups 
around needs however, indicated that while physical needs were present, often these 
needs were met by the healthcare team involved in that patient’s care and therefore would 
require no further intervention.  Conversely, psychological needs were present but, unlike 
the physical needs, largely remained unmet, highlighting the insight that qualitative 
exploration of a subject can provide.   
Understanding not just that psychological needs are present and unmet for patients, but 
being able to gain a clearer picture of the barriers to accessing support provides a novel 
insight and creates questions around the most appropriate provision of services.   The 
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theme ‘barriers to support’ raises potential questions about the most appropriate setting 
for psychosocial support to be provided.   As one participant stated, “we do need to 
perhaps have a separate clinic, not necessarily in here but somewhere else in the hospital 
or somewhere else where you can come and talk to us about it”.  The hospital ward is seen 
as an environment in which staff are there tend to physical ailments and there is some 
uncertainty about how acceptable it is to discuss psychological concerns with these medical 
staff (Ozacinci et al., under review).  Even where distress is recognised in the clinical setting, 
only for a sub-group of patients does this recognition translate to a referral to psychosocial 
support services (Keller et al., 2004).  In addition, the busy clinic setting and short 
appointment times compounded the feeling that the hospital ward is not the right place in 
which to talk about psychological wellbeing.   
The hospital from which participants were recruited consists as a hospital building only and 
does not have a dedicated psychology service, either in the building or separately, although 
there is a Liaison Psychiatry service.  There is a Macmillan centre within the hospital but 
this not always open and, given the concerns that participants have about the suitability of 
current support services meeting their needs, it is unclear to what extent patients feel that 
this is an accessible resource.  This is not unusual within hospitals in the UK, particularly the 
smaller district general hospitals.  There is an increasing recognition that cancer patients 
may require a more dedicated support service that is staffed by professionals with a 
specific expertise in supporting this patient group and that many unmet needs may lie 
beyond the remit of the treating services (Soothill et al., 2001).  There have been a number 
of political statements and healthcare initiatives that have aimed to improve the 
psychosocial care of cancer patients (Surbone et al., 2009), and over a decade ago NICE 
released guidance that stressed the importance of supportive care for cancer patients 
(2004).  However, the ongoing presence of unmet psychosocial needs and lack of a 
coherent strategy for the meeting of these needs within our healthcare system suggests 
that these measures have not had the desired impact upon patient experience.  While 
participants in this study accepted that they experienced unmet psychological needs, in 
general the number of cancer patients who would voluntarily engage with a psychological 
or psychiatric service is low.  This work highlights not just that psychological needs are 
prevalent, but also suggests areas in which improvements must be made in order to make 
support services acceptable to patients. 
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How suitable are current needs assessment tools? 
The tables of needs identified from the thematic analysis of existing needs assessment 
tools can be compared with the themes to emerge from the focus groups to determine to 
what extent the two overlap.   In general, the needs identified by participants were similar 
to the needs identified by previous needs assessment tools.  There were however, needs 
that were not endorsed by any of the participants.  No needs within the sexual or spiritual 
needs categories were endorsed by participants during the interviews; it could simply be 
that sexual and spiritual needs only arise in a smaller proportion of patients.  Alternatively, 
this could be an issue with the self-report nature of needs assessment: it is well-recognised 
that self-report of sexual behaviour can be unreliable (Schroder et al., 2003; Fenton et al., 
2000). 
Across the sample, there are many similarities in the needs identified by this haematology 
sample when compared with the existing knowledge relating to unmet needs in general 
cancer samples (Harrison et al., 2009; Richardson et al., 2007; Morrison et al., 2012) with 
physical, psychological information and healthcare professional-related needs all felt to be 
relevant by participants in this study.   This provides an indication that existing needs 
assessment tools are likely to be suitable for assessing the needs of this patient group, and, 
moving forward in this research, existing measures are likely to be appropriate for further 
quantitative work.  The work presented in this chapter indicates that the differences 
between haematology patients and wider cancer groups are not in the type of need 
experienced, but rather in the perceptions of what it means to be a cancer patient, or 
indeed a lymphoma patient. 
Limitations 
There are both benefits and limitations of conducting a study with a small sample size.  The 
intention of this study was to better understand patient experiences of need during cancer 
and how unmet needs impacted upon overall wellbeing; however, this does mean that the 
results are more difficult in terms of applicability across the whole patient population.  
Indeed, given the qualitative epistemology of this study (Smith et al., 1997; Smith, 2004), 
application of the findings to a whole patient population was not the objective of the work.  
Rather, this study was designed to provide a depth and richness that could fit alongside 
subsequent quantitative works from which wider generalisation could be inferred.   
While the interview schedule was designed to encourage open discussion, the use of the 
item pool drawn from existing assessment tools had the potential to influence the direction 
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of the discussions held within the focus groups.  Attempts were made to minimise this by 
firstly: not introducing participants to the item pool until part way through the interview to 
allow for unprompted discussion initially; for the analysis of the data to be open and not 
structured around existing needs, rather the analysis was entirely open as the researcher 
wanted to determine the extent to which themes generated did correspond with existing 
needs; and a level of reflexivity was used both throughout the focus groups themselves and 
during the analysis process whereby the researcher was aware of the potential for bias and 
continued to question whether an existing knowledge of unmet needs in cancer was 
influencing the current situation.   
There were challenges in recruitment for this study that may have impacted upon the 
sample size achieved.  While the purpose of the study was to act as a pilot study and a 
piece of qualitative research, achieving a sample size that was sufficient for a thorough 
analysis took longer than initially expected.  The challenges of recruiting a variety of 
haematological cancer diagnoses has already been discussed, there may have also been 
some systemic issues that compounded the slow recruitment: 
 The initial recruitment push was successful but this slowed.  Without the continued 
presence of the researcher in each clinic, momentum may have been lost.  In 
future research, having the researcher present to assist with recruitment may act 
to reduce clinician burden and maintain a higher rate of recruitment. 
 One clinician took the lead on recruiting participants from the hospital.  This may 
have resulted in other clinicians not feeling as though it was their responsibility to 
approach patients about taking part in the study.  In addition, not all of the 
clinicians were permanent members of staff and the knowledge that they would 
not be on staff for the duration of the project may have again served to reduce 
motivation to recruit their patients into the study. 
Implications for further work 
While this study provides us with a valuable insight into the lived experiences of 
psychosocial needs in haematological cancer patient, it also highlights the need for 
quantitative assessment of unmet need in haematology.   There is a need for large cohort 
studies with multiple haematological diagnoses recruited to inform about the unmet needs 
of different haematological diagnoses to supplement this work on patient experiences.  
Recommendations by the National Cancer Survivorship Institute (2010) include the use of 
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cohort studies as a way of mapping areas of need within cancer survivorship and using 
ongoing research to develop priorities for future studies. 
This research suggests a degree of overlap between the needs of haematological cancer 
patients and previous research conducted with other cancer diagnoses.  It is therefore 
possible that developing a haematology specific add-on for an existing needs assessment 
tool would be suitable for assessing the needs of this patient group.  This has been 
employed successfully in the assessment of quality of life, the FACT measurement scale has 
haematology specific modules (Cella et al., 2012), such as the FACT-Leu, that can be used in 
addition to the FACT general (Cella et al., 1993). 
Broadly, the needs discussed by participants can be divided into two group, those that tie 
in with what we already know about needs in cancer, and those that add something new.  
With the exception of the themes centred around the specific differences innate to being a 
haematology patient and the barriers to accessing support; the themes drawn from the 
focus groups indicate a level of similarity in the type of unmet need found in patients with 
differing cancer diagnoses.  It may be that for some areas of need, for example physical 
impact, psychological concerns or practical matters, that type of need is common across 
cancer regardless of the specific diagnosis.   
In terms of the implications for clinical practice, the idea that the physical environment in 
which psychological support is provided is influential to perceptions of acceptability may be 
an important one.  If patients perceive the hospital environment to be one in which 
physical illness in tended to, then some thought into where this service could be more 
appropriately placed may serve to make psychological or psychiatric support services more 
acceptable to general hospital patients.  These findings suggest areas of patient need that 
are directly relevant to both treating clinicians and to wider healthcare services and suggest 
areas of need that clinicians need to be aware of when interacting with patients and where 
services as a whole need to consider the current provision of support services for this 
patient group.   
In addition, this work highlights barriers that are preventing patients who would benefit 
from psychological support from attempting to access this.  If HCPs do not raise 
psychosocial concerns within the clinic, then this research indicates that many patients will 
not feel able to do so themselves, leaving these needs unaddressed.  The need for HCPs to 
raise concerns and to feel confident in their abilities to do so is key.  Existing research 
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highlights the fact that may HCPs feel a lack of confidence in their ability to manage 
psychological distress (Moorey, 2013), as such there has been an influx of training 
programmes that aim to improve confidence and efficacy.  Evaluations of these 
programmes have found that they do improve confidence but it is unclear as to whether 
there are also improvements in clinician ability to accurately detect distress and whether 
patient experiences are ultimately improved.  There was also an uncertainty from 
participants about whether existing services for cancer patients were available to 
haematology patients.  It is as yet unclear how HCPs and support staff outside of the 
haematology setting perceive this patient group and whether they feel them to fall under 
the more general label of ‘cancer patient’.    
Conclusion 
This work highlights that patients with a haematological malignancy have unmet 
psychosocial needs that rank alongside patients with other cancer diagnoses, yet 
participants reported feeling that the level of support available to them was reduced and 
that understanding of this diagnosis was limited. It was highlighted that unmet 
psychosocial needs were prevalent within this sample yet barriers to needs being met were 
identified.  Psychological need was identified across the sample yet this is a need that 
patients find difficult to address with clinicians and can therefore remain unmet.    
Psychosocial need research in patients with a haematological diagnosis is comparatively 
sparse.  As a qualitative study with a small sample size, results highlight some of the key 
areas of need as identified by patients and clearly demonstrate a need for further research 
in this area to build upon the findings presented here.   However, it should be noted that, 
as a piece of preparatory work, the purpose of this study was hypothesis generation, not 
hypothesis testing.  The important questions arising from this piece of work are addressed 
in the rest of this thesis where empirical quantitative work tracks the type, prevalence and 
severity of unmet need over time in haematological cancer patients and seeks to 
investigate the implications of need on psychological wellbeing.  
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Chapter 4 - The Unmet Psychosocial 
Needs of Haematological Cancer 
Patients and their Relationship with 
Psychological Outcomes 
Introduction 
Unmet psychosocial needs are thought to be directly related to the level of distress that a 
person might experience upon learning that they have a diagnosis of cancer, a concept that 
was discussed in Chapter 2 (Carlson, Waller, & Mitchell, 2012).  Previous researchers have 
postulated a direct link between unmet need and distress, equating the level of 
psychosocial need with degrees of concurrent emotional or psychological distress (Hall et 
al., 2014; McIllmurray et al., 2001; Armes et al., 2009).  It is, therefore, possible that the 
level of unmet psychosocial needs at the time of diagnosis may predict broader 
psychosocial wellbeing in response to a diagnosis of haematological cancer.   Prior work in 
earlier chapters of this thesis has provided an indication of the type of unmet needs that 
may be important to patients with a haematological malignancy and the specific relevance 
or importance of individual needs to this specific group of patients.  The systematic review 
detailed in Chapter Two highlighted the lack of quantitative assessment of unmet needs 
within haematological cancer patients and the potential psychological implications of the 
presence of unmet need are not well explored or defined within the related literature.  In 
Chapter Three, the perceptions of haematological cancer survivors were explored, raising 
the issue of differences between haematological cancer patients and patients with solid 
tumours.  In addition, this qualitative work identified barriers to patient access of 
appropriate support services.  This study aims to quantitatively identify the unmet 
psychosocial needs of newly diagnosed haematological cancer patients, with a special 
emphasis placed on patients diagnosed with chronic, incurable disease, and to explore the 
relationship between unmet need and psychological wellbeing in this group.  Of the papers 
included within this systematic review outlined in Chapter 2, none focussed specifically on 
the unmet needs of haematology patients at diagnosis.  Understanding what the unmet 
needs of patients are is the vital first step in the provision of support services that can 
effectively meet those needs in a manner that is both relevant and acceptable to patients.   
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The Unmet Needs of Newly Diagnosed Haematological Cancer 
Patients 
A recent report published by the Department of Health (2012) on the quality of life of 
cancer survivors highlighted that, in comparison to patients with breast, colorectal or 
prostate cancer, patients with a diagnosis of Non-Hodgkin’s lymphoma (NHL) 
demonstrated comparatively poor psychosocial outcomes.  NHL patients displayed worse 
levels of maintaining their independence, of anxiety, having the biggest problems 
completing their usual activities, the most difficulties in planning for the future, the most 
problems with benefits and displayed the highest levels of pain and discomfort.  This major 
report surveyed patients who received their diagnosis a year or more previously, indicating 
that psychosocial issues continue to affect patients long after their initial diagnosis and 
often after initial treatment has been completed.  While these findings relate to NHL only, 
and not haematological malignancies as a whole, given the overarching similarities that 
exist within this group of cancers, it seems likely that this concerning view of wellbeing is 
generalizable.  There is little research that encompasses the spectrum of haematological 
diagnoses, making further exploration vital to be able to identify their unmet needs. 
Research conducted with patients from wider cancer samples indicates that cancer 
diagnosis is a time of shock and anxiety (e.g. Cain et al., 1983; Stark & House, 2000) that 
can be one of the most profoundly challenging within the cancer experience (Boehmke & 
Dickerson, 2006): a sentiment also reflected by the haematological cancer survivors 
interviewed in the previous chapter when reflecting on this time.  The wider literature 
indicates that the need for information was felt to be relevant by some, yet for others too 
much information too soon after diagnosis can become overwhelming.  The unmet needs 
most relevant to individual patients will vary (Harrison et al., 2009), yet providing 
healthcare professionals with an awareness of the commonly occurring areas of need may 
prove helpful in facilitating conversations about needs that are not conventionally medical 
in nature. 
Haematological cancers can range from the acute and aggressive to the chronic and 
incurable.  They are notable for their specific treatment modalities, often either more 
intensive than those required for other diagnoses or, in the chronic and incurable cases, no 
active treatment may be initially required at all.   Previous research indicates that the 
prevalence of anxiety and depression in haematological cancer patients currently attending 
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treatment centres is approximately 20% (Clinton-McHarg et al., 2014).  In cases where 
active treatment is not delivered and watch and wait the chosen regime, this can be a 
direct contrast to the general understanding of what happens when a diagnosis of cancer is 
given and can bring its own distinct set of challenges.  Watch and wait is used in the case of 
indolent disease and denotes the monitoring of disease via routine blood tests, usually 
undertaken at outpatient haematology appointments at regular intervals, rather than the 
commencement of active treatment upon diagnosis (Ardeshna et al., 2003).   For some 
patients, their cancer is detected via a routine blood test that was not undertaken with the 
view to detect cancer and, at the time, the patient would typically be asymptomatic since 
they were not actively seeking resolution for symptoms relating to their resulting diagnosis.   
If a patient does present while asymptomatic, and their diagnosis is one of incurable 
disease, then the literature has implied no clinical benefit of immediate treatment in 
prolonging life or improving the outlook for that patient (Lowry & Ardenshna, 2012).   
Watch and wait might be a suitable treatment option for patients with indolent NHL 
(although not the more aggressive, curable sub-types), CLL or myeloma.   While not 
uncommon and based on sound evidence that delaying treatment will not adversely affect 
outcome (Lowry & Ardenshna, 2012), it is thought that being monitored via watch and wait 
brings with it its own distinct challenges such as the uncertainty of living with transient 
symptoms and not knowing when the disease will worsen (Bailey et al., 2004).  Watch and 
wait, sardonically referred to as ‘wait and wait’ or ‘watch and worry’ within the online 
patient community (McCabe, 2014), can bring with it considerable stress and anxiety as 
patients live with the knowledge that they will, at some unknown time point, become ill.  
This can create a sense of on-going uncertainty for a patient who may become unsure or 
unable to form future plans, or for whom the worry about what symptoms may be like 
once they arise may overshadow other life events, the concern that once their illness is 
treated, it will be too late is also a very real fear for many patients.    
The acute, aggressive cancers requiring intensive treatments have received more attention 
within the literature building up a more comprehensive understanding of some of the 
psychological challenges that accompany such a diagnosis and treatment path, notably the 
psychological impact of bone marrow and stem cell transplantation (Norkin, Hsu & 
Wingard, 2012).  Less is known about the specific issues that arise for patients who are 
given a life changing diagnosis of cancer and then told that they will not be receiving any 
treatment for the immediate future.   
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Adjusting to a Diagnosis of Cancer 
The emotional and psychological reaction to cancer diagnosis is central to how a patient 
experiences their illness.  Many are able to cope and to re-adjust, finding a new sense of 
normality (Costanzo et al., 2007).  Others, however, are unable to utilise ways of coping 
that allow them to manage their emotional and psychological distress.   The varying phases 
of living with and being treated for cancer mean that, for many, adjustment is an on-going 
process that evolves throughout the initial diagnosis period through to treatment, 
completing remission, learning that your cancer has relapsed and becoming a cancer 
survivor.    
Adjustment is a term that is often used within psycho-oncology yet the underpinnings of 
the psychological process are not yet fully understood (Brennan, 2001).  Psychological 
adjustment refers to the process of change that an individual may experience in their view 
of both themselves and their world.  This process is not innately either positive or negative 
but rather is individual to each person who experiences cancer (Brennan, 2001).   There are 
multiple theories of coping and, as a topic, it has received a huge amount of attention 
within the literature.  One model which has received considerable attention within the field 
of health psychology has been Lazarus’ Transactional Model of Stress and Coping (Lazarus 
& Cohen, 1977).  This model acts as a framework for the processes involved in how people 
cope with stressful events and situations, citing stressful situations as a transaction 
between person and environment.  The way in which a person reacts to the stressful 
events depends both upon how they appraise the event and their perceptions of the 
resources available to them to assist in managing the event (Lazarus & Cohen, 1977).  In 
essence, in the face of a stressful event, two appraisals take place.  The primary appraisal 
involves the person’s perception of an event or situation; the secondary appraisal is when 
the person assesses their own resources and options.  The resulting coping efforts are the 
means by which the person attempts to resolve or regulate the stressor.  This model has 
been repeatedly applied within health psychology research (e.g. Laubmeier et al., 2004; 
Quine & Pahl, 1991; Shaw, 2001)  and can provide a rationale for why some people are 
better able to cope with stressful events, in this instance the diagnosis of cancer, better 
than others when in similar situations.  Coping is not a fixed attribute, rather it is the innate 
ability to adapt and employ suitable cognitive or behavioural processes to reduce, avoid or 
prevent distress (Lazarus, 1992).  As a process, it is individual to each moment or situation 
and involves appraisals and responses in the context of a person’s perceived resources 
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(Lazarus, 1999).  Coping in response to stress can be conceptualised as being as much to do 
with our innate responses to stress, our own personal reactions, as with the situation that 
is acting as the cause of stress.   
Within the psycho-oncology literature, Lazarus’ model has been utilised as a framework to 
determine coping responses and strategies in the context of cancer diagnosis.  It has been 
found that cancer patient’s levels of stress is negatively correlated with the presence of 
both problem-focussed coping and emotion-focussed coping (Kim et al., 2002), that is 
people are less likely to employ effective methods of coping when stressed.  It has also 
been demonstrated that patients find optimistic, supportive coping strategies to be the 
most useful (Halstead & Fernsler, 1994) and in breast cancer patients, coping mechanisms 
have been suggested to mediate the relationship between optimism and distress (Carver et 
al., 1993).  Better understanding of how coping responses influence emotional wellbeing 
and the factors that affect successful coping in the context of a significant negative event, 
such as cancer, enables connections to be made between people’s coping styles and their 
emotional wellbeing (Hulbert-Williams et al., 2013).   
Previously, adjustment has been thought of as an end goal – to be ‘adjusted’ as being a 
state that patients will reach if they are to return to normality and a healthy psychological 
state of mind.  Brennan (2001) argued that instead, adjustment is a process of change and 
something that is constantly evolving throughout the cancer experience.  Patients typically 
do not report returning to ‘normal’ after recovering from cancer but rather they create a 
new sense of normal that accommodates their illness experiences, a potentially difficult 
adjustment to make (Schnipper, 2003).   Watson and colleagues (1998) defined adjustment 
in the context of the cognitive and behavioural changes that a patient makes in response to 
their diagnosis of cancer.   While this has been criticised for being ‘featureless’ (Brennan, 
2001), this definition does allow for individuality in the way in which patients adjust and 
does not place any positive or negative connotations on the patient.  The Mental 
Adjustment to Cancer Scale (MAC), and the subsequent Mini-MAC are tools that were 
developed to assess a patient’s psychological adjustment (Watson et al., 1988).  Though 
these specific tools have received some criticism (Hulbert-Williams et al., 2012), 
understanding the process of adjustment and the factors that might feed into poor 
adjustment is an important question in psycho-oncology.   
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There are multiple factors that are thought to feed into how successfully an individual 
adjusts and is able to cope with a diagnosis of cancer (Watson et al., 1998; Stanton et al., 
2002).  Research conducted with women with a diagnosis of breast cancer indicated that 
the presence of hope and faith, with mixed support for approach-oriented coping 
strategies also being helpful in the adjustment process during the first year post diagnosis 
(Stanton et al., 2002).  The way in which patients appraise their ability to manage both 
internal and external demands is integral to their ability to cope with a situation.  Lazarus 
and Folkman (1984) define coping as the process of managing these demands.   
Traditionally, coping theorists, and therefore their perspective on adjustment, have 
focussed on the behavioural strategies that people might employ in order to manage a 
potentially stressful situation.   
Uncertainty literature 
Successful adjustment to a cancer diagnosis can be particularly difficult when a sense of 
uncertainty is present, as is often the case for haematological cancer patients monitored 
via a watch and wait regime.  Uncertainty as a psychological concept can be defined as the 
inability to determine the meaning of illness-related events, occurring when the person is 
unable to assign meaning or to accurately predict the likely outcome (Mishel, 1988).  
Mishel’s Uncertainty in Illness Theory was the first to focus on uncertainty in the context of 
illness, although work relating to uncertainty more generally goes back much further (e.g. 
Davis, 1960).  The theory is comprised of three key components: antecedents, appraisals, 
and coping (Mishel, 1988) and proposes a model for how patients develop a sense of 
uncertainty during illness and their propensity to deal with their uncertainty (Mishel, 2006).  
Existing research relating to uncertainty in illness has found that uncertainty peaks in the 
period before diagnosis before decreasing over time but can be reignited by a recurrence.  
Unpredictability, or an exacerbation of symptoms, can result in increased uncertainty 
(Mishel, 2006).   There may be differences in uncertainty experienced in acute and chronic 
illnesses, an interesting concept in light of the highly variable prognoses and treatment 
options that exist under the umbrella term of haematological cancer.   
Uncertainty may be a key concern for patients who are monitored via watch and wait: 
there will be uncertainty related to symptom development; if, and when, treatment will be 
needed; what form such treatment will take; and, the potential impact of progressing 
disease.  Illness uncertainty can be thought of as a cognitive stressor (Johnson Wright et al., 
2009) and only when appraised as a threat does it have a negative impact on wellbeing.  In 
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the context of chronic illness, uncertainty has been found to correspond with psychological 
wellbeing (Landis, 1996), meaning that illnesses where uncertainty is likely to be raised 
have an increased potential to impact negatively upon psychological wellbeing.  The 
psychological impact of receiving a diagnosis of cancer and then not receiving any 
treatment has not been fully explored.  It is possible that, due to the lack of physical impact 
resulting from aggressive disease and intensive treatments, watch and wait patients will 
have fewer needs and a better overall quality of life (Levin, Li, Riskind, & Rai, 2007; Holzner 
et al., 2004).  Conversely, it could be that by removing the potential to treat, or fight, their 
disease, a degree of hope is also lost as patients are unable to see an end to their illness or 
predict the future impact of worsening disease and subsequent treatment while knowing 
that both are likely to happen within the near future.  More research is needed that further 
examines type of need and psychological wellbeing in haematological cancer watch and 
wait patients and looks at the impact of not being actively treated for a cancer diagnosis. 
Unmet Needs and Psychological Wellbeing 
The connection between unmet need and psychological wellbeing has received some 
attention within the psycho-oncology literature but has yet to be fully defined or examined 
within haematological cancer patients.   It is becoming increasingly well recognised that 
unmet needs are a key concern for cancer patients: a large multi-centre UK study that 
included NHL patients found that 30% of patients had five or more unmet needs at the end 
of treatment, with no improvement six months later for 60% of those patients (Armes et 
al., 2009).  Within Armes’ study, fear of recurrence, already highlighted as a key issue for 
patients within this thesis, was found to predict the presence of unmet need.  Baseline 
mood however, as assessed by the HADS, was not found to be predictive of need.  This 
work by Armes et al highlights the link between needs and outcomes, yet the percentage of 
NHL patients within this study was comparatively small at just 5%, and no other 
haematological diagnoses beyond NHL were included within the sample.  A further study to 
explore whether clinical and demographic characteristics relate to the presence of need 
found gender and age differences in the reporting of need with women reporting more 
unmet needs on average than men, and younger participants expressing higher numbers of 
unmet needs (Morrison et al., 2012).  Again, while participants with haematological cancers 
were included within this sample, in total they accounted for approximately 7% of the 
sample making it difficult to tease out any key differences in the needs expressed by these 
patients.   
130 
 
In wider cancer groups, the specific relationship between unmet need and distress has 
been better explored.  In breast cancer patients, it has been demonstrated that there is a 
strong correlation between unmet need and distress (Uchida et al., 2011) and that anxiety 
is significantly associated with the presence of unmet needs (von Heymann-Horan et al., 
2013).  Further research within a general oncology sample has indicated that the number of 
psychosocial problems is correlated with the HADS anxiety score (Schofield et al., 2012; 
Armes et al, 2009).  In palliative care, unmet needs have also been associated with quality 
of life, anxiety and depression levels (Buzgova et al., 2014).   The existing evidence-base 
linking need with psychological outcomes is small but where previous research has aimed 
to correlate unmet need with psychological wellbeing, the findings have consistently 
indicated that there is a relationship present.  However, this relationship has yet to be 
explored within a haematological sample, a group of cancers that are notable in their 
differences from solid tumours.  If found to be present, the connection between unmet 
need and psychological wellbeing has implications for both the use of needs assessment 
within the clinical setting to be expanded upon and for the provision of support services 
within the cancer setting. 
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Study Aims 
This research study aimed to answer thesis question three: 
What are the unmet psychosocial needs and psychological outcomes of newly 
diagnosed patients and are these two concepts related? 
Specific study objectives were: 
1. To identify the unmet needs of newly diagnosed haematological cancer patients. 
2. To investigate psychological wellbeing in newly diagnosed haematological cancer 
patients.  
3. To examine potential differences in need and wellbeing between patients who 
receive active treatment and those who are monitored via watch and wait; 
between genders; and between diagnostic groups. 
4. To investigate the relationship between unmet need and psychological wellbeing 
with the hypothesis that higher levels of unmet need will result in poorer 
psychological wellbeing i.e. that as unmet need increases, so too does anxiety and 
depression while quality of life will decrease. 
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Methodology 
Study Design 
A longitudinal, questionnaire design was utilised.  Participants were assessed for unmet 
psychosocial needs alongside other psychometric assessments at the point of diagnosis (or 
as close to this time point as is possible) and then again at a three months follow-up.    
Sample  
The initial aim of this study was to recruit a sample of approximately 211 participants from 
hospitals across Cheshire, Merseyside, Manchester and later North Wales.  All participants 
were required to have a diagnosis of either: chronic lymphocytic leukaemia (CLL), Non-
Hodgkin’s lymphoma (NHL) or multiple myeloma (MM) and be within three months of 
diagnosis.   The sample size was determined using GPower and an expectation, based on 
previous literature, of medium effect sizes (Coe, 2002; Cohen, 1988), power at 0.8 and the 
potential for up to 39 variables to be included within the analysis.  The calculation was 
based upon the assumption that a regression analysis would be conducted on all data 
collected.  A power analysis was also completed for additional analysis performed, a one-
way ANOVA, which indicated a required sample of 159.   
Recruitment was discussed with the clinical teams at participating hospitals during protocol 
development.  All teams indicated that the numbers indicated in the power analysis would 
be possible to achieve during the intended recruitment window of 12 months. 
Inclusion Criteria  
To be included in this study, patients were required to: 
 have a diagnosis of either: CLL, NHL or MM;  
 have been diagnosed within the last three months; 
 be a patient of either the Countess of Chester Hospital, Royal Liverpool University 
Hospital or Manchester Royal Infirmary; and 
 be able to give informed consent.  
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Exclusion Criteria 
 Anyone with a life expectancy of less than three months. 
 Those with severe developmental, learning or psychiatric conditions which may 
impair their understanding of the research and result in an inability to provide 
informed consent.  
 
The demographic information of the recruited participants is included in Table 4.1. 
Table 4.1: Participant demographic information 
Demographic  Percentage 
Gender Male               
Female 
71.4% 
28.6% 
Age 18-30 
31-40 
41-50 
51-60 
61-70 
71-80 
81-90 
5.7% 
5.7% 
11.4% 
11.4% 
31.4% 
28.6% 
5.7% 
Ethnicity White 
Black/African 
Other 
94.3% 
2.9% 
2.9% 
Employment Full-time 
Part-time 
Self-Employed 
Retired 
Not employed (ill health) 
28.6% 
2.9% 
8.6% 
48.6% 
11.4% 
Dependents 0 
1 
2 
3 
65.7% 
8.6% 
20% 
5.8% 
Diagnosis NHL 
CLL 
Myeloma 
45.7% 
22.9% 
31.4% 
Treatment Active Treatment 
Watch and Wait 
68.6% 
31.4% 
 
Procedure 
Ethical approval was given by the University of Chester Departmental Ethics Committee, 
the NHS Research Ethics Committee (NREC) and research governance approvals were 
provided by each participating site. 
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Recruitment was conducted in collaboration with the clinical team based in each of the 
participating hospitals.  Initially, three hospitals took part in the study: Countess of Chester 
Hospital, Royal Liverpool University Hospital and Manchester Royal Infirmary with the later 
addition of the North Wales Cancer Treatment Centre.    Inclusion criteria were assessed by 
the member of the clinical team within each hospital and verified with the researcher.  If it 
was deemed appropriate, the clinician conducting the appointment introduced the basic 
premise of the study to participants.  If participants were interested in learning more about 
the study, their clinician introduced them to the researcher who was available during clinic 
sessions to answer queries and to provide information packs.   
Participants who were interested in taking part in the study were provided with an 
information pack to take home with them containing an information sheet about the study 
and what taking part would involve (Appendix 14) and a consent form (Appendix 15).  
Information packs were also available from clinicians if required.   If patients wished to take 
part, they returned the participant consent form to the researcher.     
Where patients decided to participate, they were required to complete a questionnaire 
(Appendix 17) on two separate occasions: once when they were first recruited into the 
study around the time of receiving their diagnosis; and again at a three-month follow up.   
Along with the questionnaire, participants were provided with a debrief sheet (Appendix 
16) including contact details for appropriate support services.  This was posted out along 
with the questionnaire to ensure that participants had access to the information contained 
within as it might be needed.   
Upon recruitment into the study, letters were sent to the participant’s GP to inform them 
of their patient’s involvement in the study (Appendix 17).  To facilitate this, participants 
were asked to provide details of their GP on the questionnaire.  One week prior to follow 
up, a form was sent to the GP that was to be returned if a participant is no longer eligible to 
take part in the study (Appendix 18) and confirmed with the hospital.  Patients were 
defined as no longer eligible to take part if they were not expected to live longer than two 
weeks, if they were too ill to take part or if they were known to have died.   
Unfortunately, retention into the study was poor and only eight follow up questionnaires 
were received.  In light of the revised study aims and the removal of the analysis that had 
been intended to examine predictors, the decision was made to exclude this data from the 
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study, focussing instead on the cross-sectional data relating to the psychological impact of 
diagnosis.   
Informed Consent, Confidentiality and Data Protection 
Prior to completing the questionnaire, participants were requested to read the full 
information sheet and to contact the research team to ask any questions that they may 
have before deciding whether or not they wished to take part in the study.   Participants 
were given the opportunity to discuss the study with the researcher or with a member of 
their clinical team if they had any questions. 
To protect patient confidentiality, no questionnaire contained patient identifying 
information; rather each was labelled with an identification number that corresponded to 
the number assigned to the participant consent form.   Clinical data and socio-demographic 
data, as reported in Table 2 previously, was self-reported by participants and confirmed 
with the medical team if missing. 
All returned questionnaires were stored in a locked cabinet in a secure storage room at the 
University of Chester.   In accordance with the Caldicott Principles, all information was held 
on a strictly need to know basis.  All electronic data was stored on a password protected 
area on a server at the University of Chester and accessed by BS only with NHW to be 
allowed access in case of emergency.  All data analysis was conducted on university 
computers.   Long-term storage of all documents was in University of Chester secure 
archives.   
Measures 
The questionnaire included the following psychometrically valid and reliable measures 
(Appendix 17): 
 Unmet psychosocial needs: SCNS-SF34 (Bonevski et al., 2000).  The SCNS SF34 is a 
34 item measure designed to assess the unmet needs of adult cancer patients.  
Need is measured on a likert scale from 1 (no need) to 5 (high need).  Domains are 
as follows: physical and daily living (PDL); psychological (psych); health systems 
and information (HSI); patient care and support (PCS); and sexual.  This measure 
was chosen over other needs assessment tools due to its wide usage within cancer 
136 
 
research as evidenced by the systematic review (Chapter 2) and the fact that is 
was designed to assess generic needs within cancer patients.   
 
  Anxiety and depression:  Hospital Anxiety and Depression Scale (Zigmond & 
Snaith, 1983).  The HADS is a 14 item measure designed to assess levels of anxiety 
and depression.  Answers are ranked from 0-3 for each item.  The measure has two 
sub-domains: anxiety and depression, each with seven items.  This measure was 
chosen due to its wide usage both within cancer research but within the wider 
health psychology field as evidenced within the literature reviews included within 
this thesis. 
 
 Quality of life:  EORTC QLQ-C30 (Aaronson et al., 1993).  This is a 30 item QoL tool 
where items are ranked from 1 (not at all) to 4 (very much).  There are nine sub-
scales: five functional scales (physical, role, cognitive, emotional, and social); three 
symptom scales (fatigue, pain, and nausea and vomiting); and a global health and 
quality-of-life scale.  This measure was chosen due to its common usage within the 
studies included within the systematic review in Chapter 2 and the fact that it was 
designed to assess QoL within cancer specifically.  While the FACT QoL measure 
does have both leukaemia and lymphoma specific scales, having different scales in 
use within the same study was felt to reduce opportunities to draw direct 
comparisons from across the whole sample.  In addition, the EORTC QLQ-C30 was 
more widely used in the previous literature as highlighted previously, enabling 
comparisons between this sample and others.       
 
  Social Distress:  SDI-21 (Wright et al., 2008).  A measure of social distress rating 
items from 0 (no difficulty) to 3 (very much difficulty).  The measure covers a range 
of everyday difficulties experienced by cancer patients (independence, domestic 
chores, personal care, care of dependents, support for dependents, welfare 
benefits, finances, financial services, work, planning the future, communication 
with those close to you and others, plans to have a family, sexual matters, body 
image, isolation, mobility, where you live, recreation and holidays).  Questions ask 
responders about their difficulty levels, ranging from “No difficulty” to “Very 
much”.  This scale was included within the questionnaire in order to address social 
wellbeing in addition to the psychological assessments. 
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 Benefit Finding: Benefit Finding (Carver & Antoni, 2004).  A 17 item measure 
originally developed for use in breast cancer patients.  Items measured responses 
from 1 (not at all) to 5 (extremely).  Although developed for use in breast cancer 
patients, it was felt that this was the most well validated measure of benefit 
finding in cancer populations.  The content of the questionnaire and the scoring 
system was not altered in any way with the exception of the initial question that 
leads into the questionnaire, “Having had breast cancer…” being amended to 
“Having had cancer…”.  
 
 Demographic questionnaire.  This assessed demographic variables: age, gender, 
ethnicity, employment, dependents, diagnosis, and treatment.   
 
For each measure, Cronbach’s Alpha, a measure of internal consistency or how closely 
related a group of items are, was conducted.  As summarised in table 4.2, all measures 
included within the questionnaire have a Cronbach’s Alpha of above 0.7 which indicates an 
acceptable level of internal consistency (Bland & Altman, 1997), the generally accepted 
level at which a measure is deemed suitable for use within a sample.   
 
Table 4.2: Cronbach’s Alpha for measures included within study questionnaire 
Measure Cronbach’s Alpha 
HADS A 0.75 
HADS D 0.87 
SCNS SF34 0.97 
EORTC QLQ-C30 0.90 
MiniMAC 0.91 
BriefCOPE 0.85 
Benefit Finding 0.94 
SDI-21 0.87 
 
Procedure Should a Questionnaire Indicate Clinically Significant Levels of Risk 
Immediately on return of questionnaires, responses to the HADS were read as a proxy 
screen for clinically significant levels of distress (defined as 11 or more on either the anxiety 
or depression sub-scales of the HADS as defined on the HADS scoring sheet (Zigmond & 
Snaith, 1983)).  Where the participant had agreed on the consent form for the researcher 
138 
 
to do so, the researcher then approached the treating clinician for these individual patients 
to discuss an appropriate referral to support services within the participant’s treating 
hospital.  Of the 35 participants that returned the questionnaires, three met clinical cut offs 
for anxiety, two also for depression (defined as a score of more than 10 on the HADS).  In 
two cases the patient was then contacted by their clinical team for an informal 
conversation about how they were.  In neither of these cases did the patient indicate to 
their clinician that they felt that they required additional support.  This corresponds with 
previous findings that state that only a minority of cancer patients with depression want 
formal support for this (Baker-Glenn et al., 2010).  In the case of the third participant to 
meet clinical standards for distress, it was stated that psychology input had already been 
offered but had been declined.  As such, no further immediate action was taken by the 
hospital.  
Data Analysis 
Data analysis consisted of three stages in line with study hypotheses: descriptive statistics 
and exploratory analysis of whether data met parametric assumptions; sub-group 
comparisons (objective 3); and correlation between variables (objective 4).  The original 
analysis plan for the study was to also run a multiple regression in order to examine 
predictor variables for later psychological outcomes (objective 4): due to the smaller than 
anticipated sample size however, this part of the analysis was not run due to lack of power.   
Response Rates 
After 14 months of recruitment, only 35 participants had been recruited into the study 
despite the researcher typically attending four clinic sessions per week.  This was clearly 
substantially below the intended sample size but recruitment into the study had to close 
for practical reasons.  Before moving on to discuss the rest of this study, a short discussion 
of recruitment issues and actions taken in an attempt to improve recruitment follows.   
  
Advice received from our clinical collaborators in the preparation of the study indicated 
that it would be feasible to recruit 200 patients from 3 hospital sites given the geographical 
range of the three hospitals in question and their populations served.  Once it was clear 
that this would not be achieved a number of steps were taken to assess the accuracy of this 
information, and a number of minor methodological adjustments were made to 
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recruitment processes in an attempt to boost both numbers recruited into the study and 
response rates for the questionnaire. 
 
Records from the Somerset database of cancer diagnoses (anonymised) were subsequently 
analysed once the study was underway and research access had been granted.  These 
indicated that there were close to 200 diagnoses within the included clinical sites and the 
planned recruitment time period, but that this figure did not take into account patients 
who were excluded from this study, for example: those who had relapsed as opposed to 
been given a new diagnosis; those who did not meet eligibility criteria for another reason 
(e.g. capacity); those who were deemed unsuitable to take part (e.g. known high distress, 
family problems, history of complaints); those who were immediately transferred 
elsewhere and did not remain a patient within the hospital; those who died soon after 
diagnosis; and a small number that were missed during the recruitment process.   Initial 
clinical estimates made by clinical collaborators on the study were substantial 
overestimates of actual figures.   Thus, a decision was made to introduce a fourth 
recruitment site into the study (North Wales Cancer Treatment Centre).  This was a large 
enough geographical catchment area to boost numbers while still ensuring that the 
researcher would continue to be able to attend clinics in person to encourage recruitment 
that way.  The rural setting of the hospital was also felt to provide contrast with the city 
centre hospitals already participating in the study. 
 
According to Somerset Records, even once ineligible patients were deducted, and even 
with the additional fourth site included, the number of eligible patients numbered only 110 
over the recruitment period.  It remains unclear why the initial estimates from the 
clinicians were so radically out of proportion to the reality of diagnosis and this was a 
significant issue in conducting this study.    
 
A national report more recently published on the incidence of haematological malignancies 
demonstrated that between 2006 and 2008, 8718 patients were diagnosed with CLL, NHL 
or myeloma in England (NCIN, 2013).  There are 168 acute hospital trusts in England.  While 
there will be differences in the number of patients diagnosed between trusts, as a scoping 
exercise, if the total number of diagnoses is divided by the number of trusts in England, 
there will have been approximately 52 diagnoses per trust within that two year period.  As 
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recruitment took place across four sites, this would have made an approximate total 
number of diagnoses for the included sites at 208 for the period between 2006-2008.   
 
Other strategies to maximise recruitment involved the researcher, whilst in clinic (at each 
site, on either a weekly or bi-weekly basis) spending time with the Clinical Nurse Specialist 
in charge of that clinic to ensure that the list of patients attending that clinic were reviewed 
in full and all eligible patients identified.  Whilst this did not seem to improve recruitment, 
it did ensure that recruitment practice at each site was of a high standard and that study 
referral was not biased.  Where patients were identified as eligible and agreed to receive 
the study information pack, efforts were made to ensure that the researcher could meet 
with the patient in person to explain the study and to answer any questions.  Not only is 
this ethically-minded but also has been demonstrated to improve response rates (Galea & 
Tracy, 2007).    
 
Finally, part way through the recruitment window, the questionnaire was made more user 
friendly.  In line with recommendations from previous research, the questionnaire was 
printed on green paper (Fox et al., 1988) and formatted using Microsoft Word rather than 
the initial use of the Formic Software to make the design more user friendly (Dillman, 
1993).  Names and addresses were handwritten on each questionnaire and envelope (Fox 
et al., 1998), again thought to improve response rates by making the questionnaire seem 
more personal. 
 
Analysis of eligibility and recruitment rates at the end of the study demonstrated that of 
the 110 patients diagnosed, approximately 30 immediately declined to take part in the 
study (no records were kept, unfortunately, regarding who these patients were).  71 
patients provided verbal consent to receive a questionnaire pack, of which 35 (50%) were 
returned.  This is in line with expected response rates for studies of this type (Armes et al., 
2009; Hawkins et al., 2008; McDowell et al., 2010) but to have achieve the initial target 
sample size would have need recruitment over a much longer period, or across more 
clinical sites, neither of which was feasible within the constraints of this project. 
 
In light of the recruitment difficulties experienced, the aims of the study were readjusted 
and the analysis plan simplified.  The original intent was to determine whether unmet 
needs predicted psychological outcomes using a multiple regression technique.  This was 
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amended to correlations to determine the presence of the relationship with additional 
testing used to explore differences between groups.  Given the lack of existing literature 
relating to the unmet needs of newly diagnosed haematological cancer patients, even this 
smaller, more exploratory study fills a gap in the literature and makes a useful contribution 
to knowledge. 
 
The revised analysis plan consisted of descriptive statistics being run for each measure for 
the sample as a whole including means, medians, percentages and standard deviations 
calculated as appropriate to describe the sample.  Comparisons between subgroups on 
demographic, treatment and disease variables (e.g. gender, diagnosis, treatment modalities 
received) were carried out using t tests and analysis of variance for normally distributed 
continuous variables.    Correlations between unmet need and outcomes were conducted 
using Pearson’s product-moment correlation coefficient. 
Examination of both graphical displays (e.g. scatter plots, histograms, Q-Q plots) of the 
dataset and running Kolmogorov-Smirnov tests for the key variables that were to be 
included within the analysis (Table 4.3) determined that the data was normally distributed 
and that there was a linear relationship.   Type of data was also suitable with outliers also 
not presenting a problem.   There was somewhat of a floor effect present on the unmet 
need scale (SCNS) due to a high number of participants selecting the ‘no need’ response; 
however, given that the remaining key variables were normally distributed and the 
repeated questioning within the related literature with regards to the need for parametric 
conditions to be met (Bryman & Cramer, 2011; Games & Lucas, 1966), the decision was 
made to use parametric testing. 
Table 4.3:  Kolmogorov Smirnov Tests of Normality for Study Measures 
  
Kolmogorov-Smirnova 
Statistic df Sig. 
HADS Anxiety .158 25 .106 
HADS 
Depression 
.118 25 .200 
EORTC Global 
score 
.115 25 .200 
SD_16 .143 25 .200 
SDI Single items .109 25 .200 
BriefCOPE .074 25 .200 
Benefit Finding .131 25 .200 
SCNS Total .219 25 .003 
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Results 
Participants completed questionnaires that assessed their unmet psychosocial needs, their 
anxiety and depression levels, quality of life, social distress, benefit finding and coping.  
Means and standard deviations for each of these key outcomes for the sample as a whole 
are presented in Table 4: 
Table 4.4: Means and standard deviations for key measures. 
 
Measure Mean (S.D.) 
Anxiety (HADS) 5.97 (4.33) 
Depression (HADS) 4.41 (3.48) 
Quality of Life (EORTC QLQ-C30) 4.91(1.40) 
Unmet Needs (SCNS SF34) 67.5 (28.14) 
Social Distress (SDI-21) 12.3 (11.2) 
Benefit Finding 3.01 (0.99) 
 
Objective 1: Unmet Need in Newly Diagnosed Haematological Cancer 
Patients 
The first study objective was to identify the unmet needs of newly diagnosed 
haematological cancer patients.  There were a range in the number of unmet needs 
reported across the sample.  For each individual item included on the SCNS SF34, there was 
unmet need reported within the sample.   
Thirty one out of 35 participants (89%) reported at least one unmet need on the SCNS SF34 
while 19 (54%) reported five or more unmet needs.  13 participants (37%) reported the 
presence of one or more high unmet need and four participants (11%) reported five or 
more high unmet needs.   
The five most highly rated unmet needs across the sample were: 
1. Concerns about the worries of those close to you (51.4%) 
2. Not being able to do the things you used to (50%),  
3. Uncertainty about the future (44.1%),  
4. Lack of energy/tiredness (42.9%),  
5. Learning to feel in control of your situation (40%). 
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Objective 2: The Psychological Wellbeing of Newly Diagnosed 
Haematological Cancer Patients 
Study objective two was to determine the psychological wellbeing of newly diagnosed 
haematological cancer patients. 
These data indicate that, as a sample, distress rates are below the clinically significant 
range.  Looking in more detail at scatter plots of key outcomes in Figures 4.1-4.3, we can 
see that the majority of participants have low levels of anxiety and depression but that 
quality of life is more varied within the sample. 
 
Figure 4.1: Bar chart to illustrate the spread of anxiety score.
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Figure 4.2: Bar chart to show to spread of depression scores within the sample. 
 
 
Figure 4.3: Bar chart to show the spread of QoL scores within the sample. 
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The spread of data for each of these outcome measures indicates that distress is prevalent 
within only a minority of the sample.   
For anxiety, three out of 34 participants (8.8%) fell within the clinically significant range.  A 
further 10 participants (29.4%) fell within the borderline clinically significant range for 
anxiety (defined as a score of 8-10 on the HADS).  In total, 38.2% of participants reported 
anxiety levels at borderline clinically significant levels or above.  For depression, two out of 
34 (5.9%) fell within the clinically significant range.  A further three participants (8.8%) had 
scores that fell within the borderline clinically significant range.  In total, 14.7% of 
participants reported levels of depression at a borderline clinically significant level or 
above. 
Objective 3: Sample Differences in Need and Distress 
The third study objective was to investigate differences within the sample, placing an 
emphasis on the differences between diagnoses, gender and treatment modalities. 
Diagnostic Groups 
Three different haematological cancer diagnoses were included within the sample: NHL 
(45.7%), CLL (22.9%) and myeloma (31.4%). 
Table 4.5: Mean scores and standard deviations for key outcomes for each diagnostic group. 
 NHL CLL Myeloma 
Unmet Need (SCNS SF34) 77.38 (34.28) 52.25 (18.51) 63.8 (16.84) 
Anxiety (HADS) 7.75 (4.84) 3.64 (3.58) 5.00 (2.87) 
Depression (HADS) 4.94 (3.61) 2.25 (3.01)  5.30 (3.20) 
Quality of Life (EORTC 
QLQ-C30) 
4.59 (1.23) 6.62 (0.44) 4.05 (0.93) 
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Table 4.5 indicates that participants with a diagnosis of NHL had both highest levels of 
unmet need and highest distress.  Participants with CLL had the lowest levels of distress 
and the highest QoL.   
Performing a One-Way ANOVA to explore differences between the three groups indicated 
that there was a statistically significant difference between groups for QoL [F(2,31) = 
15.899, p = <.001], although not for the other outcome variables. 
Further testing (Tukey HSD) indicated that participants with a diagnosis of CLL were 
statistically different from participants with either NHL or myeloma.  The mean difference 
between CLL and both NHL and myeloma was significant at p = <.001 for both groups.  
There was no significant difference between participants with NHL and myeloma. 
Participants with CLL therefore has a significantly better QoL when compared to 
participants with NHL or myeloma.   
Gender 
The sample was 71.4% male (N = 24) and 28.6% female (N = 10).   Lack of energy/tiredness, 
uncertainty about the future and concerns about the worries of those close to you were 
the most highly rated unmet needs among female participants.  Lack of energy/tiredness, 
being informed about test results as soon as is feasible and work around the home were 
the most highly rated unmet needs by male participants. 
Table 4.6 illustrates that both genders were comparatively similar in terms of the levels of 
distress, unmet need and quality of life.  This is supported by the results of t tests 
conducted for each outcome, no statistically significant gender differences were found.  
The low number of participants may factor into the lack of statistically significant findings 
as the low N is likely to correspond to a lack of statistical power. 
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Table 4.6:  Means and standard deviations for key outcomes according to gender.  
 Male Female 
Unmet Need (SCNS SF34) 66.42 (31.84) 70.00 (17.37) 
Anxiety (HADS) 5.21 (4.54) 7.80 (3.29) 
Depression (HADS) 4.42 (3.88) 4.40 (2.46) 
Quality of Life (EORTC 
QLQ-C30) 
4.81 (1.37) 5.15 (1.51) 
 
Treatment Sub-Groups 
68.6% of the sample were currently receiving active treatment, 31.4% had been monitored 
via watch and wait since diagnosis.  Not being able to do the things you used to do, anxiety, 
concerns about the worries of those close to you, lack of energy/tiredness and uncertainty 
about the future were the most common unmet needs in participants receiving active 
treatment.  Concerns about the worries of those close to you, fears about the cancer 
spreading, worry that the results of treatment are beyond your control and being given 
explanations of those tests for which you would like explanations were the most common 
unmet needs in watch and wait patients.   
Table 4.7 highlights that there are differences in needs, distress and QoL between patients 
receiving active treatment and those being monitored via watch and wait.  Unmet needs, 
anxiety and depression are lower and QoL higher in watch and wait patients. 
On conducting t tests for each of these four outcomes, significant differences were found 
between groups for depression [t(32) = 3.31, p = .002], unmet need [t(32) = 2.56, p = .015] 
and QoL [t(32) = -3.70, p = .001].  No significant differences were found for anxiety.   
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Table 4.7:  Means and standard deviations for key outcomes according to treatment sub-group.  
 Active Treatment Watch and Wait 
Unmet Need (SCNS SF34) 75.39 (29.1) 50.90 (17.27) 
Anxiety (HADS) 6.87 (4.31) 4.09 (3.91) 
Depression (HADS) 5.60 (2.63) 1.91 (2.63) 
Quality of Life (EORTC 
QLQ-C30) 
4.39 (1.20)  6.00 (1.16) 
 
Objective 4: The Relationship between Unmet Need and 
Psychological Wellbeing 
The fourth objective for the study was to investigate the potential relationship between 
unmet need and psychological wellbeing in newly diagnosed haematological cancer 
patients.   
Correlation between Variables 
A key research question was to determine whether there was a relationship between 
unmet need and psychological wellbeing.  Correlation between variables was examined 
between unmet needs according to both needs measures used and psychological 
outcomes. 
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Table 4.8: Correlation Between Variables 
  Anxiety Depression QoL 
Benefit 
Finding 
SCNS Total Needs r .47 .60 -.53 .44 
p  .006 .000 .001 .012 
SCNS Physical and 
Daily Living Needs 
r .17 .33 -.47 .50 
p .351 .058 .006 .004 
SCNS Psychological 
Needs 
r .60 .49 -.50 .58 
p .000 .004 .003 .001 
SCNS Health Systems 
and Information 
Needs 
r .37 .57 -.37 .23 
p .033 .001 .035 .212 
SCNS Patient Care 
and Support Needs 
r .32 .50 -.44 .15 
p .063 .002 .010 .403 
SCNS Sexual Needs r .38 .52 -.52 .32 
p .027 .002 .002 .069 
 
The correlations cited within Table 4.8 indicate that there is a relationship present between 
unmet needs and psychosocial outcomes.  For needs total score, all relationships were 
found to be statistically significant.  The effect sizes observed in the significant correlations 
were within the medium-large range.  For the correlations between unmet need total score 
and each of the five measures of wellbeing, two of the effect sizes would be categorised as 
medium (anxiety and benefit finding) and three as large (depression, QoL and coping).    
The positive correlation between unmet need and anxiety and depression indicate that 
where once increases, so does the other, thereby indicating that higher levels of unmet 
needs correspond with higher levels of anxiety and depression within the sample.  The 
negative correlation between unmet need and QoL means that the opposite is true in this 
instance, where unmet need increases, QoL decreases (and vice versa).  In addition to 
correlation between total need score, sub-domain scores and outcome variables, 
correlations between each individual need item on the SCNS SF34 and key outcomes 
variables anxiety, depression and QoL were performed in order to determine whether any 
individual need items were particularly strongly correlated with an outcome (Table 4.9).   
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Table 4.9: Correlation between SCNS SF34 items and key outcome variables. 
 SCNS SF34 Item Anxiety Depression QoL 
Pain r .24 .17 -.30 
p .181 .326 .086 
Lack of energytiredness r .24 .40 -.49 
p .177 .020 .003 
Feeling unwell a lot of the time r .21 .16 -.41 
p .243 .361 .018 
Work around the home r -.03 .25 -.19 
p .852 .147 .281 
Not being able to do things you used to do r .05 .30 -.48 
p .789 .091 .005 
Anxiety r .25 .12 -.39 
p .163 .506 .024 
Feeling down or depressed r .44 .17 -.33 
p .010 .349 .060 
Feelings of sadness r .41 .11 -.45 
p .019 .543 .009 
Fears about the cancer spreading r .35 .08 -.27 
p .042 .643 .129 
Worry that the results of treatment are beyond your  
control 
r .52 .43 -.27 
p .002 .011 .130 
Uncertainty about the future r .63 .63 -.38 
p .000 .000 .030 
Learning to feel in control of your situation r .42 .58 -.45 
p .013 .000 .007 
Keeping a positive outlook r .53 .50 -.40 
p .001 .002 .021 
Feelings about death and dying r .64 .57 -.45 
p .000 .000 .008 
Changes in sexual feelings r .25 .49 -.48 
p .152 .004 .004 
Changes in your sexual relationships r .36 .56 -.56 
p .036 .001 .001 
Concerns about the worries of those close to you r .41 .51 -.47 
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p .015 .002 .005 
More choice about which cancer specialists you  see r .37 .40 -.25 
p .034 .018 .162 
More choice about which hospital you attend r .33 .44 -.28 
p .058 .010 .108 
Reassurance by medical staff tha the way you feel  is 
normal 
r .22 .59 -.17 
p .220 .000 .343 
Hospital staff attending promptly to your physical  needs r .12 .12 -.50 
p .583 .498 .003 
Hospital staff acknowledging and showing  sensitivity to 
your feelings and emotional needs 
r .31 .47 -.55 
p .074 .005 .001 
Being given written information about the important  
aspects of care 
r .33 .53 -.36 
p .060 .002 .042 
Being given information written diagrams  drawings 
about aspects of managing you illness  and sideeffects at 
home 
r .33 .32 -.45 
p .061 .067 .008 
Being given explanations of those test for which  you 
would like explanations 
r .21 .48 -.17 
p .239 .004 .326 
Being adequately informed about the benefits and  
sideeffects of treatments before you choose to  have 
them 
r .29 .58 -.23 
p .093 .000 .197 
Being informed about your test results as soon as  
feasible 
r .32 .51 -.49 
p .067 .002 .003 
Being informed about cancer which is under control  or 
diminishing that is remission 
r .27 .42 -.35 
p .122 .013 .040 
Being informed about things you can do to help  yourself 
to get well 
r .45 .46 -.29 
p .008 .006 .095 
Having access to professional counselling eg  
psychologist social worker counsellor nurse  specialist if 
you family or friends need it 
r .38 .54 -.26 
p .029 .001 .142 
Being informed about sexual relationships r .48 .45 -.43 
p .004 .008 .012 
Being treated like a person not just another case r .34 .54 -.35 
p .052 .001 .045 
Being treated in a hospital or clinic that is as  physically 
pleasant as possible 
r .31 .51 -.33 
p .074 .002 .055 
Having one member of staff with whom you can talk  to 
about all aspects of your condition treatment and  
followup 
r .29 .42 -.24 
p  .093 .013 .175 
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Seven unmet needs were found to significantly correlate with all three key outcome 
variables: uncertainty about the future; learning to feel in control of your situation; keeping 
a positive outlook; feelings about death and dying; concerns about the worries of those 
close to you; changes in your sexual relationship; and being informed about sexual 
relationships.    All of these needs fall within either the unmet psychological need or unmet 
sexual need domains on the SCNS SF34.   Where correlations between unmet need and 
outcomes were significant, the effect sizes were all at least medium with many falling 
within the large range, indicating a strong relationship between the variables.   
The decision was made not to include Bonferroni corrections within the analysis.  This 
decision was made based on several factors: Bonferroni corrections have been criticised for 
being overly conservative which can create liability for a Type II error (Cohen, 1994) and 
arguments for other testing procedures have been made (Bender & Lange, 1999).  In light 
of both these criticisms and the exploratory nature of this research when combined with 
the results of the correlation analysis being consistent with both the hypothesis stated 
under the study aims and the wider literature, Bonferonni corrections were not used.    
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Discussion 
Research relating to the unmet psychosocial needs of haematological cancer patients is 
scarce in the existing literature, with only three studies identified within the systematic 
review (Chapter 2).  This quantitative study attempted to begin to remedy this by 
identifying the unmet psychosocial needs of newly diagnosed haematological cancer 
patients.   The study objectives were: 
1. To identify the unmet needs of newly diagnosed haematological cancer patients. 
2. To investigate psychological wellbeing in newly diagnosed haematological cancer 
patients.  
3. To examine potential differences in need and wellbeing between patients who 
receive active treatment and those who are monitored via watch and wait; 
between genders; and between diagnostic groups. 
4. To investigate the relationship between unmet need and psychological wellbeing 
with the hypothesis that higher levels of unmet need will result in poorer 
psychological wellbeing. 
Considerable difficulties were encountered in recruiting the desired numbers of 
participants in order to fulfil the original analysis plan.  In light of these concerns, a number 
of attempts were made to improve recruitment and ultimately the analysis plan for the 
study was re-defined to accommodate the revised participant numbers.  An additional site 
was added, attempts were made to boost recruitment in the clinical setting by ensuring 
that all eligible participants were being approached about taking part in the study in order 
and by amending the format of the questionnaire in an attempt to make it more user-
friendly and boost response rates.  The analysis plan was subsequently simplified in an 
attempt to reduce the effect of a lack of statistical power due to low number of 
participants, while still meeting the study objectives and obtaining findings that would 
develop the current knowledge of unmet need in haematological cancer patients.   
Difficulties in recruitment may be reflective of there being so few studies identified in the 
systematic review that relate to need in haematological cancer populations.  If recruitment 
proves to be such a significant challenge, then it may be that researchers focus on the more 
common cancer groups as quicker, more accessible patient populations to recruit.  
However, the significant disparities between haematological cancer patients and those 
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with solid tumours warrant a much more in depth exploration of their psychological 
wellbeing than is currently present within the research literature.  Indeed, the psycho-
oncology literature is such that it predominantly relates to a specific sub-group of diseases 
to the exclusion of others.  A full exploration of this issue and the potential impact upon 
patient wellbeing is undertaken in Chapter 6. 
Despite this, a number of novel, important results have been found.  Understanding the 
type of need relevant to a patient group is the crucial first step in being able to efficiently 
meet these needs within the clinical setting (Watson et al., 2012; Carlson et al., 2012) and 
to be able to go on to develop effective interventions (Abrahamson, 2010).  This study 
contributes knowledge by identifying the specific unmet needs of haematological cancer 
samples at the time of diagnosis: both for the sample as a whole and by specific sub-groups 
that were felt to hold the most clinical utility.   The most highly rated unmet needs across 
the sample were: not being able to do the things you used to; lack of energy/tiredness; and 
uncertainty about the future.  Reviewing the findings from both the systematic review and 
qualitative study already detailed within this thesis reveal that fear of recurrence, 
information needs, concerns about the worries of those close to you, keeping positive, 
having a key worker and fatigue have been the most common unmet needs within these 
studies with information needs and fear of recurrence being highlighted in both pieces of 
work.   Clear patterns relating to areas of need that have relevance to haematological 
cancer patients are emerging: uncertainty about the future, including whether or not they 
are ‘cured’ from their disease; a need for understandable, relevant information; concerns 
about those close to you and fatigue (Harrison et al., 2009; Armes et al., 2009; Morrison et 
al., 2012). 
Information needs and needs relating to psychological wellbeing are not uncommon at the 
point of diagnosis (Puts et al., 2012) with up to 93% of newly diagnosed older cancer 
patients (mixed clinical sites) identifying as having unmet needs in these areas.   A 
systematic review of the unmet needs of cancer patients highlighted psychological and 
information needs as being common within cancer patients, but highlighted needs within 
the activities of daily living domain as being the most frequently reported (Harrison et al., 
2009).   These needs are different from those identified as most important within both this 
study and those already discussed in previous chapters, this may be reflective of 
differences between haematological cancer patients and more general cancer samples.  In 
this study particularly, the inclusion of watch and wait patients who were not yet 
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undergoing any treatment for their diagnosis may have reduced the importance of physical 
and daily living needs within the sample due to the absence of cancer treatments known to 
have physical side-effects.    
Anxieties about the future in light of a cancer diagnosis are common with fear of 
recurrence having an existing body of research dedicated to its understanding (Llewellyn et 
al., 2003; Rogers et al., 2008; Ozakinci et al., under review).  A recent review highlighted 
fear of recurrence as being frequently identified as the major concern for cancer survivors 
(Simard et al., 2013).  In head and neck cancer patients, it has been demonstrated that fear 
of recurrence is related to the presence of intrusive thoughts and heightened negative 
emotions (Rogers et al., 2008), unsurprising in light of the finding that unmet needs and 
psychological wellbeing are related.  Work within this thesis has demonstrated that fear of 
recurrence is also a key concern for haematological cancer patients.  The analysis of the 
correlation between individual items on the SCNS SF34 and psychological wellbeing, found 
that fears about the cancer spreading correlated with levels of anxiety in the sample.  As 
this is also found in broader cancer diagnoses this speaks to the generalisability of this 
phenomenon, highlighting the clinical importance.   
As a sample, the average distress levels were below clinically significant cut-offs as 
determined by the HADS.  Yet, the results also highlight that there is a significant minority 
of patients for whom anxiety and depression are present.  For anxiety, 38.2% of the sample 
displayed levels of anxiety at the borderline clinical cut-off or above, with a figure of 14.7% 
for depression.  In comparison, 4.7% of the general population in the UK experience anxiety 
problems with 2.6% experiencing depression (Swift et al., 2014).  This large disparity in 
prevalence rates for these disorders compared with the general population thus supports 
the proposition that a diagnosis of cancer directly impacts upon psychological wellbeing in 
haematological patients.   
As is perhaps to be expected, there were differences identified in the most common unmet 
needs within participant sub-groups, gender included, although differences between 
genders were not statistically significant.  Given previous research that indicates that 
women are at higher risk of having unmet needs (Hodgkinson, Butow, Hunt, & Wain, 2006), 
this is perhaps surprising.  Observing item by item responses, men appear to rate more 
practical needs more highly whereas women were more likely to highlight needs relating to 
their emotional wellbeing.  Women highlighting needs connected to psychological or 
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emotional domains is not a new finding, previous research looking at need in breast cancer 
samples has highlighted that women with cancer often report unmet needs within the 
psychological domain (Uchida et al., 2011), and express the need for counsellors to be 
available to help manage the psychological impact of their illness (Ruddy et al., 2013; von 
Heymann-Horan et al., 2013).    
Patients being monitored via watch and wait were less likely to highlight physical needs 
than their peers receiving treatment but conversely were more likely to have psychological 
needs relating to uncertainty and the lack of control they are currently experiencing.  This is 
not surprising finding given the nature of watch and wait; patients are given a diagnosis of 
cancer yet informed that they will not receive treatment at this time, although their 
condition is likely to worsen in the future.  The concept of uncertainty has been explored in 
patients with indolent NHL (Elphee, 2008) whereby it was also reflected that the chronic, 
incurable nature of the disease coupled with the transient, vague symptoms often 
experienced are key factors in the development of uncertainty.  It has also been 
acknowledged that the lack of treatment may feed into a sense of isolation from others and 
of anxiety (Horn & Campbell, 2004).  This sample identified fears about the cancer 
spreading and a lack of control as key unmet needs, both needs with the potential to feed 
into the anxiety that has been highlighted in previous works.   In this thesis, the findings 
were relevant to watch and wait patients that included a diagnosis of CLL as well as 
participants with NHL, really highlighting the applicability of uncertainty across diagnosis 
when watch and wait is utilised.   
The results highlighted that there were statistically significant differences in unmet need, 
depression and QoL between watch and wait patients and those actively treated.  This is in 
direct contrast to previous research that has compared psychological outcomes between 
these groups.  Reseach investigating the QoL of CLL patients found no difference between 
treatment modalities (Holzner et al., 2004); a finding also supported by Levin and 
colleagues who focussed on anxiety, depression and QoL outcomes (Levin et al., 2007).  The 
sample in the current study also included NHL and myeloma patients in addition to CLL 
participants, and this potentially explains some of the variation in findings.  The present 
study also recruited patients at the time of diagnosis, again unlike the two existing studies 
that offer different findings.  It is possible that watch and wait patients therefore initially 
have a better quality of life and psychological wellbeing than their peers who receive 
treatment, but that overtime, the uncertainty of living with a cancer diagnosis and 
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prognosis and lack of control (the key unmet needs highlighted for this group), may act to 
reduce wellbeing lessening the difference between active treatment patients.   This study 
also found that CLL patients have a better QoL than participants with NHL or myeloma, 
lending support to the hypothesis that having a mixed diagnosis sample may be in part the 
reason why this study found a significant difference between treatment groups.  The 
scarcity of research into the psychological wellbeing of this patient group means that the 
body of evidence has not yet reached saturation with regards to how we understand 
differences between haematological cancer patients that are treated and those that are 
not.   
Study Evaluation 
While this study certainly improved the existing knowledge base relating to psychological 
wellbeing in haematological cancer patients, it must be acknowledged that the work has 
limitations.  The key issue within this study, as highlighted previously, was the small 
number of participants.  In quantitative research, small sample sizes can create concerns 
about the analysis having sufficient statistical power.  Previous literature has highlighted 
that women are more likely to report unmet needs (Hodgkinson et al., 2007) than men.  
While this was the trend within this study, t tests to examine gender differences within the 
sample found no statistically significant differences.  While it may be the case that these 
gender differences were simply not present within the current sample, it must also be 
acknowledged that the small number of participants (males = 24, females = 10) may have 
resulted in a lack of power.  Power calculations indicate that, with expectations of a 
medium effect size and power at 0.8, a sample size of 82 would have been required for the 
t test to have been sufficiently powered to achieve a significant result.   
Various attempts were made to improve recruitment, including the researcher being based 
on site within the out-patient clinic at each site each week.  This allowed for the integration 
of the researcher into the clinical environment, ensuring that clinic lists were screened for 
potential participants and that clinicians were introducing potential participants to the 
study.  This also typically allowed for a face-to-face meeting between the researcher and 
the participant, meaning that any queries or concerns about the study can be addressed 
and the work is humanised by the presence of a recognised point of contact.  This limited 
the number of different hospitals with which the researcher could work however.  If 
recruitment had been undertaken from double or even triple the number of hospital sites, 
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then the desired number of participants would have been more likely to have been reached 
but this was not feasible given the time demands and scope of the PhD project.  In larger 
scale studies where support is provided by cancer research networks (e.g. in the form of 
research nurses), then recruiting from large numbers of sites becomes much more feasible.  
For the current study, it was felt that maintaining the researcher presence in hospital clinics 
was the best solution to the challenges of recruitment.  For future research projects, these 
limitations really highlight the importance of research that takes place within a larger, 
preferably multidisciplinary team so that the workload can be shared within, enabling 
larger scale recruitment and a higher degree of engagement from within the clinical setting 
itself.   
Clinical Implications 
This work has established the presence of a relationship between unmet needs and 
psychological wellbeing in haematological cancer patients.  This both adds to the existing 
evidence base on how we conceptualise need, but also lends weight to the argument that 
needs assessment should be integrated into routine practical within the clinical setting.  In 
the UK, holistic needs assessment is becoming more routine within cancer care in line with 
NICE recommendations that patients should receive individualised care and support not 
just for the medical care but also for their emotional, spiritual and social wellbeing (NICE, 
2004).  The knowledge that needs assessment can not only be used as a tool to guide 
healthcare professionals in their provision of support for their patients, but also has the 
potential to act as an indicator of a patient’s more general psychological health and 
wellbeing has clear implications for use within the clinical setting.   
This study found that unmet needs are significantly correlated with anxiety, depression, 
QoL and coping.  Unmet psychological needs have particular utility in having a relationship 
with psychological outcomes.  In the correlational analysis unmet psychological need 
correlated with anxiety, depression and coping.  Seven needs items in particular were 
identified that significantly correlated with all of these outcomes, five of which were needs 
from the psychological need domain and the remaining falling within the sexual domain.  
The relationship between unmet psychological need and psychological wellbeing is perhaps 
intuitive: where patients have unmet psychological needs then they also are more likely to 
have poorer psychological outcomes.  But it is also useful in that it provides an indication of 
specific areas or questions on a needs assessment that are most likely to provide clinicians 
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with an more general indication of overall psychological health.  In order for research and 
clinical practice to truly integrate, and for these areas of unmet needs to be addressed 
within the clinical setting, both clinicians and patients must feel comfortable in addressing 
psychosocial concerns.  Work outlined in Chapter 3 of this thesis highlighted that patients 
can often feel uncomfortable raising concerns that fall outside of a physical remit as this is 
perceived to be the primary aim of a general hospital (Ozakinci et al., under review).  
However, existing research demonstrates that this is not always an area where clinicians 
feel comfortable or skilled in discussing either (Fallowfield et al., 2001).  Further research is 
needed that aims to not only improve clinician confidence and feelings of self-efficacy, but 
this needs to translate through into an improved patient experience.  Though there is 
existing evidence that training programmes can assist here (Moorey, 2013), more work is 
needed on this aspect of doctor-patient communication.  As a health service, it is 
unreasonable to expect healthcare professionals to have a proficiency in an area where 
they may have received little training, therefore research is needed to determine the best 
way of improving both clinician self-efficacy and patient experience at the same time. 
The relationship between unmet need and the presence of active treatment was also 
investigated in this study and highlighted that the relationship was significant across all 
domains with the exception of health systems and information.  This is perhaps logical, in 
that patients who are receiving active treatment are more likely to be managing adverse 
physical side effects than watch and wait patients, which may also impact upon 
psychological and emotional wellbeing (Hong et al., 2014; So et al., 2010).  There were no 
treatment group differences with regards to whether or not patients experienced needs 
relating to the healthcare system and information provision.  This tells us that cancer 
diagnosis alone is sufficient to induce a need for information and access to healthcare 
services and clinicians.  Physical, psychological, care and sexual needs are more dependent 
upon the subsequent treatment for diagnosis and all that this entails.  While the work here 
is limited in terms of sample size, and a larger study to further explore these findings would 
act to strengthen these assertions and produce a more robust evidence base, this work 
provides a baseline of knowledge that relates to both unmet need and psychological 
wellbeing in haematological cancer patients.  The findings presented here suggest that all 
haematological cancer patients have a requirement for relevant information, and this has 
real applications in terms of intervention development and support provision.  Information 
provision was also highlighted in the qualitative work outlined in Chapter 3, along with the 
assertion that information needs to be tailored to the individual and their specific situation 
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and their desire for knowledge, thus a consistent narrative is emerging across the collection 
of studies. 
In summary, this research has highlighted the key areas of need for haematological cancer 
patients and this is in line with the previous findings highlighted within this thesis.  The 
relationship between unmet need and psychological wellbeing has been established in this 
work and this has significant potential implications for the provision of support services for 
cancer patients and will be investigated in more detail in the following chapter. 
Conclusions 
This quantitative questionnaire study has identified key unmet needs for newly diagnosed 
haematological cancers and highlighted the potential predictive utility of unmet 
psychological need in enabling clinicians to gain a more general idea of overall patient 
psychological wellbeing.  The routine assessment of unmet needs within the cancer setting 
has a direct relevance to the provision of relevant, desired support services by enabling 
healthcare professionals to gain an understanding of not only patient concerns but where 
their desire for help lies.  This study highlights key areas where there is the potential for 
unmet needs to be present in newly diagnosed haematological cancer patients, beneficial 
to clinicians conducting appointments in a time-sensitive clinic setting.  In addition, this 
work provides an indication that needs assessment could be used in a broader sense to 
provide an indication of a patient’s overall psychological health.  More research is needed 
to better understand the nature of the relationship between need and psychological 
wellbeing in order to be more effective in the detection of distress and as a precursor to 
the development of interventions that are able to target active mechanisms of change, 
thereby maximising efficiency and impact.  This will be expanded upon in the subsequent 
chapter (Chapter 5) which will detail a quantitative study investigating potential 
moderators between need and outcome.   
The major limitation of the present study was the significant challenge of recruiting 
participants.  Attempts made to improve both recruitment and response rates were 
outlined earlier within the methodology section of this chapter.  It is likely that small 
numbers of potential participants directly relates to the lack of previous research relating 
to haematological cancers.  This is not a concern that is specific to this patient group 
however, rarer cancers in general are less likely to be the subject of research in psycho-
oncology and the majority of existing research has related to women with a diagnosis of 
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breast cancer.  While there is merit in seeking to recruit patient groups where there is a 
greater certainty of achieving the desired number of participants, where this becomes at 
the expense of research in smaller groups, real gaps in the evidence base begin to form.  
There have been arguments made that, as a field, psycho-oncology needs to be moving 
forward from descriptive research to create studies that focus on the design and 
implementation of interventions that reduce distress (Moorey, 2013).  Yet for this next 
stage of research to have real scope and meaning, the evidence base on which it builds 
must be cohesive and representative of cancer patients as a whole population, rather than 
on the assumption that all will have psychological needs that fall in line with those of the 
more common diagnoses.  For an intervention to be truly effective and for patient 
outcomes to improve, then the intervention must be relevant to those patients for whom it 
aims to produce change.  Studies such as the one outlined in this thesis chapter have a real 
value in that they broaden the knowledge of how rarer cancer diagnoses affect 
psychological wellbeing and only from a unified understanding of patient need can truly 
effective interventions be developed.  As a result of the issues arising within this chapter, 
Chapter 6 will seek to broaden the discussion of researching rarer cancer diagnoses in the 
UK and to argue the case as to why research of this nature is needed. 
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Chapter 5 - The Long-Term Unmet 
Needs of Haematological Cancer 
Survivors and the Role of 
Psychological Flexibility in their 
Relationship with Psychological 
Wellbeing 
Overview  
Attempting to identify type and prevalence of unmet need in haematological cancer 
patients has been an on-going research question throughout this thesis.  This next chapter 
will build upon the previous work in an attempt to address the question of whether unmet 
needs endure after the initial shock of diagnosis and the challenges of treatment have 
ended into the survivorship phase of cancer.  This study will aim to identify the type of 
unmet needs that are most relevant to survivors and investigate the precise nature of the 
relationship between needs, wellbeing and the potential factors that may play a role in 
moderating this relationship.    Knowledge of this type is important to inform interventions 
to potentially improve patient outcomes.  Specifically, this study explored the nature of 
psychological flexibility, that is whether people are able to adapt their thinking patterns in 
light of a change in their circumstances, and whether this moderates the relationship 
between unmet need and outcomes in this sample. 
Survivorship: An on-going need for support. 
Cancer survivorship, described as living with and beyond cancer, is a field of research that is 
becoming increasingly important: the number of people surviving a diagnosis of cancer is 
currently estimated to be at around two million (NCSI, 2013) and expected to rise further 
(Maher & McConnell, 2011).  An understanding of the issues experienced by cancer 
survivors has developed over recent years, and the introduction of initiatives such as the 
National Cancer Survivorship Initiative (NCSI), resulting from the Cancer Reform Strategy 
(DoH, 2007) in the UK in 2007, has meant that the wellbeing of patients at this stage of 
their cancer experiences has been brought into the spotlight.  The Improving Outcomes 
Strategy for Cancer (DoH, 2011) highlighted that more research was needed in order to 
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determine better ways of ensuring that cancer survivors were able to return to a full and 
active life after their cancer treatment was completed.  A recent report published by the 
Department of Health (2012) on the quality of life of cancer survivors highlighted that, in 
comparison to patients with breast, colorectal or prostate cancer, patients with a diagnosis 
of Non-Hodgkin’s lymphoma (NHL) demonstrated comparatively poor psychosocial 
outcomes.  NHL patients displayed worse levels of maintaining their independence, of 
anxiety, having the biggest problems completing their usual activities, the most difficulties 
in planning for the future, the most problems with benefits and displayed the highest levels 
of pain and discomfort.  This major report surveyed patients who received their diagnosis a 
year or more previously, indicating that psychosocial issues continue to affect patients long 
after their initial diagnosis and often after initial treatment has been completed.  While 
these findings relate to NHL only, and not haematological malignancies as a whole, given 
the overarching similarities that exist within this group of cancers, it seems likely that this 
concerning view of wellbeing is generalizable.  There is little research that encompasses the 
spectrum of haematological diagnoses, making further exploration vital to be able to 
identify their unmet needs. 
Previous research on unmet needs in cancer survivors has suggested that 64% have at least 
one unmet need (Siu et al., 2013), yet there is less indication in the literature regarding the 
saliency of unmet needs during this time period.   Survivorship has in itself been described 
as an unmet need for cancer patients (Wolff et al., 2005) due to the fact that the levels of 
support and guidance received by patients typically reduces during the time after 
treatment ends.  Indeed, a study by Lobb and colleagues (2009) included in the systematic 
review (Chapter 2), indicated that almost two thirds of patients would have liked the 
opportunity to talk to a HCP about their cancer experiences.      
There is little research that looks at the long-term care needs of haematological cancer 
survivors. Three recent papers have been published based upon a study carried out in 
Australia that highlight that managing tiredness is a key concern for both Australian and 
Canadian patients (Hall et al., 2013).  This work acknowledges the potential differences that 
may exist between needs of patients in different countries, and the presence of the 
National Health Service in the UK (as opposed to a privatised healthcare system) may well 
serve to minimise some areas of need that are more relevant elsewhere.  Further work to 
emerge from this same research project indicated that 25% of haematological cancer 
survivors surveyed had a ‘high/very high’ level of unmet need on multiple items (Hall et al., 
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2014).  This provides a real suggestion that haematological cancer survivors do experience 
on-going unmet need that warrants further exploration to both confirm these findings and 
to form a comparison within a UK sample. 
Fear of recurrence is a known psychological concern for cancer survivors (Rogers et al., 
2010) and the concern that the cancer could return or spread can be enduring and intrusive 
for a significant subset of patients.  The identification of which patients will develop such 
fears has been difficult (Llewellyn et al., 2008) with further research needed to highlight 
any key patient demographics or trigger variables.  Survivors also report unmet needs 
relating to on-going fatigue, altered fertility or body image as a result of treatment and 
difficulty adjusting to normal life after experiencing a life altering change (Hammond et al., 
2008; Harrison et al., 2009).  Re-engaging with employment is an additional challenge that 
many patients must face and uncertainty around finances or being unable to find 
employment after having had cancer can also significantly impact upon psychological 
wellbeing in cancer survivors.   
There are high levels of undetected anxiety and depression reported in haematological 
populations (Zittoun et al., 1999) and feelings of powerlessness and loss of control can 
impact upon a person’s wellbeing (Rydahl-Hansen, 2005).    A recent report published by 
the Department of Health (2012) highlighted that, in comparison to patients with breast, 
colorectal or prostate cancer, patients with a diagnosis of Non-Hodgkin’s lymphoma 
displayed the poorest levels of maintaining independence, of anxiety, having the biggest 
problems completing their usual activities, the most difficulties in planning for the future, 
the most problems with benefits and displayed the highest levels of pain and discomfort.  
This report surveyed 3,300 patients who received their diagnosis a year or more previously, 
indicating that psychosocial issues continue to affect patients long after their initial 
diagnosis and often after initial treatment has been completed. 
Previous research has indicated that haematology patients experience a lower overall 
quality of life in comparison to healthy controls (Holzner, 2004).  One factor that may feed 
into the lower QoL observed in some cancer patients is the level of uncertainty faced.  
Mishel’s (1999) Uncertainty in Illness Model (as reviewed in Chapter 4) highlights how 
important structure providers such as social support, the relationship with the healthcare 
team or knowledge about their condition, along with stimuli frame, for example the 
consistency of symptoms or familiarity of events, are in establishing the level of uncertainty 
that a patient will feel.   Much of this work has come out of research conducted with 
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gynaecological, breast and prostate cancer patients, however, a review of uncertainty in 
indolent Non-Hodgkin’s lymphoma patients found that interventions designed to reduce 
uncertainty also reduced depressive symptoms and improved QoL (Elphee, 2008). 
The on-going presence of unmet psychosocial needs in survivorship is indicative of a wider 
problem experienced by cancer patients: during their diagnosis and treatment phases, 
contact with the hospital is regular and patients can be comfortable that they will be able 
to seek medical support or reassurance from their treating clinicians in a relatively short 
time frame should the need arise.  Once treatment ends however, patients typically go 
from this sense of security that comes from on-going contact with their clinicians to being 
seen at much greater intervals for follow-up appointments (Abrahamson, Durham, & Fox, 
2010).  This can result in feelings of sudden isolation or being abandoned at a time when 
research indicates that the deeper psychological impact of cancer can come into play (Lobb 
et al., 2009).  A systematic review by Harrison and colleagues (2009) found that although 
the highest level of need was present at the onset of treatment, a greater number of 
patients expressed at least some need in the period after treatment ended.  The literature 
relating to the unmet needs of haematological cancer survivors is sparse:  there are only 
two papers that directly examine the unmet needs of this specific group (Hall et al., 2014; 
Lobb et al., 2009) and one (Hall et al., 2014) details the psychometric evaluation of a needs 
assessment tool within this group rather than the specific needs of patients.  Both of these 
studies were carried out in Australia; none exist that have recruited a UK based sample.  
There is, therefore, not only a lack of research relating to the unmet needs of 
haematological cancer survivors generally, but a dearth of evidence regarding survivors 
living in the UK. 
Unmet psychosocial needs are thought to be directly related to the level of distress that a 
person might experience upon learning that they have a diagnosis of cancer (Carlson, 
Waller, & Mitchell, 2012).  Indeed, previous researchers have postulated a direct link 
between unmet need and distress, equating the level of psychosocial need with degrees of 
emotional or psychological distress (McIllmurray et al., 2001).  It is, therefore, possible that 
the level of unmet psychosocial needs may have an additional clinical application and be 
used as a more general indicator over overall psychological wellbeing.  
The research relating to interventions that aim to reduce unmet needs in cancer patients 
has yielded variable results (Stanton, 2006).  Current practice is typically such that clinicians 
aim to meet patient need in a more informal manner via the development of a trusting 
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relationship between patient and clinician, in some cases active listening has been 
employed as a way of trying to meet needs (Moorey, 2013).  More common are 
interventions that aim to reduce distress or to improve quality of life in cancer patients 
(Sheard & Maguire, 1999).  Both previous work in this thesis and past literature (Armes et 
al., 2009; Morrison et al., 2012) has highlighted a relationship between unmet needs and 
psychological wellbeing.  It is not clear to what extent unmet needs persist into the 
survivorship phase for haematological cancer patients in the UK and whether the 
relationship with wellbeing is maintained.  In addition, causality within the relationship 
between unmet need and wellbeing is not well understood.  It may be that the presence of 
unmet needs is in itself distressing and directly impacts upon psychological health; or, 
conversely, that the presence of distress may itself be the unmet need being identified.  A 
lack of understanding around the precise nature of this relationship and any additional 
factors that may also impact upon the nature of the relationship makes designing 
interventions that will effectively target the processes of change and act to reduce distress 
more difficult. Interventions that aim to reduce unmet need also often take place within 
the hospital setting where at the most basic level interventions have focussed on 
developing the communication skills of clinicians (Merckaert et al., 2005; Fallowfield et al., 
2002).  This may not adequately account for needs that predominantly affect patients in 
external settings such as home or work and, as with many areas of research within psycho-
oncology, research into this has been carried out with relatively limited cancer samples.  
More specialised interventions are available and typically provided by trained mental 
health professionals, yet referral requires the presence of a higher level of distress; this 
goes somewhat against the stance of developing interventions to reduce unmet need in 
order to prevent distress from arising in the first place.   Understanding the psychological 
mechanisms affecting the relationship between unmet needs and wellbeing creates the 
potential for the creation of interventions that accurately target the active mechanisms 
that exist with a relationship, enabling the intervention to be honed and streamlined 
(Stanton et al., 2012).  If an intervention can target specific factors that have the ability to 
create change in a person’s wellbeing while minimising additional content, then the cost of 
the intervention can be kept to the minimum required for positive change: highly desirable 
within a climate of limited resources within the healthcare system.   
Moderation 
Moderation analysis is a statistical technique that tests for interaction effects using linear 
regression analysis (Hayes, 2013).  It can be used to highlight factors that influence the way 
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in which a relationship functions; if something acts as a moderator, then, as a variable, it 
alters the strength or direction of the relationship between the predictor and outcome 
variables (Hayes, 2013).  Moderation effects can manifest in a number of ways: enhancing, 
buffering or antagonising.  If a moderator variable acts to enhance the relationship 
between predictor and outcome, then when the moderator increases, so does the effect of 
the predictor variable.  If the moderator buffers, then increasing the moderator decreases 
the effect of the predictor on the outcome variable.  In the case of antagonistic 
moderators, increasing the moderator reverses the effect of the predictor.   
Within the broader health literature, techniques such as moderation can be used to 
advance research into relationships between variables in order to be able to investigate the 
underlying mechanisms via which relationships function (MacKinnon & Leucken, 2008).  
Within this literature, moderation has been employed to ask questions such as when are 
stress levels associated with cardiovascular risk (Mausbach et al., 2008) or to refine the use 
of interventions by identifying the active mechanisms via which change can occur, for 
example in indicating that a couples-focused program is more effective for breast cancer 
patients who display higher level emotion-processing skills at the start of the intervention 
(Manne et al., 2007).   
The influence of additional factors that may affect the relationship has not yet been 
explored in the context of unmet need and psychological wellbeing.  As such, it not yet 
understood precisely how the relationship between unmet need and distress functions or 
what the active mechanisms are that affect change in wellbeing.   Developing this 
understanding is pivotal to the development of empirically based interventions that can 
directly target areas that will be most effective in influencing change (Stanton et al., 2012).  
Acceptance is a key issue for cancer patients, as one participant from the IPA study 
(Chapter 3) stated: 
"you have to get into a position mentally where you accept… rather than fear" P1 
Psychological flexibility is central to self-acceptance (Hayes et al., 2006); a person who is 
psychologically flexible is able to sit with unwanted experiences rather than trying to avoid 
or alter them in some way (Fledderus et al., 2013).  Someone who was psychologically 
inflexible may find it difficult to appreciate the context of a situation and to identify 
behaviours that are aligned to their valued and preferred way of living (Hayes et al., 2006).  
Being psychologically flexible is, in part, the ability to adapt to new situations and the 
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demands that are placed upon us.  Receiving a diagnosis of cancer, for most people, will 
mean significant changes in their daily activities, the ability to fulfil previous roles and can 
ultimately impact upon their view of themselves (Lobb et al., 2009).  This can mean that the 
goals that a person may have previously held may no longer be possible, or that the values 
that a person holds most important are re-evaluated.  It is well recognised that after being 
diagnosed with cancer, more emphasis is often placed upon relationships and living life as 
people always wanted to (Sears et al., 2003).  Such shifts in perspective are a key 
component of psychological flexibility (Hayes et al., 2006).    
Psychological flexibility is an important construct to explore in this context as it is also 
thought to be a process of change within Acceptance and Commitment Therapy (ACT; 
Hayes, Stroshal, & Wilson,2011 ; Ciarrochi, Bilich, & Godsel, 2010): as such, identifying 
whether this an important construct within cancer adjustment might inform the 
development of supportive care interventions.  ACT is an evolved form of cognitive 
behavioural therapy (CBT), that sets itself apart from traditional CBT based upon the highly 
behaviourist view of psychology that this newer form of therapy utilises (Ciarrochi & Bailey, 
2008).  Rather than challenging distressing thoughts, the central tenet of ACT is that 
thoughts and distress are accepted as a normal aspect of everyday life, and then ‘defused’ 
using a variety of techniques (Hayes et al., 2011).  In ACT, psychological acceptance of a 
situation is thought of as patterns of behaviour rather than as negative cognitions and 
therefore the main aim of research that uses ACT-based concepts is to understand how to 
predict and influence acceptance of a situation rather than to change a person’s internal 
cognitions.   The efficacy of ACT has been highlighted within multiple settings.  Much of the 
existing literature stems from the application of ACT within a clinical psychology setting 
(Ruiz, 2010), yet, given the recognised co-morbidity between cancer and distress, there is 
an argument that interventions that are successful in improving mental health would not 
also be effective when these problems are co-morbid to physical illness (Hulbert-Williams 
et al., 2014).  Indeed, the evidence base for ACT  and physical health concerns is growing 
with benefits reported for chronic pain (Dahl, Wilson, & Nilsson, 2004), cancer (Hulbert-
Williams et al., 2014) amongst others.   Within psycho-oncology, psychological flexibility 
has been utilised as a component of a behavioural change intervention in colorectal cancer 
survivors (Hawkes et al., 2009) and it has been demonstrated that living a value-centred life 
was associated with decreased levels of distress in cancer patients (Ciarrochi et al., 2010).   
Psychological flexibility has also been cited as the possible process of change via which ACT 
exerts its effects on improving mental wellbeing in adults with mild to moderate depression 
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and anxiety (Fledderus et al., 2013), indeed it is generally accepted that a measure of 
psychological flexibility can be utilised as the outcome measure for change resulting from 
an ACT intervention.   
In an outline of the philosophical and conceptual framework behind ACT, Hulbert-Williams, 
Storey and Wilson (2014) promote the importance of more ACT based research in cancer, 
suggesting that it might be a more suitable form of psychological intervention due to the 
emphasis away from problem-solving and towards acceptance of the distressing nature of 
the experience.  ACT may be particularly beneficial for cancer populations given the way it 
can be successfully employed in non-clinically distressed populations; ACT does not always 
need to resemble or be sold as a traditional psychological ‘therapy’, rather techniques that 
are central to ACT, psychological flexibility notably, can be beneficial in sub-clinical distress 
or in normalising fears, especially in cancer survivors.  Both of these concepts are far more 
prevalent and relevant within cancer populations than clinical distress.  The scope of 
interventions that target processes of change that are applicable and can be used to good 
effect in patients with sub-clinical levels of distress is therefore broader with greater 
generalisability, key in the current climate of limited resources within our healthcare 
system. 
This study explores the potential nature of psychological flexibility and its role as a possible 
mechanism of change within the relationship between unmet need and psychological 
wellbeing.  It is expected that there is a relationship between unmet need and 
psychological outcome and, therefore, that a moderation analysis can be employed to 
determine what effect psychological flexibility has on this relationship, or the way that 
unmet need and psychological flexibility interact to influence psychological outcome.   A 
model of this hypothesised relationship is depicted below: 
 
 
 
 
 
Figure 5.1: Hypothesised moderation model. 
PF 
Outcome Unmet 
Need 
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Psychological flexibility has been hypothesised as a potential moderator between unmet 
need and psychological wellbeing for this study in light of the evidence that psychological 
flexibility is both important to overall psychological health and the proposition that it is the 
mechanism of change by which ACT produces improvements in wellbeing across a range of 
patient groups (Fledderus et al., 2013).  The decision was made to run a moderation 
analysis rather than a mediation analysis due to the theoretical underpinnings of the 
research question: it was hypothesised that psychological flexibility would act as a buffer in 
the relationship between unmet needs and psychological outcome.  That is, people who 
have high levels of unmet needs were expected to exhibit poorer psychological outcomes.  
If a person has high levels of unmet needs but also has high psychological flexibility, then 
this was expected to moderate the psychological impact of the unmet needs and mean that 
outcomes were better than had the person shown poor psychological flexibility.  
Conversely, where a person has low levels of unmet needs but is also psychologically 
inflexible, it was hypothesised that psychological outcomes would be worse than might be 
expected.  This rationale is consistent with moderation (Hayes, 2013) and, therefore, the 
decision was made to conduct only this method of interaction analysis. 
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Study Aims 
The aims of this study was to answer the question: 
What are the long term psychosocial needs of haematological cancer survivors and 
does the concept of psychological flexibility moderate the relationship between need and 
psychological wellbeing? 
The study objectives were: 
1. To identify the unmet psychosocial needs of haematological cancer survivors; 
2. To explore psychological wellbeing within clinical and demographic subgroups in 
line with the study detailed in Chapter 4; 
3. To explore the relationship between unmet psychosocial needs and psychological 
outcomes in haematological cancer survivors with the hypothesis that higher levels 
of unmet need will result in poorer psychological wellbeing i.e. that as unmet need 
increases, so too does anxiety and depression while quality of life and 
psychological flexibility will decrease; 
4. To investigate the potential for psychological flexibility to moderate this 
relationship in a sample of haematological cancer survivors.  
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Methodology 
Study Design 
A cross-sectional, questionnaire design was utilised.  Participants were assessed for unmet 
psychosocial needs alongside other psychometric assessments during the survivorship 
phase of illness.    
Sample 
All participants were required to fulfil the following inclusion criteria.  Due to the nature of 
recruitment (self-screening inclusion assessment; see below), it must be assumed that 
participants match these requirements however, it was not possible to verify this. 
 Must have, or have had previously, a diagnosis of haematological cancer.  
 Must be at least 18 months post-diagnosis. 
 Participants must be over the age of 16.  
 
The required sample size was determined using GPower and an expectation of medium 
effect sizes (Coe, 2002; Cohen, 1988), power at 0.8 and the potential for up to nine 
variables (anxiety, depression, global QoL, psychological flexibility, each subdomain of the 
SCNS) to be included within a regression analysis.  This calculation indicated that 114 
participants would be required to conduct a regression analysis.  However, for each 
individual moderation analysis, there will be one dependent variable, one moderator 
variable and one outcome variable, therefore reducing the required number of participants 
for the analysis to be powered.   
In total, 91 questionnaires were completed with variable amounts of missing data.  
Demographic information for the sample is presented in Table 5.1.  
Procedure 
Ethical approval was given by the University of Chester Departmental Ethics Committee.  
Participants were recruited via advertisements placed with two of the major UK blood 
cancer charities: the Lymphoma Association and Leukaemia & Lymphoma Research.  
Lymphoma Matters is a magazine that is published by the Lymphoma Association that is 
available online and posted out to subscribers.  The magazine has a readership of over 
10000, the majority of whom are either people with lymphoma or healthcare professionals.  
An advert for people who were interested in taking part in a research study was placed in a 
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quarterly issue of the publication. Leukaemia & Lymphoma Research is a UK based charity 
who posted an advert directing survivors to the study on their website.  All advertisements 
stated that participants must have received a diagnosis of a haematological cancer a 
minimum of 18 months previously (Appendix 20).   
Table 5.1: Participant demographic information. 
Demographic  Percentage 
Gender Male 46.80% 
 Female 53.20% 
Mean Age 
Age Range 
Ethnicity 
61 (12.4) 
19 - 97 
White 
 
 Black Caribbean 1.30% 
 Chinese 1.30% 
Employment Employed 27.50% 
 Retired 45.10% 
 Fulltime Education 1.10% 
 Unable to Work 13.40% 
Diagnosis AML 1.10% 
 CLL 19.80% 
 CML 2.20% 
 Hodgkin 
Lymphoma 
8.80% 
 NHL 58.20% 
Treatment Active Treatment 78% 
 Watch and Wait 22% 
 
Participants were asked to complete a questionnaire on one occasion only.  The 
questionnaire was either completed online at a web address provided in the 
advertisement, or participants were able to contact the research team directly in which 
case the questionnaire (Appendix 21) and debrief sheet (Appendix 22) were posted out to 
the participant.  Information about taking part in the study was made available to all 
participants whether completing the questionnaire online or via post (Appendix 23).  If 
completing online, participants were required to read the information sheet before they 
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were able to progress through to the questionnaire itself.  Where participants requested 
that the questionnaire was posted out to them, they also received a printed study 
information sheet and a pre-paid reply envelope. 
After the questionnaire was completed, participants were provided with a debrief sheet 
containing contact details for appropriate support services.  This was either posted out 
along with the questionnaire to ensure that participants had access to the information 
contained within as and when it might be needed, or it was the final page of the 
questionnaire for participants who completed the questionnaire online.   
Informed Consent 
Prior to completing the questionnaire, participants were requested to read the full 
information sheet and to contact the research team to ask any questions that they may 
have before deciding whether or not they wished to take part in the study.  The 
information sheet was available online at the web address provided and was posted out to 
participants along with the questionnaire.   
All questionnaires were completed anonymously and participants were not asked to share 
identifiable information.  Therefore, participants were not asked to sign their consent but it 
was made clear in the information sheet that by completing the questionnaire, participants 
were giving their consent for their data to be used in the study. 
Confidentiality 
No member of the research team had access to any patient information until such a time 
where the patient had implicitly given their informed consent for their details to be shared 
by reading the information sheet and completing the questionnaire.  All returned 
questionnaires were stored in a locked cabinet in a secure storage room at the University 
of Chester.   In accordance with the Caldicott Principles, all information was held on a 
strictly need to know basis.  All electronic data was stored on a password protected area on 
a server at the University of Chester and accessed by BS only with NHW to be allowed 
access in case of emergency.  All data analysis was conducted on university computers.   
Long-term storage of all documents was in University of Chester secure archives.   
Measures 
The questionnaire (Appendix 21) included the following measures and was formatted using 
Formic (survey software that allows for both online and paper completion) to ensure ease 
of presentation, distribution and scoring: 
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 Unmet psychosocial needs:  SCNS-SF34 (Bonevski et al, 2000).  The SCNS SF34 is a 
34 item measure designed to assess the unmet needs of adult cancer patients.  
Need is measured on a likert scale from 1 (no need) to 5 (high need).  Domains are 
as follows: physical and daily living (PDL); psychological (psych); health systems 
and information (HSI); patient care and support (PCS); and sexual.  This measure 
was chosen over other needs assessment tools due to its wide usage within cancer 
research as evidenced by the systematic review in Chapter 2 and the fact that is 
was designed to assess generic needs within cancer patients.   
 
  Anxiety and depression:  HADS  - 14item (Zigmond & Snaith, 1983).  The HADS is a 
14 item measure designed to assess levels of anxiety and depression.  Answers are 
ranked from 0-3 for each item.  The measure has two sub-domains: anxiety and 
depression, each with seven items.  This measure was chosen due to its wide 
usage both within cancer research but within the wider health psychology field as 
evidenced within the literature reviews included within this thesis. 
 
 Quality of life:  EORTC QLQ-C30 - 30 item (Aaronson et al., 1993).  This is a 30 item 
QoL tool where items are ranked from 1 (not at all) to 4 (very much).  There are 
nine sub-scales: five functional scales (physical, role, cognitive, emotional, and 
social); three symptom scales (fatigue, pain, and nausea and vomiting); and a 
global health and quality-of-life scale.  This measure was chosen due to its 
common usage within the studies included within the systematic review in Chapter 
2 and the fact that it was designed to assess QoL within cancer specifically.  While 
the FACT QoL measure does have both leukaemia and lymphoma specific scales, 
having different scales in use within the same study was felt to reduce 
opportunities to draw direct comparisons from across the whole sample.  In 
addition, the EORTC QLQ-C30 was more widely used in the previous literature as 
highlighted previously, enabling comparisons between this sample and others.   
 
 Acceptance and Action Questionnaire: AAQ-II (Bond et al., 2011).  A 10 item 
measure where items are ranked from 1 (never true) to 7 (always true).  This 
measure was chosen as it is a well validated, general measure of psychological 
flexibility.  
 Demographic questionnaire. 
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All measures were selected for their appropriateness for the patient group and for their 
psychometric properties.    
For each measure with the exceptions of the cognitive functioning and symptoms-nausea 
subscales of the EORTC, Cronbach’s alpha was above the 0.7 range which is widely 
accepted as indicating that the measure works for the dataset (Bland & Altman, 1997).  
Cronbach’s alpha for the global score for quality of life however was 0.95, as this was the 
total that was used within the calculations for both the correlation and moderation 
analysis, it was felt that all measures represented a good fit with the sample. 
Table 5.2: Table to illustrate the Cronbach’s alpha for each measure sub-scale used within the study. 
Measure Cronbach’s Alpha 
HADS Depression 0.84, Anxiety 0.87 
EORTC QLQ-C30 Physical Functioning  0.88, Role Functioning 
0.91, Cognitive Functioning 0.44, Emotional 
Functioning 0.89, Social Functioning 0.86, 
Symptoms - NAUS 0.59, Symptoms - FAT 
0.94, Symptoms-PAIN 0.95,  
Global health score 0.95 
AAQ-II 0.88 
SCNS SF34 Psychological 0.96, Health systems and 
information 0.93, Patient care and support 
0.88, Physical and daily living 0.93, Sexual 
0.88 
 
Data Analysis 
Initially, an exploratory analysis was conducted where parametricity of data was 
determined and the reliability of the measures was explored.   Descriptive statistics were 
then used to explore the data and to form comparisons between clinical and demographic 
subgroups.   
Correlations were used to determine which predictor variables correlate with outcomes.  
Utilising a correlational design enabled the researcher to examine the direction of any such 
relationships, the strength of relationships and the statistical significance of relationships.  
This enabled the investigation of whether unmet psychosocial needs correlate with either 
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psychological flexibility or outcomes (anxiety, depression, psychological adjustment to 
cancer and quality of life) such to address hypothesis 3. 
In order to determine whether psychological flexibility acts as a moderator between unmet 
psychosocial need and the outcome variables (hypothesis outlined in Objective 4), a 
moderation analysis was employed.  The macro PROCESS developed by Andrew Hayes was 
used to perform this part of the analysis (Hayes, 2013).  This tool is downloaded into the 
SPSS software to allow researchers to conduct both moderation and mediation analyses.    
PROCESS uses an ordinary least squares or logistic regression-based path analytical 
framework for estimating two and three way interactions in moderation models along with 
simple slopes and regions of significance for probing interactions.  As a tool, PROCESS can 
be used more broadly for mediation-based analysis, yet these were the uses utilised within 
this study.   
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Results 
Objective 1: The Unmet Needs of Haematological Cancer Survivors 
Examination of both graphical displays (e.g. scatter plots, histograms, Q-Q plots) of the 
dataset and running Kolmogorov-Smirnov tests for the key variables that were to be 
included within the correlational and moderation analysis (anxiety, depression, global 
quality of life score, psychological flexibility and unmet need) determined that the data was 
normally distributed, that there was a linear relationship and, therefore, parametric testing 
was appropriate.   There was somewhat of a floor effect present on the unmet need sub-
scales due to a high number of participants selecting the ‘no need’ response; however, 
given that the remaining key variables were normally distributed and the repeated 
questioning within the related literature with regards to the need for parametric conditions 
to be met (Bryman & Cramer, 2011), the decision was made to use parametric testing. 
In total, participants answered five different measures within the questionnaire.   The 
mean and standard deviation for each sub-scale is presented in Table 3. 
Table 5.3 indicates that, across the sample as a whole, the mean scores for both anxiety 
and depression are below clinically significant thresholds (8 being borderline clinically 
significant and 10 being clinically significant) although the mean anxiety score is only 0.74 
below this threshold.  This may be somewhat misleading however, as these same data 
indicate that 51.4% of the sample are above the threshold for borderline clinically 
significant anxiety and 27% of the sample are within the clinically significant range.  For 
depression, results show that 27% of the sample is above the borderline level of clinical 
significance and 12.2% are within the clinically significant range.  This makes the levels of 
anxiety and depression within this sample above the point prevalence rates for either 
disorder within the general population (Baxter et al., 2013). 
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Table 5.3: Mean and standard deviation for each sub-scale. 
Measure (Sub-Scale) Mean (SD) 
SCNS Physical and Daily Living needs 2.19 (1.20) 
SCNS Psychological needs 2.39 (1.11) 
SCNS Health Systems and Information needs 1.77 (0.791) 
SCNS Patient Care and Support needs 1.83 (0.875) 
SCNS Sexual needs 1.91 (1.08) 
AAQ-II 50.9 (11.5) 
HADS Anxiety 7.26 (4.26) 
HADS Depression 5.19 (3.72) 
EORTC Physical Functioning 1.70 (0.766) 
EORTC Role Functioning 1.89 (0.934) 
EORTC Cognitive Functioning 1.56 (0.732) 
EORTC Emotional Functioning 1.83 (0.738) 
EORTC Sexual Functioning 1.91 (0.892) 
EORTC SYMPTOM-FATIGUE 2.15 (0.873) 
EORTC SYMPTOM-NAUSEA/VOMITING 1.18 (0.361) 
EORTC SYMPTOM-PAIN 1.56 (0.774) 
EORTC GLOBAL SCORE 5.01 (1.48) 
 
Regarding unmet needs, Table 5.3 indicates that the domain with the highest area of 
unmet need is psychological need; the mean score indicates that the average level of need 
is within the bounds of being present but satisfied.  Under ten per cent (9.9%) of the 
sample had unmet psychological needs that were within the moderate to high need range 
with almost a third of the sample reporting a need that remained unmet within this 
domain; similar figures were also reported for the physical and daily living domain.  The 
number of participants reporting an unmet need related to the health systems and 
information domain was also similar with around one third reporting an on-going unmet 
need in this area yet fewer reporting their need to be on average moderate to high within 
this domain.  The levels of unmet need present vary considerably from low need to high 
need within the sample. 
Lack of energy/tiredness and not being able to do the things you used to do were the most 
common high unmet needs (14.3%) within the sample.   12.1% of the sample report 
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uncertainty about the future as a high unmet need, with concerns about the worries of 
those close to you having the same percentage reporting high unmet need.  High unmet 
needs relating to anxiety and fears about the cancer spreading were the other two most 
commonly reported unmet needs at the high level, each present in 9.9% of the sample.  Of 
these six most common unmet needs, four are needs within the psychological domain; this 
is unsurprising given that psychological need had the highest average score of all five 
unmet need domains and concurs with information reported in the study of newly 
diagnosed patients (Chapter 4).   Figure 1 presents the mean scores for each individual 
needs item.  Lack of energy/tiredness, fears about the cancer spreading and uncertainty 
about the future are the three most commonly identified unmet needs on average across 
the sample. 
The anxiety score (on the HADS) and unmet needs responses indicate a discrepancy 
between the number of participants who scored as being anxious on the HADS and those 
who report having an unmet need for support relating to anxiety.  More participants are 
anxious than indicate a high desire for help with their anxiety.
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Objective 2: Psychological Wellbeing within Clinical Subgroups 
Gender Comparisons 
46.8% of this sample were male and 53.2% were female.  Across all five unmet need 
domains, women reported higher levels of unmet need than males.   On average, men 
scored higher on the AAQ-II (M = 54.7 (2.28), F = 47.6 (1.96)) meaning that the males in our 
sample tended to be more psychologically flexible than the women.   
Women’s mean anxiety scores were within the borderline clinically significant range (8.81 
(0.63)) while the male average anxiety score was somewhat below clinical levels (5.38 
(0.87)), indicating that women were more anxious as a group than men.  Depression scores 
showed a similar pattern with the female average being above the male average (F=6.26 
(0.68), M=3.71 (0.63)) but neither sample average was above the clinical cut off. 
The male global quality of life average was above the female average (F=4.77 (0.28), 
M=5.33 (0.29)) which ties in with the reported scores for both anxiety and depression, the 
males within our sample reported less distress as a group overall than the females.  t tests 
were used to examine potential differences between genders.  No significant differences 
were found for depression, anxiety or QoL. 
 
Figure 5.2: Mean gender scores for key outcomes. 
Treatment 
78% of the sample had received active treatment (AT) for their cancer while 22% had only 
ever been monitored via watch and wait (WW).  The maximum length of time that a 
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participant had been diagnosed and their cancer managed via watch and wait was nine 
years although 18 months to five years were more commonly reported. 
Those monitored via watch and wait had slightly higher unmet needs in the psychological 
domain (AT=2.38 (0.16), WW=2.41 (0.36)) and higher unmet needs relating to patient care 
and support (AT=1.79 (0.12), WW=1.96 (0.32)).  In other domains, those who had received 
active treatment reported higher levels of unmet needs. 
The group who were monitored via watch and wait were, on average, more psychologically 
flexible than those on active treatment (AT=49.6 (1.71), WW=55.0 (3.23)). 
For both anxiety and depression, those who had been actively treated scored higher than 
the watch and wait group (Anxiety AT=7.6 (0.62), WW=6.00 (1.3); Depression AT=5.42 
(0.56), WW=4.33 (1.05)) although neither groups mean score falls within the clinically 
significant range.   
Overall quality of life was very similar between the two groups (AT=5.00 (0.21), WW=5.04 
(0.49)).  t tests indicated that differences between the two treatment sub-groups were not 
statistically significant. 
 
Figure 5.3: Mean scores for treatment groups Active Treatment and Watch and Wait for key outcomes. 
Diagnosis 
The most common diagnosis within the sample is Non-Hodgkin lymphoma (58.2% of the 
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diagnosis of AML (1.1%), CLL (19.8%), CML (2.2%) and Hodgkin lymphoma (8.8%), the 
divisions within the sample were representative of the haematological cancer population.   
 
Participants with CLL have the highest level of unmet needs across all domains assessed 
with participants with CML typically having the lowest level of need albeit the sample size 
of participants with CML was small to be make accurate generalisations. 
 
Psychological flexibility was similar in participants with CLL, CML and Hodgkin lymphoma, 
all scoring between 54 and 55.  Flexibility was somewhat lower in participants with NHL 
with an average score of 49.2.  Anxiety levels were also higher in NHL participants at 7.92 
with all other groups’ average scores around 6.  A similar pattern occurred for depression 
with the NHL score at 5.47 with all other diagnostic groups scoring between 4 and 4.5.  The 
lowest quality of life score however was observed in the CLL group at 4.85.  NHL followed 
at 4.97 with CML the highest scoring at 6.5. 
 
 
 
Figure 5.4:  Mean scores for key outcomes according to diagnosis. 
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Objective 3: The Relationship between Unmet Need and 
Psychological Wellbeing 
For this study objective, Pearson’s r correlations between unmet psychological need 
domains and outcomes anxiety, depression and quality of life were tested in addition to 
psychological flexibility scores. 
 
Table 5.4: Correlations between SCNS sub-scales and outcomes. 
  AAQII Total 
HADS 
Anxiety 
HADS 
Depression 
EORTC 
Global  
SCNS Physical and Daily 
Living 
r -.43 .44 .64 -.82 
p .000 .000 .000 .000 
SCNS Psychological r -.71 .70 .61 -.57 
p .000 .000 .000 .000 
SCNS Health Systems and 
Information 
r -.42 .30 .40 -.48 
p .000 .016 .001 .000 
SCNS Patient Care and 
Support 
r -.55 .42 .52 -.51 
p .000 .000 .000 .000 
SCNS Sexual r -.40 .55 .36 -.40 
p .000 .000 .002 .001 
SCNS Total r -.65 .58 .65 -.71 
p  .000 .000 .000 .000 
 
The correlations cited within Table 5.4 indicate that there is a relationship present between 
unmet needs and psychosocial outcomes.  All correlations were statistically significant at 
the 0.01 level (two-tailed test) with the exception of HADS Anxiety and SCNS HSI which was 
still significant but at the 0.05 level (two-tailed test).   
The effect sizes observed were generally within the medium-large range.  For the 
correlations between unmet need total score and each of the measures of wellbeing, three 
of the effect sizes would be categorised as medium (anxiety , depression and psychological 
flexibility) and one as large (QoL).     
The positive correlation between unmet need and anxiety and depression indicate that 
where once increases, so does the other, thereby indicating that higher levels of unmet 
needs correspond with higher levels of anxiety and depression within the sample.  The 
negative correlation between unmet need and both QoL and psychological flexibility means 
that the opposite is true in this instance, where unmet need increases, the other decreases 
(and vice versa). 
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In addition to correlation between total need score, sub-domain scores and outcome 
variables, correlations between each individual need item on the SCNS SF34 and key 
outcomes variables anxiety, depression and QoL were performed (Table 5.5).   
Table 5.5: Correlation between individual needs items and outcome variables. 
  
AAQII 
Total 
HADS 
Anxiety 
HADS 
Depression 
EORTC 
Global 
Pain r -.33 .37 .55 -.68 
p  .004 .001 .000 .000 
Lack of energytiredness r -.51 .53 .64 -.77 
p .000 .000 .000 .000 
Feeling unwell a lot of the time r -.41 .50 .60 -.71 
p .000 .000 .000 .000 
Work around the home r -.34 .34 .51 -.68 
p .003 .004 .000 .000 
Not being able to do things you used to do r -.38 .38 .60 -.76 
p .001 .001 .000 .000 
Anxiety r -.63 .63 .54 -.58 
p .000 .000 .000 .000 
Feeling down or depressed r -.66 .65 .63 -.59 
p .000 .000 .000 .000 
Feelings of sadness r -.64 .67 .66 -.53 
p .000 .000 .000 .000 
Fears about the cancer spreading r -.58 .57 .45 -.49 
p .000 .000 .000 .000 
Worry that the results of treatment are 
beyond your  control 
r -.56 .51 .35 -.31 
p .000 .000 .002 .008 
Uncertainty about the future r -.74 .69 .57 -.47 
p .000 .000 .000 .000 
Learning to feel in control of your situation r -.50 .52 .36 -.39 
p .000 .000 .002 .001 
Keeping a positive outlook r -.66 .61 .53 -.54 
p .000 .000 .000 .000 
Feelings about death and dying r -.60 .57 .49 -.49 
p .000 .000 .000 .000 
Changes in sexual feelings r -.35 .52 .36 -.45 
p .002 .000 .002 .000 
Changes in your sexual relationships r -.34 .53 .35 -.44 
p .002 .000 .002 .000 
Concerns about the worries of those close 
to you 
r -.42 .46 .31 -.44 
p .000 .000 .008 .000 
More choice about which cancer specialists 
you  see 
r -.44 .29 .43 -.36 
p .000 .011 .000 .002 
More choice about which hospital you 
attend 
r -.45 .26 .44 -.36 
p .000 .025 .000 .002 
187 
 
Reassurance by medical staff that the way 
you feel  is normal 
r -.48 .45 .50 -.51 
p .000 .000 .000 .000 
Hospital staff attending promptly to your 
physical  needs 
r -.43 .42 .47 -.45 
p .000 .000 .000 .000 
Hospital staff acknowledging and showing  
sensitivity to your feelings and emotional 
needs 
r -.45 .29 .34 -.40 
p .000 .012 .003 .000 
Being given written information about the 
important  aspects of care 
r -.26 .29 .39 -.47 
p .028 .014 .001 .000 
Being given information written diagrams  
drawings about aspects of managing you 
illness  and side effects at home 
r -.28 .34 .40 -.41 
p 
.015 .003 .001 .000 
Being given explanations of those test for 
which  you would like explanations 
r -.24 .21 .27 -.25 
p .036 .068 .020 .033 
Being adequately informed about the 
benefits and  side effects of treatments 
before you choose to  have them 
r -.36 .34 .38 -.31 
p 
.002 .003 .001 .008 
Being informed about your test results as 
soon as  feasible 
r -.29 .09 .25 -.38 
p .013 .432 .033 .001 
Being informed about cancer which is 
under control  or diminishing that is 
remission 
r -.36 .28 .34 -.41 
p .001 .016 .003 .000 
Being informed about things you can do to 
help  yourself to get well 
r -.45 .52 .43 -.45 
p .000 .000 .000 .000 
Having access to professional counselling 
eg  psychologist social worker counsellor 
nurse  specialist if you family or friends 
need it 
r -.48 .51 .38 -.35 
p 
.000 .000 .001 .003 
Being informed about sexual relationships r -.41 .45 .27 -.16 
p .000 .000 .020 .175 
Being treated like a person not just another 
case 
r -.36 .27 .30 -.36 
p .002 .022 .011 .002 
Being treated in a hospital or clinic that is 
as  physically pleasant as possible 
r -.27 .11 .17 -.13 
p .022 .344 .157 .293 
Having one member of staff with whom 
you can talk  to about all aspects of your 
condition treatment and  follow up 
r -.48 .35 .33 -.40 
p .000 .002 .004 .001 
 
Table 5.5 shows the correlation between individual needs items on the SCNS SF34 and the 
outcome variables.  For 30 out of 34 items, all correlations were statistically significant at 
p≤0.05 for all variables indicating that a majority of items on the SCNS SF34 have a utility in 
providing an indication of overall psychological health. 
 
These results indicate that there are statistically significant relationships between the level 
of unmet need and psychological wellbeing.  The positive correlations between unmet 
need and both anxiety and depression indicates that high levels of unmet need are likely to 
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correspond with high levels of anxiety and depression.  The negative correlations between 
unmet need and both psychological flexibility and quality of life indicate that higher levels 
of unmet need are likely to be accompanied by lower quality of life and psychological 
flexibility.  In essence, high unmet needs correlate with poorer psychological outcomes.    
Most notable are the correlations between global QoL and unmet physical and daily living 
needs and between psychological flexibility and unmet psychological needs.  Both are 
strong negative correlations that indicate that a high unmet need relates to lower QoL or 
psychological flexibility in these instances.   It is important to acknowledge however, that 
when a large number of tests are performed, the likelihood of Type I error increases.  
However, as with Chapter 4, the decision was made not to include Bonferroni corrections 
within the analysis.  Again, due to the overly conservative nature of Bonferroni corrections, 
which can create liability for a Type II error (Cohen, 1994), and in light of the arguments 
made for other testing procedures (Bender & Lange, 1999) in addition to the consistency of 
the results with both the hypothesis stated under the study aims and the wider literature, 
Bonferonni corrections were not used.    
 
Objective 4: Moderation Analysis 
Subsequent to the correlation analysis, the final step in the analysis process was to conduct 
a moderation analysis addressing whether psychological flexibility might act as a moderator 
between unmet psychosocial needs and psychological outcomes.   In total, 15 moderation 
analyses were performed: each of the five needs sub-scales against anxiety, depression and 
quality of life, all with psychological flexibility as the moderator.  Four significant 
moderation effects were found: 
 
The relationship between unmet psychological needs and global quality of life was 
moderated by psychological flexibility (b = -0.378, 95% CI [-0.0607, -0. 0149], t = -3.297, p = 
.0016).  The model of unmet psychological need predicting quality of life while moderated 
by psychological flexibility was significant and predicted a total of 41% of variance in quality 
of life scores (R2 = .41, F (3, 64) = 24.22, p<.001).  The simple slope analysis demonstrated 
that the relationship between unmet psychological needs and global quality of life emerges 
in people with average or above average levels of psychological flexibility.  This means that 
the relationship between unmet need and QoL goes from being non-significant at low 
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levels of flexibility, to a negative relationship between need and QoL that increases in 
significance as the level of psychological flexibility increases. 
 
 
Figure 5.5:  Graph to illustrate the relationship between QoL, psychological flexibility and unmet psychological 
needs. 
The relationship between unmet sexual needs and global quality of life was also moderated 
by psychological flexibility (b = -0.0276, 95% CI [-0.051, -0.0043], t = -2.36, p = .0212).  The 
model of unmet sexual need predicting quality of life while moderated by psychological 
flexibility was significant and predicted a total of 35% of variance in quality of life scores (R2 
= .35, F (3, 66) = 15.77, p<.001).  The simple slope analysis demonstrated that the 
relationship between unmet sexual needs and global quality of life emerges in people with 
average or above average levels of psychological flexibility.  This means that the 
relationship between unmet need and QoL goes from being non-significant at low levels of 
flexibility, to a negative relationship between need and QoL that increases in significance as 
the level of psychological flexibility increases. 
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Figure 5.6:  Graph to illustrate the relationship between QoL, psychological flexibility and unmet sexual needs. 
 
The relationship between unmet patient care and support needs and anxiety was 
moderated by psychological flexibility (b = 0.136, 95% CI [0.0390, 0.234], t = 2.79, p = 
.0067).  The model of unmet patient care and support need predicting anxiety while 
moderated by psychological flexibility was significant and predicted a total of 64% of 
variance in anxiety scores (R2 = .64, F (3, 70) = 52.1, p<.001).  The results of the simple slope 
analysis indicate that the relationship between unmet patient care and support needs only 
emerges in people with average or above average levels of psychological flexibility.  This 
means that is the relationship between unmet need and anxiety goes from being non-
significant at low levels of flexibility, to a positive relationship being present between need 
and anxiety that increases in significance as the level of psychological flexibility increases. 
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Figure 5.7:  Graph to illustrate the relationship between anxiety, psychological flexibility and unmet patient care 
and support needs. 
The relationship between unmet patient care and support needs and global quality of life 
was the final relationship found to be moderated by psychological flexibility (b = -0.0542, 
95% CI [-0.0739, -0.0346], t = -5.50, p = <.0001).  The model of unmet patient care and 
support need predicting quality of life while moderated by psychological flexibility was 
significant and predicted a total of 44% of variance in quality of life scores (R2 = .44, F (3, 
68) = 29.89, p<.001).  The simple slope analysis demonstrated that the relationship 
between unmet patient care and support needs and global quality of life emerges in people 
with average or above average levels of psychological flexibility.  This means that the 
relationship between unmet need and QoL goes from being non-significant at low levels of 
flexibility, to a negative relationship between need and QoL that increases in significance as 
the level of psychological flexibility increases. 
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Figure 5.8:  Graph to illustrate the relationship between QoL, psychological flexibility and unmet patient care 
and support needs. 
The results of the moderation analysis indicate that psychological flexibility does moderate 
between unmet need and psychological outcome within specific areas.  Further 
examination also highlights that, where the moderation analysis was found to be 
significant, the effect of the moderation was partial and that the relationship between 
psychological flexibility, unmet need and outcome only emerge where average or above 
average levels of psychological flexibility are present1. 
As with the correlation analysis, it must be acknowledged that performing a high number of 
statistical tests increases the likelihood of a Type I error.   
 
1
Due to the somewhat surprising results of the moderation analysis, further analysis of the data was 
undertaken.  A factorial ANOVA confirms the presence of an interaction in the data and that the findings 
presented are reflective of the data. 
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Discussion 
The findings of this study expand the findings outlined in Chapter 4 in confirming the 
presence of a relationship between unmet psychosocial needs and psychological outcomes, 
this time in haematological cancer survivors.  It has also been demonstrated that, for the 
outcomes anxiety and QoL, psychological flexibility plays a role in moderating this 
relationship.  Psychological flexibility was found to moderate the relationship between 
unmet needs and psychological outcomes in four of the interactions tested, yet the results 
were not in line with initial expectations.  It was hypothesised that flexibility would buffer 
the impact of unmet needs on psychological wellbeing, yet the results of the moderation 
analysis found that the relationship between unmet need and psychological outcome was 
only present where levels of psychological flexibility were at average or above average 
levels for the sample.   While the findings of both the correlation analysis and the 
moderation analysis do suggest that psychological flexibility plays a role in the 
psychological wellbeing of haematological cancer survivors, the precise nature of this 
relationship requires further consideration. 
The Unmet Needs and Psychological Wellbeing of Haematological 
Cancer Survivors 
This study has highlighted the common unmet needs of haematological cancer survivors, 
an area of research that has been lacking within the existing evidence base.   Four of the six 
most commonly identified unmet needs were psychological needs, lending weight to 
existing research that has indicated that psychological concerns can persist well after 
treatment ends (Lobb et al., 2009).  This also bears similarities to the findings of the 
research outlined in Chapter 3.  Again, psychological needs emerged as being important to 
the NHL survivors interviewed and as being unmet within the sample, meaning that the 
importance of unmet psychological needs has emerged twice within this thesis within 
research conducted with haematological cancer survivors.  The most common needs 
overall include fears about the cancer spreading and uncertainty about the future.  Fear of 
recurrence is well known to be a common and significant concern for cancer patients, both 
during and well after their treatment has ended (Simard et al., 2013).  Again, this draws 
parallels with previous work outlined within this thesis (both the systematic review and the 
qualitative study), fear of recurrence was highlighted as a key need for patients.  Fear of 
recurrence was not rated as highly in Chapter 4 where the unmet needs of newly diagnoses 
patients were assessed: this is perhaps indicative of information needs and anxiety about 
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the immediate future taking priority at the time of diagnosis, and fears relating to cancer 
recurrence becoming more prominent as the initial cancer treatment draws to a close.  This 
reflects existing research across wider cancer samples (Rogers et al., 2008) whereby fear of 
recurrence can become so intrusive into a patients thoughts after initial treatment, that 
special effort to address patient fears has been undertaken within the clinic setting. 
Results indicated that both anxiety and depression within this sample are above the point-
prevalence rates found within the general population (Baxter et al., 2013; Office for 
National Statistics, 2013), tying in with the previous point that psychological needs were 
felt strongly within this patient group.  Levels of anxiety and depression were high even 
when compared to similar studies conducted in broader cancer samples (Armes et al., 
2009; Carroll et al., 2003; Stark et al., 2002), yet similar levels have previously been found 
in haematological samples (Molassiotis et al., 2011).  This suggests that distress in 
haematological cancer patients is high in comparison to other cancer diagnoses.  The 
findings also highlight a discrepancy between the levels of distress found within the sample 
(between the HADS score and responses on the unmet needs questionnaire) and those 
expressing a desire for help via their unmet needs assessment.  This finding is consistent 
with previous findings: not all of those who experience psychological distress want help to 
manage their concerns, indeed previous research has indicated that of those patient who 
experience both cancer and depression, only 36% wanted professional help to improve 
their psychological wellbeing (Baker-Glenn et al., 2011).  This finding highlights the clinical 
utility of an unmet needs assessment.  Instead of highlighting areas where patients may 
benefit from further support, an unmet needs assessment does this in addition to providing 
an indication of where the patient themselves would like to receive that support, thus 
helping to ensure that resources are allocated to both the area of greatest need but also 
where they are most likely to be accepted by the patient.  It remains important however 
that clinicians are aware of the on-going potential for distress in patients who do not report 
a desire for formal support at that time.  The findings from this study indicate that 
psychological concerns continue into survivorship and that unmet need does not need to 
be in the psychological domain in order to have a negative impact on psychological 
wellbeing.   There is a need for support in cancer survivors that is not currently being met 
by current service provision or policy.  A patient’s active desire for further support may 
change as a patient’s adjustment process evolves and the absence of formal support at the 
higher levels of the stepped-care model (National Institute for Health and Clinical 
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Excellence CSGSP, 2004; Moorey, 2013) does not mean that a patient would not benefit 
from on-going support from their current healthcare team.    
In the previous quantitative study of newly diagnosed patients (Chapter 4), there were 
significant differences in unmet need, depression and QoL between the watch and wait and 
active treatment sub-groups.  This finding was not observed in the current sample.  This 
may be reflective of the psychological impact of cancer diagnosis converging over time, 
minimising the effect of treatment on wellbeing.  Conversely, this may be indicative of a 
recruitment bias resulting from the source of participants for this study, a concern that will 
be discussed further within limitations.   
The relationship between unmet need and psychological wellbeing 
Within the context of the wider psycho-oncology literature, anxiety and QoL are key areas 
of concern for cancer patients (Stark & House, 2000; Aaronsen et al., 1993).  Anxiety levels 
have consistently been shown to be higher in cancer populations than rates of depression 
and needs assessment studies often reveal anxiety, and notably fears around recurrence, 
as dominant unmet needs for patients (Harrison et al., 2009; Lobb et al., 2009).  This was 
also evidenced in the systematic review outlined in Chapter Two where fear of recurrence 
was the single most commonly identified unmet need.    
The strongest correlations between an unmet need domain and outcome variables was the 
domain of psychological need.  This concurs with the results of the study described in 
Chapter 5 where this same result was found in a sample of newly diagnosed 
haematological cancer patients, adding weight to the assertion that the assessment of 
unmet psychological need has high levels of clinical utility.  If unmet needs are found in this 
area, the potential to also be indicative of overall psychological health means that need 
assessment carries a dual purpose for assessing clinicians.  Not only can needs assessment 
provide a direct indication of where desire for support lies, but can also be used as an 
acceptable way of measuring psychological health.  In cancer patient groups, as is the case 
in wider mental health populations, the presence of distress does not always equate to a 
desire for assistance (Baker-Glenn et al., 2011); a needs assessment is a measure of 
wellbeing that can have wider applicability in light of the findings presented within this 
thesis.   
Looking more closely at the relationship between individual need items and outcomes in 
Table 6, it was highlighted that 30 out of 34 items were significantly correlated with all 
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outcome variables.  This is in contrast to the findings in Chapter 4 where only seven items 
were found to correlate with anxiety, depression and quality of life, yet in general terms it 
can be concluded that unmet needs correlate with psychological wellbeing.  In that study, 
five of the seven items that had a relationship with all outcomes specifies fell within the 
psychological domain, strengthening the assertion that unmet psychological needs were 
important for gaining a picture of more general psychological health.  The current findings 
indicate a more general link between need and psychological wellbeing.  As patients 
transition into the survivorship phase of their illness, the expectation is often that life will 
return to normal; where this done not happen and unmet needs remain as the aftermath 
of illness, they continue to impact upon psychological wellbeing (Lobb et al., 2009).  Almost 
all needs were found to correlate with all outcomes, implying that the presence of an 
unmet need, regardless of type, has the potential to have a negative impact on wellbeing 
and QoL in cancer survivors.  
The Role of Psychological Flexibility 
The results of the moderation analysis that investigated the role of psychological flexibility 
in the relationship between unmet need and wellbeing were somewhat surprising, in fact 
being in direct contrast to the original hypothesis.  It was hypothesised that psychological 
flexibility would act as a buffer between unmet need and psychological wellbeing, reducing 
the negative impact of the presence of unmet need.  Instead, the results indicated that the 
relationship between unmet need and psychological wellbeing was only present in those 
participant with average or above average levels of psychological flexibility for the sample.    
The results indicate a division in the way in which unmet needs are experienced between 
those patients with low psychological flexibility and those with high psychological flexibility.  
The fact that the relationship between unmet need and outcome only emerges where 
psychological flexibility is at average or above average levels could be an indication that 
people who are more psychologically flexible are also more insightful generally into their 
cancer experience and the psychological impact of their disease.   Psychological flexibility is 
a key component of ACT, an intervention with six key components: acceptance; 
mindfulness; values; committed action; observing the self; and cognitive defusion (Hayes, 
2006).  Considering each of these components individually may help to contextualise the 
findings of the moderation analysis.  Mindfulness implies an awareness of the present 
moment and of one’s own thoughts and feelings within that moment (Kabat-Zinn, 2003), 
acceptance implies an ability to allow thoughts to be present without struggling with them 
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(Hayes, 2006).  If we assume that the six components of ACT are linked (Hayes, 2006) and 
that those participants who are more psychologically flexible are also more mindful, then it 
is plausible that this group of patients are those who are more likely to show an awareness 
of their unmet needs and to therefore report them on an assessment tool.  Looking at the 
values component of ACT, this relates to people living in line with a set of values that 
reflect the things that are truly most important to them.  Again, if those who are more 
psychologically flexible are more insightful into their own value systems, they are more 
likely to be aware of how a diagnosis of cancer has impacted upon their life and values, in 
turn creating an awareness of their own unmet needs.  Observation of the self, or 
observing the self within a wider context may relate to participants with higher levels of 
psychological flexibility being more able to separate their needs and thoughts from their 
core view of themselves.   Therefore, the presence of unmet needs can be viewed as a 
product of the situation rather than as an inner failing, making them more acceptable and 
more likely to be reported in the context of a needs assessment.  In short, those who are 
more psychologically flexible may be more insightful into their own unmet needs and are 
therefore more likely to report the presence of unmet need or psychological distress.  If 
people are psychologically inflexible, they may be less likely to be aware of or to 
acknowledge the impact of their diagnosis or be sufficiently aware of their own life values 
to have an awareness of how cancer has created a rift between their desired and actual 
states.   
These findings must be treated with some caution, indeed a significant moderation effect 
was not found in all interactions that were tested.  Looking more closely at where 
moderation was found to occur, psychological flexibility was found to moderate the 
relationships between: psychological need and QoL; sexual need and Qol; and patient care 
and support needs and both anxiety and QoL.   Given that the findings fell outside of the 
original hypothesis, potential explanations for this deviation will be explored. 
Given the areas of unmet need that were found to be significant within the moderation 
analyses, it is possible that the findings in fact are indicative of a methodological problem 
when using self-report measures.  For example, the reliability of reporting of unmet sexual 
needs has long been queried (Schroder et al., 2003; Fenton et al., 2000): the social context 
of having sexual needs has the potential to affect the accuracy with which such needs are 
reported.  Given that there is somewhat of a floor effect in unmet sexual needs in this 
sample, this explanation seems plausible.   
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It was possible that the measure of psychological flexibility chosen is not measuring this 
construct as expected within the sample, causing the unexpected results.  It was 
considered whether the measure was, in fact, detecting the level of insight of need in the 
sample, that is where participants scored highly on the measure were those who were 
more insightful into their diagnosis and its impact.  Yet the correlations between 
psychological flexibility and unmet need, anxiety, depression and QoL are as would be 
expected in light of the existing literature (Masuda & Tully, 2013; Ciarrochi et al., 2010); 
Cronbach’s alpha was also within the acceptable range for all measures.  Significant 
positive correlation was found between psychological flexibility and QoL with significant 
negative correlations between psychological flexibility and unmet need, anxiety and 
depression: together indicating that increased psychological flexibility is associated with 
better overall psychological health.  Given this earlier finding, it seems unlikely that the 
measure of psychological flexibility, the AAQ II, is in some way causing the unexpected 
moderation findings. 
In addition, not all unmet need assessments structure their measures in the same way and 
therefore the way in which we label this precise relationship may be dependent upon the 
measure used.  For example, the CaSUN (Hodgkinson et al., 2007), another widely used and 
respected needs assessment tool does not include a sub-scale of psychological need or of 
support needs but rather has domains that include quality of life, emotional and 
relationship issues and the impact that cancer has had on your life perspective.  With 
regards to the needs assessment tool used, the SCNS SF-34, it is perhaps unsurprising that 
unmet psychological needs were found to correlate with psychological outcomes, yet 
psychological flexibility was only found to be influential in the relationship between unmet 
psychological need and QoL, and not for either anxiety or depression.   Given that the 
moderation analysis indicated that the relationship between unmet need and QoL as 
affected by the person’s psychological flexibility, it is possible that where the relationship 
between unmet psychological need and both anxiety and depression is pre-existing, then it 
is more resistant to being affected by other factors than the relationship between need and 
QoL.   Given the small sample on which these findings were based and the somewhat 
unexpected nature of the results however, the role that psychological flexibility plays in the 
relationship between need and outcomes requires further exploration. 
Alternatively, it is possible that people with low psychological flexibility are also the group 
who are least likely to report the presence of unmet need.  As an example, the items ‘I’m 
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afraid of my feelings’ and ‘It’s ok if I remember something unpleasant’ are both included on 
the AAQ II as a measure of psychological flexibility.  It is possible that a sub-group of 
respondents who score low on this measure are doing so because they are unwilling to 
acknowledge the difficulties associated with a cancer diagnosis and are therefore also 
unwilling to acknowledge the presence of unmet need.  For some, it may be that reporting 
the presence of any type of distress or perceived weakness after cancer diagnosis is 
uncomfortable.  There is little in the existing literature that connects psychological 
inflexibility to unmet psychosocial needs, therefore it is not possible to draw comparisons 
with previous findings in cancer groups. 
It is also possible that, given the socio-demographics of the sample, there is some 
characteristic of the sample which makes the reporting of certain areas of unmet need or 
psychological flexibility either biased or inaccurate in some way which would impact upon 
the results of the analysis.  The sample was predominantly older and retired, an age group 
where sexual changes are occurring regardless of cancer diagnosis (Avis, 2000).  This may 
act to confuse findings relating to sexual needs, alternatively it may mean that sexual 
changes are accepted and not associated as a need directly related to being a cancer 
survivor.  Within the qualitative study outlined in Chapter 3, unmet sexual needs were not 
raised as being a key issue for participants, rather they were seen as being of secondary 
importance to the physical and practical implications of a cancer diagnosis.  Healthcare 
professionals can focus on the combatting of disease or make the assumption that sexual 
needs are not relevant to older adults, and the sexual implications can therefore be under-
estimated and under acknowledged (Hordern & Street, 2007).  Within this environment, 
patients can feel uncomfortable raising their concerns and the perception that only the 
physical or ‘medical’ aspects of cancer warrant further support is developed.  In turn, the 
perception that sexual needs are less valid than physical needs may be in part creating the 
floor effect observed when examining the data range for unmet sexual needs.     
Further research is needed to address these hypothetical explanations: until this time, no 
conclusive statements can be made with regards to why the findings were not as expected.  
What does seem clear is that psychological flexibility does have the potential to interact in 
the relationship between unmet needs and psychological wellbeing.  The results of the 
correlation analysis highlight the relationship between psychological flexibility and 
psychological wellbeing in line with the existing evidence base (Fledderus et al., 2013; 
Ciarrochi et al., 2010; Hulbert-Williams et al., 2014) and significant results were found in 
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the moderation analysis.  The fact that the nature of the moderation analysis finding were 
unexpected highlights the need for further research into the ways in which psychological 
flexibility interacts with an affects our psychological health: for this purpose, cohort designs 
would be more appropriate.  A thorough understanding of this is essential in order to be 
able to develop research into clinically applicable interventions that will hold real benefits 
for patients.  Without this knowledge, intervention development cannot be optimally 
efficient or the effects on patients fully understood.   
Whilst psychological flexibility was found to moderate specific relationships between 
unmet need and both anxiety and QoL, in no cases was a significant moderation found 
where depression was the outcome variable.   It has been proposed that psychological 
inflexibility may act as a risk factor for psychological difficulties, including depression 
(Biglan et al., 2008; Ciarrochi et al., 2010).  The presence of psychological inflexibility has 
also been found to predict depressive symptoms in a community sample (Shallcross et al., 
2010), together feeding into the hypothesis that those who are depressed are also more 
likely to be psychologically inflexible.  From the correlations in this data, psychological 
flexibility and depression were strongly negatively correlated, supporting the theory that 
low flexibility and high depression are related.   For all of the moderation interactions that 
were found to be significant, the relationship between unmet need and outcome only 
emerged where levels of psychological flexibility were average or above average.  It is 
possible therefore that those participants who fulfil this criteria were also those 
participants who were least likely to display symptoms of depression given that depression 
has been found to be associated with low psychological flexibility.  The group of 
participants for whom the relationship between unmet need and outcome was found to be 
present are not necessarily the group who are most likely to display signs of depression, 
providing a possible explanation as to why the interaction between unmet need and 
depression was not significant.  If higher levels of flexibility is where the relationship 
between unmet need and psychological wellbeing, then in cases where low flexibility is 
present, these participants are also most likely to be depressed and psychological flexibility 
does not function as a moderator at this level. 
Limitations 
A major limitation of this work was the small sample size, notably of some of the rarer 
types of haematological cancers including the leukaemias and myeloma.  While the sample 
is representative of the haematological cancer population where NHL, myeloma and CLL 
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are the most commonly diagnosed conditions (Public Health England, 2014), it does mean 
that the influence of the participants with CML and AML on the overall sample outcomes 
may not have as large an impact on the results as the more common diagnoses.   However, 
given that that analysis was powered, this was not an overt cause for concern.   
As the sample was recruited based on patient self-reports of whether they met the 
inclusion criteria, it was not possible to confirm the clinical demographics of the sample.  It 
was also not possible to provide any follow-up support to patients who scored highly on 
the measures for anxiety and depression as is often the case in a sample recruited from 
within a clinical setting given that the nature of recruitment meant that the usual ethical 
safeguards were not possible.  A more worrying implication is that this highlights the 
presence of a sub-group of cancer survivors who would benefit from ongoing support, yet 
the current provision of support services means that their concerns are not routinely 
picked up.   
Recruiting a sample via online blogs and newsletters that are published by relevant cancer 
charities brings a potential bias to the sample.  This was a self-selecting sample who were 
all engaged in some way with the charities prior to participation.  They could, therefore, be 
viewed as either seeking support from their contact with the charities or who were 
sufficiently well psychologically adjusted to their diagnosis that they are able to confront 
their diagnosis by engaging with charities that provide support to people like themselves.  
Previous literature has demonstrated that patients who are more anxious or depressed are 
likely to be less engaged generally with their treatment, are less motivated, and less able to 
cope with the diagnosis (Hemingway, 1999).  However, the relatively high levels of anxiety 
within the sample do not indicate that only the well-adjusted took part, prevalence rates 
such as the ones presented here goes somewhat against the perception that only the 
psychologically-well are willing to take part in research.  It may be the case therefore, that 
those who do engage with cancer charities may be more likely to be anxious or feel a need 
for additional information than those who do not seek out newsletters or blog posts online, 
a potential explanation for why anxiety levels were so high within the sample.   
Implications for interventions 
The ultimate aim of exploring the role of psychological flexibility in cancer patients is to 
better understand whether the concept could be utilised as a way of reducing distress 
within this patient group.  The findings from this work do point to the involvement of 
psychological flexibility in the presence of distress in haematological cancer patients, yet, 
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given the results of the moderation analysis, the findings are not conclusive.  The 
correlation analysis does imply a link between psychological flexibility and psychological 
wellbeing, yet the way in which this relationship functions requires further investigation. 
The findings of the moderation analysis highlight that, for one sub-group of patients, 
psychological flexibility may be linked to higher levels of insight into their own needs and 
wellbeing.  This explains why understanding patient need is so relevant and important 
within the clinical setting.  It does however, raise concerns that, for the sub-group of 
patients who are not psychologically flexible, an intervention that aims to increase 
flexibility may in fact also increase distress.  If those with low psychological flexibility 
display less insight into their unmet needs and the psychological impact of their cancer, 
then acting to increase their flexibility may also increase their awareness of their unmet 
needs.  If this were to be the case, we know that from the correlation analysis that higher 
levels of unmet need correlate with higher levels of distress; therefore, making these 
patients more aware of their unmet needs may also increase their related levels of distress, 
clearly not a desired impact of an intervention to reduce distress.  However, were the 
intervention to be ACT-based rather than centred solely on psychological flexibility, then 
the potentially negative impact of increasing psychological flexibility is likely to be 
tempered by the other skills taught within an ACT programme.  ACT is not just about 
psychological flexibility, but also encompasses teachings around acceptance and coping 
skills (Hayes et al., 2006).   Each individual element of ACT is conceptualised as a positive 
skill, rather than simply a way of avoiding distress.  Therefore, aiming to increase 
psychological flexibility within the context of a broader ACT intervention may not be such a 
concern for patients with low flexibility.  In other words, distress may be higher because of 
awareness of need, but offset by the coping skills also provided: rather than avoiding 
distress through unawareness, we could address needs and keep distress at a minimum.  
Further research is required however, that will broaden the findings of this study to assess 
wellbeing in cancer patients along with a broader range of ACT components to better 
understand their breakdown and impact within this patient group. 
Conclusions 
This study has highlighted the strong presence of a relationship between unmet need and 
psychological wellbeing in haematological cancer survivors, supporting earlier work within 
this thesis that highlighted this same relationship in newly diagnosed patients.  Further 
research is needed to determine to what extent this relationship is also true of survivors of 
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other cancer diagnoses.  If found to be so, there are implications for the way in which 
cancer patients are supported in the long-term as the results demonstrate that 
haematological cancer survivors have ongoing care needs that are not currently being met.  
Findings indicate the presence of psychological morbidity at a higher rate than is typically 
found in general populations and gives some insight into areas of unmet need for the 
patient group.   This could be due to either: haematological cancer patients having higher 
levels of unmet need; or that due to the method of recruitment, only participants with high 
levels of need were accessed.  While unmet needs relating to physical, practical or 
informational matters may decrease after treatment ceases, the physical burden of disease 
lessens and time spent in hospital decreases, the emotional impact of having had a life 
threatening diagnosis remains.  At present, cancer survivors do not routinely receive on-
going support from their treating hospital, nor would all patients wish for this, however, 
these findings indicate that this lack of support is leaving a sub-set of patients with 
psychological difficulties and unmet support needs that would benefit from further input 
from experienced cancer professionals. 
Further research is needed to explore the role that psychological flexibility plays in the 
relationship between unmet need and distress in cancer patients, to determine the precise 
nature of the relationship and whether it exists in patient groups beyond haematological 
malignancies.  This research suggests that psychological flexibility does impact upon 
distress in cancer patients, highlighting the potential clinical utility of interventions that 
target psychological flexibility, such as ACT, in reducing levels of distress, yet the 
moderation analysis generated results that were somewhat surprising and generating 
further questions around how psychological flexibility impacts upon distress in this patient 
group.  Future research should seek to develop new interventions for cancer patients that 
are effective in their ability to reduce distress and that are based on this concept in line 
with acceptable models of support for cancer patients.   If found to be effective, 
interventions that target psychological flexibility may be effective in reducing the 
aforementioned levels of distress that persist into survivorship for a sub-set of patients.   
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Chapter 6 – The Methodological 
Challenges Associated with 
Researching Rarer Cancers in the UK 
 
Overview 
Conducting psychosocial research with cancer patients is challenging.  When conducting 
research with rarer patient groups, this challenge is exacerbated.  The ability to recruit 
large numbers of patients with a rare diagnoses and to engage clinical staff, who are 
themselves extremely busy and who perhaps do not perceive psychosocial issues to be a 
priority, further compounds the issue.  These were challenges faced in the research 
presented within this thesis.  Indeed, in the work outlined in Chapter 5, difficulties 
encountered in recruitment resulted in the amendment of the original analysis plan and a 
scaling back of the methodologies employed.  In encountering and attempting to overcome 
these difficulties, a series of reflections on the broader challenges of research with rare 
cancer within the field of psycho-oncology were generated.  As a result, this thesis chapter 
will discuss key challenges to the field of psychosocial oncology and argue that it remains 
important that such research questions are addressed.  Challenges, such as the ones 
encountered here, make generalising previous findings from the psychosocial oncology 
literature into rarer cancer groups difficult, resulting in a bias in the patients on which our 
assertions as a field are based.  However, the work remains imperative and the questions 
asked valid ones. Psychosocial wellbeing in rarer cancer groups is a challenging research 
area but it is one that we must face as a discipline, moving forward with the aim of making 
high quality psychosocial care available for all.   
 
Every Patient Matters 
Despite the difficulties encountered when attempting to conduct psychosocial research 
with cancer patients, particularly those with rarer diagnoses, the work is important for 
evidence-based practice and to ensure that all patients, regardless of diagnosis or 
demographic variables, have equal access to high quality, evidence-based support services.  
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Unless problems are resolved, we are creating inequalities and discrimination within how 
able we are as a system to manage the psychosocial health of all cancer patients.  
‘Every patient matters’ is a slogan commonly seen on NHS materials, indicating that all 
patients regardless of their illness or background deserve high quality care.  While 
healthcare staff on the frontline work to achieve this aim, without a reliable evidence base 
that is grounded in high quality, relevant research, then building a picture of best practice is 
not always straightforward.  Both government and healthcare services have cited high 
quality, patient-centred healthcare for all (NICE, 2004), yet within the field of psycho-
oncology research, there are considerable disparities in the available evidence base that 
stem from the methodological challenges innate to the field.  With cancer, there are many 
different sub-groups of diseases, each with their own unique challenges, but where small 
population numbers may be seen as prohibitive to large scale clinical trials of the kind that 
are held up as the ‘gold standard’ of research.  While it may be true that recruiting large 
numbers of these rarer patient groups may require a more complex recruitment strategy, 
this should not preclude the undertaking of high quality research.  
There is political support for this rhetoric: at their most recent world congress, the 
International Psycho-oncology Society (IPOS) put forward a statement placing psychosocial 
care as a human right.  This declaration places dignity at the centre of human rights, 
following this with the belief that, for cancer patients, maintaining their dignity is best 
achieved by taking care of the patient as a whole person, inclusive of their psychological, 
social and emotional wellbeing.  A lack of acknowledgement of the impact of cancer on 
these aspects of a patient’s life is failing to acknowledge the presence of pain outside of the 
physical.  The Multinational Association of Supportive Care in Cancer (MASCC) have also 
put forward a position statement that places psychosocial care as integral to supportive 
care for cancer patients (Surbone et al., 2009).  They argue for a paradigm shift in how 
supportive cancer care is conceptualised globally to recognise the importance of 
psychosocial concerns, cultural differences and spirituality within routine cancer care.  The 
Cancer Reform Strategy (2007) acknowledged that a lack of information and an incomplete 
evidence base presents a major challenge in the reduction of inequalities within cancer 
care.  From this, the National Cancer Equality Initiative (NCEI) was born.   A report 
published by the group in 2010 (NCEI, 2010) stated that a future step for promoting 
equality in cancer care was that every patient should have access to a “high quality 
experience of their treatment and care” (page 27).  This was the first step of their 
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recommendations listed, firmly placing importance of the patient experience as 
paramount.    
 
The Importance and the Challenges of Psychosocial Oncology 
Research 
This thesis has demonstrated an important theoretical contribution to knowledge with 
regards to the application of unmet needs within the broader context of psychological 
health; a concept with clear clinical implications for the management of psychological 
wellbeing in the clinical setting.  More broadly, psychosocial oncology research tells us 
about the patient experience, something that has increasingly been recognised within the 
political and media discourse around cancer.  Psycho-oncology is concerned with the 
psychological, social, behavioural and ethical aspects of cancer.  For patients, it is the 
everyday impact of their disease that is most distressing, the deviation away from 
normality as a result of cancer (Diaz et al., 2008).  While finding a cure for cancer is 
undeniably important and research into the biomedical aspects of cancer vital, until such a 
time when a cure is found, patients must continue to live with, and beyond, the disease.  
Understanding how patients experience cancer and what their support needs are allows us 
to tailor appropriate services that best meet these needs.  Having appropriate support 
services in place ultimately reduces healthcare system burden: people who are more 
psychologically healthy are also more likely to be motivated, to adhere to treatment, to 
attend their appointments (Hemingway & Marmot, 1999), all of which cumulatively 
improve patient outcomes and have an associated cost benefit due to a less complex 
treatment pathway.   Getting appropriate psychosocial care right from the beginning of the 
cancer experience also has an associated cost benefit.  Keeping patients psychologically 
healthy and feeling supported reduces the number of patients who will later require more 
specialised psychological or psychiatric input; these are expensive services and services 
that cannot be made available to all due to cost and service provision.   
As a field, psychosocial oncology has become overly focussed on research that relates to 
those who are easiest to recruit: namely white, middle-class women.   When considering 
the difficulties in recruiting cancer patients into research, it makes sense that the most 
commonly occurring cancers are those that are best represented within the literature.  
Breast, lung, colorectal and prostate cancers are the most common cancers in the UK 
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today, together accounting for 46% of all deaths by cancer in the UK (CRUK, 2014).  The 
number of patients diagnosed with these four diseases means that researchers are more 
likely to recruit larger samples from fewer sites in a shorter time frame.  Within psycho-
oncology, however, research relating to breast cancer has dominated to the expense of 
other diagnoses.  A systematic review of research relating to cancer care found that one 
third of all existing research related to breast cancer (Bryant et al., 2014).  A second review 
examining the evidence base relating to cancer survivorship also found a predominance of 
research relating to breast cancer (Richardson et al., 2011). While there is undeniable merit 
in researching the disease that is the biggest cancer killer of women in the UK, it does mean 
that a significant portion of our understanding of the psychological and social impact of 
cancer diagnosis relates to women and to women of a specific socio-demographic 
background.   Outside of breast cancer, it is in fact men who are more likely to be 
diagnosed and subsequently die from the disease (Ferlay et al., 2010), a statistic that is 
especially true of the haematological malignancies included within this thesis.    This 
highlights the real need to broaden our understanding beyond the realms of the most 
common and easiest to recruit in order to prevent gaps in the literature from widening. 
Challenges in recruitment must not mean that rarer patient groups, or indeed patient 
demographic groups that are harder to recruit into research, do not receive a proportional 
degree of attention within the relevant body of literature.  
The dominance of certain cancers within the literature is paralleled in how the funding for 
cancer research is allocated.  The published literature reflects the fact that a majority of the 
funding for cancer research is spent on breast, lung, colorectal and prostate cancers.  In the 
United States, the National Cancer Institute released spending figures for 2012 that 
indicated that together the four most common cancer received $1438.7 million (National 
Cancer Institute, 2013).  As a comparison, bladder cancer, melanoma, NHL, uterine, kidney 
and thyroid cancers received a combined spend of $348.7 million, less than one quarter of 
what was spent on the four common cancers.  While it is reasonable that the most 
common cancers and those with the highest associated mortality rates receive an 
appropriate portion of the total spend, it cannot be forgotten that cancer is not one 
disease.  Gaining knowledge of one condition, whether biomedical knowledge or 
psychosocial, does not always translate through to other cancer diagnoses.   
In the UK, a major survey highlighted that spending on cancers can vary significantly, even 
where mortality rates are similar (CRUK, 2011).   Of the haematological cancers, NHL and 
leukaemia fare well with the percentage spending associated with the diseases exceeding 
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the percentage of deaths attributable to each.  In the cases of bladder, stomach, 
oesophageal and pancreatic cancers however, there is a higher percentage of deaths 
associated with each condition than the related amount of money spent.  Looking at brain 
cancer as one example, they are the cause of the highest number of cancer related deaths 
in children, in under 25s and in under 35s (Brain Tumour Research, 2013).  Of those 
diagnosed with a brain tumour, 58% die within a year.  Despite this, between 2002 and 
2012, brain cancers received 0.8% of NCRI spending (NCRI, 2014), a clear disparity between 
spending and the impact of the disease. 
Looking at cancer research funding more generally, cancer prevention and control receives 
surprisingly little in both the UK and the US.  In the longer term, cancer prevention is key to 
decreasing the incidence of the disease yet an NCRI report on spending on the less 
common cancers revealed that nothing had been spent in this area (NCRI, 2012).  This 
report did indicate that, of the less common cancers, haematological malignancies did fare 
better than others in terms of money spent on research, receiving 41.8% of the money 
spent on researching rarer cancer groups.   
Psychosocial oncology research is an area that typically does not fare well in comparison to 
the amount of money spent on biomedical cancer research.  The precise amount spent on 
research of this type is difficult to determine, yet indications suggest that it makes up 
approximately 2% of the total spend (NCRI, 2011).  This translates into there being 
substantially less research relating to QoL in cancer than there is biomedical research, 
despite evidence that patients value psychosocial research (Paul et al., 2011; Clinton-
McHarg, 2010).  A review of QoL literature however, found that while there is less QoL 
research within the cancer literature, research within this area is showing the greatest 
relative increase (Sanson-Fisher et al., 2010), highlighting the increasing recognition that 
high quality cancer care encompasses the whole person, not just their disease.  In addition, 
this review found that while a majority of QoL research was still conducted with breast 
cancer samples, it was in fact studies with prostate cancer that were showing the biggest 
increase.  While prostate cancer is still one the four most common cancers and already 
received a fair degree of attention within the literature, this does represent a shift in 
research priorities and a recognition that a wider variety of patient groups are deserving of 
consideration with the psycho-oncology literature.   
A collaboration between over 100 international experts in the field of cancer research into 
current gaps in breast cancer research highlighted that there are major gaps relating to 
210 
 
both interventions and support for cancer survivors and in implementing sustainable 
lifestyle changes (Eccles et al., 2013).  Given that only around 2% of cancer research 
funding goes into psychosocial research, addressing critical gaps such as this is a real 
challenge for the discipline as a whole.  There has been an increasing recognition that 
patient priorities for research are important and need to be taken into account when 
allocating funds and developing research strategies (Steward, Caird, Oliver & Oliver, 2010).  
When patient views are taken into account, the emerging research agenda is one that is 
better suited to meet patient needs given that it was developed with them in mind.  
Research that has examined patient priorities when it comes to cancer research has 
repeatedly highlighted the perceived value of psychosocial research.  Indeed the recent 
literature appears to indicate an on-going paradigm shift from professionally to consumer-
driven research (Paul, Sanson-Fisher & Carey, 2013).  While both viewpoints are 
representative of important voices within the literature, it must be recognised that patients 
themselves have rated the emotional, social and practical elements of living with cancer as 
being worthy of receiving more funding that is currently the case (Corner et al., 2007).   In 
haematology in particular, this issue has been emphasised repeatedly with both adults, 
adolescent and young adults endorsing psychosocial research (Paul et al., 2011; Clinton-
McHarg, 2010).  While finding a cure or developing new treatments is deemed important 
by patients, for those already diagnosed it is the everyday impact of cancer that causes the 
greatest impact and learning how to live with their disease is a key priority.   
There is a culture of evidence-based research and practice currently driving healthcare 
practice in the UK.  A bias in how research is funded, however, creates an on-going bias in 
future research, in that it becomes easier to obtain future funding for projects that have an 
evidence-based rationale behind them.  In order to be able to demonstrate both efficacy 
and patient acceptability of proposed interventions, high quality research is required on 
which to base the design.  Indeed, a critique of the existing psycho-oncology literature is 
that it has been described as being descriptive in nature rather than seeking to pursue new 
interventions that may act to reduce the current gaps between research and clinical 
practice (Bryant et al., 2014).   
Looking more specifically at needs research, we know from previous studies that unmet 
needs differ according to age, gender, personal history and cultural factors (Hodgkinson et 
al., 2007; Puts et al., 2012).  This highlights the importance of assessing unmet need across 
a diverse range of patients.  While research conducted with white, middle-class female 
samples is of value, it is likely to be limited in how widely it can be generalised across wider 
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diagnostic, cultural or age groups.  Previous research has provided the field with an 
excellent grounding of some of the key issues and areas of concern for cancer patients, yet 
now we must move forward and explore the extent to which these findings are applicable 
across these wider patient groups, a notion supported by the finding within this thesis that 
haematology patients experience unmet needs in similar areas to solid tumour patients.   
Haematological cancer research has predominantly centred on the biomedical and 
treatment-based, the psychological aspect of living with these diagnoses have not been 
well covered within the literature and there has been a resulting gap in the evidence base 
with regards to their psychosocial needs and ultimately how this patient group can best be 
supported.   
While recruitment and respondent bias continues to be a concern, it should also be 
acknowledged that psychosocial oncology as a sub-discipline of cancer research is 
increasingly attempting to lead the way in conducting research that is inclusive of all 
patients.  There has been an increasing attention within the literature of aging populations 
(Thewes et al., 2004), of cancer patients whose first language is not English (Ayanian et al., 
2005) or who are in some way a marginalised group such as those with cognitive difficulties 
(Allen & Mor, 1997) or those who are from an ethnic minority (Moadel et al., 2007).  The 
challenges experienced during the research outlined within this thesis were ultimately 
borne out of the fact that this work was trying to achieve this in another underserved 
cancer group: the haematological malignancies.  Given the current challenges within the 
wider field of cancer research, these problems are perhaps unsurprising. 
 
Overcoming Challenges as a Discipline 
The disparities in the existing evidence base and the difficulties in availability of research 
funding translate into real barriers to conducting psychosocial oncology research.  
Challenges that have been evident both within this thesis and across the wider field.   These 
problems must be resolved in order for the discipline to progress; yet for progress to occur, 
there must first be a clear understanding of what the difficulties are to be overcome.   
There may be a connection between research funding and the difficulty that psycho-
oncology researchers can face in the initial engagement of healthcare professionals.  In 
order for a project to be successful, funding bodies, recruitment sites, staff members and 
finally patients must be engaged and invested in the research.  Past research that has 
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explored the acceptability of taking part in research during incredibly difficult times has 
indicated that participants can find engaging in research to be helpful (Gysels, Shipman, & 
Higginson 2008a; Gysels, Shipman, & Higginson 2008b).  A study that interviewed bereaved 
relatives of cancer patients, a group that are renowned for being an ethically sensitive 
population for research engagement, found that many felt that taking part in research was 
helpful to them, even in cases where taking part had been difficult (Koffman et al., 2012).  
The often sensitive nature of the research and the perceived vulnerability of participant 
groups can lead to gatekeeping by both clinicians and family members, effectively limiting 
access to certain groups (Schofield et al., 2008), in extreme cases limiting the viability of 
projects.  It may be that, given the lack of support for psychosocial research from the 
funding bodies, there is a filtering affect whereby clinician support for this research is 
impacted and the research not viewed as a priority.   Given the already small population 
sizes of some of the rarer cancer groups, an inability to engage relevant sites or, once 
recruitment is underway, to gain access to eligible patients can hinder an already difficult 
recruitment process.  While the work contained within this PhD was successful in terms of 
engaging multiple recruitment sites, clinician gatekeeping is always a concern.  Given the 
known difficulty with clinician gatekeeping, building successful professional relationships 
with the clinicians working at each of the recruitment sites was a key challenge for this 
PhD.  Recruiting participants in person not only enabled participants to discuss the study 
directly with the researcher, but also meant that the researcher could engage directly with 
clinicians, building a rapport and ensuring that the aims of the study were well understood.   
Once clinicians are engaged in the projects and sites have agreed to take part, the next 
potential pitfall in psychosocial oncology research is engaging participants.  The nature of 
the research typically engenders the need to engage patients at a highly stressful time of 
their lives.  A cancer diagnosis is typically accompanied by large amounts of new 
information about the diagnosis, treatment pathways, clinical trials and what life will look 
like for the patient’s immediate future.  This is also likely to come during a time of high 
emotion, where the patient has had to endure the shock and distress of a cancer diagnosis 
and a shift in their expectations of what their life will look like.  Attempting to engage 
patients into psychosocial research at this time point can be incredibly difficult.   In addition 
to clinician gatekeeping, familial gatekeeping can also be problematic.  In the case of this 
particular work, there is no way of knowing whether familial gatekeeping was problematic 
for recruitment, but as all participants were allowed to take study information home with 
them to discuss with family and friends as they saw fit, it is possible that this contributed in 
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some way to the overall response rates of the studies.   For many patients, they have 
simply already had enough new information and change within their lives to contemplate 
taking on further disruption in the form of taking part in a research project.  For many 
patients, taking part in this type of research will be yet another new experience at a time 
when most patients desire stability and a sense of normality (Ekman et al., 2004).  There 
will also be a sub-set of patients who cope with their diagnosis by using avoidant coping 
strategies (Stanton et al., 2002), while these participants will be of great interest to the 
psychosocial researcher, they are also likely to be the group of patients least likely to 
engage in research that might force them to confront the thoughts and emotions relating 
to their diagnosis that they have been seeking to avoid.  While there is likely to always be a 
sub-group of patients for whom engaging in psychosocial research is deemed to be too 
distressing and so decline to participant, for others, the unfamiliarity of this type of 
research may be the key issue.  There is less publicity and awareness of cancer research 
that exists outside of the biomedical.  This problem occurs in direct relation to the degree 
of funding that is awarded to psychosocial research.  Psychosocial research has not been 
made a priority within cancer research, and until this happens, then public awareness is 
unlikely to increase.  With an increase in public awareness will come an acceptance that 
taking part in psychosocial research is an integral part of the cancer experience, much in 
the way that there is an awareness of clinical trials and the potential benefits to patients.   
If psychosocial research becomes better integrated into routine practice along with the 
biomedical research, then it will become more acceptable to all parties.  Clinicians will be 
more likely to be supportive and this will be passed on to patients who are known to follow 
the recommendations of their treating clinicians.   Improving the patient experience and 
increasing the level of supportive care available has been on the political and healthcare 
agendas for over a decade in the UK (NICE, 2004), yet there has yet to be a full uptake of 
such recommendations.  There is a gap between the mandates of governing bodies and the 
uptake of these directives within the clinical setting.  Again, this comes back to the 
perceived importance of psychosocial research.  Despite repeated recommendations for 
improved psychosocial care for patients, until this becomes a priority, the biomedical will 
continue to take precedence.   
Of course, once patients are engaged as participants in a research project, the key issue 
becomes ensuring that they remain so.  Follow up is notoriously difficult in psychosocial 
oncology research.   Attrition is common, but is a real concern for the field due to its ability 
to threaten the validity of results (Bell, 2012).  Given the nature of the people taking part in 
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research, attrition is perhaps unsurprising.  While patients may agree to take part in a 
research study, once the physical impact of treatment becomes evident, many simply feel 
too ill to continue to take part (Applebaum et al., 2012).  It must also be recognised that 
cancer is a life-threatening illness and that a sub-set of participants are likely to die during 
the study period, an issue within the study outlined in Chapter 5.  Methods of improve 
attrition rates in such instances are difficult to identify: where the researcher must focus 
their attention is on retaining all participants who do remain alive and well enough to 
continue to take part in the study.   Design of the study questionnaire, face to face 
recruitment and the engagement of the clinical team may all factor together to improve 
retention rates.   Previous work that has looked at how to maintain engagement in 
research has found that ensuring a user-friendly and interesting questionnaire design 
(Edwards et al., 2002), questionnaire length (Dillman, 1993), the colour (Fox et al., 1988), 
being addressed to a specific person (Brennan, 1992) and the order of the questions 
included all affect response rates within questionnaire studies.  In addition, the study 
having university sponsorship (Fox et al., 1988), reminders if follow up questionnaires are 
not received (Nakash et al., 2006; Brennan, 1992) and stating the benefit to society 
(Edwards et al., 2002) have also been found to improve response rates.   
More broadly, there is an ethical concern inherent to psychosocial oncology research in 
that there is a risk that asking participants about their difficulties will increase levels of 
distress in those patients.   The issue around participant burden can be contentious, yet 
previous research has demonstrated both that patients welcome research of this nature 
and has indicated ways to reduce potential burden (Pessin et al., 2008).  Considering study 
design (Aaronsen, 1991) the length and structure of questionnaire or interview can be 
beneficial in reducing burden to participants (Pessin et al., 2008).  A level of sensitivity to 
participant’s needs and concerns is required to enable participation and this must be 
reflected in the research design (Gysels, Evans & Higginson, 2012).  While the potential 
difficulties innate to the discussions around cancer and end-of life are undeniable, 
participants also report benefits from the social interaction, from the ability to make a 
contribution and to be able to talk about their illness and fears in a neutral environment 
(Pessin et al., 2008).    
While there may be ethical concerns associated with psychosocial research, the evidence 
suggests that, when a research study is well designed with minimising the potential burden 
to participants in mind, this is often unjustified when patients’ views are taken into account 
(Gysels et al., 2012).   The implication therefore, is that psychosocial oncology as a research 
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field has to work hard to make sure that the ethical concerns are managed in such a way as 
to avoid becoming a perceived barrier in terms of both ethical committees and clinician 
gatekeeping.  More pressingly, as a field there is the ethical concern that some patient 
groups are currently being under-represented within the literature and that, therefore, 
there is no evidence-base on which to base supportive care strategies for these patients. 
Personal Challenges and Reflections 
The challenges discussed during the course of this chapter are ones that impact upon the 
field of psycho-oncology as a whole, yet the personal challenges involved in undertaking a 
PhD and the reflections generated must also be acknowledged.  Of the issues highlighted 
within this chapter, there were specific areas that represented particular challenges in the 
work contained within this thesis.   
Moving chronologically through the process of conducting applied research, a series of 
difficulties were encountered.  The initial hurdle, as is the case often in research of this 
kind, was in the accessing of new sites that were willing to host the project outlined in 
Chapters 3 and 4.  This PhD project was co-funded by the local hospital, as such, it was 
possible to draw on the professional networks of those clinicians when attempting to 
recruit further sites.   The development of a psychosocial oncology research group within 
the Psychology department also provided networking opportunities that provided new 
contacts for additional sites.  However, it was still apparent that, compared to randomised 
controlled trials, psychological research was both less common and, as such, less well 
understood.   
Once sites were recruited into the project, the next challenge was engaging individual 
clinicians who were the cornerstone of the recruitment strategy throughout this PhD.  
There was variability in which individuals were willing to support the project.  Many were 
very generous with their time, for others, it was an additional time pressure where there 
was no perception of real benefit for the service.  The variations in staff enthusiasm for the 
project may be, in part, due to perceptions of ownership of the study.  The first hospital to 
become actively involved in the PhD project did so at a very early stage, indeed the 
Consultant Haematologist was involved in the proposal that secured the funding for the 
PhD.  Once up and running, the nursing staff met with the PhD researcher within the first 
week of beginning the PhD to discuss their patient group and what they perceived the 
challenges and unmet needs to be for haematology patients.  This was also the only 
hospital to be involved with both the qualitative and quantitative studies.  This meant that 
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the clinical staff in that haematology department had a sense of ownership of the project 
and clearly had a desire to see research of this kind being undertaken.  In the other three 
participating sites taking part in the study outlined in Chapter 4, this sense of ownership of 
the project, and perhaps the same level of interest in psychosocial work, could not have 
been present.   
The biggest difficulty throughout this PhD has been in the recruitment of participants into 
studies, something that has been discussed previously in both Chapter 3 and Chapter 4. 
The time spent attempting to recruit new participants meant that this was not a project 
that could be completed within a short time frame.  The importance of recruiting 
participants face to face, both in an attempt to boost recruitment and retention rates, but 
also because this was felt to be the most ethical way to approach patients, meant that the 
researcher needed to attend hospital clinics across four sites which took in excess of 20 
hours per week for over a year.  While this was an acceptable commitment within the 
bounds of a PhD project, it does make recruiting participants into psychosocial studies of 
rare cancers costly, a factor that may also influence funding decisions.   
While a source of frustration, recruitment difficulties did, at least in part, lead to the 
development of the moderation study outlined in Chapter 5.  The importance of the 
supervisory team and of having academic support became very clear and was invaluable at 
this time.  When recruitment for the study in Chapter 4 was at its most challenging there 
was a real sense of discouragement, yet having supportive and enthusiastic supervisors not 
only helped to maintain morale, but also led to the generation of new ideas and the 
evolution of the PhD to include the moderation study that not only highlighted the 
presence of a relationship between need and distress but has clear applications for future 
interventions.  Ultimately, including this study created a sense of completeness within this 
body of work, and is felt to have expanded and consolidated the contribution to knowledge 
that this thesis is able to make.   
On reflection, experiencing challenges and difficulties during the data collection process 
has ultimately contributed to this researcher’s academic development and provided a 
deeper understanding of what it is to conduct applied psychological research in the cancer 
setting.   By experiencing challenges first hand, an awareness is developed with regards to 
how these might be met going forward, fostering a pragmatic outlook for future projects.   
To conclude, if all patients are entitled to receive high quality healthcare in the UK, then 
this should hold true regardless of the population size of the patient group or the 
217 
 
psychosocial nature of the research.  If the best care is evidence-based care, as has been so 
widely cited in recent years, then research must be as open and unbiased as the healthcare 
system which it serves. 
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Chapter 7 - Conclusion and 
Implications of the Research 
Overview 
This thesis aimed to identify the specific unmet supportive care needs that are most 
relevant to haematological cancer patients, and to explore the wider psychological impact 
of unmet need within this patient group via a series of research questions:   
1. What is the current evidence base regarding the unmet psychosocial needs of 
haematological cancer patients and where do the gaps in our knowledge lie? 
 
2. What do haematological cancer patients perceive to be their key areas of 
psychosocial needs and why were those specific needs important during the 
patient experience of cancer? 
 
3. What are the unmet psychosocial needs and psychological outcomes of newly 
diagnosed patients and are these two concepts related? 
 
4. What are the long term psychosocial needs of haematological cancer survivors 
and does the concept of psychological flexibility mediate the relationship 
between need and psychological outcome? 
These individual research questions have been addressed and discussed throughout 
previous chapters of this thesis, but all ultimately come together to provide a better 
understanding of unmet need and psychological wellbeing in haematological cancer 
patients.   Throughout this body of work, the relationship between unmet need and 
distress has been conceptualised and explored within haematological cancer patients.  That 
there is a relationship is evident, and psychological flexibility has emerged as a potential 
moderator between the two.  This final chapter will bring together these findings and 
conclusions to (a) outline the key findings to emerge from the research and (b) to explore 
the clinical and research implications of the work.   
 
The Unmet Needs of Haematological Cancer Patients 
The work contained within this thesis has expanded our understanding of both the type 
and prevalence of unmet psychosocial needs present in haematological cancer patients.  
This was explored as an on-going theme throughout this thesis, with each ensuing chapter 
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seeking to build and expand on the previous work.  For the purposes of this thesis, an 
unmet psychosocial need was defined not only as a concern that related to a patient’s 
physical, psychological or social wellbeing, but as the active desire for support or assistance 
in one of those areas.  By this definition, an unmet need implies a gap between what is 
desired and what is reality for that patient.  The first study described within this thesis, a 
systematic review of unmet need within haematological malignancies, sought to identify 
those needs within this patient group.   The findings of this review confirmed the presence 
of unmet needs within haematological cancer patients, but also revealed a distinct lack of a 
comprehensive body of work on the topic.  Only three studies were identified that 
specifically explored need within haematology groups (Lobb et al., 2009; Molassiotis et al., 
2011; Hammond et al., 2008) and there was just one that included all diagnoses fitting 
under this umbrella term (Lobb et al., 2009).   In identifying this evidence gap, the 
systematic review acted as a preparatory work for subsequent studies.  Understanding 
unmet needs, or where the gap between patients’ wishes for support and the current 
service provision lies, are essential in order for future service development to be in line 
with patient requirement and for such future development to focus on the areas that are 
currently inadequate or inaccessible for the intended patient group.  In turn, understanding 
where patients want help and support is the first building block in developing support 
services and interventions that are both relevant to and acceptable to patients, in turn 
meaning that services are more likely to be used and to be efficient, minimising costs.   
In response to the lack of existing literature found in the systematic review, the 
identification of unmet needs ran as a theme throughout the entirety of this thesis, being 
at the core of each study.   Both quantitative questionnaire studies used the SCNS SF-34 to 
assess unmet need; this is considered a gold-standard tool that has been widely used 
within previous needs research (Bonevski et al., 2000; Sanson-Fisher et al., 2000) enabling 
direct comparisons between findings.  In both studies (Chapters 4 and 5), there was a floor 
effect observed in that a significant sub-group of participants expressed no unmet need for 
individual items.  Lack of energy/tiredness, not being able to do the things you used to, 
uncertainty about the future and concerns about the worries of those close to you were 
amongst the most highly rated unmet needs in both quantitative studies, suggesting that 
these are needs that are applicable throughout the cancer experience, transcending time-
points and their associated implications.  Learning to feel in control of your situation was 
also found to be highly applicable to newly diagnosed patients whereas anxiety and fears 
about the cancer spreading held a specific relevance to the cancer survivor sample.   This 
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work also highlights that unmet needs are not just relevant to patients who are newly 
diagnosed or undergoing treatment, but that they persist into survivorship, a time when 
typically the level of ongoing support available to patients from their clinical care teams 
decreases dramatically.   
The qualitative work within this thesis (Chapter 3) allowed for an expansion beyond 
quantitative identification of need into an evaluation of why needs are felt to be relevant 
and applicable to a patient group, and the barriers facing patients when attempting to 
access support for their unmet needs.  This methodology complemented the quantitative 
work contained in this thesis as it used an alternative research approach to explore the 
identification of areas of unmet need, but it also provided an additional dimension and 
depth to this understanding, moving beyond the simplistic description of quantitative work.  
Identifying and understanding the specific barriers that prevent unmet needs from 
becoming met provides insights into areas where current service provision remains 
inadequate or ill-suited for the meeting of needs; this level of exploration was better suited 
to an interpretative qualitative methodology, hence the use of IPA.  Participants in this 
study reported feeling unsure or unable to raise concerns that did not directly relate to 
their physical health; this was very much tied into the idea of the hospital being perceived 
as an environment that was primary concerned with medical, not psychologically 
supportive care.  These findings highlight the importance of psychosocial issues being 
raised within the clinical consultation and the need for healthcare professionals to be 
aware of, and be comfortable raising, potential concerns rather than expecting patients to 
raise issues themselves.  However, in order for this obstacle to be overcome in clinical 
practice, clinicians must both be aware of the type of unmet needs most common within 
their patients, and feel a sense of self-efficacy and confidence in their abilities when it 
comes to detecting and managing distress.  While there are existing training programmes 
that aim to improve clinician skill in the detection and management of distress (Moorey et 
al., 2013), there is as yet no convincing evidence that such training translates into improved 
detection rates or improved patient experience (Moorey et al., 2013), although they do 
appear to improve clinician confidence.   
In summary, this thesis adds to the existing body of research by addressing the unmet 
needs of haematological cancer patients across (a) multiple time points and (b) in patient 
sub-groups where there has previously been little focus within the scientific literature.   Key 
areas of need have been identified that are of particular relevance to this patient group, 
yet common in all studies undertaking is the finding that there are similarities between the 
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types of unmet need experienced by haematological cancer patients and those patients 
who have a solid tumour diagnosis.  Prior to this work, there was an expectation that the 
clinical differences between these two categories of cancer patient had the potential to 
translate into differences in the type of unmet need experienced, in much the same way as 
differences that result from other socio-demographic factors (Fielding et al., 2013; Harrison 
et al., 2009; Hubbard et al., 2014).  This thesis has demonstrated that this is not necessarily 
the case, and that there are some key areas of need that are broadly applicable across all 
cancer groups: unmet needs relating to the physical and practical impact of cancer; to 
uncertainty and fears about the future; the emotional and psychological impact of disease; 
the need for appropriate and relevant information; and, the need to feel supported by both 
healthcare professionals and by those close to you are relevant to patients regardless of 
the type of cancer that they are diagnosed with.  This novel finding has a real clinical 
significance both for how clinicians approach and manage unmet needs and for designing 
and implementing interventions that are designed to meet unmet needs.   If unmet needs 
are broadly applicable, this suggests that interventions that aim to meet needs more 
generally will have a wide clinical utility.  This discussion will now move on to explore three 
key messages that have emerged from this work, and have important implications; the 
finding that needs have broad applicability is particularly noteworthy within this context. 
A real success of the work contained within this thesis has been the merging of different 
methodologies to produce a body of work that is both complementary in its findings and 
has an added depth in terms of how the data can be interpreted and understood.  Each 
subsequent study design built on the previous work, cumulatively funnelling the research 
to narrow the focus of the work as it progressed.  Within this thesis, there is work that 
confirms, expands and develops the theory of unmet need within cancer patients, a 
process that by necessity must be multi-dimensional and reactive to on-going development 
of knowledge.   
   
Key Message 1: Haematological cancer patients do not identify 
as belonging to broader group of cancer patients 
If unmet needs are broadly applicable across cancer groups, then it is plausible that 
interventions designed to combat unmet needs would be applicable to all cancer patients, 
as a comprehensive group.   While the logic of this assumption is sound, the findings of the 
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empirical work in this thesis challenge this assumption and presents a rationale for why 
haematological cancer patients have been traditionally less likely to access certain 
supportive care services (Howell et al., 2013; Howell et al., 2011).   
The qualitative element of this thesis in particular really contributed to the evidence base 
by articulating some of the specific challenges associated with being a haematology patient 
from the patient perspective: notably, the perceived differences between themselves and 
solid tumour patients.  A key theme to emerge from the qualitative chapter (Chapter 3) 
was the participants’ need to feel supported as a haematology patient and the barriers that 
are preventing patients from accessing support.  Participants perceived their diagnosis to 
be poorly understood by both the general public and by some healthcare professionals; this 
was not believed to be the case for other cancers.   But, perhaps more importantly, 
participants did not identify themselves as being cancer patients and this was evident in 
two distinct ways.  First, a widely held belief within the sample was that they were 
haematology patients, or lymphoma patients: their self-identity was certainly not as a 
cancer patient.   The perceived differences between haematological and other cancers 
affected participant’s views of both how acceptable support services were and whether 
they felt comfortable accessing those support services when they are not a ‘cancer’ 
patient.   Second, some patients simply did not wish to be associated with a ‘disease label’ 
at all, and the suggestion that they should adopt the label of ‘cancer patient’ was felt to be 
unreflective of who they believe themselves to be, and the self that they wish to portray to 
the world.   If existing support services are designed for cancer patients, a group to whom 
participants did not feel a sense of belonging, then the applicability of such services is 
questioned.   This disparity between haematological and solid cancers was one of the 
clearest messages from this qualitative work; whether this notion would be supported by 
healthcare professionals or service providers has not been explored within this body of 
work, but is certainly worthy of further research.    
The question of whether patients with a haematological diagnosis should be classified 
under the umbrella of ‘cancer’ is an interesting one.  Some of the chronic diagnoses 
included within this research (e.g. indolent NHL) were most notably perceived to fit less 
neatly into what the cancer experience is generally accepted to be.  Haematology oncology 
departments are often physically separate from the oncology departments within hospitals, 
running separate clinics that are staffed primarily by haematologists rather than 
oncologists.  The prognosis of these cancers and the treatment methods employed can 
differ from those seen in the solid tumours.  Yet, haematology is still generally accepted as 
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being a sub-type of cancer, despite often sitting slightly apart.  The difficulties that some 
patients have in identifying with the cancer label, feeling themselves instead to be a 
haematology patient, have been highlighted.  On this basis, there is perhaps a case for a 
more formal differentiation between haematology and oncology, yet this does seem 
counter intuitive when considering the potential impact for patients.  While the suitability 
of support services for haematology patients has been questioned within this thesis, it still 
remains that haematology patients are allowed access to cancer services such as those run 
by Macmillan, to support groups and to more formal support services available to cancer 
patients in accordance with best practice guidelines, even if they aren’t currently choosing 
to use them.  If this label were to be taken away, it seems likely that what support is 
available would only decrease.  This brings the argument back to the previous paragraph, it 
seems likely that future work that aimed to make services more inclusive to the rarer 
cancer groups or less widely recognised groups, even if this merely represents a shift in 
perception, is what would have the most meaningful impact for patient support. 
As reported elsewhere in this thesis (e.g. Chapters Four and Six), difficulties were 
experienced when attempting to recruit large numbers of patients whose diagnosis was 
both haematological and chronic.  Difficulties in recruitment within the field of psychosocial 
oncology more generally may well be a compounding factor in the comparative lack of 
existing research in haematology; yet, as explored in Chapter Six, such difficulties do not 
mean that research undertaken with smaller patient groups is not valid, or that it cannot 
have meaningful contributions to both our theoretical understanding of the cancer 
experience and implications for clinical practice.  What the research within this thesis has 
indicated is that unmet needs are present for haematological cancer patients, regardless of 
sub-diagnosis, treatment type or time point within the cancer experience, and that 
ultimately the presence of unmet need affects psychological health.  While haematological 
cancer patients may number less than more common cancer groups, there are still 
important public health implications to be considered that result from the presence of 
unmet need to be taken into consideration.  There is a significant body of research, for 
example, that implicates both psychological and social stresses with increased mortality, 
morbidity and worsened functional status, both for general health (e.g. Kiecot-Glaser et al., 
2002) and cancer (Kroenke et al., 2006; Antoni & Lutgendorf, 2007) samples.  By 
maintaining the psychosocial health of patients, healthcare services are by default also 
ensuring that patients cope with their illness better and that they manage their illness 
more effectively by being more likely to attend appointments and adhere to treatment 
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regimes, maintain a healthy diet and exercise, and monitor their on-going symptoms 
(Adler, 2008).   Attending to patient need, therefore, has the ultimate benefit to healthcare 
services of reducing treatment-associated costs and reducing the costs related to a patient 
requiring formal psychiatric, psychological or social support.   
The extent to which participants’ perceptions regarding the applicability of existing support 
services to their concerns is grounded in reality is currently unknown.   There is little 
existing research that reports on healthcare professional’s perceptions of haematology 
patients and how they fit within a broader oncology remit.  However, a recently published 
paper has explored at why haematology patients are less likely to access palliative care 
services (Wright & Forbes, 2014); these authors suggested that there are barriers to 
collaboration between haematology and palliative care staff, and it is possible that similar 
barriers exist elsewhere.  While this thesis has presented barriers to accessing support from 
the patient’s perspective, it may also be true that there are barriers between multi-
disciplinary clinicians with regards to ease of referral between services (e.g. between 
haematology and psychological services) that is also impacting upon patient access to 
support.  Further research is needed to both further explore the clinician perspective of 
how the haematology patient fits into the cancer care setting, and to determine to what 
extent these participant’s perspectives are indicative of current service provision more 
broadly.   Whether support services themselves need amending to better suit haematology 
patients or whether they simply need to better advertise themselves to seem more 
acceptable to wider numbers of patients is worthy of future attention.  In general, the 
areas of need highlighted by participants within this thesis do not deviate significantly from 
what is already understood to be relevant to cancer patients which perhaps indicates that 
existing services would be suitable, and that it these perceptions of self-identity and 
suitability that need to be altered for optimal service delivery benefit. 
 
Key Message 2: Unmet Needs Are Associated with Poorer 
Psychological Health  
The findings reported in this thesis clearly illustrate the presence of a relationship between 
unmet need and psychological wellbeing; this is the first time that this has been fully 
explored and contextualised in a haematological cancer sample.  A strong relationship 
between the presence of unmet needs and psychological outcomes such as anxiety, 
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depression and quality of life, was observed in both newly diagnosed patients (Chapter 4) 
and cancer survivors (Chapter 5).   Across both studies, the correlation between unmet 
psychological needs and key outcomes were consistently the strongest observed, indicating 
that unmet psychological needs and psychological wellbeing are intrinsically related in this 
patient group.  This is perhaps an intuitive findings: that where psychological need is 
present, psychological problems are more likely to occur.  However, it still carries clinically 
predictive value in that holistic needs assessment has the potential to be utilised as a 
general indicator of overall psychological health. 
Focussing on individual items, or specific needs, endorsed by patients and how these 
correlate with outcomes, there were some important differences observed between the 
newly diagnosed and survivors samples.  In the newly diagnosed participant group, seven 
of the 34 items on the SCNS SF34 significantly correlate with all outcomes; five of these 
needs fell within the psychological domain.  As newly diagnosed cancer patients, there is an 
expectation that there will be a physical impact of the illness and treatment, that work and 
everyday life may be affected, and that there will be a need for information about the 
diagnosis and what comes next.  While there are needs present within these areas, the fact 
that they are perceived to be normal or to be expected meant that the presence of need in 
these areas did not impact negatively on overall psychological wellbeing As an overall need 
domains, the relationship between unmet physical need and psychological wellbeing was 
present, but this was less statistically strong at the individual need level than was observed 
for psychological needs.  This may be because, while individual needs are manageable and 
indeed expected, as a group of needs the impact is greater; this finding confirms 
suggestions made by participants in the qualitative study (Chapter 3).    
Conversely, in the sample of cancer survivors, a much higher number of individual needs 
items (30/34) were found to significantly correlate with anxiety, depression and quality of 
life.   While unmet psychological needs still had the strongest correlation as a need domain, 
the presence of a higher number of individual needs was more psychological distressing 
than was the case for newly diagnosed patients.    As cancer patients, the expectation is 
often that once treatment is completed and you become ‘cured’, and that life will then 
return to normal and the spectre of cancer will recede.  In reality, however, this is often not 
the case and for many individuals the long-term side effects of treatment, the threat of 
cancer recurrence and the removal of the on-going support from the treating hospital 
remain common areas of concern for cancer survivors after treatment.  This deviation from 
what was expected after the completion of treatment, may well be what creates the 
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negative psychological impact of on-going care needs.  Continued unmet needs serve to 
remind survivors of what they wish to forget and put behind them, and to highlight that life 
has not quite returned to the normality that was so hoped for.  Unmet needs do not have 
to fall within the psychological domain on the assessment tool to impact upon a patient’s 
psychological and emotional wellbeing, nor is their presence confined to the diagnosis and 
treatment phases of cancer.  Physical, practical or information-related needs all have the 
potential to have a psychological and emotional impact and their impact can continue into 
the survivorship phase of illness. 
Significant differences in quality of life were also observed between newly diagnosed 
patients allocated to watch and wait and those receiving active treatment; this was not, 
however, found to be the case in the survivors’ sample.  This suggests that patients 
monitored via watch and wait have a better quality of life at the time of diagnosis but that 
this difference diminishes over time.  This is logical: patients who are monitored via watch 
and wait immediately after diagnosis do not have to cope with the physical burden of 
treatment or the disruption of needing to attend hospital appointments on a regular basis.  
However, as time passes, the impact of living with uncertainty may become more impactful 
and this is likely compounded by the challenge of disease progression.  It is worth noting 
that the inclusion criteria were widened for the survivor cohort, being more inclusive of a 
range of haematological malignancies.   This may have impacted upon group means if we 
assume that different diagnoses will differ in their specific unmet needs and wellbeing.  
However, watch and wait is generally only utilised with patients with specific diagnoses, 
those included within newly diagnosed cohort, meaning that the impact of including more 
diagnoses is unlikely to have impacted upon the mean QoL of the watch and wait group.   
Anxiety and depression can be very real concerns for cancer patients, yet this will only be 
the case for a minority of patients.  While psychological morbidity can, and should, be 
detected and managed within the cancer setting, there is another, potentially much larger, 
sub-group of patients who do not reach clinical thresholds yet for whom distress is present, 
albeit at a sub-clinical level.   Formal measures of anxiety or depression would not classify 
these patients are requiring assistance, yet often it is not so clear-cut with many patients 
with sub-clinical levels of distress benefitting from additional support: the presence of 
distress increases the likelihood that patients will go on to experience clinical co-morbidity 
which increases the burden of illness for both the patient and healthcare services.  The 
presence of distress decreases treatment adherence and motivation (Manning & 
Bettencourt, 2011), with some studies indicating that overall prognosis can also be affected 
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(Pinquart & Duberstein, 2010).  For healthcare services, there is a cost implication in that 
the average length of consultations is likely to rise (Stirling, Wilson & McConnachie, 2001) 
and, that in the longer term, additional support services are more likely to be utilised.  
Holistic needs assessment has been endorsed for use within the cancer setting in the UK 
(NICE, 2004) and the relationship between unmet need and psychological health means 
that an assessment of this type may be clinically useful in identifying those patients who 
want further support yet may not reach the clinical cut-off on a formal distress measure.  
The utilisation of needs assessment in this way may help to reduce burden to both patient 
and to services by allowing needs to be met before they escalate.  The onus is placed on 
the clinician to be able to appropriately triage distress and to be able to appropriately refer 
patients on to more specialised services for further support.  This approach complements 
the NICE (2004) recommendation of the use of a tiered approach to psychological care.   
The relationship between unmet need and psychological wellbeing has implications for the 
clinical utility of needs assessment measures.   Formal psychological support is not always 
desired by patients (Baker-Glenn et al., 2010), nor well signposted by clinicians.  In light of 
the findings presented within this thesis, needs assessment takes on a new dimension as a 
more broad assessment tool for providing clinicians with an indication of the patient’s 
overall psychological health.  Patients can be theorised as falling within one of four 
quadrants (figure 1): (i) those who neither want nor need help; (ii) those who want help but 
do not need it; (iii) those who need help but do not want it; and (iv) those who both want 
and need help.   
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Figure 7.1: Diagram to illustrate the four quadrant of patients who want/need help. 
Existing measures of distress highlight patients who fall within both of the latter two 
groups, yet when assessed in this way, there will be a sub-group of patients who may 
receive an assessment for a support service that they have not desire or intention of 
accessing.  This is both unwanted and potentially distressing for the patient.  Needs 
assessment allows healthcare professionals to determine which patients fall within either 
of the two groups of patients that desire help.  The clinician must then make a decision 
with regards to what further support or referrals, if any, are appropriate for that patient.  
Peer support groups, group interventions and successful doctor-patient communication 
may all be appropriate forms of support for patients whose levels of distress are below that 
required for formal intervention from psychiatry or psychology colleagues, but who may 
benefit psychologically from support from other sources. 
Given the role that psychological flexibility is thought to play in the maintenance of general 
psychological health (Fledderus et al., 2013), the finding within this thesis that 
psychological flexibility correlates strongly with unmet needs (Chapter 5) provides further 
support for the hypothesis that unmet need could act as a more general barometer of 
psychological health.   An unmet needs assessment is not directly psychological in nature 
and, therefore, may prove to be more acceptable to a broader range of patients than 
psychological or psychiatric measures.  It is also a more generic assessment tool which may 
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also act to improve uptake by general medical staff who do not always feel proficient in 
using a more specialist measure (Mitchell, Kaar, Coggan, & Herdman, 2008).   The 
additional benefit of the premise of using needs assessment as a measure of psychological 
health is that there are already multiple directives from both policy makers (NICE, 2004; 
Department of Health, 2011 ) and cancer charities (Young et al., 2012) that state that needs 
assessment should be an integral part of cancer care for all patients.   The fact that the 
evidence base and the policy makers have been commending the use of needs assessment 
for more than a decade should translate into a broad uptake within the clinical setting 
nationally, yet, this does not consistently seem to be the case.   Clearly, there is further 
work to be done with regards to the routine uptake of needs assessment within the clinical 
setting and barriers to the implementation of such need investigating.   
The work contained in this thesis highlights the importance of unmet need as a concept 
both within the scientific literature and within the clinical setting.  This creates 
opportunities for both a deeper theoretical understanding of the presence of distress in 
cancer patients and how this arises, and for the development of interventions.  Some 
cancer patients experience significant psychological distress and others do not, but the 
reasons behind this are not well understood.  The insights provided within this thesis 
indicate that the presence of unmet need, a gap between what is real and what is desired 
with regards to a patient’s supportive care, may, at least partially, provide an explanation 
for the distress that is present in a sub-group of patients.   It is, therefore, likely that 
interventions that are designed to meet unmet need in cancer patients will display a 
broader clinical utility and will also act to improve the psychological wellbeing of patients 
more generally.  In the current climate of limited healthcare resources, implementing 
supportive care measures that have the greatest clinical impact will always be of benefit.    
 
Key Message 3: Psychological Flexibility Impacts upon the 
Relationship between Need and Wellbeing and Affects the 
Experience of Distress in Patients 
The study of haematological cancer survivors (Chapter 5) demonstrated the relationship 
that is present between psychological flexibility, unmet needs and psychological wellbeing.  
Correlational analysis highlighted that higher levels of psychological flexibility relate to 
lower anxiety, depression, unmet need and higher quality of life; a finding that is consistent 
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with previous research that has linked psychological flexibility to better overall 
psychological health (Ciarrochi et al., 2010; Fledderus et al., 2013; Hayes et al., 2008).  The 
discovery that the relationship between unmet need and psychological wellbeing is only 
present in people with higher levels of psychological flexibility was novel, and contributes 
to the current theoretical understanding of the presence of both unmet need and distress 
in cancer patients.  This finding was somewhat surprising; the hypothesis explored was that 
high levels of psychological flexibility would buffer the impact of unmet need on 
psychological wellbeing, when, in fact, the data showed the opposite to be true.  
Considering the role of psychological flexibility within an acceptance and commitment 
framework (Hayes, 2004), however, potential explanations are to be found.  According to 
this framework, we would expect that people who display higher levels of psychological 
flexibility are also more likely to be more mindful, demonstrating a deeper awareness of 
their unmet needs and an awareness of the impact of their cancer diagnosis than someone 
who is very psychologically inflexible.  The increased reporting of unmet need in people 
who are more psychologically flexible may be in part due to a relationship between 
increased flexibility and mindfulness.  These concepts are related to an increased 
awareness of one’s own life values (Hayes et al., 2006), as such, the likelihood that 
someone will be more aware of how their diagnosis has created a gap between their 
current situation and how they would wish to live in line with their identified values, an 
unmet need, is increased.   However, these findings also indicate that an intervention 
based around psychological flexibility must be approached with some caution.  While 
psychological flexibility was found to be correlated with better psychological outcomes, it 
was also demonstrated that for the sub-group of patients who are psychologically 
inflexible, there are potential risks associated with attempting to change this.  If increasing 
psychological flexibility will increase insight and awareness into the impact of a cancer 
diagnosis and unmet needs, then it is plausible that increasing psychological flexibility will 
also increase distress if people become more aware of the negative impact of their disease.  
Interventions must have a dual focus, therefore, providing distress reduction training, in 
combination with awareness-raising initiatives.  This has particular relevance, for example, 
to the rise of mindfulness based interventions in the cancer setting:  these interventions 
are very effective at improving awareness but place less emphasis on coping with distress. 
The finding that psychological flexibility plays a role in moderating the presence of distress 
in cancer patients builds upon existing literature that places psychological flexibility as the 
active component of change in ACT (Fledderus et al., 2013).  A recent review suggested that 
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ACT is a potentially important model for intervention in the cancer setting by virtue of 
psychological flexibility as its underlying framework (Hulbert-Williams, Storey & Kelly, 
2014).  In order for the eventual implementation of an intervention to become widespread, 
it must be both clinically effective (based upon sound empirical evidence) and cost-
effective (given the limited resources available within healthcare).  Conceptualising an 
intervention to improve psychological flexibility within an ACT framework counters the 
potential to increase distress in cancer patients: ACT also teaches coping skills and 
problem-solving (Hayes et al., 2006), mechanisms that give patients the skills to manage 
their psychological health.   
Studies such as the one outlined in Chapter 5 strengthen the rationale for interventions 
that are intrinsically related to psychological flexibility, by demonstrating how the construct 
functions as an active component of change within the potential reduction of distress, and 
this has previously been highlighted as a priority for psychosocial oncology research 
(Stanton et al., 2012).  Understanding where active change occurs and for whom an 
intervention is likely to be successful allows for interventions to be developed that 
specifically target this, therefore reducing elements that do not produce any psychological 
change or benefit.  As a result, interventions can be developed that are honed and 
streamlined to these active elements, thus making them as effective as possible while 
containing only elements that will produce change.  This also make them cost-effective.  
There has already been some exploration of ACT within cancer groups, with early research 
indicating that positive changes to wellbeing are observed (Hulbert-Williams et al., 2014).  
The next step is to determine both the feasibility and patient acceptability of implementing 
such interventions on a larger scale within the cancer setting. 
   
Implications for Research 
The findings contained within this thesis have multiple implications for research.  The first 
key finding, that unmet needs appear to be broadly applicable across cancer groups is 
indicative of a lack of need for further descriptive needs-based research.  Rather than 
continuing to explore type of prevalence of unmet need within discrete patient sub-groups, 
instead the psycho-oncology research community needs to look towards large scale, 
inclusive cohort studies that examine unmet need across cancer groups over time.  This 
would confirm the finding of broad applicability of unmet need across cancer patients as an 
inclusive group and to determine how unmet needs evolve over time.   The work contained 
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in Chapter 6 highlighted the difficulties in conducting large scale studies, particularly when 
attempting to recruit patients with a rare cancer diagnosis.  However, as discussed within 
that chapter, difficulties at the practical level should not preclude attempts at creating high 
quality research that asks important questions about the cancer experience. 
A deeper understanding is needed of how different cancer patient groups perceive 
themselves to sit within this broader group.  Findings from within this thesis have 
highlighted the view held by haematology patients that they do not feel a sense of 
belonging with other cancer patients, rather believing themselves to be a distinct group.  
This had implications for the perceived acceptability of support services that were 
advertised as being for cancer patients.  This is a novel finding, and the degree to which this 
might also be true of other cancer groups, particularly other rarer cancer groups, is not 
known.  In addition, there is a lack of evidence that explores the perceptions of healthcare 
and service providers.  Further qualitative work would allow for exploration of the views of 
additional stakeholders, healthcare professionals and service providers, to determine 
whether there are common beliefs held across different groups.  If it transpires that the 
differences exist in patient perceptions only, then there is work to be done on how to make 
support services more acceptable to wider groups of patients.  Perhaps most pertinent is 
the question of whether people ultimately identify with the term cancer patient, or indeed, 
whether they want to: if the answer is no, then engagement with support services targeted 
at cancer patients is likely to be low regardless of whether unmet needs are present. 
This thesis has highlighted key differences between haematological and solid tumour 
patients, yet fundamentally the key areas of unmet need are not dissimilar across groups.  
All patients have psychological needs, physical and practical needs, and the need for 
information.  While there may be some mileage in exploring the unmet needs of other rare 
cancer groups, the more pertinent question is now how best to meet need in all cancer 
groups.  That there is a relationship between unmet need and psychological wellbeing is 
becoming evident, but warrants further exploration to determine how it can best be 
utilised to improve patient outcomes within the clinical setting.  If the ultimate aim of any 
intervention run by healthcare services is to improve patient experience and wellbeing, 
then implementing interventions that target unmet needs would seem logical.   This is the 
only sure fire way to address causality, therefore making them gold-standard research 
designs.  Not only have unmet needs been shown to relate to psychological wellbeing, but 
in the wider literature to patient satisfaction (Asadi-Lari, Tamburini & Gray, 2009).   
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Finally, having made a theoretical contribution to knowledge with the finding that 
psychological flexibility is influential in the relationship between unmet need and distress, 
further work is needed to expand upon this finding and to develop psychological 
interventions to reduce distress in patients.  The first step in this process would be to 
explore how this finding relates to other components within an ACT-based framework.  
Mindfulness already has a growing evidence base with relation to its success within the 
cancer setting and there have been studies that have indicated that living a values-based 
life produces benefits for cancer patients (Ciarrochi et al., 2010).  As a tenet of ACT, 
psychological flexibility has already been shown to produce improvements in wellbeing in 
cancer patients, it has been utilised as a component of a behavioural change intervention 
in colorectal cancer patients (Hawkes et al., 2009), but this evidence base is still in its 
infancy (Hulbert-Williams et al., 2014) and is limited in how widely it has been employed in 
terms of specific cancer diagnoses.  In addition, the success to which such interventions 
have demonstrated improvements in wellbeing has been variable: existing interventions 
lack convincing evidence for long term benefits, which may be due to the active 
components of change not being targeted (Fledderus et al., 2013; Hulbert-Williams et al., 
2014).  Yet the finding that flexibility moderates the relationship between need and distress 
highlights ACT as being of prime importance for intervention research.   
The findings within this thesis also present an alternative explanation for the mechanism of 
flexibility in cancer adjustment.  It is possible that interventions that aim to raise 
psychological flexibility in patients who are psychologically inflexible may act to increase 
awareness and, therefore, distress.  This needs to be both explored as a topic of research, 
but also borne in mind in the ethical design of intervention research with cancer patients.  
Future research into interventions should seek to expand on earlier work, taking into 
account the findings from this thesis that indicate that psychological flexibility is the 
influential in the relationship with distress and therefore a promising candidate for being 
the active component in the gains seen in ACT interventions.  On this assumption, targeting 
an intervention directly at psychological flexibility will allow for a more streamlined and 
potentially cost-effective intervention, yet requires considerable thought in how to target 
an intervention towards the patient group likely to benefit.  In the current climate of 
limited resources, brief interventions have grown in popularity and usage not just within 
psycho-oncology but across mental health care more generally (Roy-Byrne et al., 2009; 
McNaughton, 2009).   ACT interventions hold particular promise for reducing costs given 
the evidence that suggest it can be effective both as a brief intervention and that it can be 
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delivered by non-experts.  Producing the largest improvements in the shortest timeframe is 
ultimately beneficial for all stakeholders: patients, services and commissioners.  
 
Implications for Clinical Practice 
There are many implications for clinical practice to be borne out of the research findings 
contained within this thesis, most of which have been discussed previously.  One of the key 
messages to emerge from this body of work is that unmet needs assessment has a broader 
clinical utility than has previously been appreciated.  The use of needs assessment has 
increased over recent years due to multiple recommendations (NICE, 2004; APPCG, 2009), 
yet has typically been used as a way to determine whether additional input is required or 
to signpost for additional referrals.  While such usage is appropriate, this can be expanded 
upon both in terms of our understanding of why this is helpful for patients, and in 
understanding potential broader usage of assessments.   General maintenance of 
psychological health is important, even more so in the context of a life-threatening 
diagnosis.  A needs assessment can also be used by the clinical team as a way to monitor 
psychological health and to ensure that psychosocial care is made available to all.  There 
also needs to be an awareness that if a patient indicates that they have needs in the 
physical, practical or information domains, that these needs can still impact upon 
psychological and emotional wellbeing and that the healthcare team need to be engaged in 
broader discussions with their patients to fully understand the psychosocial impact of 
cancer.   The four patient categories of both need and distress as illustrated in Figure 1 
highlight that some patients with high needs fall below distress screening thresholds yet 
some with high levels of distress do not want help.  Thus, for optimal provision of support, 
both unmet needs and distress measures can be used in combination.  Needs assessment 
provides an excellent initial baseline assessment of the need for additional support, with 
distress measures having a subsequent utility in being able to guide follow up supportive 
care.   
The findings contained within this thesis shed light on potential ways of reducing distress in 
cancer patients.  The role of psychological flexibility in the relationship between need and 
distress suggests that psychological interventions with a basis in ACT will be of benefit, yet 
the connection between unmet need and distress also indicates that more basis clinical 
interventions may also act to improve psychological health.  Findings from the quantitative 
elements of this thesis indicate that a large number of individual needs items as included 
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on the SCNS SF34 are related to key psychosocial outcomes: anxiety, depression and 
quality of life.  This suggests that interventions designed to act at lower levels of the 
stepped care model (NICE, 2004), and that can be provided by all healthcare professionals 
involved in a patient’s care, have the potential to improve these outcomes.  Therefore, 
improved communication, targeted information giving, and improved practical assistance 
all have the potential to have impact on psychological health in a way that may not have 
been fully appreciated previously.  This thesis adds a new depth to existing work by 
expanding the application of on-going initiatives and by strengthening the theoretical 
understanding that must feed into the way in which we seek to support cancer patients in 
the clinical setting.   
 
Conclusion 
Unmet needs are fundamentally linked to distress and to broader psychological health in 
haematological cancer patients.  There are significant relationships between unmet needs, 
anxiety, depression, quality of life and psychological flexibility.  In addition, unmet needs 
are not confined to the diagnosis and treatment time-points but rather persist into 
survivorship, a time when support for cancer patients decreases in the UK.  It is well 
recognised that distress is a key issue in cancer patients; this work provides a theoretical 
contribution to knowledge that may be instrumental in finding new ways to detect and 
manage distress in the clinical setting.  The findings contained within this thesis indicate 
potentially useful mechanisms to reduce both unmet need and distress in cancer patients: 
future research needs to build on this work, especially with regards to how patient identity 
affects the acceptability of support services and the use of ACT –based interventions within 
the cancer setting.  There are, nonetheless, clear implications for clinical practice to emerge 
from this work: particular areas of unmet need of most relevance to haematological cancer 
patients have been highlighted and more immediate ways of managing need within the 
clinical setting have been discussed.   Psychosocial need remains common, unmet and 
distressing in haematological cancer patients.  As a system, healthcare services need to 
work more consistently and coherently to manage psychosocial issues in cancer patients, 
and ultimately reduce associated levels of distress and improve patient outcomes.  
 
 
237 
 
 
 
238 
 
Reference List 
 
Aaronson, N. et al (1993). The European Organization for Research and Treatment of 
Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in 
oncology. Journal of the National Cancer Institute, 85, 365-376.  
Aaronsen, N. (2006). Methodologic issues in assessing the quality of life of cancer patients.  
Cancer, 67(S3), 844-850. 
Abrahamson, K., Durham, M. & Fox, R. (2010). Managing the unmet psychosocial and 
information needs of patients with cancer. Patient Intelligence, 2, 45-52. 
Ahmedzai, S. et al. (2004). Improving access to specialist palliative care: Developing a 
screening measure to assess the distress caused by advanced illness that may require 
referral to specialist palliative care.  Sheffield: Sheffield Palliative Care Studies Group: 
University of Sheffield and Trent Palliative Care Centre.  
Anderson, M. & Johnson, J. (1994). Restoration of body image and self-esteem for women 
after cancer treatment: a rehabilitative strategy. Cancer Practice, 2(5), 345-349. 
Ansell, P.  et al (2007). What determines referral of UK patients with haematological 
malignancies to palliative care services? An exploratory study using hospital records. 
Palliative Medicine, 21(6), 487-492.  
Antoni, M. et al (2001). Cognitive-behavioural stress management intervention decreases 
the prevalence of depression and enhances benefit finding among women under treatment 
for early-stage breast cancer. Health Psychology, 20, 20-32.  
Applebaum, A. et al (2012). Factors associated with attrition from a randomised control 
trial of meaning-centered group psychotherapy for patients with advanced cancer.  Psycho-
Oncology, 21(11), 1195-1204. 
Ardeshna, K. et al (2003). Long-term effect of a watch and wait policy versus immediate 
systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a 
randomised controlled trial. The Lancet, 362, 516-522. 
Armes, J. et al (2009). Patients' Supportive Care Needs Beyond the End of Cancer 
Treatment: A Prospective, Longitudinal Survey. Journal of Clinical Oncology, 27(36), 6172-
6179.  
Asadi-Lari, M., Tamburini, M. & Gray, D. (2004). Patients' needs, satisfaction, and health 
related quality of life: Towards a comprehensive model.  Health and Quality of Life 
Outcomes, 2, 32-47. 
Ashbury F., et al (1998). A Canadian survey of cancer patients' experiences: Are their needs 
being met? Journal of Pain Symptom Management, 16:298-306. 
Aubeeluck, A. et al (2012). ‘All the burden on all the carers’: exploring quality of life with 
family caregivers of Huntington’s disease patients. Quality of Life Research, 21, 1425–1435 
Avis, N. (2000). Sexual function and aging in men and women: community and population-
based studies.  The Journal of Gender-specific Medicine, 3(2), 37-41. 
Badr, H. & Carmack Taylor, C. (2009). Sexual dysfunction and spousal communication in 
couples coping with prostate cancer.  Psycho-oncology, 18, 735-746. 
239 
 
Bailey, D. et al (2004). Uncertainty intervention for watchful waiting in prostate cancer.  
Cancer Nursing, 27(5), 339-346. 
Baker-Glenn, E., Park, B., Granger, L., Symonds, P. & Mitchell, A.J. (2011). Desire for 
psychological support in cancer patients with depression or distress: validation of a simple 
help question. Psycho=Oncology, 20(5), 525-531. 
Baxter, A., Scott, K., Vos, T. & Whiteford, H. (2013). Global prevalence of anxiety disorders: 
a systematic review and meta-regression.  Psychological Medicine, 43(5),  897-910. 
Bell, M. (2012). Bias due to differential attrition: what matters and what may not.  Available 
at: http://sydney.edu.au/medicine/news/news/2012/Oct/GI-abstract-srs1012.pdf.  Last 
accessed on 01/01/2015.   
Bland, J. & Altman, D. (1997). Statistics notes: Cronbach's alpha. British Medical Journal, 
314, 572. 
Boberg, E. et al (2003). Assessing the unmet information, support and care delivery needs 
of men with prostate cancer.  Patient Education and Counselling, 49, 233-242. 
Boehmke, M. & Dickerson, S. (2007). The diagnosis of breast cancer: Transition from health 
to illness. Oncology Nursing Forum, 33, 1121-1127.   
Bond, F. et al (2011). Preliminary psychometric properties of the Acceptance and Action 
Questionnaire – II: A revised measure of psychological flexibility and acceptance. Behavior 
Therapy, 42(4), 676-688. 
Bonevski, B., Sanson-Fisher, R., Girgis, A., Burton, L., Cook, P., Boyes, A., & Supportive Care 
Rev, G. (2000). Evaluation of an instrument to assess the needs of patients with cancer. 
Cancer, 88(1), 217-225.  
Boyes, A., Girgis, A., & Lecathelinais, C. (2009). Brief assessment of adult cancer patients' 
perceived needs: development and validation of the 34-item Supportive Care Needs Survey 
(SCNS-SF34).  Journal of evaluation in clinical practice, 15(4), 602-606.  
Brain Tumour Research (2013). Report on National Research Funding July 2013.  Available 
at: 
http://www.braintumourresearch.org/uploads/document/BrainTumourResearchNationalF
undingReportJuly_2013draft9_897.pdf. Last accessed on 11/09/2014.   
Brennan, J. (2001). Adjustment to cancer – coping or personal transition? Psycho-oncology, 
10, 1-18. 
Brocki J. & Wearden, A. (2006). A critical evaluation of the use of interpretative 
phenomenological analysis (IPA) in health psychology. Psychology and Health, 21(1), 87 - 
108. 
Brown, L. et al (2010). The association of depression and anxiety with health-related quality 
of life in cancer patients with depression and/or pain. Psycho-Oncology, 19(7),734-41. 
Bryant, J. et al (2014).Examining and addressing evidence-practice gaps in cancer care: a 
systematic review. Implementation Science, 9, 37-44. 
Brymer, A. & Cramer, D. (1994). Quantitative data analysis for social scientists. Oxford: 
Routledge. 
Bultz, B. & Carlson, L. (2005). Emotional distress: the sixth vital sign in cancer care.  Journal 
of Clinical Oncology, 23, 6440-6441. 
240 
 
Buzgova, R., Hajnova, E., Sikorova, L. & Jarosova, D. (2014). Association between unmet 
needs and quality of life in hospitalised cancer patients no longer receiving anti-cancer 
treatment.  European Journal of Cancer Care, 23(5), 685-694. 
Cain, E. et al (1983). Psychosocial reactions to the diagnosis of gynecologic cancer. 
Obstetrics & Gynecology, 62(5), 635-641. 
Campbell, H.S. et al (2010). Psychometric properties of cancer survivors’ unmet needs 
survey. Supportive Care in Cancer, 19, 221-230 
Cancer Research UK (2013). Non-Hodgkin Lymphoma.  Available at: 
http://publications.cancerresearchuk.org/downloads/Product/CS_REPORT_NHL.pdf. Last 
accessed on 22/05/2014. 
Cancer Research UK (2014). Leukaemia (all subtypes combined) statistics.  Available at: 
http://www.cancerresearchuk.org/cancer-info/cancerstats/types/leukaemia/. Last 
accessed on 02/07/2014. 
Cancer Research UK (2014). Statistics and outlook for acute myeloid leukaemia.  Available 
at: http://www.cancerresearchuk.org/about-cancer/type/aml/treatment/statistics-and-
outlook-for-acute-myeloid-leukaemia.  Last accessed on 01/01/2015 
Caplan, L., Helzlsouer, K., Shapiro, S., Wesley, M. & Edwards, B. (1996). Reasons for delay in 
breast cancer diagnosis. Preventative Medicine, 25(2), 218-224.   
Carlson, L.E. & Bultz, B.D. (2004). Efficacy and medical cost offset of psychosocial 
interventions in cancer care: Making the case for economic analyses. Psycho-Oncology, 
13(12), 837–849. 
Carlson, L. et al (2004) High levels of untreated distress and fatigue in cancer patients. 
British Journal of Cancer, 90(12), 2297–2304. 
Carlson, L. E., Waller, A., & Mitchell, A. J. (2012). Screening for Distress and Unmet Needs in 
Patients With Cancer: Review and Recommendations.  Journal of Clinical Oncology, 30(11), 
1160-1177.  
Carroll, B., Kathol., R., Noyes, R., Wald, T. Clamon, G. (1993). Screening for depression and 
anxiety in cancer patients using the Hospital Anxiety and Depression Scale.  General 
Hospital Psychiatry, 15(2), 69-74. 
Carver, C. et al (1993). How coping mediates the effect of optimism on distress: A study of 
women with early stage breast cancer. Journal of Personality and Social Psychology, 65(2), 
375-390. 
Carver, C.S. & Antoni, M. H. (2004). Finding benefit in breast cancer during the year after 
diagnosis predicts better adjustment 5 to 8 years after diagnosis. Health Psychology,  26, 
595-598.  
Cella, D.F. et al (1993). The Functional Assessment of Cancer Therapy (FACT) scale: 
Development and validation of the general measure. Journal of Clinical Oncology, 11(3), 
570-579. 
Cella, D.F. et al (2012). Measuring Health-Related Quality of Life in Leukemia: The 
Functional Assessment of Cancer Therapy – Leukemia (FACT-Leu) Questionnaire. Value in 
Health, 15(8), 1051-1058. 
Chalmers, K. et al (2003). Reports of information and support needs of daughters and 
sisters of women with breast cancer.  European Journal of Cancer Care, 12, 81-90. 
241 
 
Ciarrochi, J. Bilich, L., & Godsel, C. (2010). Psychological flexibility as a mechanism of 
change in Acceptance and Commitment Therapy. In Ruth Baer’s (Ed), Assessing Mindfulness 
and Acceptance: Illuminating the Processes of Change.(pp. 51-76). Oakland, CA: New 
Harbinger Publications. 
 
Ciarrochi, J. & Bailey, A. (2008). A CBT-practitioner's Guide to ACT: How to Bridge the Gap 
Between Cognitive Behavioral Therapy and Acceptance and Commitment Therapy.  
Oakland, CA: New Harbinger Publications. 
Clarke, J. (2011). What is a systematic review? Evidence-based nursing, 14(3), 64-64.  
Clavarino, A. M., Lowe, J. B., Carmont, S.-A., & Balanda, K. (2002). The needs of cancer 
patients and their families from rural and remote areas of Queensland. The Australian 
journal of rural health, 10(4), 188-195.  
Clinton-McHarg, T. et al (2014). Anxiety and depression among haematological cancer 
patients attending treatment centres: Prevalence and predictors. Journal of Affective 
Disorders, 165, 176-181. 
Clinton-McHarg, T. et al. (2010). Determining research priorities for young people with 
haematological cancer: A value-weighting approach.  European Journal of Cancer, 46, 3263-
3270.  
Coe, R. (2002). It's the Effect Size, Stupid: What effect size is and why it is important.  Paper 
presented at the British Educational Research Association Conference, Exeter, September. 
Available at: http://www.leeds.ac.uk/educol/documents/00002182.htm. Last accessed on 
02/01/2015. 
Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). New 
Jersey: Lawrence Erlbaum. 
Cohen, J. (1994). The earth is round (p < .05).  American Psychologist, 49(12), 997-1003. 
Corner, J. et al. (2007). The research priorities of patients attending UK cancer treatment 
centres: findings from a modified nominal group study.  British Journal of Cancer,  96,  875-
881.   
Coyle, N. et al (1996). Development and validation of a patient needs assessment tool 
(PNAT) for oncology clinicians.  Cancer Nursing, 19, 81-92.   
CRUK (2014). Cancer mortality statistics.  Available at: 
http://www.cancerresearchuk.org/cancer-info/cancerstats/mortality/.  Last accessed on 
01/01/2015. 
CRUK (2013). Myeloma.  Available et: http://www.cancerresearchuk.org/about-
cancer/type/myeloma/. Last accessed on 17/10/2013. 
CRUK (2013). Hodgkin Lymphoma.  http://www.cancerresearchuk.org/about-
cancer/type/hodgkins-lymphoma/. Last accessed on 17/10/2013.   
Dahl J., Wilson K.G. & Nilsson A. (2004). Acceptance and Commitment Therapy and the 
treatment of persons at risk for long-term disability resulting from stress and pain 
symptoms: a preliminary randomized trial. Behavior Therapy, 35, 785–802. 
Denford, S., Harcourt, D., Rubin, L. & Pusic, A. (2010). Understanding normality: a 
qualitative analysis of breast cancer patients concepts of normality after mastectomy and 
reconstructive surgery.  Psycho-Oncology, 20(5), 553-558. 
242 
 
Department of Health (2011). Improving outcomes: a strategy for cancer.  Available at: 
https://www.gov.uk/government/publications/the-national-cancer-strategy Last accessed 
on 02/01/2015.   
Department of Health (2012). Quality of life of cancer survivors in England: Report on a 
pilot survey using Patient Reported Outcome Measures (PROMS).  Available at: 
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/213192/
9284-TSO-2900701-PROMS.pdf. Last accessed on 01/01/2015. 
Detmar, S. B., Aaronson, N. K., Wever, L. D. V., Muller, M., & Schornagel, J. H. (2000). How 
are you feeling? Who wants to know? Patients' and oncologists' preferences for discussing 
health-related quality-of-life issues. Journal of Clinical Oncology, 18(18), 3295-3301.  
DH, Macmillan Cancer Support & NHS Improvement (2013). Living with & Beyond Cancer: 
Taking Action to Improve Outcomes (an update to the 2010 The National Cancer 
Survivorship Initiative Vision).  Available at: 
https://www.gov.uk/government/publications/living-with-and-beyond-cancer-taking-
action-to-improve-outcomes.  Last accessed on 12/05/2014. 
Doyal, L. & Gough, I. (1991). A theory of human need. Palgrave Macmillan , New York, USA.  
Earle, E. et al (2005). Follow-up care for childhood cancer survivors: A focus group analysis. 
European Journal of Cancer, 41, 2882–2886 
Eccles, S. et al. (2013). Critical research gaps and translational priorities for the successful 
prevention and treatment of breast cancer.  Breast Cancer Research, 15, R92. 
Edwards, B. & Clarke, V. (2003). The psychological impact of a cancer diagnosis on families: 
The influence of family functioning and patients' illness characteristics on depression and 
anxiety. Psycho-Oncology, 13(8), 562-576. 
Ekman, I. et al (2004). Maintaining Normality and Support Are Central Issues When 
Receiving Chemotherapy for Ovarian Cancer.  Cancer Nursing, 27(3), 177-182. 
Emmanuel, L., Alpert, H. & Emmanuel E. (2001). Concise screening questions for clinical 
assessments of terminal care: the needs near the end-of-life care screening tool. Palliative 
Medicine,  4(4), 465-74. 
Eysenck, H. J. (1995). Meta-analysis of best-evidence synthesis? Journal of evaluation in 
clinical practice, 1(1), 29-36.  
Fallowfield, L., Ratcliffe, D., Jenkins, V. & Saul, J. (2001). Psychiatric morbidity and its 
recognition by doctors in patients with cancer.  British Journal of Cancer,  84(8), 1011-1015.   
Fallowfield L, Jenkins V, Farewell V, Saul J, Duffy A, Eves R. (2002). Efficacy of a Cancer 
research UK communications skills training model for oncologists: a randomised controlled 
trial. Lancet,  359, 650–656. 
Fenton, K., Johnson, A., McManus, S. & Erens, B. (2001). Measuring sexual behaviour: 
methodological challenges in survey research.  Sexually Transmitted Infections, 77, 84-92. 
Fielding, R. et al (2013). Attributing variance in supportive care needs during cancer: 
Culture-service, and individual differences, before clinical factors.  PLOS One, 8(5), e65099. 
First, M. & Gibbon, M. (2004). The Structured Clinical Interview for DSM-IV Axis I Disorders 
(SCID-I) and the Structured Clinical Interview for DSM-IV Axis II Disorders (SCID-II).  
Comprehensive handbook of psychological assessment, Vol. 2: Personality assessment. 
Hoboken, NJ, US: John Wiley & Sons Inc.   
243 
 
Fledderus, M., Bohlmeijer, E., Fox, JP., Schreurs, K. and Spinhoven, P. (2013).  The role of 
psychological flexibility in a self-help acceptance and commitment therapy intervention for 
psychological distress in a randomised control trial.  Behaviour Research and Therapy, 51 
(3), 142-151. 
Galea, S. & Tracy, M. (2007). Participation Rates in Epidemiologic Studies.  Annals of 
Epidemiology, 17(9), 643-653. 
Ganz, P. et al (1992). The CARES: a generic measure of health-related quality of life for 
patients with cancer.  Quality of Life Research, 1, 19-29. 
Gibbs, A. (1997) Focus groups. Available from: 
http://www.soc.surrey.ac.uk/sru/SRU19.html . Last accessed on 12/11/2013. 
Giorgi, A. & Giorgi, B. (2008) Phenomenology. In Jonathan A. Smith (ed). Qualitative 
Psychology: A Practical Guide to Research Methods (2nd ed., pp. 26-52). London: Sage 
Publications Ltd. 
Grande, G., Myers, L. & Sutton, S. (2006). How do patients who participate in cancer 
support groups differ from those who do not? Psycho-Oncology, 15, 321-334. 
Green, S. (2005). Systematic reviews and meta-analysis. [Article]. SMJ Singapore Medical 
Journal, 46(6), 270-273.  
Grov, E. K., Dahl, A., Moum, T. & Fossa, S. (2005). Anxiety, depression and quality of life in 
caregivers of patients with cancer in late palliative phase.  Annals of Oncology, 16, 1185-
1191. 
Gurevich, M. et al (2002). Stress response syndromes and cancer: conceptual and 
assessment issues.  Psychosomatics, 43, 259-281. 
Gysels, M., Shipman, C. & Higginson, I. (2008a). Is the qualitative research interview an 
acceptable medium for research with palliative care patients and carers? BMC Medical 
Ethics, 9, 7-12. 
Gysels, M., Shipman, C. & Higginson, I. (2008b). “I Will Do It If It Will Help Others:” 
Motivations among patients taking part in qualitative studies in palliative care.  Journal of 
Pain and Symptom Management, 35,  347-355. 
Gysels, M. Evans, C. & Higginson, I. (2012). Patient, caregiver, health professional and 
researcher views and experiences of participating in research at the end of life: a critical 
interpretive synthesis of the literature.  BMC Medical Research Methodology, 12, 123-140. 
Hack, T. F., Degner, L. F., Parker, P. A., & Team, S. C. (2005). The communication goals and 
needs of cancer patients: A review. Psycho-Oncology, 14(10), 831-845.  
Halcomb, E. et al (2007). Literature review: considerations in undertaking focus group 
research with culturally and linguistically diverse groups. Journal of Clinical Nursing, 16(6), 
1000-1011. 
Hall, A. et al (2014). The Survivor Unmet Needs Survey (SUNS) for haematological cancer 
survivors: a cross-sectional study assessing the relevance and psychometric properties. 
BMC Health Services Research, 14, 211. 
Hall, A. et al (2013). Unmet needs of Australian and Canadian haematological cancer 
survivors: a cross-sectional international comparative study.  Psycho-Oncology 22, 2032-
2038.   
244 
 
Halldorsdottir, S. and Hamrin, E. (1997). Caring and uncaring encounters within nursing and 
healthcare from the cancer patient’s perspective.  Cancer Nursing, 20, 120-128. 
Halstead, M. & Fernsler, J. (1994). Coping strategies of long-term cancer survivors. Cancer 
Nursing,17(2), 94–100. 
Hammond, C. et al (2008). Non-Hodgkin's lymphoma survivors' fertility and sexual function-
related information needs. Fertility and Sterility, 90(4), 1256-1258.  
Harrison, J. D., Young, J. M., Price, M. A., Butow, P. N., & Solomon, M. J. (2009). What are 
the unmet supportive care needs of people with cancer? A systematic review. Supportive 
Care in Cancer, 17(8), 1117-1128.  
Hawkins, N. et al (2008). Informational needs of patients and perceived adequacy of 
information available before and after treatment of cancer. Journal of Psychosocial 
Oncology, 26(2), 1-16.  
Hayes, A. (2013). Introduction to Mediation, Moderation, and Conditional Process Analysis: 
A Regression-Based Approach. New York: Guildford Press.   
Hayes, S., Luoma, J., Bond, F., Masuda, A. & Lillis, J. (2006). Acceptance and Commitment 
Therapy: Model, processes and outcomes. Behaviour Research and Therapy, 44, 1-25. 
Hayes, S.C., Strosahl, K.D. and Wilson K.G. (2011).  Acceptance and Commitment Therapy: 
The process and practice of mindful change.  New York:  Guildford Press. 
Helgason, A. R., Dickman, P. W., Adolfsson, J., et al. (2001). Emotional isolation: Prevalence  
and the effect on well-being among 50-80-year-old prostate cancer patients. Scandinavian  
Journal of Urology and Nephrology, 35 , 97–101. 
 
Helms, H., O’Hea, E. & Corso, M. (2008). Body image issues in women with breast cancer.  
Psychology, Health & Medicine, 13, 313-325. 
Hemingway, H., & Marmot, M. (1999). Clinical evidence - Psychosocial factors in the 
etiology and prognosis of coronary heart disease: systematic review of prospective cohort 
studies. Western Journal of Medicine, 171(5-6), 342-350.  
Higgins, J. P. T., Thompson, S. G., & Spiegelhalter, D. J. (2009). A re-evaluation of random-
effects meta-analysis. Journal of the Royal Statistical Society Series a-Statistics in Society, 
172, 137-159.  
HMRN (2014). Incidence.  Available at: https://www.hmrn.org/Statistics/incidence. Last 
accessed on 22/05/2014. 
Hodgkinson, K. et al (2007). Assessing unmet supportive care needs in partners of cancer 
survivors: The development and evaluation of the Cancer Survivors' Partners Unmet Needs 
measure (CaSPUN). Psycho-Oncology, 16(9), 805-813.  
Hodgkinson, K. et al (2007). The development and evaluation of a measure to assess cancer 
survivors' unmet supportive care needs: The CaSUN (Cancer Survivors' Unmet Needs 
measure). Psycho-Oncology, 16(9), 796-804.  
Hodgkinson, K., Butow, P., Hunt, G. E., & Wain, G. (2006). Predictors of psychosocial 
outcomes and supportive care needs in cured cancer survivors. Psycho-Oncology, 15(2), 
S100-S100.  
245 
 
Holland, J., Watson, M., & Dunn, J. (2011). The IPOS New International Standard of Quality 
Cancer Care: integrating the psychosocial domain into routine care. Psycho-Oncology, 
20(7), 677-680.  
Holland, J. & Alici, Y. (2010). Management of distress in cancer patients.  The Journal of 
Supportive Oncology, 8, 4-12. 
Holzner, B. et al (2004). Quality of life of patients with chronic lymphocytic leukemia: 
results of a longitudinal investigation over 1 yr. European Journal of Haematology, 72(6), 
381-9. 
Hong, J., Tian, J. & Wu, L. (2014). The influence of chemotherapy-induced neurotoxicity on 
psychological distress and sleep disturbance in cancer patients.  Current Oncology, 21(4), 
174-180. 
Hopwood, P. (1993). The assessment of body image in cancer patients.  European Journal of 
Cancer, 29, 276-281. 
Hordern, A. & Street, A. (2007). Communicating about patient sexuality and intimacy after 
cancer: mismatched exctations and unmet needs.  Medical Journal of Australia 186(5): 224-
227. 
Howell, D. et al (2010). Haematological malignancy: are patients appropriately referred for 
specialist palliative and hospice care? A systematic review and meta-analysis of published 
data. Palliative Medicine, 25, 630-641.   
Howell, D. A., Shellens, R., Roman, E., Garry, A. C., Patmore, R., & Howard, M. R. (2011). 
Haematological malignancy: are patients appropriately referred for specialist palliative and 
hospice care? A systematic review and meta-analysis of published data. Palliative Medicine, 
25(6), 630-641.  
Howell, D. et al (2013). Variations in specialist palliative care referrals: findings from a 
population-based patient cohort of acute myeloid leukaemia, diffuse large B-cell lymphoma 
and myeloma.  BMJ Supportive and Palliative Care,  0, 1-7. 
Howie J. et al (1999). Quality at general practice consultations: cross sectional survey. 
British Medical Journal, 319, 738-743. 
Hubbard, G., Venning, C., Walker, A., Scanlon, K. & Kyle, R. (2014). Supportive care needs of 
women with breast cancer in rural Scotland. Supportive Care in Cancer [Epub ahead of 
print] Available at: http://www.ncbi.nlm.nih.gov/pubmed/25391226 . Last accessed on 
01/01/2015. 
Hughes, P.M., Bath, P.A., Ahmed, N. & Noble, B. (2010). What progress has been made 
towards implementing national guidance on end of life care? A national survey of UK 
general practices. Palliative Medicine, 24(1), 68-78. 
Hulbert-Williams, N., Storey, L. & Wilson, K. (2014).   Psychological interventions for 
patients with cancer:  psychological flexibility and the potential utility of Acceptance and 
Commitment Therapy.  European Journal of Cancer Care, 24, 15-27. 
Hulbert-Williams, N., Morrison, V., Wilkinson, C. & Neal, R. (2013). Investigating the 
cognitive precursors of emotional response to cancer stress: Re-testing Lazarus's 
transactional model.  British Journal of Health Psychology, 18, 97-121. 
Hulbert-Williams, N. et al (2012). The Mini-MAC Scale: Re-analysis of its psychometric 
properties in a sample of 160 mixed cancer patients. Psycho-Oncology, 21, 792-797.  
246 
 
Hunter, J. E., & Schmidt, F. L. (2000). Fixed effects vs. random effects meta-analysis models: 
Implications for cumulative research knowledge. International Journal of Selection and 
Assessment, 8(4), 275-292.  
Ibbotson, T., Maguire, P., Selby, P., Priestman, T. & Wallace, L. (1994). Screening for anxiety 
and depression in cancer patients: the effects of disease and treatment.  European Journal 
of Cancer, 30, 37-40. 
Jacobsen, P. et al (1998). Posttraumatic Stress Disorder Symptoms after Bone Marrow 
Transplantation for Breast Cancer. Psychosomatic Medicine, 60(3), 366-371. 
Jacobsen, P.B. (2007). Screening for psychological distress in cancer patients: Challenges 
and opportunities. Journal of Clinical Oncology, 25(29), 4526-4527. 
Jacobsen, P. & Jim, H. (2008). Psychosocial interventions for anxiety and depression in adult 
cancer patients: Achievements and challenges. CA: A Cancer Journal for Clinicians, 58 (4), 
214-230. 
Johnson Wright, L., Afari, N. & Zautra, A. (2009). The illness uncertainty concept: A review.  
Current Pain and Headache Reports, 13(2), 133-138. 
Janz, N. et al (2008). Racial/ethnic differences in adequacy of information and support for 
women with breast cancer.  Cancer, 113, 1058-1067. 
Jenkins, V., Fallowfield, L., & Saul, J. (2001). Information needs of patients with cancer: 
results from a large study in UK cancer centres. British Journal of Cancer, 84(1), 48-51.  
Johnson, R. & Onwuegbuzie, A.  (2004).  Mixed methods research: A research paradigm 
whose time has come.  Educational Researcher, 33(7), 14-26. 
Johnson Vickberg, S. et al (2001). Global meaning and psychological adjustment among 
survivors of bone marrow transplant. Psycho-Oncology 10, 29-39.   
Kabat-Zinn, J. (2003). Mindfulness-based interventions in context: Past, present, and 
future.  Clinical Psychology: Science and Practice 10(2): 144–156. 
Khan, K. S., Kunz, R., Kleijnen, J., & Antes, G. (2003). Five steps to conducting a systematic 
review. Journal of the Royal Society of Medicine, 96(3), 118-121.  
Kim, H., Yeom, H., Seo, Y., Kim, N. & Yoo, Y. (2002). Stress and coping strategies of patients 
with cancer. A Korean study. Cancer Nursing, 25(6),425-31. 
Koffman, J. et al. (2012). Bereaved relatives’ views about participating in cancer research.  
Palliative Medicine, 4(26), 379-383. 
Kraus, P. (1999). Body image, decision making, and breast cancer treatment. Cancer 
Nursing, 22(6), 421-427. 
Krizek, C., Roberts, C., Ragan, R., Ferrara, J. & Lord, B. (1999). Gender and cancer support 
group participation.  Cancer Practice, 7(2), 1065-1074. 
Lam, W. et al (2011). Unmet supportive care needs: a cross-cultural comparison between 
Hong Kong Chinese and German Caucasian women with breast cancer.  Breast Cancer 
Research and Treatment, 130, 531-541. 
Laubmeier, K., Zakowski, S. & Bair, J. (2004). The role of spirituality in the psychological 
adjustment to cancer: A test of the transactional model of stress and coping.  International 
Journal of Behavioural Medicine, 11(1), 48:55. 
247 
 
Lazarus, R. (1992). Coping with the stress of illness. WHO Regional Publications. European 
Series, 44, 11-31. 
Lazarus, R.S. & Cohen, J.B. (1977). “Environmental Stress”. In I. Altman and J.F. Wohlwill 
(eds.), Human Behavior and Environment. (Vol 2) New York: Plenum. 
Lepore, S.J. & Coyne, J.C. (2006). Psychological interventions for distress in cancer patients: 
a review of reviews. Annals of Behavioral Medicine, 32, 85-92. 
Leukaemia & Lymphoma Research (2011). Watch and wait.  Monitoring while treatment is 
not necessary.  Available at: 
https://leukaemialymphomaresearch.org.uk/sites/default/files/watch_and_wait_dec_2011
_0.pdf. Last accessed on 12/12/14. 
Levin, T.T., Li, Y., Riskind, J. & Rai, K. (2007). Depression, anxiety and quality of life in a 
chronic lymphocytic leukemia cohort. General Hospital Psychiatry, 29, 251–256. 
Liang, L. et al (1990). Identifying priorities of psychosocial need in cancer patients. British 
Journal of Cancer, 62, 1000-1003.   
Linden, W., Vodermaier, A., Mackenzie, R. & Greig, D. (2012). Anxiety and depression after 
cancer diagnosis: prevalence rates by cancer type, gender and age.  Journal of Affective 
Disorders, 141, 343-351. 
Llewellyn, C. et al (2008). Can we predict which head and neck cancer survivors develop 
fears of recurrence? Journal of Psychosomatic Research, 65, 525–532. 
Lobb, E. A. et al (2009). When the safety net of treatment has been removed: Patients' 
unmet needs at the completion of treatment for haematological malignancies. Patient 
Education and Counseling, 77(1), 103-108.  
Lowry, L. & Ardeshna, K. (2012). Has single-agent Rituximab replaced watch-and-wait for a 
patient with asymptomatic low-grade Follicular Lymphoma? Cancer Journal, 18, 390-395. 
Mackenzie, N. & Knipe, S. (2006). Research dilemmas: Paradigms, methods and 
methodology.  Issues in Educational Research, 16, 193-205. 
MacKinnon, D. & Leucken, L. (2008). How and for whom? Mediation and moderation in 
health psychology.  Health Psychology, 27(2), S99. 
Macmillan (2013). Fighting the fight alone: Isolation among cancer patients. Available at: 
http://www.macmillan.org.uk/Documents/AboutUs/MAC13970_Isolated_cancer_patients_
media_reportFINAL.pdf.  Last accessed on 01/01/2015. 
Macmillan (2011) Non-Hodgkin Lymphoma. Available at: 
http://www.macmillan.org.uk/Cancerinformation/Cancertypes/Lymphomanon-
Hodgkin/Non-Hodgkinlymphoma.aspx. Last accessed on 21/9/12. 
Maher J. & McConnell, H. (2011). New pathways of care for cancer survivors: adding the 
numbers. British Journal of Cancer, 105, S5–S10. 
Manitta, V. J., Philip, J. A. M., & Cole-Sinclair, M. F. (2010). Palliative Care and the Hemato-
Oncological Patient: Can We Live Together? A Review of the Literature. Journal of Palliative 
Medicine, 13(8), 1021-1025.  
Manning, M. & Bettencourt, B. (2011). Depression and medication adherence among 
breast cancer survivors: bridging the gap with the theory of planned behaviour.  Psychology 
& Health, 26(9),1173-87. 
248 
 
Masuda, A & Tully, E. (2012). The role of mindfulness and psychological flexibility in 
somatization, depression, anxiety, and general psychological distress in a nonclinical college 
sample.  Journal of Evidence-Based Complementary and Alternative Medicine, 17(1), 66-71. 
McCabe, T. (2014, May 27). My Story: Watching, Waiting and Worrying.  Retrieved from: 
http://lightthenightma.wordpress.com/tag/small-lymphocytic-lymphoma/ 
McCallum, M. et al (2014). Supportive care needs after gynacologic cancer: Where does 
sexual health fit in? Oncology Nursing Forum, 41, 297-306. 
McDowell, M. et al (2010). Prospective predictors of psychosocial support service use after 
cancer.  Psycho-Oncology, 20, 788-791. 
McGrath, P. (2001). Caregivers' insights on the dying trajectory in hematology oncology. 
Cancer Nursing, 24(5), 413-421. 
McGrath, P. (2002). Qualitative Findings on the Experience of End-of-Life Care for 
Haematological Malignancies. American Journal of Hospice and Palliative Care, 19(2), 103-
111. 
McGrath, P., & Joske, D. (2002). Palliative care and haematological malignancy: a case 
study. Australian health review : a publication of the Australian Hospital Association, 25(3), 
60-66.  
McGrath, P. & Holewa, H. (2006). Special considerations for haematology patients in 
relation to end-of-life care: Australian findings. European Journal of Cancer Care, 16(2), 
164-171. 
McIllmurray, M. B. et al (2001). The psychosocial needs of cancer patients: findings from an 
observational study. European Journal of Cancer Care, 10(4), 261-269.  
McNaughton, J. (2009). Brief interventions for depression in primary care: A systematic 
review.  Canadian Family Physician, 55(8), 789-96.   
Merckaert, I., Libert Y., & Razavi, D. (2005). Communication skills training in cancer care: 
where are we and where are we going? Current Opinion in Oncology, 17, 319–330. 
Meredith, C. et al (1996). Information needs of cancer patients in west Scotland: Cross 
sectional survey of patients' views. British Medical Journal, 313(7059), 724-726.  
Mesters, N. et al (2001) Measuring information needs among cancer patients. Patient 
Education and Counseling, 43(3), 253-262. 
Mishel, M. (1999) Uncertainty in chronic illness. Annual Review of Nursing Research, 7, 
269–294. 
Mistry, A., Wilson, S., Priestman, T., Damery, S., & Haque, M. (2010). How do the 
information needs of cancer patients differ at different stages of the cancer journey? A 
cross-sectional survey.  JRSM short reports, 1(4), 30-30.  
Mitchell, A., Kaar, S., Coggan, C. & Herdman, J. (2008). Acceptability of common screening 
methods used to detect distress and related mood disorders—preferences of cancer 
specialists and non-specialists. Psycho-Oncology, 17, 226-236. 
Mitchell, A. (2011). Detecting and managing psychological distress in women with cancer: 
an update of recent evidence. The Obstetrician & Gynaecologist, 13(1), 22-28. 
249 
 
Mitchell, A. et al (2011). Prevalence of depression, anxiety, and adjustment disorder in 
oncological, haematological, and palliative care settings: a meta-analysis of 94 interview-
based studies.  The Lancet Oncology, 12, 160-174. 
Mitchell, A. (2013). Screening for cancer-related distress: when is implementation 
successful and when is it unsuccessful? Acta Oncologica, 52, 216-224. 
Moja, L. P. et al (2005). Assessment of methodological quality of primary studies by 
systematic reviews: results of the metaquality study cross sectional study. [Article]. British 
Medical Journal, 330(7499), 1053-1055.  
Molassiotis, A. et al (2011) Unmet supportive care needs, psychological well-being and 
quality of life in patients living with multiple myeloma and their partners. Psycho-Oncology, 
20, 88-97 
Montori, V. M., Wilczynski, N. L., Morgan, D., Haynes, R. B., & Hedges, T. (2005). Optimal 
search strategies for retrieving systematic reviews from Medline: analytical survey. British 
Medical Journal, 330(7482), 68-71.  
Moorey, S. (2013). ‘I know they are distressed. What do I do now?’ Psycho-Oncology, 22, 
1946–1952. 
Morrison, V. et al (2012). Common, important, and unmet needs of cancer outpatients. 
European Journal of Oncology Nursing, 16(2), 115-123.  
Nagia, A. et al (1993). A comparison of American and Egyptian cancer patient’s attitudes 
and unmet needs. Cancer Nursing, 16, PDF only.  
National Cancer Action Team (2013). Holistic Needs Assessment for people with cancer.  A 
practical guide for healthcare professionals.  Available at: http://www.ncsi.org.uk/wp-
content/uploads/Holistic-Needs-Assessment-practical-guide.pdf. Last accessed on 
19/05/2014. 
National Cancer Institute (2014). Cancer research funding.  Available at: 
http://www.cancer.gov/cancertopics/factsheet/NCI/research-funding.  Last accessed on 
01/01/2015.   
National Cancer Equality Initiative (2010). Reducing cancer inequality: evidence, progress 
and making it happen - a report by the National Cancer Equality Initiative.  Available at: 
http://webarchive.nationalarchives.gov.uk/20130107105354/http://www.dh.gov.uk/prod_
consum_dh/groups/dh_digitalassets/@dh/@en/@ps/documents/digitalasset/dh_114354.
pdf.  Last accessed 01/01/2015. 
NCRI (2012). The National Cancer Research Institute (NCRI) and Cancer52 Research into less 
common cancers: An analysis of research spend by Cancer52 members and National Cancer 
Research Institute (NCRI) Partners in 2012.  Available at: http://www.ncri.org.uk/wp-
content/uploads/2013/11/2013-NCRI-Research-less-common-cancers-Cancer-521.pdf. Last 
accessed on 11/09/2014.   
NCRI (2013). The National Cancer Research Institute (NCRI) Cancer research in the UK 2002-
2011: An overview of the research funded by NCRI Partners. Available at: 
http://www.ncri.org.uk/wp-content/uploads/2013/11/2013-NCRI-cancer-research-spend-
Uk-2002-2011.pdf. Last accessed on 11/09/2014. 
Newell, S.A., Sanson-Fisher, R.W. & Savolainen, N.J. (2002). Systematic review of 
psychological therapies for cancer patients: overview and recommendations for future 
research.  JNCI, 94, 558-584. 
250 
 
Newman, I., Ridenour, C., Newman, C. & DeMarco, G.M.P., Jr. (2003). A typology of 
research purposes and its relationship to mixed methods research. In A. Tashakkori & C. 
Teddlie, (Eds.) Handbook of mixed methods in social & behavioural research (pp. 167-188). 
Thousand Oaks, CA: Sage. 
NICE (2003). Improving outcomes in haematological cancers.  Available at: 
http://www.nice.org.uk/guidance/ta251/documents/leukaemia-chronic-myeloid-first-line-
dasatinib-nilotinib-and-standarddose-imatinib-appraisal-consultation-document2 Last 
accessed on 10/07/2015.   
NICE (2004).  Improving supportive and palliative care for adults with cancer.  Available at: 
https://www.nice.org.uk/guidance/csgsp. Last accessed on 13/12/14. 
Norkin, M., Hsu, J. & Wingard, J. (2012). Quality of Life, Social Challenges, and Psychosocial 
Support for Long-Term Survivors After Allogeneic Hematopoietic Stem-Cell Transplantation.  
Seminars in Hematology, 49(1), 104-109. 
Osse, B. et al (2004). Towards a new clinical tool for needs assessment in the palliative care 
of cancer patients: the PNPC instrument.  Journal of Pain and Symptom Management,  28, 
329-341.   
Office for National Statistics (2013). Measuring National Well-being - Health, 2013.  
Available at: http://www.ons.gov.uk/ons/dcp171766_310300.pdf. Last accessed on 
01/01/2015.  
Onwuegbuzie, A. & Leech, N. (2004). Enhancing the interpretation of “Significant” Findings: 
The role of mixed methods research. The Qualitative Report,  9, 770-792. 
Oxman, A. D. (1994). Systematic reviews – Checklists for review articles.  British Medical 
Journal, 309(6955), 648-651.  
Palmer, M., Larkin, M., de Visser, R. & Fadden, G. (2010). Developing an Interpretative 
Phenomenological Approach to Focus Group Data. Qualitative Research in Psychology, 7, 
99-121. 
Park, B. & Hwang, S. (2012). Unmet needs of breast cancer patients relative to survival 
duration.  Yonsei Medical Journal, 53, 118-125. 
Park, C., Zlateva, I. & Blank, T. (2009). Self-identity after cancer: “survivor”, “victim”, 
“patient” and “person with cancer”.  Journal of General Internal Medicine, 23,  S430-5. 
Parker, P. et al (2001). Breaking bad news about cancer: Patients’ preferences for 
communication. Journal of Clinical Oncology, 19(7), 2049-2056. 
Paul, C.L. et al. (2011). Cutting the research pie: a value-weighting approach to explore 
perceptions about psychosocial research priorities for adults with haematological cancers.  
European Journal of Cancer Care, 20, 345-353.   
Perz, J., Ussher, J., Butow, P. & Wain, G. (2011). Gender differences in cancer carer 
psychological distress: an analysis of moderators and mediators.  European Journal of 
Cancer Care, 20, 610-619. 
Pinquart, M. & Duberstein, P. (2010). Depression and cancer mortality: a meta-analysis. 
Psychological Medicine, 40, 1797-1810. 
Pitceathly, C. & Maguire, P. (2003). The psychological impact of cancer on patient’s 
partners and other key relatives: a review.  European Journal of Cancer, 39, 1517-1524. 
251 
 
Pollock, K., Cox, K., Howard, P., Wilson, E. & Moghaddam, N. (2008). Service user 
experiences of information delivery after a diagnosis of cancer: a qualitative study. 
Supportive Care in Cancer, 16(8), 963-973.  
Pope, C. & Mays, N. (1995). Reaching the parts other methods cannot reach: An 
introduction to qualitative methods in health and health services research.  British Medical 
Journal, 311, 42-45. 
Preyde, M., et al (2010). Exploratory Survey of Patients' Needs and Perceptions of 
Psychosocial Oncology. Journal of Psychosocial Oncology, 28(3), 320-333. 
Przezdziecki, A. et al (2012). My changed body: breast cancer, body image, distress and 
self-compassion. Psycho-Oncology, 22(8), 1872-1879. 
Public Health England (2014). Trends in incidence and outcome for haematological cancers 
in England: 2001-2010.  Available at: 
http://www.ncin.org.uk/cancer_type_and_topic_specific_work/cancer_type_specific_work
/haematological_cancers/. Last accessed on 01/01/2015. 
Puts, M. T. E., Papoutsis, A., Springall, E., & Tourangeau, A. E. (2012). A systematic review of 
unmet needs of newly diagnosed older cancer patients undergoing active cancer 
treatment. Supportive Care in Cancer, 20(7), 1377-1394.  
Quine, L. & Pahl, J. (2006).  Stress and coping in mothers caring for a child with severe 
learning difficulties: A test of Lazarus' transactional model of coping.  Journal of Community 
and Applied Social Psychology, 1(1), 57-70.   
Refsgaard, B. & Frederiksen, K. (2013). Illness-related emotional experiences of patients 
living with incurable lung cancer: A qualitative metasynthesis.  Cancer Nursing, 36(3), 221-
228.   
Reisfield, G. & Wilson, G. (2004). Use of metaphor in the discourse on cancer.  Journal of 
Clinical Oncology, 22, 4024-4027. 
Richardson, A. et al (2007). Patients' needs assessment in cancer care: a review of 
assessment tools. Supportive Care in Cancer, 15(10), 1125-44. 
Richardson, A. et al (2011). Knowledge, ignorance and priorities for research in key areas of 
cancer survivorship: findings from a scoping review. British Journal of Cancer, 105, S82-S94.   
Rogers S., Scott, B., Lowe, D., Ozakinci, G. & Humphris, G. (2010) Fear of recurrence 
following head and neck cancer in the outpatient clinic. European Archives of 
Otorhinolaryngology, 267, 1943–1949. 
Roman, E. & Smith, A. (2011). Epidemiology of lymphomas. Histopathology, 58, 4-14. 
Romsaas, E.P. et al (1983). A method for assessing the rehabilitation needs of oncology 
outpatients. Oncology Nursing Forum, 10(3), 17-21.  
Rosenberg, S. et al (2013). Body image in recently diagnosed young women with early 
breast cancer.  Psycho-Oncology, 22, 1849-1855. 
Roy-Byrne, P. et al (2009). Brief intervention for anxiety in primary care patients.  Journal of 
the American Board of Family Medicine, 22(2), 175-86. 
Royle, P., Bain, L., & Waugh, N. (2005). Systematic reviews of epidemiology in diabetes: 
finding the evidence. BMC medical research methodology, 5, 2.  
252 
 
Ruddy, K. et al (2013). Young Women with Breast Cancer: A Focus Group Study of Unmet 
Needs. Journal of Adolescent and Young Adult Oncology, 2(4), 153-160. 
Ruiz, F. (2010). A Review of Acceptance and Commitment Therapy (ACT) Empirical 
Evidence: Correlational, Experimental Psychopathology, Component and Outcome Studies. 
International Journal of Psychology and Psychological Therapy, 10, 125-162. 
Rutten, L. J. F., Arora, N. K., Bakos, A. D., Aziz, N., & Rowland, J. (2005). Information needs 
and sources of information among cancer patients: a systematic review of research (1980-
2003). Patient Education and Counselling, 57(3), 250-261.  
Rydahl-Hansen, S. (2005). Hospitalized patients experienced suffering in life with incurable 
cancer.  Scandinavian Journal of Caring Sciences, 19(3), 213-22. 
Sansom-Daly, U., Peate, M., Wakefield, C., Bryant, R. & Cohn, R. (2012) A systematic review 
of psychological interventions for adolescents and young adults living with chronic illness.  
Health Psychology, 31, 380-393.  
Sanson-Fisher, R., Girgis, A., Boyes, A., Bonevski, B., Burton, L., & Cook, P. (2000). The 
unmet supportive care needs of patients with cancer. Cancer, 88(1), 225-236.  
Sanson-Fisher, R.W., Bonevski, B., Green, L.W. & D'Este, C. (2007). Limitations of the 
randomized controlled trial in evaluating population-based health interventions. American 
Journal of Preventative Medicine, 33, 155-161. 
Sanson-Fisher, R.W. et al. (2010). Quality of life research: is there a difference in output 
between the major cancer types? European Journal of Cancer Care, 19, 714-720. 
Sanson-Fisher, R. et al (2012). Advancing the evidence in cancer: psychosocial multicentre 
trials.  Trials, 13, 171-179.   
Satin, J., Linden, W. & Phillips, M. (2009). Depression as a predictor of disease progression 
and mortality in cancer patients.  Cancer, 115, 5349-5361. 
Sayers, A. (2008). Tips and tricks in performing a systematic review. British Journal of 
General Practice, 58(547), 136-136.  
Schnipper, H. (2001). Life after breast cancer. Journal of Clinical Oncology, 19, 3581-3584. 
Schofield, P. et al (2003). Psychological responses of patients receiving a diagnosis of 
cancer. Annals of Oncology, 14(1), 48-56. 
Schofield, P. et al. (2008). Lung cancer: challenges and solutions for supportive care 
intervention research. Palliative and Supportive Care, 6, 281-287.  
Schofield, P. et al. (2012). Cancer Treatment Survey (CaTS): Development and validation of 
a new instrument to measure patients’ preparation for chemotherapy and radiotherapy. 
Psycho-Oncology, 21(3), 307-315.  
Schroder, K., Carey, M. & Vanable, P. (2003). Methodological challenges in research on 
sexual risk behaviour II: Accuracy of self-reports.  Annals of Behavioural Medicine, 26(2), 
104-123. 
Seale, C. (2001). Sporting cancer: struggle language in news reports of people with cancer.  
Sociology of Health and Illness, 23, 308-329. 
253 
 
Siu, M., Catton, P., Jones, J., and Jadad, J.R. (2013). A pilot study examining the unmet 
needs of cancer survivors living with polypathology.  Current Issues in Oncology, 20(3), 
e266-e269. 
Shaw, C. (1999). A framework for the study of coping, illness behaviour and outcomes.  
Journal of Advanced Nursing, 29(5), 1246-1255. 
Shea, B. et al (2007). Development of AMSTAR: a measurement tool to assess the 
methodological quality of systematic reviews. BMC medical research methodology, 7.  
Sheard, T  & Maguire, P. (1999). The effect of psychological intervention on anxiety and 
depression in cancer patients: results of two meta-analyses. British Journal of Cancer, 
80(11), 1770-1780. 
Sherman, R. et al (2005). Dialogue among survivors of hematopoietic cell transplantation: 
Support group themes. Journal of Psychosocial Oncology, 23(1), 1-24. 
Smith, J.A., Flowers, P. & Larkin, M. (2009) Interpretative phenomenological analysis: 
theory, method and research. Los Angeles: Sage. 
Smith, J.& Osborn, M. (2008) Interpretative phenomenological analysis. In JA Smith (Ed) 
Qualitative Psychology: A Practical Guide to Methods (second ed) London: Sage. 
Smith, J. A. (2004) Reflecting on the development of interpretative phenomenological 
analysis and its contribution to qualitative research in psychology. Qualitative Research in 
Psychology, 1, 39-54. 
Smith, M., Redd, W., Peyser, C. & Vogl, D. (1999). Post-traumatic stress disorder in cancer: 
A review. Psycho-oncology, 8(6), 521-537. 
Smith, V., Devane, D., Begley, C. M., & Clarke, M. (2011). Methodology in conducting a 
systematic review of systematic reviews of healthcare interventions. BMC medical research 
methodology, 11, 15-21. 
So, W. et al (2010). Anxiety, depression and quality of life among Chinese breast cancer 
patients during adjuvant therapy. European Journal of Oncology Nursing, 14(1), 17-22. 
Sollner, W. et al. (2001) How successful are oncologists in identifying patient distress, 
perceived social support, and need for psychosocial counselling? British Journal of Cancer, 
84(2), 179-185. 
Sontag S. (1978) Illness as Metaphor. Vintage Press, New York, USA. 
Soothill, K. et al (2004). Grouping cancer patients by psychosocial needs. Journal of 
Psychosocial Oncology, 22(2), 89-109. 
Soothill, K., et al (2003). The universal, situational, and personal needs of cancer patients 
and their main carers. European journal of oncology nursing, 7(1), 5-13. 
Soothill, K. et al (2001). The significant unmet needs of cancer patients: probing 
psychosocial concerns. Supportive Care in Cancer, 9(8), 597-605. 
Spiegel, D. & Giese-Davis, J. (2003). Depression and cancer: mechanisms and disease 
progression.  Mood Disorders and Medical Illness, 54, 269-282. 
Stanton, A.L., Leucken, L.J., MacKinnon, D.P. and Thompson, E.H. (2012).  Mechanisms in 
psychosocial interventions for adults living with cancer:  Opportunity for integration of 
254 
 
theory, research, and practice.  Journal of Consulting and Clinical Psychology, 81(2), 318-
335. 
Stanton, A. (2006). Psychosocial concerns and interventions for cancer survivors. Journal of 
Clinical Oncology, 24, 5132-5137. 
Stanton, A., Danoff-Burg, S. & Huggins, M. (2002). The first year after breast cancer 
diagnosis: hope and coping strategies as predictors of adjustment.  Psycho-oncology, 11, 
93-102. 
Stark, D. et al (2002). Anxiety disorders in cancer patients: Their nature, associations, and 
relation to quality of life. Journal of Clinical Oncology, 20(14), 3137-3148. 
Stark, D. & House, A. (2000).  Anxiety in cancer patients.  British Journal of Cancer, 83(10), 
1261-1271. 
Stewart, R., Caird, J., Oliver, K. & Oliver, S. (2011). Patients’ and clinicians’ research 
priorities.  Health Expectations, 14, 439-448. 
Stirling, A., Wilson, P. & McConnachie (2001). Deprivation, psychological distress, and 
consultation length in general practice.  British Journal of General Practice, 51, 456-460. 
Surbone, A. et al (2010). Psychosocial care for patients and their families is integral to 
supportive care in cancer: MASCC position statement.  Supportive Care in Cancer, 18, 255-
263. 
Swift, P. et al (2014). Living with anxiety: Understanding the role and impact of anxiety in 
our lives.  Available at: 
http://www.mentalhealth.org.uk/content/assets/PDF/publications/living-with-anxiety-
report.pdf?view=Standard Last accessed on 01/01/2015. 
Tamburini, M. et al (2000). Assessment of hospitalized cancer patients’ needs by the needs 
evaluation questionnaire. Annals of Oncology, 11, 31–37. 
Takahashi, M. et al (2007). Impact of breast cancer diagnosis and treatment on women’s 
sexuality: a survey of Japanese patients.  Psycho-oncology, 17(9),  901-907.   
Taylor, S. et al (1986). Social support, support groups, and the cancer patient. Journal of 
Consulting and Clinical Psychology, 54(5), 608-615. 
Taylor S.E. (1983) Adjustment to threatening events: a theory of cognitive adaptation. 
American Psychologist, 58, 1161–1173. 
Taylor-Ford, M. et al (2013). Body image predicts quality of life in men with prostate 
cancer.  Psycho-Oncology, 22, 756-761. 
Thomas, C. et al (2001). What are the psychosocial needs of cancer patients and their 
carers?  Available at: http://eprints.lancs.ac.uk/13787/1/Psychosocial_Needs_Report.pdf . 
Last accessed on 02/01/2015.   
Turner, J., Kelly, B., Swanson, C., Allison, R. & Wetzig, N. (2005). Psychosocial impact of 
newly diagnosed advanced breast cancer.  Psycho-Oncology, 14(5), 396-407.   
Uchida, M. et al (2011). Patients' supportive care needs and psychological distress in 
advanced breast cancer patients in Japan. Japanese Journal of Clinical Oncology, 41(4), 530-
536. 
255 
 
Ussher, J., Kirsten, L., Butow, P. & Sandoval, M. (2006). What do cancer support groups 
provide which other supportive relationships do not? The experience of peer support 
groups for people with cancer. Social Science & Medicine, 62(10), 2565-2576. 
Von Heymann-Horan, A. et al (2013). Unmet needs of women with breast cancer during 
and after primary treatment: A prospective study in Denmark.  Acta Oncologica, 52, 382-
390. 
Watson, E. et al (2012). Personalised cancer follow-up: risk stratification, needs assessment 
or both? British Journal of Cancer, 106(1), 1-5.  
Watson, M. & Bultz, B. (2010). Distress, the 6th vital sign in cancer care.  Psycho-Oncologie, 
4, 159-163. 
Watson, M. et al (1988). Development of a questionnaire measure of adjustment to cancer: 
the MAC scale.  Psychological Medicine, 18, 203-209. 
Weber, C. et al (2001). Body experience and mental representation of body image in 
patients with haematological malignancies and cancer as assessed with the Body Grid. 
British Journal of Medical Psychology, 74(4):507-21. 
Wen, K.-Y., & Gustafson, D. H. (2004). Needs assessment for cancer patients and their 
families. Health and quality of life outcomes, 2, 11.  
Wicksell, R., Melinn, L., Lekander, M. & Olsson, G. (2009). Evaluating the effectiveness of 
exposure and acceptance strategies to improve functioning and quality of life in 
longstanding pediatric pain – A randomized controlled trial. Pain, 141, 248-257.    
Wilczynski, N. L., Haynes, R. B., & Hedges, T. (2007). EMBASE search strategies achieved for 
retrieving methodologically high sensitivity and specificity sound systematic reviews. 
Journal of Clinical Epidemiology, 60(1), 29-33.  
Wright, B. & Forbes, K. (2014). Haematologists’ perceptions of palliative care and specialist 
palliative care referral: a qualitative study.  BMJ Supportive & Palliative Care, Online First: 
24 September 2014 doi:10.1136/bmjspcare-2014-000689. 
Wright, P. et al (2008). Measurement and interpretation of social distress using the social 
difficulties inventory (SDI). European Journal of Cancer, 44, 1529-1535. 
Young, N. et al (2012). Holistic Needs Assessment and Care Planning.  Available at: 
http://www.ncsi.org.uk/wp-content/uploads/HNA-and-CP-Sharing-Good-Practice.pdf.  Last 
accessed on 02/01/2015. 
Zabora, J. et al (2001). The prevalence of psychological distress by cancer site. Psycho-
Oncology, 10(1), 19–28. 
Zigmond, A.S. & Snaith, R.P. (1983). The Hospital Anxiety and Depression Scale. Acta 
Psychiatrica Scandinavica, 67, 361-370. 
Zittoun, R. et al (1999). Assessment of quality of life during intensive chemotherapy or 
bone marrow transplantation. Psycho-Oncology, 8(1), 64-73. 
 
 
 
256 
 
Appendices 
Appendix 1: Example data extraction form 
Data Extraction Form - 1 
Author: Andrykowski, MA, Cordova, MJ, Hann, DM, Jacobsen, PB, Fields, KK, Phillips, G. 
Year: 1999 
Country: USA 
Reference: Andrykowski, M.A. et al, (1999) Patients’ psychosocial concerns following stem 
cell transplantation. Bone Marrow Transplantation 24: 1121-1129.  
Source: Bone Marrow Transplantation (journal) 
Study objective: To determine the nature, frequency, correlates and temporal trajectory of 
concerns of stem cell transplant recipients. 
Sample description:  SCT recipients.  Mean age of 46, mean 17 months post SCT.  Mixed 
cancer sample.  61% female.   
Recruitment: Drawn from the roster of SCT recipients at either the Blood and Marrow 
Transplant Programme at the University of Kentucky or the Blood and Marrow Transplant 
Programme at the Moffitt Cancer Centre. 
Sample size: 110 
Inclusion and exclusion criteria: At least 18 years of age; have undergone either autologous 
or allogenic SCT for malignant disease; have no current evidence of malignant disease; be 
living outside of the hospital; have undergone SCT between 2 months and 6 years prior; 
read, write and understand English; provide written informed consent.  
Time period:  
Setting: Patients were recruited at hospital and then completed the questionnaire at home.  
Intervention (if applicable):  N/A questionnaire study 
Outcome measures used: Questionnaire – demographic information, SCT Concerns 
Questionnaire, WHO performance scale. 
Statistics:  SPSS – multiple regression analysis, one way ANOVA, chi-square 
Limitations: Not using a longitudinal design.  Lack of a comparison group.  Sample recruited 
from only 2 centres – diversity.  Females and breast cancer patients overrepresented in 
sample.  Severity of concerns not assessed, merely presence.   
257 
 
Implications: Identified common concerns in people post-SCT, has the potential to guide 
future interventions.   Identified clinical and demographic information that is linked to the 
likelihood that specific concerns will be reported.   
Author comments:  Talks about use for future interventions 
Reviewer comments: 
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Appendix 2: Example quality assessment form 
1. Question / objective sufficiently described? YES 
2. Study design evident and appropriate? YES 
3. Method of subject/comparison group selection or source of information/input 
variables described and appropriate? YES 
4. Subject (and comparison group, if applicable) characteristics sufficiently described? 
YES 
5. If interventional and random allocation was possible, was it described? N/A 
6. If interventional and blinding of investigators was possible, was it reported? N/A 
7. If interventional and blinding of subjects was possible, was it reported? N/A 
8. Outcome and (if applicable) exposure measure(s) well defined and robust to 
measurement / misclassification bias? means of assessment reported? YES 
9. Sample size appropriate? YES 
10. Analytic methods described/justified and appropriate? YES 
11. Some estimate of variance is reported for the main results? YES 
12. Controlled for confounding? YES 
13. Results reported in sufficient detail? YES 
14. Conclusions supported by the results? YES 
 
Score:  22/22 
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Appendix 3: Stage one of thematic analysis of existing needs assessment 
tools. 
Table to summise the first stage of the thematic analysis of existing needs assessment 
tools.  Table includes the name of the tool, each item included in the assessment and the 
area of need that each question corresponds with. 
Assessment Tool Item Theme 
   
PNAT (Patient Needs 
Assessment Tool) 
Mobility Mobility 
 Communication Communication 
 ADL's Physical Functioning 
 Bowel and Bladder Function Physical Functioning 
 Discomfort Pain / Discomfort 
 Alertness and mentation Cognitive Function 
 Prior psychological 
adjustment 
Coping 
 Depression Depression 
 Anxiety Anxiety 
 Attitude towards disease Coping 
 Attitude towards treatment Pessimism 
 Practical support Practical issues 
 Individual support network Support networks 
 Non-medical support 
network 
Support networks 
 Medical support network Availability of medical 
care 
 Financial security Financial 
   
NEST 1 Financial 
 2 Availability of medical 
care 
 3 Support networks 
 4 Practical issues 
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 5 Psychological wellbeing 
 6 Spiritual 
 7 Relationships 
 8 Benefit finding 
 9 Physical functioning 
 10 Depression / anxiety 
 11 Relationship with medical 
team 
 12 Communication 
 13 Communication 
   
PNPC (Problems and Needs in 
Palliative Care Questionnaire) 
ADL's and Instrumental Activities of Daily Living 
 1 Practical issues 
 2 Practical issues 
 3 Practical issues 
 4 Practical issues 
 5 Practical issues 
 6 Practical issues 
 7 Practical issues 
 Physical symptoms  
 1 Pain / discomfort 
 2 Cognitive functioning 
 3 Fatigue 
 4 Sleeping problems 
 5 Physical functioning 
 6 Physical functioning 
 7 Physical functioning 
 8 Physical functioning 
 9 Physical functioning 
 10 Physical functioning 
 11 Physical functioning 
 12 Physical functioning 
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 13 Appearance 
 14 Physical functioning 
 15 Sexual needs 
 16 Physical functioning 
 17 Physical functioning 
 18 Physical functioning 
 Role Activities  
 1 Identity 
 2 Psychological wellbeing 
 3 Employment 
 4 Practical issues 
 Financial and administrative 
issues 
 
 1 Financial 
 2 Financial 
 3 Practical issues 
 4 Practical issues 
 5 Practical issues 
 Social issues  
 1 Relationships 
 2 Support networks 
 3 Relationships 
 4 Relationships 
 5 Guilt 
 6 Perceptions of others 
 7 Disagreements 
 8 Support networks 
 9 Someone to talk to 
 10 Practical issues 
 11 Perceptions of others 
 12 Perceptions of others 
 13 Perceptions of others 
 14 Loneliness 
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 15 Loneliness 
 Psychological issues  
 1 Depression 
 2 Depression 
 3 Fear 
 4 Fear 
 5 Fear 
 6 Fear 
 7 Fear 
 8 Coping 
 9 Communication 
 10 Guilt 
 11 Shame 
 12 Emotional wellbeing 
 13 Appearance 
 14 Benefit finding 
 15 Coping 
 Spiritual issues  
 1 Identity 
 2 Relationships 
 3 Spiritual 
 4 Spiritual 
 5 Acceptance 
 Autonomy  
 1 Autonomy 
 2 Social 
 3 Autonomy 
 4 Autonomy 
 5 Autonomy 
 6 Autonomy 
 7 Autonomy 
 8 Autonomy 
 9 Autonomy 
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 Information Needs  
 1 Information 
 2 Information 
 3 Information 
 4 Information 
 5 Information 
 6 Information 
 7 Information 
 8 Information 
 9 Information 
 Problems in consultations  
 1 Communication 
 2 Communication 
 3 Communication 
 Overriding problems in 
quality of care 
 
 1 Medical care 
 2 Medical care 
 3 Medical care 
 4 Medical care 
 5 Medical care 
 6 Medical care 
 7 Medical care 
 8 Medical care 
 9 Medical care 
 Concerning the GP  
 1 Medical care 
 2 Medical care 
 3 Medical care 
 4 Medical care 
 5 Medical care 
 6 Medical care 
 7 Medical care 
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 8 Medical care 
 9 Medical care 
 10 Medical care 
 11 Medical care 
 12 Medical care 
 13 Medical care 
 14 Medical care 
 15 Medical care 
 16 Medical care 
 17 Medical care 
 18 Medical care 
 19 Medical care 
 20 Medical care 
 Concerning the specialist  
 1 Information 
 2 Medical care 
 3 Medical care 
 4 Medical care 
 5 Medical care 
 6 Medical care 
 7 Medical care 
 8 Medical care 
 9 Medical care 
 10 Medical care 
 11 Medical care 
 12 Medical care 
 13 Medical care 
 14 Medical care 
 15 Medical care 
 16 Medical care 
 17 Medical care 
 18 Medical care 
 19 Medical care 
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NEQ (Needs Evaluation 
Questionnaire) 
1 Information 
 2 Information 
 3 Information 
 4 Information 
 5 Involvement in care 
 6 Information 
 7 Relationship with medical 
team 
 8 Communication 
 9 Pain / discomfort 
 10 Practical issues 
 11 Respect as an individual 
 12 Medical care 
 13 Medical care 
 14 Medical care 
 15 Financial  
 16 Financial  
 17 Psychological wellbeing 
 18 Spiritual 
 19 Peer support 
 20 Support networks 
 21 Identity 
 22 Support networks 
 23 Perceptions of others 
   
SCNS-LF59 1 Pain / discomfort 
 2 Fatigue 
 3 Physical functioning 
 4 Physical functioning 
 5 Sleeping problems 
 6 Practical issues 
 7 Independence 
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 8 Independence 
 9 Spiritual 
 10 Psychological wellbeing 
 11 Anxiety 
 12 Depression 
 13 Depression 
 14 Disease fears 
 15 Disease fears 
 16 Disease fears 
 17 Treatment worries 
 18 Disease fears 
 19 Acceptance 
 20 Treatment worries 
 21 Uncertainty 
 22 Control of own illness 
 23 Making the most of life 
 24 Keeping positive 
 25 Spiritual 
 26 Spiritual 
 27 Changes to lifestyle 
 28 Peer support 
 29 Perceptions of others 
 30 Sexual needs 
 31 Sexual needs 
 32 Concerns about others 
 33 Concerns about others 
 34 Financial 
 35 Practical issues 
 36 Medical care 
 37 Support networks 
 38 Respect as an individual 
 39 Involvement in care 
 40 Involvement in care 
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 41 Respect as an individual 
 42 Medical care 
 43 Respect as an individual 
 44 Relationship with medical 
team 
 45 Peer support 
 46 Information 
 47 Information 
 48 Information 
 49 Information 
 50 Communication 
 51 Communication 
 52 Information 
 53 Information 
 54 Psychological support 
 55 Information 
 56 Respect as an individual 
 57 Environment 
 58 Involvement in care 
 59 Having a key worker 
   
NAT 1 Spiritual 
 2 Financial 
 3 Practical issues 
 4 Social factors 
 5 Psychological wellbeing 
 6 Physical functioning 
 7 Information 
 8 Caregiver wellbeing 
 9 Caregiver wellbeing 
 10 Caregiver wellbeing 
 11 Caregiver wellbeing 
 12 Caregiver wellbeing 
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 13 Caregiver wellbeing 
 14 Caregiver wellbeing 
 15 Caregiver wellbeing 
   
CARES (Cancer Rehabilitation 
Evaluation System) 
1 Physical functioning 
 2 Physical functioning 
 3 Physical functioning 
 4 Physical functioning 
 5 Practical issues 
 6 Practical issues 
 7 Practical issues 
 8 Practical issues 
 9 Social roles 
 10 Social roles 
 11 Social roles 
 12 Activities 
 13 Physical functioning 
 14 Physical functioning 
 15 Eating 
 16 Eating 
 17 Eating 
 18 Employment 
 19 Employment 
 20 Pain / discomfort 
 21 Pain / discomfort 
 22 Pain / discomfort 
 23 Pain / discomfort 
 24 Appearance 
 25 Appearance 
 26 Appearance 
 27 Information 
 28 Involved in care 
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 29 Involved in care 
 30 Communication 
 31 Communication 
 32 Communication 
 33 Communication 
 34 Communication 
 35 Communication 
 36 Involved in care 
 37 Involved in care 
 38 Appearance 
 39 Appearance 
 40 Body Image 
 41 Anxiety 
 42 Depression 
 43 Anger 
 44 Psychological wellbeing 
 45 Coping 
 46 Sleeping problems 
 47 Cognitive functioning 
 48 Cognitive functioning 
 49 Cognitive functioning 
 50 Relationships with friends 
and family 
 51 Relationships with friends 
and family 
 52 Relationships with friends 
and family 
 53 Relationships with friends 
and family 
 54 Relationships with friends 
and family 
 55 Relationships with friends 
and family 
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 56 Relationships with friends 
and family 
 57 Relationships with friends 
and family 
 58 Relationships with friends 
and family 
 59 Relationships with friends 
and family 
 60 Support networks 
 61 Support networks 
 62 Relationships with friends 
and family 
 63 Relationships with friends 
and family 
 64 Anxiety around treatment 
 65 Anxiety around treatment 
 66 Anxiety around treatment 
 67 Anxiety around treatment 
 68 Anxiety around treatment 
 69 Anxiety around treatment 
 70 Anxiety around treatment 
 71 Disease fears 
 72 Worries about the future 
 73 Worries about the future 
 74 Sexual needs 
 75 Sexual needs 
 76 Sexual needs 
 77 Sexual needs 
 78 Medical care 
 79 Medical care 
 80 Medical care 
 81 Medical care 
 82 Financial  
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 83 Financial  
 84 Practical issues 
 85 Appearance 
 86 Anxiety around treatment 
 87 Physical functioning 
 88 Physical functioning 
 89 Childcare 
 90 Concerns about children 
 91 Concerns about children 
 92 Employment 
 93 Employment 
 94 Employment 
 95 Employment 
 96 Employment 
 97 Employment 
 98 Employment 
 99 Sexual needs 
 100 Sexual needs 
 101 Sexual needs 
 102 Sexual needs 
 103 Relationship 
 104 Relationship 
 105 Relationship 
 106 Relationship 
 107 Relationship 
 108 Relationship 
 109 Relationship 
 110 Relationship 
 111 Relationship 
 112 Relationship 
 113 Relationship 
 114 Relationship 
 115 Relationship 
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 116 Relationship 
 117 Relationship 
 118 Relationship 
 119 Relationship 
 120 Relationship 
 121 Relationship 
 122 Relationship 
 123 Relationship 
 124 Relationship 
 125 Relationship 
 126 Problems with 
treatments 
 127 Problems with 
treatments 
 128 Problems with 
treatments 
 129 Problems with 
treatments 
 130 Problems with 
treatments 
 131 Problems with 
treatments 
 132 Problems with 
treatments 
 133 Problems with 
treatments 
 134 Problems with 
treatments 
 135 Problems with 
treatments 
 136 Problems with 
treatments 
 137 Problems with 
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treatments 
 138 Problems with 
treatments 
 139 Problems with 
treatments 
   
ISNQ (Information and 
Support Needs Questionnaire) 
1 Information 
 2 Information 
 3 Information 
 4 Information 
 5 Information 
 6 Regular appointments 
 7 Information 
 8 Information 
 9 Information 
 10 Information 
 11 Information 
 12 Communication 
 13 Support to be 
independent 
 14 Support to be 
independent 
 15 Knowledgeable 
professionals 
 16 Information 
 17 Communication 
 18 Information 
 19 Support with family 
issues 
 20 Information 
 21 Information 
 22 Information 
 23 Information 
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 24 Support 
 25 Information 
 26 Information 
 27 Support 
 28 Someone to talk to 
 29 Peer support 
   
PNI (Patient Needs Inventory) 1 Health professional 
 2 Health professional 
 3 Health professional 
 4 Communication 
 5 Respect as an individual 
 6 Communication 
 7 Communication 
 8 Health professional 
 9 Involvement in care 
 10 Information 
 11 Information 
 12 Information 
 13 Information 
 14 Information 
 15 Support network 
 16 Support network 
 17 Support network 
 18 Someone to talk to 
 19 Support network 
 20 Childcare 
 21 Spiritual 
 22 Emotional wellbeing 
 23 Uncertainty 
 24 Spiritual 
 25 Spiritual 
 26 Psychological wellbeing 
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 27 Concerns about others 
 28 Spiritual 
 29 Peer support 
 30 Loneliness 
 31 Religious 
 32 Anger 
 33 Spiritual 
 34 Guilt 
 35 Sexual needs 
 36 Independence 
 37 Maintaining control 
 38 Appearance 
 39 Perceptions of others 
 40 Identity 
 41 Psychological support 
 42 Practical issues 
 43 Fatigue 
 44 Eating 
 45 Practical issues 
 46 Practical issues 
 47 Financial 
 48 Practical issues 
   
OCPC (Oncology Clinic Patient Checklist) Information 
  Fatigue 
  Pain 
  Physical - eating related 
  Physical - communication 
  Breathing 
  Physical - toileting related 
  Transportation 
  ADLs 
  Practical assistance at 
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home 
  Medical supplies 
  Employment 
  Social activities 
  Psychological 
  Concerns about family 
  Relationships 
  Treatment side effects 
   
SPARC 1 Someone to talk to 
 2 Pain 
 3 Memory 
 4 Symptoms 
 5 Symptoms 
 6 Breathings 
 7 Symptoms 
 8 Symptoms 
 9 Symptoms 
 10 Symptoms 
 11 Toileting 
 12 Toileting 
 13 Symptoms 
 14 Symptoms 
 15 Sleeping 
 16 Sleeping 
 17 Appetite 
 18 Weight 
 19 Symptoms 
 20 Appearance 
 21 Symptoms 
 22 Control over symptoms 
 23 Anxiety 
 24 Low mood 
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 25 Confusion 
 26 Concentration 
 27 Loneliness 
 28 Depression  
 29 Depression  
 30 Depression  
 31 Sexual 
 32 Worries about death 
 33 Religious needs 
 34 Independence 
 35 ADLs 
 36 Household tasks 
 37 Feeling alone 
 38 Concerns about family 
 39 Support from family 
 40 Amount of help needed 
 41 Treatment 
 42 Treatment 
 43 Personal affairs 
 44 Someone to talk to 
 45 Information 
   
CaSUN   
 1 Information 
 2 Information for others 
 3 Understandable 
information 
 4 High quality medical care 
 5 Accessible health care 
 6 To feel involved 
 7 Staff communication 
 8 Medical accountability 
 9 Access to alternative 
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therapies 
 10 Stress 
 11 Treatment complications 
 12 Adjustment 
 13 Fertility 
 14 Employment 
 15 Financial 
support/benefits 
 16 Insurance 
 17 Legal services 
 18 Parking 
 19 Fear of recurrence 
 20 Emotional support 
 21 Supporting others 
 22 Impact on others 
 23 New relationships 
 24 Peer support 
 25 Talking about cancer 
 26 Body image 
 27 Sexual 
 28 Key worker 
 29 Moving on 
 30 Changes in beliefs 
 31 Perceptions of others 
 32 Expectations of others 
 33 Making decisions despite 
uncertainty 
 34 Spiritual beliefs 
 35 Making life count 
 36 N/A 
 37 N/A 
 38 N/A 
 39 N/A 
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 40 N/A 
 41 N/A 
 42 N/A 
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Appendix 4: Stage two of thematic analysis of existing needs assessment 
tools. 
All items to emerge from the thematic analysis of existing needs assessment tools. 
All Items 
 
Mobility 
Communication 
Physical functioning 
Pain / discomfort 
Cognitive function 
Coping 
Depression 
Anxiety 
Pessimism 
Practical issues 
Support networks 
Availability of medical care 
Financial 
Spiritual 
Benefit finding 
Psychological wellbeing 
Relationships 
Relationship with medical team 
Fatigue 
Sleeping problems 
Appearance 
Sexual needs 
Identity 
Employment 
Someone to talk to 
Disagreements 
Perceptions of others 
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Loneliness 
Fears 
Guilt 
Shame 
Emotional wellbeing 
Acceptance 
Autonomy 
Social 
Information 
Medical care 
Involvement in care 
Respect as an individual 
Peer support 
Independence 
Disease fears 
Treatment worries 
Uncertainty 
Control over own illness 
Making the most of life 
Keeping positive 
Changes to lifestyle 
Concerns about others 
Psychological support 
Environment 
Having a key worker 
Social factors 
Caregiver wellbeing 
Social roles 
Activities 
Eating 
Body image 
Anger 
Relationships with friends and family 
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Anxiety around treatment 
Worries about the future 
Childcare 
Concerns about children 
Relationship 
Problems with treatments 
Regular appointments 
Support to be independent 
Support with family issues 
Health professional 
Maintaining control 
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Appendix 5: Tabulated items from thematic analysis of needs assessment 
tools. 
Items from thematic analysis of needs assessment tools grouped into needs domains as 
presented to participants of the focus group. 
Physical 
Mobility 
Pain 
Discomfort 
Fatigue 
Sleeping problems 
Eating related 
Drinking related 
Ability to do the 
things I used to do 
Breathing 
Bathroom related 
Washing and 
dressing 
Weight 
 
Psychological 
Coping 
Depression 
Anxiety 
Feeling upset 
Keeping positive 
Wellbeing 
Someone to talk 
to 
Support from 
professionals 
Peer support 
Loneliness 
Negative emotions 
Adjusting to my 
diagnosis 
Stress 
Fear of recurrence 
Changes in my 
beliefs 
Uncertainty 
Anger 
Moving on 
 
 
 
Identity  
Body image 
Independence 
Respect as an 
individual 
Maintaining a 
sense of control 
  
Social 
Support networks 
Relationship with 
partner 
Relationship with 
family 
Relationship with 
friends 
Children 
Forming new 
relationships 
Perceptions of other 
Expectations of others 
Feeling different 
 
Practical Issues 
Childcare 
Transport 
Household tasks 
Parking 
Insurance 
Personal affairs 
 
Medical/Health 
Professional 
Availability of 
medical care 
Relationship with 
medical team 
Quality of medical 
care 
Worries about 
illness 
Worries about 
treatment 
Having a key 
worker 
Environment 
Involvement in 
care 
Sexual 
Sexual Needs 
Fertility 
Information 
Receiving 
understandable 
information 
Information for others 
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Availability of 
medical supplies 
Access to 
alternative 
therapies 
Treatment side 
effects 
 
 
 
Communication 
Bringing up the topic 
of cancer 
Communicating with 
medical staff 
 
 
 
Cognitive Function 
Memory 
Concentration 
Understanding 
 
Financial 
Financial support 
 
Spiritual 
Acceptance 
Worries about the 
future 
Religious beliefs 
 
Employment 
Gaining employment 
Maintaining 
employment 
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Appendix 6: Key areas of need for each participant. 
Each participant was asked to highlight the individual needs from the list as presented in 
Appendix 3 that had been most important to them during their experience.   
David William James 
Keeping positive Fatigue Fatigue 
Expectation of recurrence Weight Eating related 
Support networks Coping  Receiving 
understandable 
information 
Expectations of others Keeping positive Information for others 
Insurance Parking Financial support 
Having a key worker Having a key worker  
Receiving understandable information Treatment side effects  
Bringing up the topic of cancer Receiving 
understandable 
information 
 
Acceptance Financial support   
   
   
Mark Ray Daphne 
Discomfort Sleeping problems Pain 
Eating related Fatigue Fatigue 
Washing and dressing Mobility Sleeping problems 
Weight loss Eye sight Eating related 
Anxiety Hearing Keeping positive 
Keeping positive Parking Support from 
professionals 
Adjusting to my diagnosis Having a key worker Adjusting to my 
diagnosis 
Fear of recurrence Information needs to 
be available 
Fear of recurrence 
Body image (appearance and outward 
manifestation of disease) 
Information about side 
effects 
Body image 
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Relationship with partner Peer support Relationship with 
partner 
Parking Unable to work Having a key worker 
Availability of medical care Anxiety and depression 
after remission 
Relationship with 
medical team 
Relationship with medical team Memory Access to alternative 
therapies 
Quality of medical care Concentration Bringing up the topic of 
cancer 
Worries about illness Help dealing with DWP Peer support 
Treatment side effects Being positive Concentration 
Receiving understandable information   
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Appendix 7: Quotations from each participant corresponding with areas of need from which the final analysis structure was 
developed. 
 
    David William James Mark Ray Daphne 
Theme Sub-themes       
Care Treatment I wasn't very happy 
with the treatment I 
was getting there 
P1; “you expect the 
treatment to make 
you feel ill.  That’s 
what I found, when I 
started it, I expected 
to feel bad” P1 
"I was in a week 
later, for an 
operation, and, 
erm, which was 
quite an 
interesting 
experience" P2 
"you’re 
struggling 
against this 
nasty little 
disease and 
very nasty 
treatment" P3 
"When you’re in 
it and the 
treatment is 
there and you 
think, right, 
from here we’re 
going to have 
chemo next, 
we’re going to 
have this next, 
we’ll have 
reconstructive 
"Treatment side-
effects, I think 
it's absolutely 
vital on that list." 
P5;  
“the side 
effects of the 
treatment.  You 
need more 
help.” P6; "is 
that what we're 
supposed to 
expect after?" 
P6 
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stuff" P4 
  Diagnosis  "basically I sat in 
front of him and he 
said 'you've got 
cancer'" P1; "he said, 
what you got is 
probably incurable, 
and you need to see 
a specialist.  And 
then, off you go.  
So." P1 
“I think he knew 
what was the 
matter, but he 
didn’t say 
anything to me, 
he fast-tracked 
me to the 
hospital” P2 
“when they do 
tell you it’s 
cancer… it 
knocks the 
wind out of 
your sails” P3 
that's the most 
stressful part of 
it all I reckon P4 
the diagnosis 
process was 
rather fraught P5 
“it was a hell of 
a relief to know 
there was 
something 
wrong, rather 
than me 
thinking it 
was…” P6 
Psychological Psychological “it’s always in the 
back of your mind, it 
never leaves you” P1 
. “I think the 
anxiety there 
is, um, 
probably you 
get a bit 
anxious about 
knowing 
everything 
that’s going 
“they’re the 
ones which I felt 
most strongly 
and they’re the 
ones which I 
didn’t get any 
help with” P4 
And I was in one 
hell of a state.  
Mentally.  And, I 
still am. P5 
"I think you 
cover a lot up" 
P6 
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on, erm, and is 
it going to… is 
it going to 
work” P3 
  Emotional "on my first 
birthday, I was 
driving down, and 
tears were 
streaming down" P1 
“Being positive, 
and not let it get 
you down at all. 
Trust, and be 
positive” P2 
. "I think the 
emotional bit 
comes right at 
the end" P4 
 "one very 
tearful evening 
where I thought 
this could 
possibly be my 
last Christmas" 
P5;  
"I was so angry, 
and I mean 
angry." P6 
  Guilt         “I think there’s a 
certain amount 
of guilt there 
yes” P5 
. 
  Coping instead of feeling 
sorry for myself I'd 
write about the 
previous day P1 
I do some charity 
work with the 
cancer and 
lymphoma local 
group P2 
. But... I couldn't 
get into that big 
emotional 
feeling P4 
I'm not a 
religious person 
but, erm, putting 
words... 
together... I 
. 
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found helped, 
helped me cope 
P5 
  FoR you have to get into 
a position mentally 
where you accept 
the recurrence, 
rather than fear it P1 
. “And I suppose 
you do things 
like, if you 
notice a little 
mole on the 
back of your 
hand, it can be 
a problem” P3 
. you get the little 
aches and pains.  
They usually 
start as I was 
saying about a 
fortnight before 
my next check 
up P5 
“worries for the 
future, I can’t 
say that’s not 
a… you don’t 
want, you 
never want to 
face the facts 
do you” P6 
  End of 
treatment 
      "you kind of get 
fired off at the 
end" P4 
“My problems 
arose after I’d 
finished the 
chemo. And, I 
just finished.  I 
had nothing 
left.” P5 
. 
  Hope/positivity    “keeping 
positive.  I think 
you need 
people around 
"certain cancers 
have been 
my attitude right 
the way through 
. 
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that’s one of the 
most important 
things.” P2 
you that, even 
if they don't 
think it, they 
need to show 
it that they've 
got a positive 
attitude P3; 
successfully 
treated haven't 
they? For a long 
time!" P4 
was that I was 
going to beat it 
P5 
Social Relationships   "Support 
networks don't 
mean very much 
to me I'm afraid" 
P2 
"A few people 
that, erm, 
where you 
thought you 
were closer to, 
as you say, 
they sort of, 
backed off a 
bit.  But others 
were very 
supportive." 
P3 
“Certain close 
friends find it 
very difficult 
and they back 
off” P4 
I couldn't speak 
to him because 
of the way I was, 
within myself P5 
I didn't want to 
make contact 
cos I just 
couldn't cope 
cos I was up to 
here P6 
Support   After that initial “I don’t actually . . . “I even went to 
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diagnosis, I had to go 
and make my own 
follow up P1 
agree with you 
about support 
groups you see, 
because, I’ve 
been to one and 
found it to be 
one of the most 
depressing 
experiences of 
my life” P2 
Boots chemist 
for some help 
one Saturday 
morning, cos I 
was desperate” 
P6 
  Contact with 
hospital 
“I was coming in 
here every three 
weeks or every 
couple of months.  
And that was really 
helpful because 
you’re constantly 
seeing the same 
people, who are 
experts in their field 
. . “And then you 
get fired off at 
the end.  You’re 
at home aren’t 
you?” P4 
“it’s needing to 
know there is 
somebody” P5 
. 
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all the time” P1 
  Psychological we do perhaps need 
to have a separate 
clinic, not necessarily 
in here but 
somewhere else in 
the hospital or 
somewhere else 
where you can come 
and talk to us about 
it P1 
I honestly can't 
see how it would 
help me in the 
slightest.  It 
would just be a 
waste of my time 
P2 
“they don’t 
really 
advertise it to 
you much” P3 
“I’d rather have 
somebody 
prescribe 
something than 
deep, psycho, 
self analysis” P4 
“I don’t think the 
support is there” 
P5 
. 
  Reassurance  both of them 
independently said, 
if you're going to get 
cancer, get this one 
P1 
. . .     
  For family She was pretty upset 
about it P1 
.  "the family 
suffer worse" 
P3 
.     
Practical   this is where you “You do need you could help “They do go to “dealing with if only they had 
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need... someone like 
Macmillan to help 
you P1 
someone who 
knows the system 
to help you” P2 
at home but 
just... didn't 
feel like it.  
Just didn't 
seem to 
have... the 
energy P3 
quite a lot of 
effort don’t they 
to find out who 
you live with, 
who’s there, 
what your 
properties like” 
P4 
those sorts of 
people (DWP) 
was difficult and, 
erm, it would 
have been very 
difficult to get 
anything in 
writing from 
anyone here I 
feel” P5 
a little side 
room for the 
days that you, 
for the days 
that people are 
really sick P6 
Information Delivery   “he went through 
it all and 
explained it all to 
me and what was 
going to happen” 
P2 
words of one 
syllable… and 
plain, simple 
English P3 
. that's fine with 
me, you know 
that's the way I 
want the 
information P5 
. 
  Personalised they also give you 
the five to ten year 
prognosis, which is, 
not very helpful 
there has got to 
be a happy 
medium P2 
. when you first 
start you get all 
these generic 
leaflets on you 
“relevant to your 
diagnosis, that’s 
very important” 
P5 
. 
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when you're forty-
something P1 
know, how do 
you get a wig, I 
don't need a 
wig, what's 
going to happen 
if, what's the 
likely side 
effect. P4 
  Availability   I find it very 
difficult to 
understand the 
system in all 
honesty P2 
 “there was 
nothing that 
the doctor 
could say, this 
is what you’ve 
got, right now 
this will 
explain 
everything” P3 
"I think you get 
as much 
information as 
you, as you ask 
for" P4 
. yes it's a 
guideline really 
and having... a 
criteria to... 
what you, what 
you should put 
up with P6 
Haematology Other's 
understanding 
“when I say to 
people I’ve got 
lymphoma, they say, 
. . “they think 
cancer’s cancer, 
and it isn’t is 
. “My GP again, 
gave me 
tramadol which 
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what’s that then?” 
P1 
it?” P4 I couldn’t take, 
and he said he 
couldn’t 
prescribe 
anything else 
without a lot 
of, without a 
lot of research 
on what I’d 
already got” P6 
  Differences “I’m in remission 
and, you know, hope 
to be so for as long 
as possible but, 
there’s no outward 
signs.  Now, if you’ve 
had aggressive 
breast cancer and, 
for instance, you’ve 
had a mastectomy… 
. . . . “if you’d had 
breast cancer it 
would have 
been fine” P6; 
“but once, with 
breast cancer, 
once they take 
it away it 
makes a big 
difference” P6 
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and your body image 
changes.  Whereas 
here there isn’t 
much to take away, 
it’s all, it’s more 
medicine as opposed 
to surgery and it’s 
more like diabetes 
that’s controlled” P1 
  Support 
available 
        I think to have 
someone like 
that on the ward 
(support nurse), 
who is not 
dealing with 
chemotherapy 
and all the rest 
of it P5 
“Now if you’ve 
got cancer, the 
Macmillan 
nurses are 
superb” P6 
Medical Communicatio
n 
    “even though 
they kept 
“Liverpool knew 
exactly what the 
. “I said I’m not 
having any 
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explaining 
things… they 
use big words 
and names of 
stuff.  If it was 
written down 
you’d probably 
be able to take 
it in easier” P3 
people had 
done here, 
people here 
knew what 
Liverpool had 
done” P4 
more, I’ve only 
come to see Dr 
Lee.  Anyway, 
next thing he 
comes and says 
you’ve got 
another six” P6 
  Cognition         memory's gone, 
concentration's 
a problem P5 
I can't 
concentrate 
long enough, 
which after 50 
years is a bit 
difficult P6 
  Interactions 
with HCPs 
the butcher of the 
(location) P1 
. “I think I just 
got me 
knickers in a 
right twist 
because they 
they have a 
different 
bedside manner 
don't they? P4 
it's the 
determination of 
the staff, I felt 
that they were 
going about 
it was done 
jokingly but 
inside you're 
god how much 
longer? P6 
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kept, oh, oh 
this is 
wrong…” P3 
things in such a 
way that just 
added to my 
own 
determination 
P5 
  Key worker your key worker 
thing, but that was 
very interesting and 
very important P1 
Seeing the same 
person every 
time so you don't 
have to explain 
everything else to 
them again P2 
. . . “I just feel if 
only I had 
somebody like 
Laura, like Dee, 
somebody who 
would go 
through things 
with you… 
when you’re 
desperate.  
That’s what 
we’re short of.”  
P6 
  Staff know what they're “I think the staff you're not “Absolutely the staff here I can't speak 
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doing, the staff here 
do it all day every 
day P1 
there were 
fantastic” P2 
anything 
special but it is 
a nasty thing 
to have and 
they used to, 
really, put you 
at your ease 
actually P3 
brilliant.  Really 
high emotional 
intelligence” P4 
have been 
absolutely 
phenomenal P5 
highly enough 
of them P6 
Physical   “as you get older the 
physical needs and 
issues change 
regardless of how 
well you are” P1 
“I was aware that 
I was very tired at 
the time, and 
since then it’s not 
really made much 
difference to me” 
P2 
“putting it 
straight 
forward, I felt 
absolutely 
knackered” P3 
“that’s the main 
need, trying to 
keep yourself 
strong enough 
when you’ve 
really had no 
appetite” P4 
Yes, the, the 
exhaustion does 
continue.  I find 
that I can't do 
what I used to. 
P5 
it's the fatigue, 
it's doing things 
P6 
Cancer Uniqueness “I don’t know if 
people who haven’t 
experienced that can 
quite understand” 
P1 
. . . . I think, you 
don't know 
how hard it is 
P6 
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  Perceptions people don't expect 
you to die anymore 
P1 
I don't know 
what people 
expect of you 
when you're ill, 
I'm not one to be 
going around 
moping and 
groaning P2 
“a lot of 
people think 
as soon as 
you’ve 
mentioned 
cancer, they 
think god, 
we’ll be 
burying him 
soon” P3 
“everyone talks 
about, again, 
you know, the 
media, 
fighting… 
battling cancer, 
fighting cancer, 
so and so’s 
beaten cancer 
four times.  
Well, I… I don’t 
know what that 
means really.” 
P4 
.   
  Giving 
something 
back 
I go along to show 
people that it's not 
just people in their 
70s that suffer from 
this P1 
. . I did this whole 
school assembly 
once, I just said 
to all the kids, 
look... I woke up 
one morning 
. Certainly if I 
could go and... 
give support, I 
would do. P6 
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and had a lump 
the size of an 
orange on my 
shoulder P4 
Identity Appearance     “I think it’s 
worse for a 
woman than it 
is for a fella” 
P3 
“That was the 
biggest thing I 
was worried 
about, body 
image” P4 
. “I just felt a 
freak” P6 
  Sense of self I think, sometimes, if 
you've had cancer, 
people see you as a 
cancer sufferer, or a 
recovering cancer 
sufferer, rather than 
as John or Fred or 
Mary P1 
“you get into 
that… cancer… 
sufferer” P2 
. even at the time 
I was pretty 
touchy about it 
P4 
“I had the fishing 
but that didn’t 
matter, just 
looking at the 
world going past 
and realising 
that, yeah I am 
still part of it” P5 
. 
  Respect “I think sometimes, 
if you’ve had cancer, 
people see you as a 
. “I always felt 
that I was 
being treated 
“you get treated 
differently 
though” P4 
“I found the 
respect as an 
individual rather 
. 
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cancer sufferer, or a 
recovering cancer 
sufferer, rather than 
as John or Fred” P1 
with the 
greatest 
respect on the 
ward” P3 
difficult” P5 
Work   “I think, gaining 
employment, after 
diagnosis… is 
something that is 
potentially more 
difficult” P1 
“It depends who 
you work for” P2 
"Erm (pause) 
special work 
colleagues I’ve 
got, I had a 
litre bottle of 
single malt 
whisky to open 
at the end of 5 
years (all 
laugh), I’ll 
keep that for 
then" P3 
"I was just 
thinking, right, 
I’m gonna be off 
work now, for 6 
months on full 
pay, 6 months 
on half pay and 
just dealt with 
all of the 
practical things" 
P4 
“A fear of 
returning to 
work” P5 
. 
Barriers to 
support 
Feel unable to 
ask for help 
  “When you’re not 
used to doing 
that, and perhaps 
not comfortable 
. “I think the 
support is there 
if you, you want 
it.  You just ask.  
if I had a 
problem, there 
was no way I 
could let them 
“They say you 
can ring the 
ward but you 
don’t want to 
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with doing that” 
P2 
But I think 
sometimes, do 
you not think 
people are 
afraid to ask? In 
case, because 
everyone’s 
busy, I think 
some people get 
it in their head, 
oh I can’t, I’d 
better not ask in 
case they’re 
busy” P4 
know P5 ring the ward 
because you’ve 
got bad arms” 
P6 
  Clinics too busy “I don’t know if 
you’ve been to clinic 
here recently, 
there’s a hundred 
people out there” P1 
I kept saying that 
I, I'm sorry, I 
don't like 
troubling you P2 
. . I don't think the 
support is there.  
And the reason 
for that again is 
down to time. P5 
“That’s the 
problem, to 
realise just how 
busy they are” 
P6 
  Psychosocial  "he said, because . . “I was just this front that  "But I was 
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not discussed we can only give you 
a short amount of 
time because there's 
so many people who 
need to be seen 
through this clinic, 
we haven't touched 
on the psychological 
apsects of what 
we're doing" P1 
sitting there 
listening, 
reading my 
paper, being as 
jolly as possible 
when someone 
came round so, 
maybe they 
thought, well 
this is a guy who 
doesn’t seem to 
be presenting as 
anything” P4 
you put up... 
they don't know 
how to get 
through P5 
reluctant 
because... 
pride.  Erm, but 
yes I think you 
cover a lot up." 
P6 
  Physical more 
important 
        “I was so 
grateful and so 
lucky that in my 
first session of 
chemo all I got…  
And to see other 
people there… 
. 
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how can I be 
dragging nurses 
away from them 
to deal with the 
way I was 
thinking about 
things, not 
feeling, but 
thinking about 
things?  It just 
didn’t come into 
the equation.” 
P5 
  Not important 
enough 
        “his time is far 
too valuable to 
be doing that.  
So, again, you 
tend not to talk 
through the 
problems you 
. 
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have with him.” 
P5 
Understandin
g experiences 
Comparisons 
with others 
I went along to my 
first support group 
at the Lymphoma 
Association and 
there's a lady there 
who was diagnosed 
wih NHL 18 years 
ago P1 
I've been very 
fortunate in my 
life, I've hardly 
ever been ill, so, I 
accepted that it 
was my turn, if 
you like, to be ill 
P2 
I think I was 
very lucky P3 
. to see him 
deteriorate over 
the next three 
months and 
die... err, was 
horrendous P5 
people don't 
seem to get a 
lot of pain 
but... erm, pain 
in your arms I 
found was 
dreadful P6 
Control Taking control that's when I 
referred myself to 
(Dr), because they 
couldn't find me a 
haematologist within 
about, two months, 
which I didn't think 
was good enough P1 
“I went for a 
number two (hair 
cut), because I 
thought I’m not 
going to go 
around looking 
like tufty” P2 
you've just got 
to get on with 
it P3 
the doctors will 
go in and sort it 
out, that was 
my attitude P4 
took on the what 
will be will be 
type attitude 
and put all my 
faith in the 
people here P5 
"Mind over 
matter" P6 
  Feeling in 
control as 
I've done all this, 
there's stacks of 
But you also 
know what it is 
you get a bit 
anxious about 
I did feel as if 
we knew exactly 
If it's... cancer... 
so what? I know 
if you knew, 
you can deal 
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coping mech paper in my office at 
home P1 
P2 knowing 
everything 
that's going on 
P3 
where we were 
and what the 
next step was, 
and broadly 
what the 
significance of 
every part of 
the intervention 
was really P4 
where I am. P5 with it can't 
you P6 
Environment   “we do need to 
perhaps have a 
separate clinic, not 
necessarily in here 
but somewhere else 
in the hospital or 
somewhere else 
where you can come 
and talk to us about 
it” P1 
“I really didn’t 
want to go back 
there, it 
depressed me no 
end that… 
experience” P2 
once I was out 
of there, I was 
back to normal 
P3 
very little of the 
conversation on 
the ward was 
about your 
condition P4 
I always liked to 
be in the same 
place for my 
chemo P5 
. 
Personal   it kind of makes you it concentrates .       
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changes a different person at 
the end of it P1 
your mind a little 
bit P2 
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Appendix 8:  Patient Information Flyer 
INFORMATION FLYER:  Experiences of Living with Cancer – The 
Patient’s Perspective 
What is the study about? 
A research team at the University of Chester are carrying out some 
research that is investigating unmet psychosocial needs in 
Haematological Cancers and how people adjust to life after they receive 
their diagnosis.  Psychosocial needs are all of a person’s non-medical 
needs, for example wanting someone to talk to about your feelings, 
changes in the way that you might feel about yourself or more practical 
issues such as travel to and from the hospital.  
At present, the team at the university are looking to recruit participants 
to take part in focus groups, that is group interviews, to discuss what 
their psychosocial needs were at the time of the diagnosis, during their 
treatment and after the treatment has ended.  
The aim of this research is to gain a clearer understanding of what the 
priorities are relating to psychosocial need for people who have been 
diagnosed with a haematological cancer with the hope that this 
knowledge will make it easier to meet other patient’s needs in the 
future.   
 
What will happen if I indicate that I would like to be contacted by 
someone at the University of Chester? 
311 
 
If you indicate on the consent form that you would like to be contacted 
by someone at the University of Chester, then you would be agreeing to 
allow someone at the university to have your name and address so that 
an information pack could be sent to you by post. 
Saying yes to this does not mean that you are agreeing to take part in 
the study.  It simply means that you are happy for more information to 
be posted out to you.  If, when you read the information pack you 
decide not to take part that is not a problem.  You will not need to do 
anything further and the research team will remove your contact 
details from their records.   Whether or not you decide to take part in 
the study will have no impact upon your treatment at the Countess of 
Chester Hospital.  
If you have any questions, please speak to a member of the team on 
the Haematology Oncology ward.  
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Appendix 9: Consent Form 
Project Title:  Living with Cancer – Patient perspectives.  
Contact details:   
Brooke Swash 
University of Chester, 
Department of Psychology, 
Critchley Building, 
Parkgate Road, 
Chester, 
CH1 4BJ 
b.swash@chester.ac.uk 
 
Dr Nick Hulbert-Williams 
University of Chester, 
Department of Psychology, 
Critchley Building, 
Parkgate Road, 
Chester, 
CH1 4BJ 
n.hulbertwilliams@chester.ac.uk 
 PLEASE INITIAL BOX 
1. I confirm that I have read and understood the 
information sheet and that I have had the 
opportunity to ask questions. 
 
 
2. I understand that my participation is voluntary 
and that I am free to withdraw at any time, 
without giving reason.  I understand that if I leave 
part-way through the focus group, then my data 
may still be used.  
 
 
3. I agree to take part in the above study.  
 
 
 
4. I agree to the focus group being audio recorded.  
 
 
 
5. I agree to anonymised quotations being used in 
publications. 
 
6. I understand that information shared within the 
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focus group is to be treated as confidential.  
  
  
 
 
Name of Participant    Date    Signature 
 
 
 
 
Name of Researcher    Date    Signature 
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Appendix 10:  Study Invitation Letter 
INVITATION TO TAKE PART IN A FOCUS GROUP –  
‘Living with Cancer – Patient perspectives’ 
Dear                                     , 
I am writing to you from the University of Chester.  I am a PhD student carrying out 
research looking the unmet psychosocial needs experienced by people with 
haematological cancers.  I am writing to invite you to take part in a focus group that 
will be running in Chester.  The aim of the focus groups is to learn people’s opinions 
regarding their experiences of need during their illness and what they feel is 
important at this time.  Your views and ideas would be very valuable and will be 
used to help change and improve how needs are met for people with 
haematological cancer in the future.   
I have included an information sheet that will hopefully answer all of the questions 
that you may have about the study.  
If you can, please take a moment to read through the information that is attached 
and if you feel that this is something that you would be interested in being involved 
in, then please return the participant consent form in the pre-paid envelope.  
Should you wish to take part, then details of when and where the focus group will 
be held will be sent to you.  
I would like to thank you for taking the time to read this later and the 
accompanying information, 
Yours sincerely, 
Brooke Swash 
University of Chester, 
Department of Psychology, 
Chritchley Building, 
Parkgate Road, 
Chester, 
CH1 4BJ 
315 
 
Appendix 11: Patient Information Sheet 
INFORMATION SHEET  
Study Title:   Living with Cancer – Patient and professional perspectives.  
You are being invited to take part in a research study. Before deciding whether or 
not you would like to take part, it is important that you understand why the study is 
being done and what your participation would involve.  Please take some time to 
read the following information carefully. 
What is the purpose of the study? 
Receiving a diagnosis of cancer and all that comes after this is often a very 
distressing time.  Unmet psychosocial needs are all of the non-medical needs that 
may arise concerning a person’s practical, emotional, psychological and supportive 
needs.  This can include anything from wanting someone to talk to about how you 
are feeling to more practical concerns such as childcare or transport to and from 
the hospital.  Existing research shows that meeting these psychosocial needs can be 
really important for helping a person get through such a difficult time.   
This study aims run a series of focus groups with people who either have a 
diagnosis of a haematological cancer or who are now in remission and with the 
healthcare professionals who care for them to find out more about the unmet 
psychosocial needs that are the most important and relevant to them.   
Why have I been invited to take part? 
During an appointment with your medical team at the Countess of Chester Hospital, 
you were given some information about this study and indicated that you were 
happy to be contacted with more information regarding the study.  If you have 
changed your mind about wanting to take part, then please refer to the next 
section.  
Do I have to take part? 
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No.  It is entirely up to you whether or not you would like to take part in this study. 
Choosing to take part will have no impact upon any further treatment or follow up 
that you may have scheduled at the Countess of Chester hospital and details of 
your participation are completely confidential.  If you decide that you do not wish 
to participate then the research team will remove your contact details from their 
records and you will not be contacted again.  
If you do decide that you would like to take part and then change your mind, then 
you are free to withdraw. If you start to take part in the focus group but then feel 
that you would like to leave, that is OK too but please be aware that we may still 
analyse the part of the discussion that you have already taken part in.  
Unfortunately, we can’t avoid this as it may impact on our ability to include what 
other participants have said during the discussion.  Also, you do not have to answer 
any question that you don’t want to.   
What will taking part involve? 
If you do decide to take part then you will be invited to attend a focus group.  
Hopefully we will be able to coincide the timing of the focus groups with 
participant’s existing clinic visits at the Countess of Chester Hospital.  The purpose 
of the focus group will be to allow people to talk about their needs throughout their 
illness and to discuss the importance of different needs.  We will be focussing on 
the psychosocial aspects of needs rather than the medical issues.  If at any point 
you do not wish to answer a question then you are under no obligation to do so.    
The focus groups will be audio recorded so that transcripts of the conversations can 
be written up afterwards.  The transcripts of the focus groups will then be analysed 
to determine which psychosocial needs have been identified during the focus 
groups and which were felt to be the most important.  
What are the possible benefits of taking part? 
There will be no direct benefits to you from taking part.  What this study aims to do 
is to improve our understanding of unmet psychosocial needs in haematological 
cancer patients so that these needs can be better met for others in the future.  
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What are the possible disadvantages of taking part? 
While we hope that these focus groups will be a positive experience that will allow 
you to look back and reflect on your experiences with others, we also understand 
that talking about being ill and what that was like with other people may be 
upsetting.  Before agreeing to take part, you should consider whether you feel that 
discussing your illness and your needs during this time is something that you would 
feel able to do.    
There are the time implications of taking part, it is expected that the focus group 
will last approximately 60 minutes, although it may take a little longer.  If we are 
unable to hold the focus group on a day when you are visiting the hospital for a 
clinic visit, then we will reimburse your travel expenses. 
What should I do if I want to take part? 
A participant consent form has also been included in this pack.  If you would like to 
take part, please complete this form and return it in the envelope provided.  
Confidentiality  
The data provided by you will only be used for the purposes of this study.  
Information will be stored securely and confidentially and in any reports, papers or 
write ups you will remain entirely anonymous.  All data will be stored in accordance 
with the Data Protection Act and University Research policies.  Once analysis is 
completed, the transcripts of the focus groups will be kept on a password protected 
CD in secure university archives.  Paper based documents will also be kept securely 
within the university.  All archived research data will be confidentially destroyed 
after ten years.   
Who is organising and funding the study? 
The research is being organised and carried out by a research team based at the 
University of Chester.  The lead researcher is Brooke Swash although the team also 
includes Dr Nick Hulbert-Williams and Professor Ros Bramwell at the University of 
Chester and Dr Edwin Lee at the Countess of Chester Hospital.  The research is 
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being funded by both the University of Chester and the Countess of Chester 
Hospital NHS Foundation Trust.  
Who has reviewed this study? 
Ethical approval has been sought from both the University of Chester and NRES 
(NHS ethics).  Local research governance approval has been sought from the 
Countess of Chester NHS Foundation Trust.  
What if something goes wrong? 
If you have any concerns or complaints regarding this study, please contact the 
Head of Department, Department of Psychology, University of Chester, or the 
Patient Advice and Liaison Service (PALS) at the Countess of Chester Hospital. 
What will happen to the results of the study? 
This study is part of a PhD project being completed at the University of Chester and 
will be written up as part of the thesis.  In addition, the results will be written up as 
a research paper that will be submitted for publication within health psychology 
and cancer-related academic journals.  In all cases, participants will remain 
anonymous.  If you would like a summary of the results, please contact Brooke 
Swash via the contact details below.  
Contact details for further information: 
Brooke Swash 
 
University of Chester, 
Department of Psychology, 
Critchley Building, 
Parkgate Road, 
Chester, 
CH1 4BJ 
b.swash@chester.ac.uk 
Dr Nick Hulbert-Williams 
University of Chester, 
Department of Psychology, 
Critchley Building, 
Parkgate Road, 
Chester, 
CH1 4BJ 
n.hulbertwilliams@chester.ac.uk 
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I would like to thank you for taking the time to read this information sheet.  Please 
keep this sheet for future reference. 
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Appendix 12:  Demographic Questionnaire 
Please complete the following questionnaire by circling the appropriate answer: 
1. Are you: Male  Female 
 
2. What is your age range?: 18-30  31-40  41-50 
 51-60     61-70  71-80 
 81-90  90+ 
 
3. Which of the following best describes you:     
          
    Employed full-time  Employed part-time  Self-
employed         Retired    Full-time education 
 Other    Not employed (seeking work)  
 Not employed (ill health) 
 
4. Do you care for any dependants?:  One Two   Three        Three+ 
 
5. Are you:         
          
           White  Black-African  Black-Caribbean 
 Asian-Indian Asian-Pakistani  Asian-Bangladeshi 
 Chinese           Other (please 
specify)…………………………………………………… 
 
6. What type of cancer were you diagnosed 
with?.......................................................... 
 
7. How long ago did you receive your 
diagnosis?............................................................. 
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8. What treatments did you 
receive?.............................................................................................................
.............. 
 
 
Thank You 
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Appendix 13: Ethical approval letter 
Part of the research infrastructure for Wales funded by the National Institute for Social Care and Health Research, Welsh Government. 
Yn rhan o seilwaith ymchwil Cymru a ariannir gan y Sefydliad Cenedlaethol ar gyfer Ymchwil Gofal Cymdeithasol ac Iechyd, 
Llywodraeth Cymru 
Cynhelir Cydweithrediad Gwyddor Iechyd Academaidd y Sefydliad Cenedlaethol ar 
gyfer Ymchwil Gofal Cymdeithasol ac Iechyd gan Fwrdd Addysgu Iechyd Powys 
The National Institute for Social Care and Health Research Academic Health Science 
Collaboration is hosted by Powys Teaching Health Board 
 
North Wales REC (Central & East) 
G1/G2 Croesnewydd Hall 
Croesnewydd Road 
Wrexham Technology Park 
Wrexham LL13 7YP 
Telephone : 01978 726377 
E-mail : tracy.biggs@wales.nhs.uk 
Website : www.nres.nhs.uk 
 
03 January 2013 
Miss Brooke E Swash 
PhD Student 
University of Chester 
University of Chester, Department of Psychology, 
Chritchley Building, Parkgate Road, 
Chester 
CH1 4BJ 
 
Dear Miss Swash 
Study title: Unmet psychosocial needs and their role in 
psychological adjustment to a diagnosis of 
haematological cancer: A comparison between 
treatment subgroups. 
REC reference: 12/WA/0366 
IRAS project ID: 108725 
Thank you for your letter of 2 January 2013. I can confirm the REC has received the 
documents listed below and that these comply with the approval conditions detailed 
in our 
letter dated 21 December 2012 
 
Documents received 
The documents received were as follows: 
Document Version Date 
Participant Information Sheet 3 02 January 2013 
Approved documents 
The final list of approved documentation for the study is therefore as follows: 
Document Version Date 
Covering Letter 19 November 2012 
Covering Letter 12 December 2012 
Evidence of insurance or indemnity 09 July 2012 
GP/Consultant Information Sheets 1 13 November 2012 
GP/Consultant Information Sheets 1 13 November 2012 
Investigator CV 19 November 2012 
Investigator CV 
Investigator CV 
Letter from Sponsor 13 November 2012 
Letter of invitation to participant 2 07 December 2012 
Participant Consent Form 1 13 November 2012 
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Participant Information Sheet 3 02 January 2013 
Protocol 2 12 December 2012 
Questionnaire: HADS 
Questionnaire: Mini-MAC Scale 
Questionnaire: QLQ-C30 
Questionnaire: SCNS-SF34 
Questionnaire: SDI 
Questionnaire: Brief COPE 
Questionnaire: Benefit Finding 
Questionnaire: Survey of cancer patient's needs 
Questionnaire: Demographic Questionnaire 1 19 November 2012 
REC application 1 21 November 2012 
Response to Request for Further Information 12 December 2012 
Summary/Synopsis 1 13 November 2012 
You should ensure that the sponsor has a copy of the final documentation for the 
study. It is 
the sponsor's responsibility to ensure that the documentation is made available to 
R&D 
offices at all participating sites. 
 
12/WA/0366 Please quote this number on all correspondence 
 
Yours sincerely 
Mrs Tracy Biggs 
Committee Coordinator 
 
E-mail: tracy.biggs@wales.nhs.uk 
 
Copy to: Mark Helsdon, University of Chester 
Ms Sheila Williams, Countess of Chester Hospital NHS Foundation Trust 
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Appendix 14: Participant Information Sheet 
Adjusting to a diagnosis of cancer: Treatment group differences. 
You are being invited to take part in a research study.  Before deciding whether or 
not you would like to take part, it is important that you understand the purpose of 
the study and what taking part would involve.  Please take some time to read 
through the following information.   
What is the purpose of this study? 
Receiving a diagnosis of cancer can sometimes be difficult and upsetting.   Many 
people will find ways of managing and of coping with illness, however, for some 
people it will have a negative impact upon their life and their sense of wellbeing.  
This study aims to assess how people respond to their diagnosis, and how this 
changes over time in people who have been recently diagnosed with 
haematological cancer.  We are trying to better understand the factors that cause 
distress and who is most at risk of experiencing distress after their diagnosis.  
Having a greater understanding of how people adjust to a new diagnosis would 
mean that in the future we will be better able to prevent people from experiencing 
distress by providing more efficient support to those who need it most. 
Why have I been invited to take part? 
We are recruiting people from several hospitals in the North West of England and 
North Wales who have been recently diagnosed with haematological cancer to take 
part in this survey about adjusting to your diagnosis.   
Do I have to take part? 
No.  It is entirely up to you whether or not you would like to take part in this study.  
Choosing to take part will have no impact upon any further treatment or follow up 
that you may have scheduled at your hospital and details of your participation are 
completely confidential.    
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If you do decide to take part and then later change your mind, then you are free to 
withdraw from the study at any time.   
What will taking part involve? 
If you do decide to take part, then you will be invited to complete a questionnaire 
on two separate occasions that will contain questions about your life and how 
things might have changed upon receiving your diagnosis.  We will post out the first 
questionnaire as soon as you agree to take part in this study and the second 
questionnaire will be posted out to you three months later.   The questionnaire can 
be filled in in your own time, at home.   
Please be aware that the questionnaire you will be asked to complete contains 
questions that were developed for general cancer groups and therefore some 
questions may not be directly relevant to your situation.  If you feel that any of the 
questions asked are not relevant to you, then simply highlight as not relevant.  This 
is fine and will still be very useful to us when we analyse the results of this study.    
We will be asking for your GP contact details on the demographic questionnaire 
included within this information pack.  This is so that we can inform your GP that 
you are a participant in this study.  We will also be contacting your GP before we 
send out the second questionnaire to confirm continued eligibility.   
We may require access to your medical records.  This is to allow us to confirm the 
diagnosis and treatments received by participants.  We will be accessing your 
records for demographic data only and this will be treated with the utmost 
confidentiality.   
What should I do if I want to take part? 
A participant consent form has been included in this pack.  If you would like to take 
part, please complete the form and return it in the envelope provided.  
Confidentiality 
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The data provided by you will only be used for the purposes of this study.  
Information will be stored securely and confidentially and in any reports, papers or 
write ups you will remain entirely anonymous.  All data will be stored in accordance 
with the Data Protection Act and with University Research policies.  All electronic 
data and analysis will be maintained on secure university computers.  Once analysis 
is completed, data will be kept on a password protected CD in secure university 
archives.  All paper documents will also be kept securely within the university.  All 
archived research data will be confidentially destroyed after ten years.  
What happens if my questionnaire indicates that I might benefit from more help 
from my hospital’s support services? 
In rare cases, a participant’s returned questionnaire may indicate that they are 
experiencing considerable distress as a result of their illness.  If this were to happen, 
then the research team would have a duty of care to ensure that the participant is 
offered some extra support.  The research team would therefore use the 
identification number at the top of your questionnaire to find the participant’s 
name and contact details.  The research team would then get in touch with the 
Consultant at the hospital to discuss how to support the participant.  Further 
support could range from informal advice from your Consultant to a referral to your 
hospital’s psychological support services.   
Who is organising and funding the study? 
The research is being organised and carried out by a research team based at the 
University of Chester.  The lead researcher is Brooke Swash although the team also 
includes Dr Nick Hulbert-Williams and Professor Ros Bramwell.  The research is 
being funded by both the University of Chester and the Countess of Chester 
Hospital NHS Foundation Trust. 
Who has reviewed this study? 
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Ethical approval has been sought from both the University of Chester and by the 
North Wales REC (Central and East).  Local research governance approval has been 
sought at each of the participating hospitals.   
What if something goes wrong? 
If you have any concerns or complaints regarding this study, please contact the 
Head of Department, Department of Psychology, University of Chester, or the 
Patient Advice and Liaison Service (PALS) at your treating hospital.  
What will happen to the results of the study? 
This study is part of a PhD project being completed at the University of Chester and 
will be written up as part of the thesis.  In addition, the results will be written up as 
part of a research paper that will be submitted for publication within relevant 
academic journals.  In all cases, participants will remain anonymous.  If you would 
like a summary of the results, please contact Brooke Swash via the contact details 
provided below.   
Contact details for further information: 
Brooke Swash 
University of Chester, 
Department of Psychology, 
Critchley Building, 
Parkgate Road, 
Chester, 
CH1 4BJ 
b.swash@chester.ac.uk 
 
07827807466 
Dr Nick Hulbert-Williams 
University of Chester, 
Department of Psychology, 
Critchley Building, 
Parkgate Road, 
Chester, 
CH1 4BJ 
n.hulbertwilliams@chester.ac.uk 
 
 
I would like to thank you for taking the time to read this information sheet.  Please 
keep this sheet for future reference. 
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Appendix 15: Participant Consent Form 
Study - Adjusting to a diagnosis of cancer: Treatment group differences.    
Contact details:   
Brooke Swash 
University of Chester, 
Department of Psychology, 
Critchley Building, 
Parkgate Road, 
Chester, 
CH1 4BJ 
b.swash@chester.ac.uk 
01244 5133179 
 
Dr Nick Hulbert-Williams 
University of Chester, 
Department of Psychology, 
Critchley Building, 
Parkgate Road, 
Chester, 
CH1 4BJ 
n.hulbertwilliams@chester.ac.uk 
 PLEASE INITIAL BOX 
7. I confirm that I have read and understood the 
information sheet and that I have had the 
opportunity to ask questions. 
 
 
8. I understand that my participation is voluntary and 
that I am free to withdraw at any time, without 
giving reason.   
 
 
9. I agree to take part in the above study. 
 
10. I understand that if my questionnaire indicates 
any cause for concern, then the research team 
may contact my hospital in order to discuss this 
further.  
 
11. I consent to allow the research team access to key 
information about my diagnosis and treatment 
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from my medical records. 
 
12. I consent to allow the research team to contact 
my GP regarding my involvement in the study. 
  
 
 
  
 
 
Name of Participant    Date    Signature 
 
 
 
 
Name of Researcher    Date    Signature 
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Appendix 16: Debrief Sheet 
Adjusting to a diagnosis of cancer: Treatment group differences.  
 
Dear …….………., 
On behalf on the research team, I am writing to thank you for taking the time to 
participant in our research study.  You contributions are greatly valued.  You are not 
required to do anything further or to provide any further information. 
If you would like to receive a general summary of the results then please do let us 
know and we will be happy to provide this for you.  At present, the data generated 
by the questionnaires is being analysed and we are confident that the information 
that you and your fellow participants were able to share with us will greatly 
contribute towards our understanding of psychological health and wellbeing after 
receiving a cancer diagnosis.   
I would like to assure you that all of your personal details and the information that 
you gave us will be treated confidentially and all identifying information will be 
removed in our study write up.  
Please feel free to contact us if you have any further questions about the study.  
Any questions or concerns that you may have relating to your medical condition or 
treatment would be best addressed to your GP or the cancer team at the hospital 
where you were treated. 
Cancer can cause a great deal of distress and confusion both at the time of 
diagnosis and even after treatment has finished.  If you think that talking to 
someone about your experiences may be of benefit to you, the following telephone 
numbers might be helpful: 
Macmillan Cancer Support: 0808 808 0000 
Cancer Help UK: 0808 800 4040 
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The Samaritans: 08457 909090 
 
Once again, I would like to thank you for taking part in our research.  We wish you 
all the very best in the future. 
Brooke Swash 
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Appendix 17:  Letter to GP 
Dear [GP name], 
I am writing to inform you that your patient, [insert name], has consented to take part in a 
research study, ‘Adjusting to a diagnosis of cancer: Treatment group differences.’, being 
run by the University of Chester.  You do not need to do anything at this time. 
Patient name: 
This study is investigating psychological adjustment to receiving a diagnosis of 
haematological cancer, forming comparisons between those receiving active treatment and 
those monitored on a ‘watch and wait’ regime. 
There will be no changes to your patient’s treatment or follow up as a result of their 
participation in our study.  Participation will involve the completion of a questionnaire both 
at the time of diagnosis and at a three month follow up. 
In order to satisfy ethical requirements, we will need to contact you prior to the completion 
of the follow up questionnaire to confirm that your patient is still eligible to take part.   
If you have any questions regarding the study, please do not hesitate to get in touch. 
With best wishes, 
Brooke Swash 
Gladstone Fellowship Psychology PhD Student 
University of Chester 
Department of Psychology 
Chritchley Building 
Parkgate Road 
Chester 
CH1 4BJ 
 
Phone: 01244 513179 
Email: b.swash@chester.ac.u 
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Appendix 18:  Follow-up Letter to GP 
Dear [GP name], 
Following on from my letter dated [insert date] regarding [patient name] involvement in 
the study “Adjusting to a diagnosis of cancer: Treatment group differences”, I am writing 
to you to confirm this person’s continued eligibility to take part in this study.  We require 
that participants are alive and have a life expectancy of over two weeks. 
Please let us know if you feel that this patient’s continued involvement in this would not be 
appropriate and the reason(s) for this.    
Potential reasons for exclusion: 
 This person is not expected to survive more than two weeks; 
 This person is too ill to take part; 
 This person is known to have died; 
 Any other reason. 
 
With best wishes, 
Brooke Swash 
University of Chester, 
Department of Psychology, 
Chritchley Building, 
Parkgate Road, 
Chester, 
CH1 4BJ 
 
b.swash@chester.ac.uk 
01244 513179 
 
……………………………………………………………………………………………………………………………………………
……………… 
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(Please remove this slip and return in the pre-paid envelope.) 
Patient name: 
This person remains eligible for inclusion in the study ‘Adjusting to a diagnosis of cancer: 
Treatment group differences’. 
Yes 
No 
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Appendix 19:  Microsoft Word version of study questionnaire (as completed by participants) 
Please complete the following questionnaire by putting an X in the box for the appropriate answer: 
 
Are you: Male   Female               
 
What is your age range:  18-30  31-40   41-50   51-60   
61-70   71-80   81-90   90+            
 
Which of the following best describes you:   Employed full-time   Self-employed 
Full-time education   Not employed (ill health)   Employed part-time 
Retired    Not employed (seeking work)  Other 
 
Do you care for any dependents?: No       One        Two   Three   Three+ 
 
Are you:  White  Black-Caribbean  Asian-Pakistani  Chinese 
     Black-African Asian-Indian   Asian-Bangladeshi  Other 
 
What type of cancer were you diagnosed with?.…………………………………………………………………………………………… 
How long ago did you receive your diagnosis?................................................................................................... 
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Have you received treatment for your diagnosis?    
  Yes  Please specify…………………………………………………………………………………………………. 
  No, I am being monitored on ‘Watch and Wait’ 
 
Please could you provide us with your GP’s name and address: 
……………………………………………………………………………………………………………………………………………………………………… 
……………………………………………………………………………………………………………………………………………………………………… 
……………………………………………………………………………………………………………………………………………………………………… 
(SCNS SF34) To help us plan better services for people diagnosed with cancer, we are interested in 
whether or not need which you may have faced as a result of having cancer have been met.  For every 
item on the following pages, indicate whether you have needed help with this issue within the last 
month as a result of having cancer.  Put a X in the box which best describes whether you have needed 
help with this in the last month.  There are five possible answers: 
1. Not applicable – This was not a problem for me as a result of having cancer. 
2. Satisfied – I did need help with this, but my need was satisfied at the time. 
3. Low need – This item caused me concern or discomfort.  I had little need for additional help. 
4. Moderate need – This item caused me concern or discomfort.  I had some need for additional 
help. 
5. High need – This item caused me concern or discomfort.  I had a strong need for additional help. 
 
 1 2 3 4 5 
Pain      
Lack of energy / tiredness      
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Feeling unwell a lot of the time      
Work around the home      
Not being able to do the things you used to      
Anxiety      
Feeling down or depressed      
Feelings of sadness      
Fears about the cancer spreading      
Worry that the results of treatment are beyond your control      
Uncertainty about the future      
Learning to feel in control of your sitation      
Keeping a positive outlook      
Feelings about death and dying      
Changes in sexual feelings      
Changes in your sexual relationships      
Concerns about the worries of those close to you      
More choice about which cancer specialists you see      
More choice about which hospital you attend      
Reassurance by medical staff that the way you feel is normal      
Hospital staff attending promptly to your physical needs      
Hospital staff acknowledging, and showing sensitivity to, your feelings 
and emotional needs 
     
Being given written information about the important aspects of care      
338 
 
Being given information (written, diagrams, drawings) about aspects 
of managing your illness and side effects at home 
     
Being given explanations for those tests for which you would like 
explanations 
     
Being adequately informed about the benefits and side-effects of 
treatments before you choose to have them 
     
Being informed about your test results as soon as feasible      
Being informed about cancer that is under control or diminishing 
(that is, remission) 
     
Being informed about things you can do to help yourself get well      
Having access to professional counselling (e.g. psychologist, social 
worker, counsellor, nurse specialist) if you, family or friends need it 
     
Being informed about sexual relationships      
Being treated like a person not just another case      
Being treated in a hospital or clinic that is as physically pleasant as 
possible 
     
Having one member of staff with whom you can talk about all aspects 
of your condition, treatment and follow-up 
     
 
(HADS) This questionnaire is designed to help us know how you are feeling.  Read each one and tick the 
reply which comes closest to how you have been feeling IN THE PAST WEEK.   
Don’t take too long over your replies; your immediate reaction to each item will probably be more 
accurate than a long thought-out response. 
I feel tense or wound up:  
Most of the time  A lot of the time  From time to time  Not at all 
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I still enjoy the things I used to: 
Definitely as much  Not quite as much  Only a little  Hardly at all 
I get a sort of frightened feeling as if something awful is about to happen: 
Very definitely and quite badly  Yes, but not too badly    
A little, but it doesn’t worry me  Not at all 
I can laugh and see the funny side of things: 
As much as I always could  Not quite so much now  Definitely not so much now 
Not at all  
Worrying thoughts go through my mind: 
A great deal of the time  A lot of the time  From time to time, but not often  
Only occasionally 
I feel cheerful:  
Not at all  Not often  Sometimes O Often 
I can sit at ease and feel relaxed: 
Definitely  Usually  Not often  Not at all 
I feel as if I am slowed down: 
Nearly all the time  Very often  Sometimes  Not at all 
I get a sort of frightened feeling like “butterflies” in the stomach: 
Not at all  Occasionally    Quite often  Very often 
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I have lost interest in my appearance: 
Definitely  I don’t take as much care as I should  I may not take quite as much care 
I take just as much care 
I feel restless as if I have to be on the move: 
Very much indeed  Quite a lot  Not very much     Not at all 
I look forward with enjoyment to things: 
As much as I ever did  Rather less than I used to  Definitely less than I used to 
Hardly at all 
I get sudden feelings of panic: 
Very often indeed  Quite often  Not very often  Not at all 
I can enjoy a good book or radio/TV programme: 
Often  Sometimes  Not often  Very seldom 
 
 
 
(EORTC QLQ-C30) We are interested in some things about you and your health, please answer all 
questions yourself by ticking the response that best applies to you, there are not ‘right’ or ‘wrong’ 
answers.   
 Not at all A little Quite a 
bit 
Very 
much 
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Do you have any trouble doing strenuous activities like 
carrying a heavy shopping bag or a suitcase? 
    
Do you have any trouble taking a long walk?     
Do you have any trouble taking a short walk outside of the 
house? 
    
Do you need to stay in bed or a chair during the day?     
Do you need help with eating, dressing, washing yourself or 
using the toilet? 
    
DURING THE PAST WEEK     
Were you limited in doing either your work or other daily 
activities? 
    
Were you limited in pursuing your hobbies or other leisure 
time activities? 
    
Were you short of breath?     
Have you had pain?     
Did you need rest?     
Have you had trouble sleeping?     
Have you felt weak?     
Have you lacked appetite?     
Have you felt nauseated?     
Have you vomited?     
Have you been constipated?     
Have you had diarrhoea?     
Were you tired?     
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Did pain interfere with your daily activities?     
Have you had difficulty in concentrating on things, like 
reading a newspaper or watching the television? 
    
Did you feel tense?     
Did you worry?     
Did you feel irritable?     
Did you feel depressed?     
Have you had difficulty remembering things?     
Has your physical condition or medical treatment interfered 
with your family life? 
    
Has your physical condition or medical treatment interfered 
with your social activities? 
    
Has your physical condition or medical treatment caused 
you financial difficulties? 
    
     
 
 
For the following questions please tick the number that best applies to you: 
How would you rate your overall health during the past week? 
1  2  3  4  5  6  7 
Very poor               Excellent 
 
How would you rate your overall quality of life during the past week: 
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1  2  3  4  5  6  7 
Very poor               Excellent 
 
 
 
 
 
 
 
A number of statements are given below which best describe people’s reactions to having cancer.  
Please tick the box to the right of each statement, indicating how far it applies to you at present. 
 Definitely does 
NOT apply to me 
Does NOT 
apply to me 
Applies to 
me 
Definite
ly 
applies 
to me 
At the moment I take one day at a time     
I see my illness as a challenge     
I’ve put myself in the hands of God     
I feel like giving up     
I feel very angry about what has happened 
to me 
    
I feel completely at a loss about what to 
do 
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It is a devastating feeling     
I count my blessings     
I worry about the cancer returning or 
getting worse 
    
I try to fight the illness     
I distract myself when thoughts about my 
illness come into my head 
    
I can’t handle it     
I am apprehensive     
I am not very hopeful about the future     
I feel there is nothing I can do to help 
myself 
    
I think it is the end of the world     
Not thinking about it helps me cope     
I am very optimistic     
I’ve had a good life and what’s left is a 
bonus 
    
I feel that life is hopeless     
I can’t cope     
I am upset about having cancer     
I am determined to beat this illness     
Since my cancer diagnosis I now realise 
how precious life is and I’m making the 
most of it 
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I have difficulty believing that this 
happened to me 
    
I make a positive effort not to think about 
my illness 
    
I deliberately push all thoughts of cancer 
out of my mind 
    
I suffer great anxiety about it     
I am a little frightened      
 
 
 
 
 
 
(Benefit Finding) Cancer patients sometimes feel that having cancer makes contributions to their lives, as 
well as causing problems.  Indicate how much you agree with the following. 
Having had cancer… 
 Not at 
all 
A little Moderately Quite a 
bit 
Extremely 
Has lead me to be more accepting of things      
Has taught me to adjust to things I cannot 
change 
     
Has helped me take things as they come      
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Has brought my family closer together      
Has made me more sensitive to family issues      
Has taught me that everyone has a purpose in 
life 
     
Has shown me that all people need to be loved      
Has made me realise the importance of 
planning for my family’s future 
     
Has made me more aware and concerned for 
the future of all human beings 
     
Has taught me to be patient      
Has lead me to deal better with stress and 
problems 
     
Has lead me to meet people who have become 
some of my best friends 
     
Has contributed to my overall emotional and 
spiritual growth 
     
Has helped me to become more aware of the 
love and support available from other people 
     
Has helped me realise who my real friends are      
Has helped me become more focussed on 
priorities, with a deeper sense of purpose in 
life 
     
Has helped me to become a stronger person, 
more able to cope effectively with future life 
challenges 
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(SDI 21) Sometimes people who have, or have had cancer find that they have a number of everyday 
difficulties to cope with following their diagnosis.  These may be to do with things like their family life, 
social activities, finances and work.  We are interested in finding out what difficulties and problems 
patients have to cope with.  Only when we find out the range and depth of these difficulties can we 
begin to make plans for giving support to patients who need it. 
1. Please answer each question carefully and tick the response that best describes your answer. 
2. Please answer each question as honestly as possible. 
3. If you are not completely sure which answer is most accurate, tick the box which you feel is most 
appropriate. 
4. Please tick the ‘no difficulty’ box if a question does not apply to you. 
5. Please do not spend too long on each statement. 
During the PAST MONTH: 
 No 
difficulty 
A little Quite a bit Very much 
Have you had any difficulty in maintaining your 
independence? 
    
Have you had any difficulty in carrying out your 
domestic chores? (e.g. cleaning, gardening, cooking, 
shopping) 
    
Have you had any difficulty managing your own 
personal care? (e.g. bathing, washing, dressing) 
    
Have you had any difficulty with looking after those 
who depend on you? (e.g. children, dependent adults, 
pets) 
    
Have any of those close to you (e.g. partner, children, 
parents) had any difficulty with the support available 
to them? 
    
Have you had any difficulties with benefits? (e.g. 
statutory sick pay, attendance allowance, disability 
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living allowance) 
Have you had any financial difficulties?     
Have you had any difficulty with financial services? 
(e.g. loans, mortgages, pensions, insurance) 
    
Have you had any difficulty concerning your work? (or 
education if you are a student) 
    
Have you had any difficulty planning for your own or 
your family’s future? (e.g. care of dependents, legal 
issues, business affairs) 
    
Have you had any difficultly with communicating with 
those closest to you? (e.g. partner, children, parents) 
    
Have you had any difficulty with communicating with 
others? (e.g. friends, neighbours, colleagues, dates) 
    
Have you had any difficulty concerning sexual 
matters? 
    
Have you had any difficultly concerning plans to have 
a family? 
    
Have you had any difficultly concerning your body 
image? 
    
Have you felt isolated?     
Have you had any difficulty getting around? (e.g. 
transport, car parking, your mobility) 
    
Have you had any difficulty with where you live? (e.g. 
space, access, damp, heating, neighbours, security) 
    
Have you had any difficulty with carrying out your 
recreational activities (e.g. hobbies, pastimes, social 
pursuits) 
    
Have you had any difficulty with your plans to travel 
or take a holiday? 
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Have you had any difficulty with any other area of 
your everyday life? 
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Appendix 20: Study Advertisement 
Would you be willing to take part in a research 
study? 
 
We are a research team based at the University of Chester and are looking for people to take part 
in a research study on the wellbeing of people living with haematological cancer.  The study is 
part of a PhD project that is investigating the unmet needs of people who have had a diagnosis of 
haematological cancer and how living with cancer affects a person’s wellbeing and their everyday 
life. 
 
Taking part in the study will involve completing a questionnaire about your needs, concerns and 
wellbeing.   
 
If you are: 
 
a) over the age of 16 and; 
 
b) received a diagnosis of lymphoma, leukaemia or myeloma 18 months or more ago, then we would 
love to hear from you! 
 
For more information or to receive the questionnaire by post you can contact the research team via 
the contact details below.  You can also complete the questionnaire online by going to the web 
address listed below. 
 
Brooke Swash 
University of Chester 
Department of Psychology 
Chritchley Building 
Parkgate Road, 
Chester CH1 4BJ 
 
Phone: 07827 807466 
 
Email: b.swash@chester.ac.uk 
 
Web address: http://formicweb.chester.ac.uk/webforms/?TAG=Longtermpsychologicaladjustment 
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Appendix 21: Questionnaire 
The AAQ-II is presented below.  The SCNS SF34, HADS and EORTC QLQ-C30 can be found under 
Appendix 19. 
AAQ-2 
 
Below you will find a list of statements. Please rate how true each statement is for you by circling a 
number next to it. Use the scale below to make your choice.  
 
1 2 3 4 5 6 7 
never 
 true 
very seldom 
true 
seldom  
true 
sometimes  
true 
frequently  
true 
almost 
always true 
always  
true 
       
1. Its OK if I remember something unpleasant. 1 2 3 4 5 6 7 
2. My painful experiences and memories make it difficult for me to 
live a life that I would value. 
1 2 3 4 5 6 7 
3. I’m afraid of my feelings. 1 2 3 4 5 6 7 
4. I worry about not being able to control my worries and feelings. 1 2 3 4 5 6 7 
5. My painful memories prevent me from having a fulfilling life. 1 2 3 4 5 6 7 
6. I am in control of my life. 1 2 3 4 5 6 7 
7. Emotions cause problems in my life. 1 2 3 4 5 6 7 
8. It seems like most people are handling their lives better than I 
am. 
1 2 3 4 5 6 7 
9. Worries get in the way of my success. 1 2 3 4 5 6 7 
10. My thoughts and feelings do not get in the way of how I want to 
live my life. 
1 2 3 4 5 6 7 
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Appendix 22: Debrief Sheet 
 
Dear …….………., 
On behalf on the research team, I am writing to thank you for taking the time to 
participate in our research study.  You contributions are greatly valued.  You are not 
required to do anything further or to provide any further information. 
If you would like to receive a general summary of the results then please do let us know 
and we will be happy to provide this for you.  At present, the data generated by the 
questionnaires is being analysed and we are confident that the information that you and 
your fellow participants were able to share with us will greatly contribute towards our 
understanding of the psychological health and wellbeing of people living with a diagnosis 
of cancer.   I would also like to assure you that all of the information that you gave us 
will be treated confidentially.  
Please feel free to contact us if you have any further questions about the study.  Any 
questions or concerns that you may have relating to your medical condition or 
treatment would be best addressed to your GP or the cancer team at the hospital where 
you were treated. 
Cancer can cause a great deal of distress and confusion no matter how long ago a 
diagnosis was given.  If you think that talking to someone about your experiences may 
be of benefit to you, the following telephone numbers might be helpful: 
Macmillan Cancer Support: 0808 808 0000 
Cancer Help UK: 0808 800 4040 
The Samaritans: 08457 909090 
Once again, I would like to thank you for taking part in our research.  We wish you all the 
very best in the future. 
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Appendix 23: Patient Information Sheet 
Long-term Psychological Adjustment in Haematological Cancer Patients. 
You are being invited to take part in a research study.  Before deciding whether or not 
you would like to take part, it is important that you understand the purpose of the study 
and what taking part would involve.  Please take some time to read through the 
following information.   
What is the purpose of this study? 
Living with a diagnosis of cancer can sometimes be difficult and can mean that people 
find themselves adjusting to a new way of living.   Many people will find ways of 
managing and of coping with their illness, however, for some people it will have a 
negative impact upon their life and their sense of wellbeing.  This study aims to assess 
how people adjust to living with, and beyond, a diagnosis of cancer and we are trying to 
better understand the factors that cause distress.  Having a greater understanding of 
how people adjust to their diagnosis and the factors that play a role in this would mean 
that in the future we will be better able to prevent people from experiencing distress by 
providing more efficient support to those who need it most. 
Am I eligible to take part in the study? 
In order to take part in the study, you will need to match several eligibility criteria: 
 Be over the age of 18 
 Have, or have had in the past, a diagnosis of a haematological cancer (this can 
include any leukaemia, lymphoma or myeloma) 
 Have received your diagnosis at least 18 months ago. 
What will taking part involve? 
If you do decide to take part, then you will be invited to complete a questionnaire that 
will contain questions about your life, how you are feeling and general questions about 
your wellbeing.   There are two options for completing the questionnaire.  You can 
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either complete the questionnaire online by going to the web page 
http://formicweb.chester.ac.uk/webforms/?TAG=Longtermpsychologicaladjustment or 
by contacting the research team via the contact details provided at the end of this 
information sheet and a questionnaire will be sent to you via post. 
What should I do if I want to take part? 
If you would like to take part in our study, please either go the web page 
http://formicweb.chester.ac.uk/webforms/?TAG=Longtermpsychologicaladjustment or 
contact the research team via the contact details provided. 
If you any specific requirements, for example if you would like to receive the 
questionnaire in large print, then please contact Brooke Swash for an informal 
discussion. 
Confidentiality 
The data provided by you will only be used for the purposes of this study.  Information 
will be stored securely and confidentially and in any reports, papers or write ups you will 
remain entirely anonymous.  All data will be stored in accordance with the Data 
Protection Act and with University Research policies.  All electronic data and analysis will 
be maintained on secure university computers.  Once analysis is completed, data will be 
kept on a password protected CD in secure university archives.  All paper documents will 
also be kept securely within the university.  All archived research data will be 
confidentially destroyed after ten years.  
What happens if I want further support after completing the questionnaire? 
The questionnaire that you fill out will be used for research purposes only and all 
responses will be anonymous, as such the research team are not in a position to provide 
any further support or follow-up help in response to your responses. 
Some of the questions on this questionnaire will ask about how you are currently feeling 
and how well you feel that you are coping.  It is possible that thinking about these issues 
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could be upsetting or will raise some concerns for you.  If you do feel that you would 
benefit from some additional support or would like someone to talk to about your 
diagnosis, we recommend that you either arrange an appointment to see your General 
Practitioner, or, for more general support you can contact the following organisations: 
Samaritans: 08457 90 90 90 
Macmillan Cancer Support: 0808 808 0000 
Who can I speak to if I have any questions about my illness or the care that I receive? 
This study is for research purposes only, as such the research team are not able to advise 
you on your illness.  If you feel that you need to speak to someone about your condition, 
we advise that you contact your GP or the hospital where you received your treatment. 
Who is organising and funding the study? 
The research is being organised and carried out by a research team based at the 
University of Chester.  The lead researcher is Brooke Swash although the team also 
includes Dr Nick Hulbert-Williams and Professor Ros Bramwell.  The research is being 
funded by both the University of Chester and the Countess of Chester Hospital NHS 
Foundation Trust. 
Who has reviewed this study? 
Ethical approval has been sought from the University of Chester.  
What if I am unhappy about any aspect of this study? 
If you have any concerns or complaints regarding this study, please contact the Head of 
Department, Department of Psychology, University of Chester.  
What will happen to the results of the study? 
This study is part of a PhD project being completed at the University of Chester and will 
be written up as part of the thesis.  In addition, the results will be written up as part of a 
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research paper that will be submitted for publication within relevant academic journals.  
In all cases, participants will remain anonymous.   
If you would like to receive a summary of the results, please contact Brooke Swash.  In 
addition, a summary of the research will be published in Lymphoma Matters.   
Contact details for further information: 
Brooke Swash 
University of Chester, 
Department of Psychology, 
Critchley Building, 
Parkgate Road, 
Chester, 
CH1 4BJ 
b.swash@chester.ac.uk 
07827807466 
Dr Nick Hulbert-Williams 
University of Chester, 
Department of Psychology, 
Critchley Building, 
Parkgate Road, 
Chester, 
CH1 4BJ 
n.hulbertwilliams@chester.ac.uk 
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